0001854445 false FY 0001854445 2021-07-01 2022-06-30 0001854445 2022-09-20 0001854445 2022-06-30 0001854445 2021-06-30 0001854445 2020-07-01 2021-06-30 0001854445 GGIC:SoftwareServicesMember 2021-07-01 2022-06-30 0001854445 GGIC:SoftwareServicesMember 2020-07-01 2021-06-30 0001854445 GGIC:SoftwareLicenseMember 2021-07-01 2022-06-30 0001854445 GGIC:SoftwareLicenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:CommonStockMember 2020-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001854445 us-gaap:RetainedEarningsMember 2020-06-30 0001854445 2020-06-30 0001854445 us-gaap:CommonStockMember 2021-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001854445 us-gaap:RetainedEarningsMember 2021-06-30 0001854445 us-gaap:CommonStockMember 2020-07-01 2021-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2021-06-30 0001854445 us-gaap:RetainedEarningsMember 2020-07-01 2021-06-30 0001854445 us-gaap:CommonStockMember 2021-07-01 2022-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2022-06-30 0001854445 us-gaap:RetainedEarningsMember 2021-07-01 2022-06-30 0001854445 us-gaap:CommonStockMember 2022-06-30 0001854445 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001854445 us-gaap:RetainedEarningsMember 2022-06-30 0001854445 us-gaap:IPOMember 2021-07-02 0001854445 us-gaap:IPOMember 2021-07-01 2021-07-02 0001854445 GGIC:SecurityPurchaseAgreementMember 2021-11-01 2021-11-30 0001854445 2021-11-30 0001854445 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember GGIC:TwoCustomersMember 2021-07-01 2022-06-30 0001854445 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerOneMember 2021-07-01 2022-06-30 0001854445 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerTwoMember 2021-07-01 2022-06-30 0001854445 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember GGIC:TwoCustomersMember 2020-07-01 2021-06-30 0001854445 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerOneMember 2020-07-01 2021-06-30 0001854445 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerTwoMember 2020-07-01 2021-06-30 0001854445 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember GGIC:TwoCustomersMember 2021-07-01 2022-06-30 0001854445 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerOneMember 2021-07-01 2022-06-30 0001854445 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerTwoMember 2021-07-01 2022-06-30 0001854445 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember GGIC:TwoCustomersMember 2020-07-01 2021-06-30 0001854445 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerOneMember 2020-07-01 2021-06-30 0001854445 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember GGIC:CustomerTwoMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2021-07-01 2022-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2020-07-01 2021-06-30 0001854445 us-gaap:TransferredOverTimeMember 2021-07-01 2022-06-30 0001854445 us-gaap:TransferredOverTimeMember 2020-07-01 2021-06-30 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember 2022-02-01 2022-02-01 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember 2022-02-01 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember srt:MaximumMember 2022-02-01 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember GGIC:ContingentConsiderationLiabilityMember 2022-02-01 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember srt:MaximumMember 2022-02-01 2022-02-01 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember 2022-01-01 2022-06-30 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember 2021-07-01 2022-06-30 0001854445 GGIC:MembershipInterestSaleAgreementMember GGIC:Sector5DigitalLLCMember us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2022-06-30 0001854445 2022-02-01 2022-06-30 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2021-08-01 2021-08-31 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2021-08-31 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember us-gaap:OperatingExpenseMember 2022-06-01 2022-06-30 0001854445 GGIC:XRTerraIncMember 2021-10-01 2021-10-31 0001854445 GGIC:XRTerraIncMember 2021-10-31 0001854445 GGIC:PulpoARLLCMember 2022-05-01 2022-05-31 0001854445 GGIC:PulpoARLLCMember 2022-06-01 2022-06-30 0001854445 srt:ScenarioForecastMember GGIC:PulpoARLLCMember 2022-09-01 2022-09-30 0001854445 GGIC:PulpoARLLCMember 2022-05-31 0001854445 GGIC:SectorFiveDigitalLLCMember 2021-07-01 2022-06-30 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2021-07-01 2022-06-30 0001854445 GGIC:XRTerraIncMember 2021-07-01 2022-06-30 0001854445 GGIC:PulpoARLLCMember 2021-07-01 2022-06-30 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember us-gaap:CustomerRelationshipsMember 2021-08-31 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-08-31 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2021-08-31 0001854445 GGIC:XRTerraLLCMember us-gaap:TechnologyBasedIntangibleAssetsMember 2021-10-31 0001854445 GGIC:XRTerraLLCMember 2021-10-31 0001854445 GGIC:PulpoARLLCMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-05-31 0001854445 GGIC:PulpoARLLCMember 2022-05-31 0001854445 GGIC:Sector5DigitalMember us-gaap:CustomerRelationshipsMember 2022-06-30 0001854445 GGIC:AUGGDMember us-gaap:CustomerRelationshipsMember 2022-06-30 0001854445 GGIC:XRTerraLLCMember us-gaap:CustomerRelationshipsMember 2022-06-30 0001854445 GGIC:PulpoARLLCMember us-gaap:CustomerRelationshipsMember 2022-06-30 0001854445 us-gaap:CustomerRelationshipsMember 2022-06-30 0001854445 GGIC:Sector5DigitalMember us-gaap:CustomerRelationshipsMember 2021-07-01 2022-06-30 0001854445 GGIC:AUGGDMember us-gaap:CustomerRelationshipsMember 2021-07-01 2022-06-30 0001854445 GGIC:Sector5DigitalMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-30 0001854445 GGIC:AUGGDMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-30 0001854445 GGIC:XRTerraLLCMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-30 0001854445 GGIC:PulpoARLLCMember us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-30 0001854445 us-gaap:TechnologyBasedIntangibleAssetsMember 2022-06-30 0001854445 us-gaap:TechnologyBasedIntangibleAssetsMember 2021-07-01 2022-06-30 0001854445 GGIC:Sector5DigitalMember 2022-06-30 0001854445 GGIC:AUGGDMember 2022-06-30 0001854445 GGIC:XRTerraLLCMember 2022-06-30 0001854445 GGIC:PulpoARLLCMember 2022-06-30 0001854445 us-gaap:CashMember 2022-06-30 0001854445 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember 2022-06-30 0001854445 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member 2022-06-30 0001854445 us-gaap:FairValueInputsLevel1Member us-gaap:InvestmentsMember 2022-06-30 0001854445 us-gaap:FairValueInputsLevel1Member us-gaap:InvestmentsMember 2021-07-01 2022-06-30 0001854445 us-gaap:MeasurementInputPriceVolatilityMember GGIC:Sector5DigitalLLCMember 2022-06-30 0001854445 us-gaap:MeasurementInputDiscountRateMember GGIC:Sector5DigitalLLCMember 2022-06-30 0001854445 us-gaap:MeasurementInputRiskFreeInterestRateMember GGIC:Sector5DigitalLLCMember 2022-06-30 0001854445 us-gaap:EstimateOfFairValueFairValueDisclosureMember GGIC:Sector5DigitalLLCMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:ChangeDuringPeriodFairValueDisclosureMember GGIC:Sector5DigitalLLCMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:CarryingReportedAmountFairValueDisclosureMember GGIC:Sector5DigitalLLCMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 GGIC:Sector5DigitalLLCMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:EstimateOfFairValueFairValueDisclosureMember GGIC:AUGGDMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:ChangeDuringPeriodFairValueDisclosureMember GGIC:AUGGDMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:CarryingReportedAmountFairValueDisclosureMember GGIC:AUGGDMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 GGIC:AUGGDMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:FairValueInputsLevel3Member 2022-06-30 0001854445 us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001854445 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001854445 us-gaap:CarryingReportedAmountFairValueDisclosureMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001854445 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2022-06-30 0001854445 us-gaap:TransferredAtPointInTimeMember 2021-06-30 0001854445 us-gaap:TransferredOverTimeMember 2022-06-30 0001854445 us-gaap:TransferredOverTimeMember 2021-06-30 0001854445 GGIC:NoteOneMember 2019-12-01 2019-12-31 0001854445 GGIC:NoteOneMember 2019-12-31 0001854445 GGIC:NoteOneMember 2021-01-01 2021-06-30 0001854445 GGIC:NoteOneMember 2020-12-01 2021-01-31 0001854445 GGIC:NoteOneMember 2021-01-31 0001854445 GGIC:NoteOneMember GGIC:ThirdYearInterestMember 2020-07-01 2021-06-30 0001854445 GGIC:NoteOneMember 2021-06-30 0001854445 GGIC:NoteOneMember 2021-07-01 2022-06-30 0001854445 GGIC:NoteTwoMember 2021-03-01 2021-03-31 0001854445 GGIC:NoteTwoMember 2021-03-31 0001854445 GGIC:NoteTwoMember 2020-07-01 2021-06-30 0001854445 GGIC:NoteTwoMember 2022-06-30 0001854445 GGIC:NoteTwoMember 2021-07-01 2022-06-30 0001854445 GGIC:NoteTwoMember 2021-06-30 0001854445 GGIC:NoteTwoMember 2022-06-01 2022-06-30 0001854445 GGIC:PaycheckProtectionProgramMember 2022-03-01 2022-03-31 0001854445 GGIC:PaycheckProtectionProgramMember 2021-02-01 2021-02-28 0001854445 us-gaap:IPOMember 2021-07-01 2021-12-31 0001854445 us-gaap:IPOMember 2022-06-30 0001854445 us-gaap:IPOMember 2021-07-01 2022-06-30 0001854445 us-gaap:IPOMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-06-30 0001854445 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:IPOMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-06-30 0001854445 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:IPOMember us-gaap:ValuationTechniqueOptionPricingModelMember 2022-06-30 0001854445 GGIC:SecuritiesPurchaseAgreementMember 2021-11-01 2021-11-30 0001854445 us-gaap:InvestorMember GGIC:SecuritiesPurchaseAgreementMember 2021-07-01 2022-06-30 0001854445 GGIC:SecuritiesPurchaseAgreementMember 2021-11-30 0001854445 GGIC:SecuritiesPurchaseAgreementMember 2021-07-01 2022-06-30 0001854445 us-gaap:ValuationTechniqueOptionPricingModelMember GGIC:SecuritiesPurchaseAgreementMember 2022-06-30 0001854445 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember GGIC:SecuritiesPurchaseAgreementMember 2022-06-30 0001854445 us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ValuationTechniqueOptionPricingModelMember GGIC:SecuritiesPurchaseAgreementMember 2022-06-30 0001854445 us-gaap:InvestorMember 2021-07-01 2022-06-30 0001854445 us-gaap:InvestorMember us-gaap:IPOMember 2022-06-30 0001854445 us-gaap:InvestorMember us-gaap:IPOMember 2021-07-01 2022-06-30 0001854445 us-gaap:InvestorMember us-gaap:IPOMember GGIC:SecuritiesPurchaseAgreementMember 2022-06-30 0001854445 us-gaap:InvestorMember 2020-07-01 2021-06-30 0001854445 us-gaap:InvestorMember 2021-06-30 0001854445 us-gaap:IPOMember us-gaap:CommonStockMember 2021-07-01 2022-06-30 0001854445 us-gaap:CommonStockMember us-gaap:ConvertibleNotesPayableMember 2021-07-01 2022-06-30 0001854445 us-gaap:CommonStockMember GGIC:AUGGDMember 2021-07-01 2022-06-30 0001854445 us-gaap:CommonStockMember GGIC:S5DMember 2021-07-01 2022-06-30 0001854445 us-gaap:CommonStockMember GGIC:LegacyAcquisitionObligationMember 2021-07-01 2022-06-30 0001854445 us-gaap:CommonStockMember GGIC:LegacyAcquisitionObligationMember 2020-07-01 2021-06-30 0001854445 GGIC:VendorsMember 2021-07-01 2022-06-30 0001854445 GGIC:VendorsMember 2020-07-01 2021-06-30 0001854445 us-gaap:StockOptionMember 2021-07-01 2022-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2022-06-30 0001854445 GGIC:TwentySixteenEquityIncentivePlanMember 2021-07-01 2022-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2021-07-01 2022-06-30 0001854445 GGIC:TwoThousandSixteenEquityIncentivePlanMember 2020-07-01 2021-06-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2021-07-01 2022-06-30 0001854445 us-gaap:ResearchAndDevelopmentExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2021-07-01 2022-06-30 0001854445 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2021-07-01 2022-06-30 0001854445 us-gaap:SellingAndMarketingExpenseMember 2020-07-01 2021-06-30 0001854445 us-gaap:CostOfSalesMember 2021-07-01 2022-06-30 0001854445 us-gaap:CostOfSalesMember 2020-07-01 2021-06-30 0001854445 GGIC:BoardOptionExpenseMember 2021-07-01 2022-06-30 0001854445 GGIC:BoardOptionExpenseMember 2020-07-01 2021-06-30 0001854445 GGIC:StockOptionsMember 2021-07-01 2022-06-30 0001854445 GGIC:StockOptionsMember 2020-07-01 2021-06-30 0001854445 GGIC:WarrantsMember 2021-07-01 2022-06-30 0001854445 GGIC:WarrantsMember 2020-07-01 2021-06-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2021-07-01 2022-06-30 0001854445 us-gaap:ConvertibleDebtSecuritiesMember 2020-07-01 2021-06-30 0001854445 2018-06-30 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2022-03-31 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2022-03-31 0001854445 GGIC:AugmentedRealityInvestmentsPtyLtdMember 2021-07-01 2022-06-30 0001854445 GGIC:IndependentMember 2022-06-30 0001854445 GGIC:Kabaq3DTechnologiesLLCMember 2021-08-01 2021-08-31 0001854445 GGIC:Kabaq3DTechnologiesLLCMember us-gaap:StockOptionMember 2021-08-01 2021-08-31 0001854445 GGIC:Kabaq3DTechnologiesLLCMember us-gaap:StockOptionMember 2021-08-31 0001854445 GGIC:KreatARLLCMember 2021-08-01 2021-08-31 0001854445 GGIC:KreatARLLCMember us-gaap:StockOptionMember 2021-07-01 2022-06-30 0001854445 GGIC:KreatARLLCMember 2022-06-30 0001854445 GGIC:KreatARLLCMember us-gaap:CommonStockMember 2021-07-01 2022-06-30 0001854445 GGIC:SFiveDCurrentPortionMember 2022-06-30 0001854445 GGIC:SFiveDCurrentPortionMember 2021-06-30 0001854445 GGIC:AUGGDMember 2022-06-30 0001854445 GGIC:AUGGDMember 2021-06-30 0001854445 GGIC:KabaqThreeDTechnologiesLLCMember 2022-06-30 0001854445 GGIC:KabaqThreeDTechnologiesLLCMember 2021-06-30 0001854445 GGIC:KreatARLLCMember 2022-06-30 0001854445 GGIC:KreatARLLCMember 2021-06-30 0001854445 GGIC:BrightlineInteractiveLLCMember GGIC:BLIAgreementMember 2022-05-01 2022-05-31 0001854445 GGIC:BrightlineInteractiveLLCMember GGIC:BLIAgreementMember 2022-05-31 0001854445 GGIC:BLIAgreementMember us-gaap:SubsequentEventMember 2022-08-01 2022-08-31 0001854445 GGIC:BrightlineInteractiveLLCMember 2021-12-01 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-K

 

(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the year ended June 30, 2022

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______ to _______

 

Commission file number 001-40556

 

THE GLIMPSE GROUP, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   81-2958271

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

15 West 38th St, 9th Fl, New York, NY 10018   10018
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (917) 292-2685

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value per share   VRAR   The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class

None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer     Accelerated filer  
Non-accelerated filer     Smaller reporting company  
        Emerging growth company  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

 

As of September 20, 2022, the aggregate market value of the registrants voting and non-voting common stock held by non-affiliates of the registrant was $63,068,992 based on the closing sale price as reported on The Nasdaq Stock Market LLC of $5.92 per share.

 

As of September 20, 2022, 13,593,734 shares of the registrant’s common stock were issued and outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

THE GLIMPSE GROUP, INC.

ANNUAL REPORT ON FORM 10-K

FOR THE YEAR ENDED JUNE 30, 2022

 

  Page
PART I 3
Item 1. Business 3
Item 1A. Risk Factors 13
Item 1B. Unresolved Staff Comments 26
Item 2. Properties 26
Item 3. Legal Proceedings 26
Item 4. Mine Safety Disclosures 26
   
PART II 27
Item 5. Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 27
Item 6. [Reserved] 28
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations 28
Item 7A. Quantitative and Qualitative Disclosures About Market Risk 39
Item 8. Financial Statements and Supplementary Data 39
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures 39
Item 9A. Controls and Procedures 39
Item 9B. Other Information 40
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 40
   
PART III 40
Item 10. Directors, Executive Officers and Corporate Governance 40
Item 11. Executive Compensation 46
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 49
Item 13. Certain Relationships and Related Transactions, and Director Independence 51
Item 14. Principal Accountant Fees and Services 52
   
PART IV 53
Item 15. Exhibits and Financial Statement Schedules 53
Item 16. Form 10-K Summary 56
Signatures 57

 

1

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

This report includes statements of our expectations, intentions, plans, and beliefs that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Nonetheless, it is important for an investor to understand that these statements involve risks and uncertainties. These statements relate to the discussion of our business strategies and our expectations concerning future operations, margins, profitability, liquidity, and capital resources and to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable. We have used words such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “think,” “estimate,” “seek,” “expect,” “predict,” “could,” “project,” “potential,” and other similar terms and phrases, including references to assumptions, in this report to identify forward-looking statements. These forward-looking statements are made based on expectations and beliefs concerning future events affecting us and are subject to uncertainties, risks and factors relating to our operations and business environment, all of which are difficult to predict and many of which are beyond our control, that could cause our actual results to differ materially from those matters expressed or implied by these forward-looking statements.

 

Such risks and other factors also include those listed in Item 1A. “Risk Factors” and elsewhere in this report and our other filings with the Securities and Exchange Commission (“SEC”). When considering these forward-looking statements, you should keep in mind the cautionary statements in this report and the documents incorporated by reference. New risks and uncertainties arise from time to time, and we cannot predict those events or how they may affect us. We assume no obligation to update any forward-looking statements after the date of this report as a result of new information, future events or developments, except as required by applicable laws and regulations.

 

When used in this annual report, the terms the “Company,” “Glimpse Group,”, “Glimpse,” “we,” “us,” “ours,” and similar terms refer to The Glimpse Group, Inc., a Nevada corporation, and its subsidiaries.

 

As of the date of this annual report, we currently own and operate numerous wholly-owned subsidiary companies (“Subsidiary Companies”, “Subsidiaries”): Adept Reality, LLC (dba Adept XR Learning), QReal, LLC, KreatAR, LLC (dba Post Reality), D6 VR, LLC, Immersive Health Group, LLC (dba IHG), Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), Early Adopter, LLC, MotionZone, LLC (dba AUGGD), Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey), XR Terra, LLC, Sector 5 Digital, LLC (“S5D”), PuploAR, LLC (a subsidiary company of QReal) and, as of August 1, 2022, Brightline Interactive, LLC (“BLI”). In addition, we own one inactive subsidiary company, In-It VR, LLC (dba Mezmos), which may be reactivated based on need and market conditions and a legal entity in Australia - Glimpse Group Australia Pty Ltd.

 

2

 

 

PART I

 

ITEM 1. BUSINESS

 

History

 

The Glimpse Group, Inc. was incorporated on June 15, 2016, under the laws of the State of Nevada and is headquartered in New York, New York.

 

On July 6, 2021, the Company completed its initial public offering (“IPO”). In connection with the IPO, the Company’s common stock began trading on the Nasdaq Capital Market on and as of July 1, 2021. In conjunction with its IPO, the Company sold approximately 1.91 million shares of its common stock at $7.00 per share, raising approximately $11.82 million in net proceeds after fees and expenses.

 

COMPANY OVERVIEW

 

We are a Virtual (“VR”) and Augmented (“AR”) Reality platform company, comprised of a diversified group of wholly-owned and operated VR and AR companies, providing enterprise-focused software, services and solutions. We believe that we offer significant exposure to the rapidly growing and potentially transformative VR, AR and immersive technology markets, while mitigating downside risk via our diversified model and ecosystem.

 

Our platform of VR/AR subsidiary companies, collaborative environment and diversified business model aims to simplify the challenges faced by companies in the emerging VR/AR industry, potentially improving each subsidiary company’s ability to succeed, while simultaneously providing investors an opportunity to invest directly into the emerging VR/AR industry via a diversified infrastructure.

 

By leveraging our platform, we strive to cultivate and manage the business operations of our VR/AR subsidiary companies, with the goal of allowing each underlying company to better focus on mission-critical endeavors, collaborate with the other subsidiary companies, reduce time to market, optimize costs, improve product quality and leverage joint go-to-market strategies. Subject to operational, market and financial developments and conditions, we intend to carefully add to our current portfolio of subsidiary companies via a combination of organic expansion and/or outside acquisition.

 

The VR/AR immersive technology industry is an early-stage technology industry with nascent markets. We believe that this industry has significant growth potential across verticals, may be transformative and that our diversified platform and ecosystem create important competitive advantages. Our subsidiary companies currently target a wide array of industry verticals, including but not limited to: Corporate Training, Education, Healthcare, Branding/Marketing/Advertising, Retail, Financial Services, Food & Hospitality, Media & Entertainment, Architecture/Engineering/Construction (“AEC”), Corporate Events and Presentations, Beauty and Cosmetics, Government & Defense and Social VR support groups and therapy. We do not currently target direct-to-consumer (“B2C’) customers, we focus primarily on the business-to-business (“B2B”) and business-to-business-to-consumer (“B2B2C”) segments. In addition, we are hardware agnostic.

 

3

 

 

The Glimpse Platform

 

We develop, commercialize and market innovative and proprietary VR/AR immersive technology software products, solutions and intellectual property (“IP”). Our platform is currently comprised of numerous active wholly-owned subsidiary companies, each targeting different industry segments in a non-competitive, collaborative manner. Our experienced management and dynamic VR/AR entrepreneurs have deep domain expertise, providing the foundation for value-add-collaborations throughout our ecosystem.

 

Each of our subsidiary companies share operational, financial and IP infrastructure, facilitating shorter time-to-market, higher quality products, reduced development costs, fewer redundancies, significant go-to-market synergies and, ultimately, a higher potential for success for each subsidiary company. We believe that our collaborative platform is unique and necessary, especially given the early nature of the VR/AR industry. By offering technologies and solutions in various industry segments, we aim to reduce dependency on any one single subsidiary company, technology or industry segment.

 

We believe that three core tenets enhance our probability of success: (1) our ecosystem of VR/AR companies, (2) diversification and (3) profitable growth.

 

(1) Our ecosystem of VR/AR software and service companies provides significant benefits to each subsidiary company and our group as a whole. We believe that the most notable benefits are: (a) economies of scale, cost efficiencies and reduced redundancies; (b) cross company collaboration, deep domain expertise, IP and knowledge transfer; (c) superior product offerings; (d) faster time to market; (e) enhanced business development and sales synergies; and (f) multiple monetization paths. In an emerging industry that is lacking in infrastructure, we believe that our ecosystem provides a distinct competitive advantage relative to a single, standalone company in the industry.

 

(2) By design, we incorporate multiple aspects of diversity to reduce the risks associated with an early stage industry, create multiple monetization venues and improve the probabilities of success. There is no single point of failure or dependency. This is created through: (a) ownership of numerous wholly-owned subsidiary companies operating in different industry segments; (b) targeting large industries with clear VR/AR use-cases; (c) developing and utilizing various technologies and IP; (d) expanding to different geographic technology centers in a hub model under our umbrella; and (e) across industries, having a wide array of customers and potential acquirers/investors.

 

(3) From our inception, we have balanced minimizing operational cash burn with capturing the growth opportunities in front of us. This remains an important factor driving our strategy to: (a) focus on enterprise software and services, only onboarding companies that are generating revenues or clearly could in the short term; (b) target solutions that are based on use cases that have a clear return on investment (“ROI”) and can be effectively developed from existing technologies and hardware; and (c) centralize costs to reduce inefficiencies. By striving to balance cash burn and growth, our goal is to lower dilution and support greater independence from capital markets, thereby increasing resiliency and maximizing upside potential.

 

As part of our platform, we provide a centralized corporate structure, which significantly reduces general and administrative costs (financial, operational, legal & IP), streamlines capital allocation and helps in coordinating business strategies. This allows our subsidiary company general managers to focus their time and effort almost exclusively on the core software, product and business development activities relating to their subsidiary.

 

Additionally, aligned economic incentives encourage cross-Company collaboration. Substantially all of our employees own equity in our Company. The leadership team of each subsidiary company, in addition to their equity ownership in Glimpse, often also have an economic interest in their particular subsidiary company. This economic interest is negotiated with lead management of a subsidiary company upon their joining our Company, and typically takes form in either: i) a 5-10% economic interest in the total net sale proceeds of the subsidiary upon a divestiture event or ii) additional Glimpse equity issuances based on revenue milestones achieved by the subsidiary company over a period of several years (typically three years). Thus, there is benefit to them not only when their subsidiary company succeeds but also when any of the other subsidiaries succeeds, and when Glimpse as a whole succeeds. We believe that this ownership mechanism is a strong driver of cross-pollination of ideas and fosters collaboration. While each subsidiary company owns its own IP, our parent company currently owns 100% of each subsidiary company. In addition, there will be perpetual licensing agreements between our subsidiary companies, so that if a subsidiary company is divested, then the remaining subsidiaries, if utilizing the IP of a divested subsidiary company, will continue to retain usage rights post-divestiture.

 

4

 

 

Active Glimpse Subsidiary Companies

 

 

  1. QReal, LLC (dba QReal): Creation of lifelike photorealistic 3D interactive digital models and experiences in AR
     
  2. Adept Reality, LLC (dba Adept XR Learning): VR/AR solutions for higher education learning and corporate training
     
  3. KreatAR, LLC (dba PostReality): AR presentation tools for design, creation and collaboration
     
  4. D6 VR, LLC: VR/AR data visualization and data-analysis tools and collaboration for Financial Services and other data intensive industries
     
  5. Immersive Health Group, LLC (IHG): VR/AR platform for evidence-based and outcome driven healthcare solutions
     
  6. Foretell Studios, LLC (dba Foretell Reality): Customizable social VR platform for behavioral health, support groups, collaboration and soft skills training
     
  7. Number 9, LLC (dba Pagoni VR): VR broadcasting solutions and environments for events, education, media & entertainment
     
  8. Early Adopter, LLC (EA): AR/VR solutions for K-12 education
     
  9. MotionZone, LLC (dba AUGGD): AR software and solutions for the Architecture, Engineering and Construction (AEC) segments
     
  10. Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey): a development center in Turkey, primarily developing and creating 3D models for QReal
     
  11. XR Terra, LLC (dba XR Terra): Immersive technologies teaching courses and training
     
 

12.

Sector 5 Digital, LLC (S5D): Corporate immersive experiences and events

     
  13. PulpoAR, LLC (PulpoAR): AR try-on technologies, targeting the Beauty and Cosmetics industry; a subsidiary company of QReal
     
  14. Brightline Interactive, LLC (BLI): Immersive and interactive experiences, training scenarios, and simulations for both government and commercial customers.

 

5

 

 

Key Business Developments During Fiscal Year 2022

 

Initial Public Offering (“IPO”)

 

On July 1, 2021, the Company completed an IPO of common stock on the NASDAQ under the symbol “VRAR”, at a price of $7.00 per share.

 

The Company sold approximately 1.91 million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

In connection with the IPO, the underwriter was issued a warrant to purchase 87,500 shares of common stock at $7.00 per share. The warrant cannot be exercised prior to December 30, 2021, and expires in June 2026.

 

In conjunction with the IPO, the outstanding convertible promissory notes (the “March 2021 Notes” and the “December 2019 Notes”) were converted and satisfied in full through issuance of 0.324 million shares of common stock. The Company has no other convertible promissory notes outstanding after the IPO.

 

Securities Purchase Agreement (“SPA”)

 

In November 2021, the Company sold $15.0 million worth of its common stock and warrants to certain institutional investors in a private placement pursuant to a SPA. The Company realized net proceeds (after underwriting, professional fees and listing expenses) of $13.58 million.

 

Under the terms of the SPA, the Company sold 1.50 million shares of its common stock and warrants to purchase 0.75 million shares of common stock. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The warrants have an exercise price of $14.63 per share. Warrants to purchase 0.56 million shares could be exercised immediately and expire in November 2026, and warrants to purchase 0.19 million shares were not exercisable prior to May 2022 and expire in May 2027.

 

AUGGD Asset Acquisition

 

In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC (dba AUGGD), completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd (“ARI”), an Australia based company providing augmented reality software and services. AUGGD targets the Architecture, Engineering and Construction market segments.

 

In conjunction with this acquisition, the Company established a new legal entity - “Glimpse Australia” - which may, in time, become a fully operational subsidiary company focused on facilitating the potential introduction of our products and services to the Australian markets and, in addition to AUGGD, potentially adding other Australian VR/AR companies to Glimpse Australia over time.

 

Initial consideration for the asset purchase was $0.75 million payable in Company common stock. In August 2021, the Company issued 77,264 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, priced at the time of issuance and with a floor issuance price of $7.00 per share. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology.

 

In June 2022, AUGGD achieved its initial Year 1 revenue milestone, and in July 2022 ARI was issued common shares of Company equating to approximately $0.57 million.

 

6

 

 

XR Terra Asset Acquisition

 

In October 2021, the Company, through its wholly owned subsidiary company, XR Terra, LLC, completed an acquisition of certain assets from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming.

 

Initial consideration for the purchase was $0.60 million payable 50% in Company common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through September 2024, priced at the time of issuance and with a floor issuance price of $7.00 per share. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees and technology.

 

Sector 5 Digital Acquisition

 

On December 2, 2021, the Company entered into a Membership Interest Sale Agreement (the “Agreement”), with Sector 5 Digital (S5D) and each of the equity holders of S5D named therein (collectively, the “Members”). S5D is an enterprise focused, immersive technology company that combines innovative storytelling with emerging technologies for industry leading organizations.

 

On February 1, 2022, the Company consummated the transaction and S5D became a wholly-owned subsidiary of the Company. The aggregate consideration consisted of: (a) $4.0 million cash paid at the February 1, 2022 closing (the “Closing”); (b) 277,201 shares of the Company’s common stock valued at the date of acquisition, valued at $4.0 million at the time the Agreement was entered and released from escrow to the Members at Closing; and (c) future purchase price considerations (“contingent consideration”) payable to the Members, up to a residual of $19.0 million ($2.0 million in cash which was escrowed at Closing). The $19.0 million is based and payable on S5D and the Company’s achievement of certain revenue growth milestones during the three years post-Closing, the payment of which shall be made up to $2.0 million in cash and the remainder in common stock of the Company, priced at the dates of the future potential share issuance subject to a common stock price floor of $7.00/share.

 

S5D had revenue for calendar year 2021 (prior to acquisition) of approximately $4 million.

 

PulpoAR Asset Acquisition

 

In May 2022, the Company, through its wholly owned subsidiary companies, QReal, LLC and PulpoAR, LLC, completed an acquisition of certain assets, as defined, from PulpoAR Pulpoar Bilisim Anonim Sirketi, a Turkey based AR technology e-commerce company providing virtual try-on solutions primarily for the Beauty and Retail markets.

 

Initial consideration for the purchase was $2.0 million, payable 75% in shares of the Company’s common stock (subject to a common stock floor price of $7.00/share) and 25% in cash. In May and June 2022, the Company collectively paid $0.50 million cash and will issue in September 2022 214,286 shares of common stock to satisfy the purchase price. The asset acquisition agreement provides for additional contingent consideration in the form of Company common stock and cash if certain future revenue targets are achieved through December 2024, priced at the time of issuance and with a floor issuance price of $7.00 per share. No liabilities were assumed as part of the acquisition and the primary assets acquired included employees and technology.

 

7

 

 

Brightline Interactive, LLC Acquisition

 

In May 2022, the Company entered into an Agreement and Plan of Merger (the “BLI Agreement”) to purchase all of the membership interests of Brightline Interactive, LLC (“BLI”), an immersive technology company that provides VR and AR based training scenarios and simulations for commercial and government customers. The transaction’s total potential purchase price is $32.5 million, with an initial payment of $8.0 million upon closing, consisting of $3.0 million in cash and approximately 0.71 million shares of the Company’s common stock valued at $5.0 million at the time the Agreement was entered (and issued at Closing based on a common stock floor price of $7.00/share). Future potential purchase price considerations, up to $24.5 million, are based on BLI’s achievement of revenue growth milestones in the three years post-closing, the payment of which shall be made up to $12 million in cash and the remainder in common shares of the Company, priced at the date of the future potential share issuance subject to a common stock price floor of $7.00/share.

 

In August 2022, the BLI transaction closed and BLI became a wholly-owned subsidiary of the Company. $3 million in cash was paid and approximately 0.71 million shares of Company stock was issued to the sellers.

 

The Company is currently determining its potential contingent liability for the purchase, as well as allocation of the purchase price amongst the assets purchased, intangible assets, goodwill and liabilities assumed.

 

BLI had revenue for calendar year 2021 of approximately $5 million.

 

The VR and AR (XR) Markets

 

Virtual Reality (VR) fully immerses the user in a digital environment via a head mounted display (“HMD”), where the user is blocked out of their immediate physical environment. Augmented Reality (AR) is a less immersive experience, where the user views their immediate physical environment with digital images overlaid, via a phone, tablet or a dedicated HMD such as smart glasses. While distinct, VR and AR are related, utilize some similar underlying technologies and are expected to become increasingly interconnected - combined they are often referred to as Immersive Technology (XR).

 

VR and AR are emerging technologies, and the markets for them are still nascent. We believe that XR technologies and solutions have the potential to fundamentally transform how people and businesses interact, further enabling remote work, education and commerce. XR is also expected to increasingly interconnect with other emerging technologies such as artificial intelligence, computer vision, big data, NFT and crypto currencies. Additionally, HMD and telecommunication (5G) advancements have been driving vast improvements in capabilities and ease of use, while significantly reducing headset cost. As a result, market adoption has accelerated and is expected to continue. Leading technology companies such as Meta/Facebook, Apple, Microsoft, Google, Samsung, Sony and HP have been at the forefront of VR/AR hardware development and software infrastructure, while also increasing integration of their products with AR and VR capabilities.

 

Since Facebook released its first VR headset as a consumer product in 2016 (after its $2B+ acquisition of Oculus), successive iterations of it, as well as others, have become significantly lighter, more comfortable, lower priced, with higher resolution and increasingly wireless/mobile. With a standalone mobile headset, users no longer need an expensive gaming computer to power the headset and they also do not have a wire tethered to that computer restricting movement. These advances have facilitated easier corporate procurement and integration. The accelerating rollout of 5G should enable further improvement in user experience since with 5G, remote processing and heavier, real time applications become possible without noticeable visual lag, allowing for lighter, smaller, more comfortable HMDs with longer battery life.

 

Based on Artillery Intelligence’s market forecasts, the VR and AR markets are forecasted to grow by approximately 50% in 2022 to over $25 billion and expected to exceed $35 billion by 2023. In particular, VR and AR enterprise software – the segment we are focused on – is projected to grow by approximately 50% in 2022 to over $7 billion and expand to more than $10 billion in 2023.

 

8

 

 

Business Development and Sales

 

We utilize a hybrid approach to the sales and distribution of our software products and services.

 

At our subsidiary company level, each company has its own business development and sales team, the size of which depends on its stage of development. Each subsidiary company’s general manager is responsible for business development, and as the subsidiary gains market traction, its business development and sales team are expanded as needed.

 

Our subsidiary companies’ business development and sales teams are enhanced by the shared resources and influence of our ecosystem. Our management takes an active role in the business development activities of each subsidiary company and in the overall development and integration of sale strategies, goals and budgets. As an integral part of the business development and sales processes, each subsidiary company’s general manager is very familiar with the product offerings of other subsidiary companies and leverages those into his or her own efforts when appropriate. This leads to substantial cross marketing collaboration.

 

We believe that a subsidiary company’s ability to demonstrate to potential customers scale as part of our ecosystem of companies, combined with our subsidiary’s ability to offer its products and solutions as well as those of our other subsidiary companies in an integrated manner, represents a key competitive advantage. We believe our customers often view us as a “one-stop-shop” for all their VR/AR needs and an expert in the emerging VR/AR space.

 

We and our subsidiary companies continue to develop a shared partner ecosystem to further scale business and expand our solutions into new and existing target markets.

 

Competitive Environment

 

We believe that our competitors in the VR/AR industry are focused on two primary segments: VR/AR Hardware (headsets) and Software.

 

VR/AR Hardware (Headsets) (“Hardware”):

 

We do not develop any Hardware, and our software and service solutions are mostly compatible with any Hardware. We believe that Hardware development, commercialization and distribution are highly capital intensive and there is not yet large enough scale or mass adoption in the VR/AR industry to justify such expenditures for a smaller company. As such, there are relatively few participants on the Hardware side, some very large (for example: Meta/Facebook, Microsoft, Samsung, Google, Apple, HTC, HP, Lenovo, Sony and Epson) and some much smaller (for example: Magic Leap, Pico, Valve, Varjo and Vuzix). In general, Hardware cycles have been accelerating and performance improving, with simplified usability and reduced end-user costs. The more advanced, easier to use and cheaper the Hardware becomes, the higher the potential for the development of robust software applications and increased market adoption of VR/AR solutions.

 

VR/AR Software (“Software”):

 

In contrast to VR/AR Hardware, Software is highly fragmented with hundreds of VR/AR Software companies targeting different segments and solutions. Many are consumer oriented, whereas we are entirely enterprise focused (B2B, B2B2C). We believe that the AR/VR Software segment is currently far less competitive than traditional software markets, as most companies in the space tend to be early stage and often underfunded.

 

While competition is evolving and increasing, there is currently no dominant player in any particular VR/AR Software segment. We believe that we have the potential to become a leader in the VR/AR Software space in general and that each of our subsidiary companies has the potential to become a significant player in their particular industry sector.

 

As previously described, we believe that our structure, ecosystem and integrated capabilities create significant competitive advantages for each of our subsidiary companies, not available to other Software companies in the VR/AR space. By owning and operating a diverse set of VR/AR companies, we believe that we significantly improve each of our subsidiary company’s ability to succeed by addressing many of the challenges early stage companies face and expanding each’s opportunity set and capabilities.

 

We believe that there are a select number of earlier stage companies of approximately our size that provide VR/AR Software and could be viewed as potential competitors. In addition, several of the larger technology players provide general infrastructure VR/AR Software. In particular: ARCore from Google and ARKit from Apple, which enable AR functionality on smartphones and tablets; and Unity and Epic Unreal, which enable software languages used in VR and AR programing. We do not view these larger companies as competition, but rather as complementary to our business (indeed, some of these are customers of ours). We believe infrastructure software benefits us, and the industry at large, as they are not industry specific and enable companies like us to more effectively build industry specific solutions, thereby saving significant costs and development efforts.

 

9

 

 

Platform Expansion and Diversification Strategy

 

As described above in “Competitive Environment,” the VR/AR software and services industries are highly fragmented. There are numerous potential acquisition targets that, while having established a niche market position, product or technology, have limited resources and ability to pursue growth initiatives. We intend to leverage our position and relative scale in the industry in order to continue to add to our platform both earlier stage companies and technologies and, subject to the availability of capital and appropriate targets, more mature companies. Beyond the expected financial impact of each such potential addition, these could also enhance our ecosystem, technology, scale and competitive position. These potential acquisitions may be domestic or international. If there is sufficient scale in a certain geographic location (beyond our current NYC headquarters), then a new hub may be established in such location, with several subsidiary companies operating in that hub, under the overall Glimpse umbrella. We currently have multiple locations in the US, offices in several locations in Turkey and an international presence in the UK, Australia and Israel.

 

Strategic Divestitures

 

Each one of our subsidiary companies has the potential to be divested or spun off. Although the purpose of our platform is to grow and develop the ecosystem on which each of our subsidiaries can mature by benefitting from collaboration, each subsidiary company targets a specific industry vertical (i.e. Healthcare, Education, Corporate Training, etc.) and as such has a distinct set of potential acquirers or investors. If a subsidiary company is divested and the proceeds are substantive, then our intent is to distribute the majority of the net proceeds to our shareholder base, if such distribution would not jeopardize our growth and operations.

 

Intellectual Property

 

Our intellectual property is an integral part of our business strategy and practice. In accordance with industry practice, we protect our proprietary products, technology and competitive advantage through a combination of contractual provisions and trade secrets, patents, copyright and trademark laws in the United States and other jurisdictions where business is conducted.

 

As of the date of this disclosure and summarized in the table below, we have been issued 10 patents by the United States Patent and Trademark Office (the “USPTO”) and have an additional 4 filed patent applications in process.

 

10

 

 

Title of Invention   Subsidiary   Initial Filing Date   Issuance Date  

Patent

Number

                 
Issued Patents:   Pagoni VR   06-21-2018   Oct ‘19   10445941
Interactive Mixed Reality System for a Real World Event                
                 
Immersive Display System with Adjustable Perspective   Pagoni VR   11-27-2018   Sept ‘20   10764553
                 
Augmented Reality Geolocation Using Image Matching   Post Reality   08-22-2018   March ‘21   10949669
                 
System for Sharing User-Generated Content   Pagoni VR   06-12-2019   Aug ‘21   11095947
                 
Presenting a Simulated Reality Experience in a Preset Location   Post Reality   06-14-2019   Nov ‘21   11189097
                 
Virtual Reality System Cross Platform   Foretell Reality   04-23-2019   April ‘22    11294453
                 
Simulated Reality Adaptive User Space   Foretell Reality   07-26-2019   April ‘22   11288868
                 
 Marker-Based Positioning of Simulated Reality   KreatAR   04-23-2019   July ‘22   11380011
                 
System and Method for Generating an Augmented Reality Experience   Brightline   11-19-2020   April ‘22   11302038
                 
Immersive Ecosystem   Brightline   08-05-2020   June ‘22   11373383
                 
Filed Patents:                
                 
Presentation Interface and Immersion Platform   Pagoni VR   04-30-2019        
                 
Simulated Reality Risks Mitigation System   IHG   07-19-2019        
                 
Real-Time Visualization of Head Mounted Display User Reactions   D6   04-06-2022        
                 
Audio Processing In a Virtual Environment   Adept Reality   06-22-2022        

 

We may continue to file for patents regarding various aspects of our products, services and technologies at a later date depending on the costs and timing associated with such filings. We may make investments to further strengthen our copyright protection going forward, although no assurances can be given that we will be successful in such patent and trademark protection endeavors. We seek to limit disclosure of our intellectual property by requiring employees, consultants, and partners with access to our proprietary information to execute confidentiality agreements and non-competition agreements (when applicable) and by restricting access to our proprietary information. Due to rapid technological change, we believe that establishing and maintaining an industry and technology advantage in factors such as the expertise and technological and creative skills of our personnel, as well as new services and enhancements to our existing services, are more important to our business and profitability than other available legal protections. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy aspects of our services or to obtain and use information that we regard as proprietary. The laws of many countries do not protect proprietary rights to the same extent as the laws of the U.S. Litigation may be necessary in the future to enforce our intellectual property rights, to protect our trade secrets, to determine the validity and scope of the proprietary rights of others or to defend against claims of infringement. Any such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results and financial condition. There can be no assurance that our means of protecting our proprietary rights will be adequate or that our competitors will not independently develop similar services or products. Any failure by us to adequately protect our intellectual property could have a material adverse effect on our business, operating results and financial condition. See “Risk Factors—Risks Related to our Business.”

 

11

 

 

Business Cycles

 

Based on our history and information available to date, we have not been able to identify any seasonality of cycles within our business. Since VR/AR is an emerging industry, market and customer education are material and therefore the length of the typical sales cycle can be between 3 and 18 months, depending on the size and complexity of the proposed solution and the customer’s level of understanding of the VR/AR space and prior experience.

 

Economic Dependence

 

For the year ended June 30, 2022, one customer accounted for approximately 40% of our revenues and another for approximately 14% of our revenues. These same customers accounted for approximately 26% and 0% of revenues, respectively, for the year ended June 30, 2021. No other customer accounted for more than 10% of our revenues for the year ended June 30, 2022. A customer that did not account for material revenues in the year ended June 30, 2022, accounted for 23% of our revenues for the fiscal year ended June 30, 2021. For the fiscal year ended June 30, 2021, no other customer accounted for 10% or more of our revenues.

 

We operate in an early stage industry, and customers are exploring various options for AR and VR solutions and acting as early adopters of VR and AR solutions. As such, there has been a high degree of variance on our source of revenues while customers are on-boarded and our software product and solutions are integrated, measured and digested. A customer that may account for a higher concentration of revenue in one period may not account for any revenue in subsequent periods.

 

With the recent addition of S5D and subsequent addition of Brightline Interactive, we have significantly increased our scale and are approaching a point with less variability in customer concentration and less dependency on any one customer in the aggregate. That being said, we continue to have a handful of customers that comprise the majority of our revenues. A significant reduction in revenue from our larger customers could have a material negative impact on our operations.

 

Typically, customer contracts can be canceled at any time by the customer upon 30-90 day written notice (depending on the size and complexity of the contract). In such an event, the customer would owe the Company unpaid amounts up until the point of cancelation. For most customers we charge 25-50% of the contract value upfront and the amounts are usually not refundable, mitigating some of the contract cancellation risk. While it does happen on occasion, it is rare that a signed contract is canceled.

 

12

 

 

Facilities

 

We are based in New York, New York, with a lease through 2024.

 

We have a lease in Fort Worth, Texas for the operations of S5D, and with the subsequent acquisition of Brightline Digital, we have a lease in Ashburn, VA.

 

Our current facilities are leased and adequate to meet our ongoing needs. If we require additional space or expand geographically, we may seek additional facilities on commercially reasonable terms at such time.

 

We also lease four offices in Turkey, for the operations of Glimpse Turkey and PulpoAR.

 

Human Capital

 

We currently have approximately 200 full time employees, primarily software developers, engineers and 3D artists. Of these, approximately 100 are based in the US and 100 internationally (primarily in Turkey).

 

Corporate Information

 

Information contained on our websites, including www.theglimpsegroup.com, shall not be deemed to be part of this filing or incorporated herein by reference and should not be relied upon by prospective investors for the purposes of determining whether to invest in the Company.

 

ITEM 1A. RISK FACTORS

 

RISKS RELATED TO OUR BUSINESS

 

The Company is an early stage technology company

 

We were incorporated on June 15, 2016 and are an early stage technology development company, comprised of a wholly-owned group of early stage companies in the VR and AR space. As such, we are subject to the risks associated with being an early stage company operating in an emerging industry, including, but not limited to, the risks set forth herein.

 

Health epidemics, including the current COVID-19 pandemic, have had, and could in the future have, an adverse impact on our business, operations, and the markets and communities in which we, our partners and customers operate. For example, sales cycles have generally lengthened and some customers have delayed purchase decisions.

 

Our business and operations could be adversely affected by health epidemics, including the current COVID-19 pandemic, impacting the markets and communities in which we, our partners and customers operate. The COVID-19 pandemic has caused significant business and financial markets disruption worldwide and there remains uncertainty around the duration of this disruption on both a nationwide and global level, as well as the ongoing effects on our business.

 

The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition will depend on future developments that are uncertain and unpredictable. As a result of the COVID-19 pandemic, we have seen the length of our sale cycles generally increase and some of our customers have delayed purchase decisions. A decline in revenue or the collectability of our receivables could harm our business.

 

We continue to monitor the COVID-19 situation and the potential effects on our business and operations. While the spread and impact of COVID-19 has stabilized, there is no guarantee that a future outbreak of this or any other widespread epidemics will not occur, or that the global economy will recover, either of which could harm our business.

 

13

 

 

We have incurred significant net losses since inception and anticipate that we will continue to incur net losses for the foreseeable future and may never achieve or maintain profitability.

 

Since inception, we have incurred significant net losses. As of June 30, 2022 and June 30, 2021, we had an accumulated deficit of approximately $28 million and $22 million respectively. The net loss for the fiscal year ended June 30, 2022 was approximately $5.97 million and fiscal year ended June 30, 2021 was approximately $6.09 million. To date, we have devoted our efforts towards securing financing, building and evolving our technology platform and creating an infrastructure that allows for the growth of such technology platform. In the past, the combination of operating losses, cash expected to be used to continue operating activities and uncertain conditions relating to additional capital raises and continued revenue growth created an uncertainty about the Company’s ability to continue as a going concern. Doubt about the Company’s ability to continue as a going concern was alleviated on our financial statements for the year ended June 30, 2022 and for the year ended June 30, 2021. We expect to continue to incur significant expenses and potential operating losses for the foreseeable future. While our cash balance is currently well above our annual net cash expenses, we do anticipate that our expenses will increase if, and as, we continue to:

 

  hire and retain additional sales, accounting and finance, marketing and engineering personnel;
     
  build out our product pipeline;
     
  add operational, financial and management information systems and personnel; and
     
  maintain, expand, protect and enforce our intellectual property portfolio.

 

To become profitable, we must continue to grow our revenue base and control expenditures. This will require us to be successful in a range of challenging activities, and our expenses will increase as we continue to develop and bring our current products, as well as new ones, to market. We may never succeed in any or all of these activities and, even if we do, we may never generate revenue that is significant or sufficient to achieve profitability. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable or to sufficiently fund our operations through financing activity could potentially, again, create an uncertainty about the Company’s ability to continue as a going concern.

 

Based on our recent financing activity we believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for more than one year.

 

Based on our financing activities in fiscal year 2022, which included our IPO and a private placement, and revenue growth during the fiscal year, we believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for more than one year. Consequently, our financial statements have been prepared under the assumption that we will continue as a going concern. However, we have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. In the future, if we are unable to obtain sufficient funding to support our operations, we could be forced to delay, reduce or eliminate some or all of our development and growth initiatives, and our financial condition and results of operations will be materially and adversely affected and we may be unable to continue as a going concern. In the future, reports from our independent registered public accounting firm may also contain statements expressing substantial doubt about our ability to continue as a going concern. If we seek additional financing to fund our business activities in the future and there remains substantial doubt about our ability to continue as a going concern, investors or other financing sources may be unwilling to provide additional funding to us on commercially reasonable terms or at all.

 

We may not be successful in raising additional capital necessary to meet expected increases in working capital needs. If we need additional funding for operations and we are unable to raise it, we may not be able to continue our business operations.

 

We expect our working capital needs to increase in the future as we continue to expand and enhance our operations. Our ability to raise additional funds through equity or debt financings or other sources will depend on the financial success of our current business and successful implementation of our key strategic initiatives, financial, economic and market conditions and other factors, some of which are beyond our control. No assurance can be given that we will be successful in raising the required capital at reasonable cost and at the required times, or at all. Further equity financings may have a dilutive effect on shareholders and any debt financing, if available, may require restrictions to be placed on our future financing and operating activities. If we require additional capital and are unsuccessful in raising that capital, we may not be able to continue our business operations and advance our growth initiatives, which could adversely impact our business, financial condition and results of operations.

 

14

 

 

Our market is competitive and dynamic. New competing products and services could be introduced at any time that could result in reduced profit margins and loss of market share.

 

The AR and VR industries are very dynamic, with new technology and services being introduced by a range of players, from larger established companies to start-ups, on a frequent basis. Our competitors may announce new products, services, or enhancements that better meet the needs of end-users or changing industry standards. Further, new competitors or alliances among competitors could emerge. Increased competition may cause price reductions, reduced gross margins and loss of market share, any of which could have a material adverse effect on our business, financial condition and results of operations.

 

Furthermore, the worldwide AR and VR markets are increasingly competitive. A number of companies developing AR and VR products and services compete for a limited number of customers. Some of our competitors in this market have substantially greater financial and other resources, larger research and development staffs, and more experience and capabilities in developing, marketing and distributing products. Potential pricing pressure could result in significant price erosion, reduced profit margins and loss of market share, any of which could have a material adverse effect on our business, results of operations, financial position and liquidity.

 

Our plans for growth will place significant demands upon our resources. If we are unsuccessful in achieving our plan for growth, our business could be harmed.

 

We are actively marketing our products domestically and internationally. The plan places significant demands upon managerial, financial, and human resources. Our ability to manage future growth will depend in large part upon several factors, including our ability to rapidly:

 

  build or leverage, as applicable, a network of business partners to create an expanding presence in the evolving marketplace for our products and services;
     
  build or leverage, as applicable, sales teams to keep end-users and business partners informed regarding the technical features, issues and key selling points of our products and services;

 

  attract and retain qualified technical personnel in order to continue to develop reliable and flexible products and provide services that respond to evolving customer needs;
     
  develop support capacity for end-users as sales increase, so that we can provide post-sales support without diverting resources from product development efforts; and
     
  expand our internal management and financial controls significantly, so that we can maintain control over our operations and provide support to other functional areas as the number of personnel and size increases.

 

Our inability to achieve any of these objectives could harm our business, financial condition and results of operations.

 

We have material customer concentration, with a limited number of customers accounting for a material portion of our 2022 revenues.

 

For the years ended June 30, 2022 and 2021, our five largest customers, accounted for approximately 66% and 64% of our revenues, respectively. There are inherent risks whenever a large percentage of total revenues are concentrated with a limited number of customers. It is not possible for us to predict the future level of demand for our services that will be generated by these customers or the future demand for the products and services of these customers in the end-user marketplace. In addition, revenues from these customers may fluctuate from time to time based on the commencement and completion of projects, the timing of which may be affected by market conditions or other facts, some of which may be outside of our control. Further, some of our contracts with these customers permit them to terminate our services at any time (subject to notice and certain other provisions). If any of these customers experience declining or delayed sales due to market, economic or competitive conditions, we could be pressured to reduce the prices we charge for our services or we could lose a major customer. Any such development could have an adverse effect on our margins and financial position, and would negatively affect our revenues and results of operations and/or trading price of our common stock.

 

15

 

 

We anticipate our products and technologies will require ongoing research and development (“R&D”) and we may experience technical problems or delays and may not have the funds necessary to continue their development, which could lead our business to fail.

 

Our R&D efforts are subject to the risks typically associated with the development of new products and technologies based on emerging and innovative technologies, including, for example, unexpected technical problems or the possible insufficiency of funds for completing development of these products or technologies. If we experience technical problems or delays, further improvements in our products or technologies and the introduction of future products or technologies could be delayed, and we could incur significant additional expenses and our business may fail.

 

We anticipate that we may require additional funds to increase or sustain our current levels of expenditure for the R&D of new products and technologies, and to obtain and maintain patents and other intellectual property rights in these technologies, the timing and amount of which are difficult to forecast. Any funds we need may not be available on commercially reasonable terms or at all. If we cannot obtain the necessary additional capital when needed, we might be forced to reduce our R&D efforts which would materially and adversely affect our business. If we attempt to raise capital in an offering of shares of our common stock, preferred stock, convertible securities or warrants, our then-existing stockholders’ interests will be diluted.

 

Our success depends on our ability to anticipate technological changes and develop new and enhanced products and services.

 

The markets for our products and services are characterized by rapidly changing technology, evolving industry standards and increasingly sophisticated customer requirements. The introduction of products embodying new technology and the emergence of new industry standards can negatively impact the marketability of our existing products and can exert price pressures on existing products. It is critical to our success that we are able to anticipate and react quickly to changes in technology or in industry standards and to successfully develop, introduce, and achieve market acceptance of new, enhanced and competitive products and services on a timely basis and cost-effective basis. We invest substantial resources towards continued innovation; however, there can be no assurance that we will successfully develop new products and services or enhance and improve our existing products and services, that new products and services and enhanced and improved existing products and services will achieve market acceptance or that the introduction of new products and services or enhanced existing products and services by others will not negatively impact us. Our inability to develop products and services that are competitive in technology and price and that meet end-user needs could have a material adverse effect on our business, financial condition or results of operations.

 

Development schedules for technology products and services are inherently uncertain. We may not meet our products and/or services development schedules, and development costs could exceed budgeted amounts. Our business, results of operations, financial position and liquidity may be materially and adversely affected if the products or product enhancements that we develop are delayed or not delivered due to developmental problems, quality issues or component shortage problems, or if our products or product enhancements do not achieve market acceptance or are unreliable. We or our competitors will continue to introduce products embodying new technologies. In addition, new industry standards may emerge. Such events could render our existing products obsolete or not marketable, which would have a material adverse effect on our business, results of operations, financial position and liquidity.

 

We place significant decision making powers with our subsidiaries’ management, which presents certain risks that may cause the operating results of individual subsidiaries to vary.

 

We believe that our practice of placing significant decision making powers with each of our subsidiaries’ management is important to our successful growth and allows us to be responsive to opportunities and to our customers’ needs. However, this practice could make it difficult to coordinate procedures across our operations and presents certain risks, including the risk that we may be slower or less effective in our attempts to identify or react to problems affecting an important business issue, or that we would be slower to identify a misalignment between a subsidiary’s and our overall business strategy. Inconsistent implementation of corporate strategy and policies at the subsidiary level could materially and adversely affect our financial position, results of operations and cash flows and prospects.

 

16

 

 

The operating results of an individual subsidiary may differ from those of another subsidiary for a variety of reasons, including market size, customer base, competitive landscape, regulatory requirements and economic conditions affecting a particular industry vertical. As a result, certain of our subsidiaries may experience higher or lower levels of profitability and growth than other subsidiaries.

 

The failure to attract, hire, retain and motivate key personnel could have a significant adverse impact on our operations.

 

Our success depends on the retention and maintenance of key personnel, including members of senior management and our technical, sales and marketing teams. Achieving this objective may be difficult due to many factors, including competition for such highly skilled personnel; fluctuations in global economic and industry conditions; changes in our management or leadership; competitors’ hiring practices; and the effectiveness of our compensation programs. The loss of any of these key persons could have a material adverse effect on our business, financial condition or results of operations. Competition for qualified employees is particularly intense in the technology industry. Our failure to attract and to retain the necessary qualified personnel could seriously harm our operating results and financial condition. Competition for such personnel can be intense, and no assurance can be provided that we will be able to attract or retain highly qualified technical and managerial personnel in the future, which may have a material adverse effect on our future growth and profitability.

 

Our financial results may fluctuate substantially for many reasons, and past results should not be relied on as indications of future performance.

 

Our revenues and operating results may fluctuate from quarter to quarter and from year to year due to a combination of factors, including, but not limited to:

 

  varying size, timing and contractual terms of orders for our products and services, which may delay the recognition of revenue;
     
  competitive conditions in the industry, including strategic initiatives by us or our competitors, new products or services, product or service announcements and changes in pricing policy by us or our competitors;
     
  market acceptance of our products and services;
     
  our ability to maintain existing relationships and to create new relationships with customers and business partners;
     
  the discretionary nature of purchase and budget cycles of our customers and end-users;
     
  the length and variability of the sales cycles for our products;
     
  general weakening of the economy resulting in a decrease in the overall demand for our products and services or otherwise affecting the capital investment levels of businesses with respect to our products or services;
     
  timing of product development and new product initiatives;
     
  changes in customer mix;
     
  increases in the cost of, or limitations on, the availability of materials;
     
  changes in product mix; and
     
  increases in costs and expenses associated with the introduction of new products.

 

17

 

 

Further, the markets that we serve are volatile and subject to market shifts that we may be unable to anticipate. A slowdown in the demand for AR or VR products and services can have a significant adverse effect on the demand for our products and services in any given period. Our customers may cancel or delay purchase orders for a variety of reasons, including, but not limited to, the rescheduling of new product introductions, changes in our customers’ inventory practices or forecasted demand, general economic conditions affecting our customers’ markets, changes in our pricing or the pricing of our competitors, new product announcements by us or others, quality or reliability problems related to our products, or selection of competitive products as alternate sources of supply.

 

Thus, there can be no assurance that we will be able to reach profitability on a quarterly or annual basis. We believe that our revenue and operating results will continue to fluctuate, and that period-to-period comparisons are not necessarily indications of future performance. Our revenue and operating results may fail to meet the expectations of public market analysts or investors, which could have a material adverse effect on the price of our common stock. In addition, portions of our expenses are fixed and difficult to reduce if our revenues do not meet our expectations. These fixed expenses magnify the adverse effect of any revenue shortfall.

 

Our plans for implementing our business strategy and achieving profitability are based upon the experience, judgment and assumptions of our key management personnel, and available information concerning the communications and technology industries. If management’s assumptions prove to be incorrect, it could have a material adverse effect on our business, financial condition or results of operations.

 

Our centralized management will have significant discretion over directing our resources and if management does not allocate resources effectively, our business, financial condition or result of operations could be harmed.

 

Our centralized management has significant discretion over directing our resources to any and all of our subsidiary companies. As a consequence, it is possible that one or more of our subsidiary companies will not receive adequate capital or management resources. If a subsidiary company does not receive adequate capital or resources, it may not be able to commercialize its products and services, or if its products and services are already commercialized, it may not be able to keep such products and services competitive. Therefore, if we don’t allocate resources effectively, our business, financial condition or result of operations could be harmed.

 

Competitive pricing pressure may reduce our gross profits and adversely affect our financial results.

 

If we are unable to maintain our pricing due to competitive pressures or other factors, our margins will be reduced and our gross profits, business, results of operations, and financial condition would be adversely affected. The subscription prices for our software platforms, cloud modules, and professional services may decline for a variety of reasons, including competitive pricing pressures, discounts, anticipation of the introduction of new solutions by our competitors, or promotional programs offered by us or our competitors. Competition continues to increase in the market segments in which we operate, and we expect competition to further increase in the future.

 

Our future growth depends on our ability to attract, retain customers, and the loss of existing customers, or failure to attract new ones, could adversely impact our business and future prospects.

 

Once the platform is further developed, the size of our community of customers on our platforms is critical to our success. Our ability to achieve profitability in the future will depend, in large part, on our ability to add new customers, while retaining and even expanding offerings to existing customers. Our customers can generally decide to cease using our solutions at any time. While we have experienced customer growth, this growth may not continue at the same pace in the future or at all. In addition, it is possible that the ongoing effects of COVID-19 may have a deleterious effect on our customer growth in the future. Achieving growth in our customer base may require us to engage in increasingly sophisticated and costly sales and marketing efforts that may not result in additional customers. We may also need to modify our pricing model to attract and retain such customers. If we fail to attract new users or fail to maintain or expand existing relationships in a cost-effective manner, our business and future prospects may be materially and adversely impacted.

 

18

 

 

The continued operation of our business depends on the performance and reliability of the Internet, mobile networks, and other infrastructure that is not under our control.

 

Our business depends on the performance and reliability of the Internet, mobile networks, and other infrastructure that is not under our control. Disruptions in such infrastructure, including as the result of power outages, telecommunications delay or failure, security breach, or computer virus, as well as failure by telecommunications network operators to provide us with the bandwidth we need to provide our products and offerings, could cause delays or interruptions to our products, offerings, and platforms. Any of these events could damage our reputation, resulting in fewer users actively using our platforms, disrupt our operations, and subject us to liability, which could adversely affect our business, financial condition, and operating results.

 

If we do not make our platforms, including new versions or technology advancements, easier to use or properly train customers on how to use our platforms, our ability to broaden the appeal of our products and services and to increase our revenue could suffer.

 

In order to get full use of our platforms, users generally need training. We provide a variety of training and support services to our customers, and we believe we will need to continue to maintain and enhance the breadth and effectiveness of our training and support services as the scope and complexity of our platforms increase. If we do not provide effective training and support resources for our customers on how to efficiently and effectively use our platforms, our ability to grow our business will suffer, and our business and results of operations may be adversely affected. Additionally, when we announce or release new versions of our platforms or advancements in our technology, we could fail to sufficiently explain or train our customers on how to use such new versions or advancements or we may announce or release such versions prematurely. These failures on our part may lead to our customers being confused about use of our products or expected technology releases, and our ability to grow our business, results of operations, brand and reputation may be adversely affected.

 

Interruptions, performance problems or defects associated with our platforms may adversely affect our business, financial condition and results of operations.

 

Our reputation and ability to attract and retain customers and grow our business depends in part on our ability to operate our platforms at high levels of reliability, scalability and performance, including the ability of our existing and potential customers to access our platforms at any time and within an acceptable amount of time. Interruptions in the performance of our platforms, whether due to system failures, computer viruses or physical or electronic break-ins, could affect the availability of our platforms. We have experienced, and may in the future experience, disruptions, outages and other performance problems due to a variety of factors, including infrastructure changes, introductions of new functionality, human or software errors, capacity constraints due to an overwhelming number of customers accessing our platforms simultaneously, denial of service attacks or other security-related incidents.

 

It may become increasingly difficult to maintain and improve our performance, especially during peak usage times and as our customer base grows and our platforms becomes more complex. If our platforms are unavailable or if our customers are unable to access our platforms within a reasonable amount of time or at all, we may experience a loss of customers, lost or delayed market acceptance of our platforms, delays in payment to us by customers, injury to our reputation and brand, legal claims against us, significant cost of remedying these problems and the diversion of our resources. In addition, to the extent that we do not effectively address capacity constraints, upgrade our systems as needed and continually develop our technology and network architecture to accommodate actual and anticipated changes in technology, our business, financial condition and results of operations, as well as our reputation, may be adversely affected.

 

Further, the software technologies underlying our platforms are inherently complex and may contain material defects or errors, particularly when new products are first introduced or when new features or capabilities are released. We have from time to time found defects or errors in our platforms, and new defects or errors in our existing platforms or new products may be detected in the future by us or our users. We cannot assure you that our existing platforms and new products will not contain defects. Any real or perceived errors, failures, vulnerabilities, or bugs in our platforms could result in negative publicity or lead to data security, access, retention or other performance issues, all of which could harm our business. The costs incurred in correcting such defects or errors may be substantial and could harm our business. Moreover, the harm to our reputation and legal liability related to such defects or errors may be substantial and could similarly harm our business.

 

19

 

 

If we fail to timely release updates and new features to our platforms and adapt and respond effectively to rapidly changing technology, evolving industry standards, changing regulations, or changing customer needs, requirements or preferences, our platforms may become less competitive.

 

The markets in which we compete are subject to rapid technological change, evolving industry standards, and changing regulations, as well as changing customer needs, requirements and preferences. The success of our business will depend, in part, on our ability to adapt and respond effectively to these changes on a timely basis. Accordingly, our ability to increase our revenue depends in large part on our ability to maintain, improve and differentiate our existing platforms and introduce new functionality.

 

We must continue to improve existing features and add new features and functionality to our platforms in order to retain our existing customers and attract new ones. If the technology underlying our platforms become obsolete or do not address the needs of our customers, our business would suffer.

 

Revenue growth from our products depends on our ability to continue to develop and offer effective features and functionality for our customers and to respond to frequently changing data protection regulations, policies and end-user demands and expectations, which will require us to incur additional costs to implement. If we do not continue to improve our platforms with additional features and functionality in a timely fashion, or if improvements to our platforms are not well received by customers, our revenue could be adversely affected.

 

If we fail to deliver timely releases of our products that are ready for commercial use, release a new version, service, tool or update with material errors, or are unable to enhance our platforms to keep pace with rapid technological and regulatory changes or respond to new offerings by our competitors, or if new technologies emerge that are able to deliver competitive solutions at lower prices, more efficiently, more conveniently or more securely than our solutions, or if new operating systems, gaming platforms or devices are developed and we are unable to support our customers’ deployment of games and other applications onto those systems, platforms or devices, our business, financial condition and results of operations could be adversely affected.

 

We are an “emerging growth company,” and we cannot be certain if the reduced reporting and disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.

 

We are an “emerging growth company,” as defined in the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies,” including the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, or Section 404, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Pursuant to Section 107 of the JOBS Act, as an emerging growth company, we may choose to elect to use the extended transition period for complying with new or revised accounting standards until those standards would otherwise apply to private companies. As a result, our consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make our common stock less attractive to investors. In addition, if we cease to be an emerging growth company, we will no longer be able to use the extended transition period for complying with new or revised accounting standards.

 

We will remain an emerging growth company until the earliest of: (1) the last day of the fiscal year following the fifth anniversary of our initial public offering; (2) the last day of the first fiscal year in which our annual gross revenue is $1.07 billion or more; (3) the date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the date we qualify as a “large accelerated filer,” with at least $700 million of equity securities held by non-affiliates.

 

We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. For example, if we do not adopt a new or revised accounting standard, our future results of operations may not be as comparable to the results of operations of certain other companies in our industry that adopted such standards. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.

 

20

 

 

RISKS RELATED TO OUR ACQUISITION STRATEGY

 

We may be unable to obtain additional financing, if required, to fund the existing operations of the business, complete future acquisitions or to fund the development and commercialization of the companies, technologies, or intellectual property.

 

Our primary business strategy is to: 1) generate and increase revenues of existing subsidiary companies and 2) to further enhance our presence in the VR/AR market through the acquisition of additional VR/AR companies, technologies, or intellectual property. If our existing subsidiary companies do not achieve sufficient levels of revenue and profits, we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements to finance the operations of the business.

 

Additionally, there can be no assurance that we will be able to successfully identify, acquire or profitably manage such additional companies, technologies, or intellectual property or successfully integrate these, if any, into the Glimpse ecosystem without substantial costs, delays or other operational or financial problems. If potential acquisition targets are unwilling to accept our equity as the consideration for their businesses, then we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements to finance the acquisition transaction. If we complete a business combination, we may require additional financing to fund the operations or growth of an acquisition target. Further, acquisitions involve a number of other special risks, including possible adverse effects on our operating results, diversion of management’s attention, dependence on retention, hiring and training of key personnel, risks associated with unanticipated problems or legal liabilities, and realization of acquired intangible assets, some or all of which could have a material adverse effect on our business, financial condition and results of operations. In addition, there can be no assurance that the companies, technologies, or intellectual property acquired in the future, if any, will generate anticipated revenues and earnings. As a result, we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements. To the extent that we are unable to acquire additional companies, technologies, or intellectual property or integrate those successfully, our ability to generate and increase our revenues may be reduced significantly. As a result, we may be required to seek additional financing through the issuance of equity or debt securities or other arrangements. As an early-stage company, we cannot assure that such financing will be available on acceptable terms, if at all.

 

With respect to our future acquisition strategy, no assurance can be made that we will have the funds necessary to make future acquisitions. To the extent that additional financing proves to be unavailable, that fact will likely have a negative impact on our business and we may be compelled to restructure the operations of the business or abandon a particular contemplated business combination.

 

If we fail to integrate any existing or acquired subsidiaries into the Glimpse ecosystem, we may not realize the anticipated benefits of the collaborative Glimpse ecosystem and the integration of any acquisitions, which could harm our business, financial condition or results of operations.

 

Even though Glimpse’s ecosystem provides a centralized corporate structure and the potential for cross company collaboration synergies, each subsidiary company has its own business development, technology development, sales team and general manager. Although we believe that the integration of our existing subsidiary companies has been a success, there is still continued risk that we may encounter difficulties related to continued integration of the existing subsidiary companies in the future. There is also the risk that the business development, sales team and general manager of a future acquired subsidiary are unsuccessful. Some of these risks are out of our control. Successfully integrating any acquired subsidiary may be more difficult, costly or time-consuming than we anticipate, or we may not otherwise realize any of the anticipated benefits of such acquisition. Any of the foregoing could adversely affect our business, financial condition or results of operations.

 

21

 

 

We have made a number of acquisitions in the past and we intend to make more acquisitions in the future. Our ability to identify complementary assets, products or businesses for acquisition and successfully integrate them could affect our business, financial condition and operating results.

 

In the future, we intend to continue to pursue acquisitions of assets, products or businesses that we believe are complementary to our existing business and/or to enhance our market position or expand our product portfolio. There is a risk that we will not be able to identify suitable acquisition candidates available for sale at reasonable prices, complete any acquisition, or successfully integrate any acquired product or business into our operations. We may face competition for acquisition candidates from other parties including those that have substantially greater available resources. Acquisitions may involve a number of other risks, including:

 

  diversion of management’s attention from other subsidiaries;
     
  disruption to our ongoing business;
     
  failure to retain key acquired personnel;
     
  difficulties in integrating acquired operations, technologies, products, or personnel;
     
  unanticipated expenses, events, or circumstances;
     
  assumption of disclosed and undisclosed liabilities; and
     
  inappropriate valuation of the acquired in-process R&D, or the entire acquired business.

 

If we do not successfully address these risks or any other problems encountered in connection with an acquisition, the acquisition could have a material adverse effect on our business, results of operations and financial condition. Problems with an acquired business could have a material adverse effect on our performance or our business as a whole. In addition, if we proceed with an acquisition, our available cash may be used to complete the transaction, diminishing our liquidity and capital resources, or shares may be issued which could cause significant dilution to existing shareholders.

 

RISKS RELATED TO OUR INTELLECTUAL PROPERTY

 

If we cannot obtain and maintain appropriate patent and other intellectual property rights protection for our technology, our business will suffer.

 

The value of our software and services is dependent on our ability to secure and maintain appropriate patent and other intellectual property rights protection. We intend to continue to pursue additional patent protection for our new software and technology. Although we own multiple patents covering our technology that have already been issued, we may not be able to obtain additional patents that we apply for, or that any of these patents, once issued, will give us commercially significant protection for our technology, or will be found valid if challenged. Moreover, we have not obtained patent protection for our technology in all foreign countries in which our products might be sold. In any event, the patent laws and enforcement regimes of other countries may differ from those of the United States as to the patentability of our personal display and related technologies and the degree of protection afforded.

 

Any patent or trademark owned by us may be challenged and invalidated or circumvented. Patents may not be issued from any of our pending or future patent applications. Any claims and issued patents or pending patent applications may not be broad or strong enough and may not be issued in all countries where our products can be sold or our technologies may not be licensed to provide meaningful protection against any commercial damage to us. Further, others may develop technologies that are similar or superior to our technologies, duplicate our technologies or design around the patents owned by us. Effective intellectual property protection may be unavailable or limited in certain foreign countries. Despite our efforts to protect our proprietary rights, unauthorized parties may attempt to copy or otherwise use aspects of our processes and devices that we regard as proprietary. Policing unauthorized use of our proprietary information and technology is difficult and our efforts to do so may not prevent misappropriation of our technologies. In the event that our intellectual property protection is insufficient to protect our intellectual property rights, we could face increased competition in the market for our products and technologies, which could have a material adverse effect on our business, financial condition and results of operations.

 

22

 

 

We may become engaged in litigation to protect or enforce our patent and other intellectual property rights or in International Trade Commission proceedings to abate the importation of goods that would compete unfairly with our products. In addition, we may have to participate in interference or reexamination proceedings before the US Patent and Trademark Office, or in opposition, nullification or other proceedings before foreign patent offices, with respect to our patents or patent applications. All of these actions would place our patents and other intellectual property rights at risk and may result in substantial costs to us as well as a diversion of management attention. Moreover, if successful, these actions could result in the loss of patent or other intellectual property rights protection for the key technologies on which our business strategy depends.

 

In addition, we rely in part on unpatented proprietary technology, and others may independently develop the same or similar technology or otherwise obtain access to our unpatented technology. To protect our trade secrets, know-how and other proprietary information, we require employees, consultants, financial advisors and strategic partners to enter into confidentiality agreements. These agreements may not provide meaningful protection for our trade secrets, know-how or other proprietary information in the event of any unauthorized use, misappropriation or disclosure of those trade secrets, know-how or other proprietary information. In particular, we may not be able to fully or adequately protect our proprietary information as we conduct discussions with potential strategic partners. If we are unable to protect the proprietary nature of our technology, it will harm our business.

 

Despite our efforts to protect our intellectual property rights, intellectual property laws afford us only limited protection. A third party could copy or otherwise obtain information from us without authorization. Accordingly, we may not be able to prevent misappropriation of our intellectual property or to deter others from developing similar products or services. Further, monitoring the unauthorized use of our intellectual property is difficult. Litigation may be necessary to enforce our intellectual property rights or to determine the validity and scope of the proprietary rights of others. Litigation of this type could result in substantial costs and diversion of resources, may result in counterclaims or other claims against us and could significantly harm our results of operations. In addition, the laws of some foreign countries do not protect our proprietary rights to the same extent as do the laws of the United States.

 

As is commonplace in technology companies, we employ individuals who were previously employed at other technology companies. To the extent our employees are involved in research areas that are similar to those areas in which they were involved at their former employers, we may be subject to claims that such employees or we have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of the former employers. Litigation may be necessary to defend against such claims. Litigation of this type could result in substantial costs to us and divert our resources.

 

We also depend on trade secret protection through confidentiality and license agreements with our employees, subsidiaries, licensees, licensors and others. We may not have agreements containing adequate protective provisions in every case, and the contractual provisions that are in place may not provide us with adequate protection in all circumstances. The unauthorized reproduction or other misappropriation of our intellectual property could diminish the value of our brand, competitive advantages or goodwill and result in decreased sales.

 

We may incur substantial costs or lose important rights as a result of litigation or other proceedings relating to our products, patents and other intellectual property rights.

 

In recent years, there has been significant litigation involving patents and other intellectual property rights in many technology-related industries. Until recently, patent applications were retained in secrecy by the US Patent and Trademark Office until and unless a patent was issued. As a result, there may be US patent applications pending of which we are unaware that may be infringed by the use of our technology or a part thereof, thus substantially interfering with the future conduct of our business. In addition, there may be issued patents in the United States or other countries that are pertinent to our business of which we are not aware. We and our customers could be sued by other parties for patent infringement in the future. Such lawsuits could subject us and them to liability for damages or require us to obtain additional licenses that could increase the cost of our products, which might have an adverse effect on our sales.

 

In addition, in the future we may assert our intellectual property rights by instituting legal proceedings against others. We may not be able to successfully enforce our patents in any lawsuits we may commence. Defendants in any litigation we may commence to enforce our patents may attempt to establish that our patents are invalid or are unenforceable. Any patent litigation could lead to a determination that one or more of our patents are invalid or unenforceable. If a third party succeeds in invalidating one or more of our patents, we may experience greater competition from such party and from others. Our ability to derive sales from products or technologies covered by these patents could be adversely affected.

 

23

 

 

Whether we are defending the assertion of third party intellectual property rights against our business as a result of the use of our technology, or we are asserting our own intellectual property rights against others, such litigation can be complex, costly, protracted and highly disruptive to our business operations by diverting the attention and energies of management and key technical personnel. As a result, the pendency or adverse outcome of any intellectual property litigation to which we are subject could disrupt business operations, require the incurrence of substantial costs and subject us to significant liabilities, each of which could severely harm our business.

 

Plaintiffs in intellectual property cases often seek injunctive relief. Any intellectual property litigation commenced against us could force us to take actions that could be harmful to our business and thus to our sales, including the following:

 

● discontinuing selling the products that incorporate or otherwise use technology that contains our allegedly infringing intellectual property;

 

● attempting to obtain a license to the relevant third party intellectual property, which may not be available on reasonable terms or at all; or

 

● attempting to redesign our products to remove our allegedly infringing intellectual property.

 

If we are forced to take any of the foregoing actions, we may be unable to sell products that incorporate our technology at a profit or at all. Furthermore, the measure of damages in intellectual property litigation can be complex, and is often subjective or uncertain. If we were to be found liable for infringement of proprietary rights of a third party, the amount of damages we might have to pay could be substantial and is difficult to predict. Decreased sales of our products incorporating our technology would adversely affect our results of operations. Any necessity to procure rights to the third party technology might cause us to negotiate the royalty terms of the third party license which could increase our cost of production or, in certain cases, terminate our ability to build some of our products entirely.

 

Our failure to renew, register or otherwise protect our trademarks could have a negative impact on the value of our brand names and our ability to use those names in certain geographical areas.

 

We believe our copyrights and trademarks are integral to our success. We rely on trademark, copyright and other intellectual property laws to protect our proprietary rights. If we fail to properly register and otherwise protect our trademarks, service marks and copyrights, we may lose our rights, or our exclusive rights, to them. In that case, our ability to effectively market and sell our products and services could suffer, which could harm our business.

 

RISKS RELATED TO OUR SECURITIES AND OTHER RISKS

 

Our stock price may be volatile, and the value of our common stock may decline.

 

We cannot predict the prices at which our common stock will trade. Factors that could cause fluctuations in the trading price of our common stock include the following:

 

  actual or anticipated fluctuations in our financial condition or results of operations;
     
  variance in our financial performance from expectations of securities analysts;
     
  changes in the pricing of the solutions on our platforms;
     
  changes in our projected operating and financial results;
     
  changes in laws or regulations applicable to our platforms;

 

24

 

 

  announcements by us or our competitors of significant business developments, acquisitions or new offerings;
     
  sales of shares of our common stock by us or our shareholders;
     
  significant data breaches, disruptions to or other incidents involving our platforms;
     
  our involvement in litigation;
     
  conditions or developments affecting the AR and VR industries;
     
  future sales of our common stock by us or our stockholders, as well as the anticipation of lock-up releases;
     
  changes in senior management or key personnel;
     
  the trading volume of our common stock;
     
  changes in the anticipated future size and growth rate of our market;
     
  general economic and market conditions; and
     
  other events or factors, including those resulting from war, incidents of terrorism, global pandemics or responses to these events.

 

Broad market and industry fluctuations, as well as general economic, political, regulatory and market conditions, may also negatively impact the market price of our common stock. In addition, technology stocks have historically experienced high levels of volatility. In the past, companies who have experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future, which could result in substantial expenses and divert our management’s attention.

 

If securities or industry analysts do not publish research or publish unfavorable or inaccurate research about our business, the market price and trading volume of our common stock could decline.

 

The market price and trading volume of our common stock may be heavily influenced by the way analysts interpret our financial information and other disclosures. We do not have control over these analysts. If few securities analysts commence coverage of us, or if industry analysts cease coverage of us, our stock price could be negatively affected. If securities or industry analysts do not publish research or reports about our business, downgrade our common stock, or publish negative reports about our business, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our stock price to decline and could decrease the trading volume of our common stock.

 

We do not intend to pay dividends for the foreseeable future and, as a result, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.

 

We have never declared or paid any cash dividends on our capital stock, and, subject to the discretionary dividend policy described in Part II, Item 5 of this report, we do not intend to pay any cash dividends in the foreseeable future. Any determination to pay dividends in the future will be at the discretion of our board of directors. Accordingly, you may need to rely on sales of our common stock after price appreciation, which may never occur, as the only way to realize any future gains on your investment.

 

Costs as a result of operating as a public company are significant, and our management is required to devote substantial time to compliance with our public company responsibilities and corporate governance practices.

 

As a public company, we incur significant legal, accounting, insurance, investor relations and other expenses that we did not incur as a private company, which we expect to further increase after we are no longer an “emerging growth company.” The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Capital Market, and other applicable securities rules and regulations impose various requirements on public companies. Our management and other personnel devotes a substantial amount of time to compliance with these requirements. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly.

 

25

 

 

An active trading market for our securities may not exist, which would adversely affect the liquidity and price of our securities.

 

The price of our securities may vary significantly due to results of operation, general market or economic conditions. Furthermore, an active trading market for our securities may not exist or be sustained. You may be unable to sell your securities unless a market can be established and sustained.

 

The requirements of being a public company may strain our resources and distract our management, which could make it difficult to manage our business, particularly after we are no longer an “emerging growth company.”

 

We are required to comply with various regulatory and reporting requirements, including those required by the SEC. Complying with these reporting and other regulatory requirements is time-consuming and results in increased costs to us and could have a negative effect on our results of operations, financial condition or business.

 

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) and the requirements of the Sarbanes-Oxley Act. These requirements may place a strain on our systems and resources. The Exchange Act requires that we file annual, quarterly and current reports with respect to our business and financial condition. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal controls over financial reporting. To maintain and improve the effectiveness of our disclosure controls and procedures, we need to commit significant resources, hire additional staff and provide additional management oversight. We will be implementing additional procedures and processes for the purpose of addressing the standards and requirements applicable to public companies. Sustaining our growth also will require us to commit additional management, operational and financial resources to identify new professionals to join our firm and to maintain appropriate operational and financial systems to adequately support expansion. These activities may divert management’s attention from other business concerns, which could have a material adverse effect on our results of operations, financial condition or business.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

None.

 

ITEM 2. PROPERTIES

 

We are based in New York, New York. Our current facilities are leased and adequate to meet our ongoing needs. If we require additional space or expand geographically, we may seek additional facilities on commercially reasonable terms at such time. Due to Covid-19 constraints, in March 2020 our personnel began working primarily on a remote basis, without detrimental effects. We returned to partial in person work in July 2021 and expect to continue as such for the foreseeable future, subject to Covid-19 developments.

 

We also lease an office in Fort Wort, Texas and several small offices in Turkey for the operations of Glimpse Turkey.

 

ITEM 3. LEGAL PROCEEDINGS

 

We are not a party to any material pending legal proceedings.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable

 

26

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Information with Respect to our Common Stock

 

Our common stock is traded on the Nasdaq Capital Market, LLC, or Nasdaq, and began trading on July 1, 2021 under the symbol “VRAR”.

 

Holders of Record

 

As of September 20, 2022, we had approximately 7,700 shareholders of record.

 

Recent Sales of Unregistered Securities

 

None.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

Dividends

 

We have never declared or paid cash dividends on our capital stock. Although we currently intend to retain all available funds and future earnings, if any, to fund the development and expansion of our business, we are committed, subject to the limitations on distributions under Nevada law, to pay certain distributions in the event (i) we sell the business of any of our subsidiaries; or (ii) we report consolidated net income on our fiscal year end audited financial statements. No assurances can be made that any such milestone will be achieved or if achieved that our Board of Directors will approve any distribution in connection therewith.

 

Distribution upon sale of business. In the event we sell all or substantially all of the business of any of our subsidiaries, whether by means of a merger, asset sale, stock sale or otherwise, for a price in excess of $10,000,000, we may distribute no less than 85% of the after-tax net proceeds for such sale. However, such distribution shall be subject to a determination by our Board of Directors that there exist no special circumstances that would prevent it from approving such distribution or the extent thereof. Such special circumstances could include, but not be limited to, the Company or any of its subsidiary companies contemplating or actively being engaged in a prospective acquisition or acquisitions that may require the use of such net proceeds, or other uses integral to the operations, growth or business development of any existing subsidiary company. Moreover, such distribution may be waived, in writing, by the holders of a majority of our securities holders entitled to vote, voting together as a single class.

 

Distribution of consolidated net income. In the event our annual audited financial statements report consolidated net income, we may distribute, within 90 days after completion of such audit, 10% of the consolidated net income for such fiscal year. However, such distribution shall be subject to a determination by our Board of Directors that there exist no special circumstances that would prevent it from approving such distribution or the extent thereof. Such special circumstances could include, but not be limited to, the Board of Directors determining that such distribution, which could have otherwise been reinvested into our existing businesses, would impair our ability to execute on our business strategy. Moreover, such distribution may be waived, in writing, by the holders of a majority of our securities holders entitled to vote, voting together as a single class.

 

Subject to the distribution intentions discussed above, any future determination regarding the declaration and payment of dividends, if any, will be subject to the limitations on distributions under Nevada law, will be at the discretion of our board of directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects, and other factors our board of directors may deem relevant. In addition, our ability to pay dividends may be restricted by any agreements we may enter into in the future.

 

27

 

 

ITEM 6. [RESERVED]

 

Not required.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The objective of this Management’s Discussion and Analysis is to allow investors to view the Company from management’s perspective, considering items that would have a material impact on future operations. The following discussion and analysis of the results of operations and financial condition of The Glimpse Group, Inc. and its wholly owned subsidiaries (collectively referred to as “Glimpse” or the “Company”) as of and for the years ended June 30, 2022 and 2021 should be read in conjunction with our consolidated financial statements and the notes to those consolidated financial statements that are included elsewhere in this Annual Report. References in this Management’s Discussion and Analysis of Financial Condition and Results of Operations to “us”, “we”, “our” and similar terms refer to the Company. This Management’s Discussion and Analysis of Financial Condition and Results of Operations contains statements that are forward-looking. These statements are based on current expectations and assumptions that are subject to risk, uncertainties and other factors. These statements are often identified by the use of words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate,” or “continue,” and similar expressions or variations. Actual results could differ materially because of the factors discussed in “Risk Factors” elsewhere in this Annual Report, and other factors that we may not know.

 

Overview

 

We are a Virtual (“VR”) and Augmented (“AR”) Reality platform company, comprised of a diversified group of wholly-owned VR and AR companies, providing enterprise-focused software, services and solutions. We believe that we offer significant exposure to the rapidly growing and potentially transformative VR and AR immersive technology markets, while mitigating downside risk via our diversified model and ecosystem.

 

The Company was incorporated as The Glimpse Group, Inc. in the State of Nevada, on June 15, 2016 and is headquartered in New York, New York. Glimpse currently owns and operates numerous subsidiary companies (“Subsidiary Companies”, “Subsidiaries”): Adept Reality, LLC (dba Adept XR Learning), QReal, LLC (dba QReal), KreatAR, LLC (dba Post Reality), D6 VR, LLC, Immersive Health Group, LLC (dba IHG), Foretell Studios, LLC (dba Foretell Reality), Number 9, LLC (dba Pagoni VR), Early Adopter, LLC, MotionZone, LLC (dba AUGGD), Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey), XR Terra, LLC, Sector 5 Digital, LLC (“S5D”), PuploAR, LLC (a subsidiary company of QReal) and, as of August 1, 2022, Brightline Interactive, LLC (“BLI”). In addition, we own one inactive subsidiary company, In-It VR, LLC (dba Mezmos), which may be reactivated based on need and market conditions and a legal entity in Australia - Glimpse Group Australia Pty Ltd.

 

Glimpse’s ecosystem of VR/AR subsidiary companies, collaborative environment and diversified business model aim to simplify the challenges faced by entrepreneurs in the emerging VR/AR industry, potentially improving each subsidiary company’s ability to succeed, while simultaneously providing investors an opportunity to invest directly into the emerging VR/AR industry via a diversified platform.

 

Leveraging its platform, the Company strives to cultivate and manage the business operations of its VR/AR subsidiary companies, with the goal of allowing each underlying company to better focus on mission-critical endeavors, collaborate with the other subsidiary companies, reduce time to market, optimize costs, improve product quality and leverage joint go-to-market strategies. Subject to operational, market and financial developments and conditions, Glimpse intends to carefully add to its current portfolio of subsidiary companies via a combination of organic expansion and/or outside acquisitions.

 

Glimpse’s subsidiary companies target a wide array of industry verticals, including but not limited to: Corporate Training, Education, Healthcare, Branding & Marketing, Retail, Financial Services, Food & Hospitality, Media & Entertainment and Social VR group meetings. The Company does not currently target direct-to-consumer (“B2C’) customers, focusing primarily on the business-to-business (“B2B”) and business-to-business-to-consumer (“B2B2C”) segments. In addition, we are hardware agnostic.

 

28

 

 

We currently have approximately 200 full time employees, primarily software developers, engineers and 3D artists. Of these, approximately 100 are based in the US and 100 internationally (primarily in Turkey).

 

Impact of COVID-19

 

In January 2020, an outbreak of a new strain of coronavirus, COVID-19, was identified in Wuhan, China. Through the first quarter of 2020, the disease became widespread around the world, and on March 11, 2020, the World Health Organization declared a pandemic.

 

The COVID-19 pandemic caused significant business and financial markets disruption worldwide and there was significant uncertainty around the duration of this disruption and its ongoing effects on our business. For our business specifically, this primarily manifested itself in prolonged sales cycles which generally increased by several months. In addition, some of our customers put purchase decisions on hold, in particular customers in our hospital and education segments. These have since recovered to varying extents.

 

We continue to monitor the situation and the effects on our business and operations. While some level of potential uncertainty remains, given the current state of the pandemic our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 to be material to our business and operations.

 

The following information should be read in conjunction with our Consolidated Financial Statements and related notes contained in this Annual Report.

 

Critical Accounting Policies and Estimates and Recent Accounting Pronouncements

 

Basis of Presentation

 

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). While our significant accounting policies are more fully described in our financial statements, we believe the following accounting policies are the most critical to aid in fully understanding and evaluating this management discussion and analysis.

 

Principles of Consolidation

 

The consolidated financial statements include the balances of the Company and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Accounting Estimates

 

The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, warrants, revenue recognition, cost of goods sold and allocation of the purchase price of assets relating to business combinations.

 

Business Combinations

 

The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred.

 

The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows. Estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.

 

29

 

 

Intangible assets (other than Goodwill)

 

Intangibles represent the allocation of a portion of an acquisitions purchase price. Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets. The Company reviews intangibles, being amortized, for impairment when current events indicate that the fair value may be less than the carrying value.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Goodwill is not amortized but instead is tested at least annually for impairment, or more frequently when events or changes in circumstances indicate that goodwill might be impaired.

 

Fair Value of Financial Instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy, which is based on three levels of inputs, the first two of which are considered observable and the last unobservable, that may be used to measure fair value, is as follows:

 

● Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities;

 

● Level 2 — inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

 

● Level 3 — unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The Company classifies its cash equivalents and investments within Level 1 of the fair value hierarchy on the basis of valuations based on quoted prices for the specific securities in an active market.

 

The Company’s contingent consideration is categorized as Level 3 within the fair value hierarchy. Contingent consideration is recorded within contingent consideration, current and contingent consideration, non-current in the Company’s consolidated balance sheets as of June 30, 2022 and 2021. Contingent consideration has been recorded at its fair values using unobservable inputs and have included using the Monte Carlo simulation option pricing framework, incorporating contractual terms and assumptions regarding financial forecasts, discount rates, and volatility of forecasted revenue. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist.

 

The Company’s other financial instruments consist primarily of accounts receivable, note receivable, accounts payable, accrued liabilities and other liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximated fair value due to its short-term nature and market rate of interest.

 

30

 

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured.

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A portion of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. Other contracts can include various services and products which are at times capable of being distinct, and therefore may be accounted for as separate performance obligations.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

For distinct performance obligations recognized at a point in time, any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue/contract liabilities and deferred costs/contract costs, respectively, in the accompanying consolidated balance sheets. Contract assets include cash and equity based payroll costs, and may include payments to consultants and vendors.

 

For distinct performance obligations recognized over time, the Company records a contract asset (costs in excess of billings) when revenue is recognized prior to invoicing, or a contract liability (billings in excess of costs) when revenue is recognized subsequent to invoicing.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

31

 

 

Revenue for a significant portion of Software Services projects and solutions (projects whereby, the development of the project leads to an identifiable asset with an alternative use to the Company) is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project. Certain other Software Services revenues are custom project solutions (projects whereby, the development of the custom project leads to an identifiable asset with no alternative use to the Company, and, in which, the Company also has an enforceable right to payment under the contract) and are therefore recognized based on the percentage of completion using an input model with a master budget. The budget is reviewed periodically and percentage of completion adjusted accordingly.

 

Revenue for Software Services consulting services and website maintenance is recognized when the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are significant contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the nascent industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Reclassifications

 

Certain accounts in the prior period financial statements have been reclassified for comparative purposes to conform with the presentation in the current period financial statements.

 

Recently Issued Pronouncements

 

Leases

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (Topic 842). The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of, a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company plans to adopt this standard on July 1, 2022. The Company does not anticipate this adoption will have a material effect on its consolidated financial statements.

 

32

 

 

Financial Instruments – Credit Losses

 

In June 2016, the Financial Accounting Standards Board (the “FASB”) issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to calculate credit loss estimates (Accounting Standards Codification – “ASC” 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Highlights

 

RESULTS OF OPERATIONS FOR THE YEARS ENDED JUNE 30, 2022 AND 2021

 

Summary P&L

 

   For the Year Ended         
   June 30,   Change 
   2022   2021   $   % 
   (in millions)     
Revenue  $7.27   $3.42   $3.85    113%
Cost of Goods Sold   1.24    1.46    (0.22)   -15%
Gross Profit   6.03    1.96    4.07    208%
Total Operating Expenses   12.37    7.91    4.46    56%
Loss from Operations before Other Income (Expense)    (6.34)   (5.95)   (0.39)   7%
Other Income (Expense), net   0.38    (0.14)   0.52    -371%
Net Loss  $(5.96)  $(6.09)  $0.13    -2%

 

Revenue

 

   For the Year Ended         
   June 30,   Change 
   2022   2021   $   % 
   (in millions)     
Software Services  $6.72   $3.08   $3.64    118%
Software License/Software as a Service   0.55    0.34    0.21    62%
Total Revenue  $7.27   $3.42   $3.85    113%

 

Total revenue for the year ended June 30, 2022 was approximately $7.27 million compared to approximately $3.42 million for the year ended June 30, 2021, an increase of approximately 113%. This growth was due to the addition of new subsidiaries, new customers and increased business with existing customers.

 

33

 

 

We break out our revenues into two main categories – Software Services and Software License.

 

  Software Services revenues are primarily comprised of VR/AR projects, services related to our software licenses and consulting retainers.

 

  Software License revenues are comprised of the sale of our internally developed VR/AR software as licenses or as software-as-a-service (“SaaS”).

 

For the year ended June 30, 2022, Software Services revenue was approximately $6.72 million compared to approximately $3.08 million for the year ended June 30, 2021, an increase of approximately 118%. This growth was due to the addition of new subsidiaries, new customers and increased business with existing customers.

 

For the year ended June 30, 2022, Software License revenue was approximately $0.55 million compared to approximately $0.34 for the year ended June 30, 2021, an increase of approximately 62%. As the VR and AR industries continue to mature, we expect our Software License revenue to continue to grow on an absolute basis and as an overall percentage of total revenue.

 

For the year ended June 30, 2022, non-project revenue (i.e., VR/AR software and services revenue only), was approximately $4.18 million compared to approximately $1.72 million for the year ended June 30, 2021, an increase of approximately 143%. For the year ended June 30, 2022, non-project revenue accounted for approximately 58% of total revenues compared to approximately 50% for the year ended June 30, 2021.

 

Cost of Revenue

 

Cost of revenue for the year ended June 30, 2022 was $1.24 million compared to $1.46 million for the year ended June 30, 2021, a decrease of approximately 15%. Lower cost of revenue was driven by the increase in higher margin non-project revenue and expanded utilization of our Turkey based staff.

 

For the year ended June 30, 2022, our gross profit was approximately $6.03 million representing a gross profit margin of approximately 83%, compared to a gross profit of approximately $1.96 million representing a gross profit margin of approximately 57% for the year ended June 30, 2021. The increase in gross profit margin was primarily due to an increase in non-project revenue, improved project management and expanded utilization of Turkey based staff.

 

For the year ended June 30, 2022 and 2021, internal staffing was approximately $1.02 million (82% of total cost of revenue) and approximately $1.35 million (92% of total cost of revenue), respectively. The decrease in internal staffing as a percentage of total cost of revenue was due to the addition of S5D revenue from February 1, 2022, which has a larger component of external staffing.

 

Operating Expenses

 

   For the Year Ended         
   June 30,   Change 
   2022   2021   $   % 
   (in millions)     
Research and development expenses  $6.16   $3.18   $2.98    94%
General and administrative expenses   4.93    2.21    2.72    123%
Sales and marketing expenses   3.14    1.27    1.87    147%
Additional asset purchase consideration   0.57    1.25    (0.68)   -54%
Change in fair value of acquisition contingent consideration   (2.43)   -    (2.43)   NA 
Total Operating Expenses   12.37    7.91    4.46    56%

 

34

 

 

Operating expenses for the year ended June 30, 2022 were approximately $12.37 million compared to $7.91 million for the year ended June 30, 2021, an increase of approximately 56%, primarily due to increases in research and development, general and administrative, and sales and marketing expenses. These increases are driven by the four acquisitions in fiscal year 2022, associated infrastructure to support a greater revenue base and the increased expenses attributable to operations of a public company commencing July 1, 2021.

 

Research and Development

 

Research and development expenses for the year ended June 30, 2022 were approximately $6.16 million compared to $3.18 million for the year ended June 30, 2021, an increase of approximately 94%. This increase is primarily driven by increased headcount to support increased revenue, software product development, and four acquisitions made in fiscal year 2022.

 

For the year ended June 30, 2022, non-cash stock option expenses relating to research and development included approximately $1.47 million of employee compensation expenses, comprising approximately 24% of total research and development expenses. For the year ended June 30, 2021, non-cash stock option expenses relating to research and development included approximately $1.38 million of employee compensation expenses, comprising approximately 43% of total research and development expenses. Over time, we expect non-cash stock options research and development expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash in compensation.

 

General and Administrative

 

General and administrative expenses for the year ended June 30, 2022 were approximately $4.93 million compared to $2.21 million for the year ended June 30, 2021, an increase of approximately 123%. The increase is driven by acquisition related expenses (professional fees and intangible asset amortization), public company related expenses (directors’ and officers’ insurance, investor relations, listing fees and expanded board of directors), increased headcount and infrastructure expenses related to support increased revenue and four acquisitions made in fiscal year 2022.

 

For the year ended June 30, 2022, non-cash stock option and common stock expenses relating to general and administrative expenses included approximately $0.89 million of employee, board of directors and other compensation expenses, comprising approximately 18% of total general and administrative expenses. For the year ended June 30, 2021, non-cash stock option and common stock expenses relating to general and administrative expenses included approximately $0.62 million of employee, board of directors and other compensation expenses, comprising approximately 28% of total general and administrative expenses. Over time, we expect non-cash stock options and common stock general and administrative expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash in compensation.

 

Sales and Marketing

 

Sales and marketing expenses for the year ended June 30, 2022 were approximately $3.14 million compared to $1.27 million for the year ended June 30, 2021, an increase of approximately 147%. The increase was primarily due to increased headcount to support increased revenue and four acquisitions made in fiscal year 2022.

 

For the year ended June 30, 2022, non-cash stock option and common stock expenses relating to sales and marketing included approximately $0.68 million of employee, vendor and fee compensation expenses, comprising approximately 22% of total sales and marketing expenses. For the year ended June 30, 2021, non-cash stock option and common stock expenses relating to sales and marketing included approximately $0.55 million of employee, vendor and fee compensation expenses, comprising approximately 43% of total sales and marketing expenses. Over time, we expect non-cash stock options and common stock sales and marketing expenses, as a percentage of the total related expenses, to continue to decrease as we utilize a larger portion of cash in compensation.

 

35

 

 

Additional Asset Purchase Consideration

 

Additional asset purchase consideration expenses for the year ended June 30, 2022 were approximately $0.57 million compared to $1.25 million for the year ended June 30, 2021, a decrease of approximately 54%. The expense in 2022 represents additional purchase consideration related to the purchase of AUGGD. The expense in 2021 represents additional purchase consideration triggered in that fiscal year as a result of the Company’s IPO related to the purchase of QReal and Post Reality prior to 2021.

 

Change in Fair Value of Acquisition Contingent Consideration

 

Change in fair value of acquisition contingent consideration expense for the year ended June 30, 2022 was approximately $2.43 million of income, compared to none for the year ended June 30, 2021. The gain in 2022 represents a decrease in the fair value of contingent consideration liability related to the S5D acquisition between acquisition closing date, February 1, 2022 and June 30, 2022. The change is primarily driven by the decrease in the common stock price of Glimpse during that period.

 

Other Income (Expense)

 

   For the Year Ended         
   June 30,   Change 
   2022   2021   $   % 
   (in millions)     
Forgiveness of Paycheck Protection Program loans  $0.62   $0.55   $0.07    13%
Interest income   0.03    0.01    0.02    200%
Interest expense   -    (0.18)   0.18    NA 
Loss on conversion of convertible notes   (0.28)   (0.52)   0.24    -46%
Total Other Income (Expense), net   0.37    (0.14)   0.51    364%

 

Other income (expense), net for the year ended June 30, 2022 consisted of other net income of approximately $0.37 million compared to other net expense of approximately $0.14 million for the year ended June 30, 2021, an increase of greater than 100%. The increase was primarily due to a reduction in interest expense (pre-IPO notes were converted to equity at IPO) and a decrease in the loss on conversion of convertible notes in fiscal year 2022 versus fiscal year 2021.

 

Net loss

 

For the years ended June 30, 2022 and 2021, loss from operations before other income (expense) were approximately $6.34 million and $5.95 million, respectively, an increase of approximately 7% year-over-year, primarily driven by an increase in operating expenses outpacing an increase in revenue and gross profit.

 

For the year ended June 30, 2022, we incurred a net loss of approximately $5.96 million compared to a net loss of approximately $6.09 million for the year ended June 30, 2021, an improvement of approximately 2% year-over-year, primarily driven by increases in revenue, gross profit and other income (expense) outpacing growth in operating expenses.

 

Non-GAAP Financial Measures

 

The following discussion and analysis includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to, and should not be considered as alternatives to, net income, operating income, and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of the Company nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.

 

36

 

 

Our management uses and relies on EBITDA and Adjusted EBITDA, which are non-GAAP financial measures. We believe that both management and shareholders benefit from referring to the following non-GAAP financial measures in planning, forecasting and analyzing future periods. Our management uses these non-GAAP financial measures in evaluating its financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the described excluded items.

 

The Company defines Adjusted EBITDA as earnings (or loss) from continuing operations before the items in the table below. Adjusted EBITDA is an important measure of our operating performance because it allows management, investors and analysts to evaluate and assess our core operating results from period-to-period after removing the impact of items of a non-operational nature that affect comparability.

 

We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between the Company and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measures and the corresponding GAAP measures provided by each company under applicable SEC rules.

 

The following table presents a reconciliation of net loss to Adjusted EBITDA for the years ended June 30, 2022 and 2021:

 

   For the Year Ended 
   June 30, 
   2022   2021 
   (in millions) 
Net loss  $(5.97)  $(6.09)
Interest expense   -    0.18 
Depreciation and amortization   0.54    0.03 
EBITDA (loss)   (5.43)   (5.88)
Stock based compensation expenses   3.08    3.08 
Stock based financing related expenses   0.28    0.52 
Stock based acquisition contingent consideration costs   0.57    1.36 
Acquisition expenses   0.58    - 
Non cash change in fair value of acquisition contingent consideration   (2.43)   - 
Forgiveness of Paycheck Protection Program loans   (0.62)   (0.55)
Adjusted EBITDA (loss)  $(3.97)  $(1.47)

 

Fiscal Year 2022 Adjusted EBITDA loss increased by $2.5 million compared to that of Fiscal Year 2021. This reflects operating expenses outpacing revenue and gross profit driven by the four acquisitions made in fiscal year 2022, associated infrastructure to support a greater revenue base and the increased expenses attributable to operations of a public company commencing July 1, 2021.

 

37

 

 

Liquidity and Capital Resources

 

   For the Year Ended         
   June 30,   Change 
   2022   2021   $   % 
   (in millions)     
Net cash used in operating activities  $(4.94)  $(1.21)  $(3.73)   -308%
Net cash used in investing activities   (5.06)   (0.03)   (5.03)   16800%
Net cash provided by financing activities   26.48    1.97    24.51    1244%
Net increase (decrease) in cash and cash equivalents   16.48    0.73    15.75    -2158%
Cash, cash equivalents and restricted cash, beginning of year   1.77    1.04    0.73    70%
Cash, cash equivalents and restricted cash, end of period  $18.25   $1.77   $16.48    931%

 

Operating activities

 

Net cash used in operating activities for the year ended June 30, 2022 was approximately $4.94 million, compared to approximately $1.21 million for the year ended June 30, 2021, reflecting operating expenses outpacing revenue and gross profit driven by the four acquisitions made in fiscal year 2022, associated infrastructure to support a greater revenue base and the increased expenses attributable to operations of a public company commencing July 1, 2021.

 

Investing activities

 

Net cash used in investing activities for the year ended June 30, 2022 was approximately $5.06 million compared to approximately $28,000 for the year ended June 30, 2021. The increase primarily represents cash paid for acquisitions, along with increased purchase of equipment for additional infrastructure and purchase of investments.

 

Financing activities

 

Cash flow provided from financing activities during the year ended June 30, 2022 was $26.48 million, compared to $1.97 million for the prior period. 2022 reflects the net proceeds from our IPO and SPA common stock transactions and exercise of stock options offset by issuance of a note receivable. 2021 financing activities reflect proceeds from convertible promissory notes, proceeds from a Paycheck Protection Plan loan and issuance of common stock to investors, offset by prepaid payments made for our IPO.

 

Capital Resources

 

As of June 30, 2022, the Company had cash and cash equivalent balances of $16.25 million, plus $0.24 million of liquid corporate bond investments. In addition, there is a $2.0 million cash escrow for contingent consideration of the S5D acquisition, payable upon achievement of S5D and the Company’s performance targets (refundable to Glimpse if targets not achieved).

 

As of June 30, 2022, the Company had no outstanding debt obligations.

 

As of June 30, 2022, the Company had no issued and outstanding preferred stock.

 

The Company believes that it is sufficiently funded to meet its operational plan and future obligations beyond the 12-month period from the date of this filing.

 

38

 

 

Emerging Growth Company Status

 

We are an “emerging growth company”, as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including, but not limited to, not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As an emerging growth company we can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We intend to avail ourselves of these options. Once adopted, we must continue to report on that basis until we no longer qualify as an emerging growth company.

 

We will cease to be an emerging growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary of our initial public offering; (ii) the first fiscal year after our annual gross revenues are $1.07 billion or more; (iii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year. We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. If, as a result of our decision to reduce future disclosure, investors find our common stock less attractive, there may be a less active trading market for our common stock and the price of our common stock may be more volatile.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

All financial information required by this Item is attached hereto at the end of this report beginning on page F-1 and is hereby incorporated by reference.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of disclosure controls and procedures. We maintain “disclosure controls and procedures,” as such term is defined in Rule 13a-15(e) and 15d-15(f) under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to provide reasonable assurance that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

Our management, with the participation of the Chief Executive Officer and the Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of such period.

 

In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, we are required to apply judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

39

 

 

Management’s report on internal control over financial reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the 2013 framework set forth in the report entitled Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). The COSO framework summarizes each of the components of a company’s internal control system, including (i) the control environment, (ii) risk assessment, (iii) control activities, (iv) information and communication, and (v) monitoring.

 

Based on our evaluation under the 2013 framework in Internal Control — Integrated Framework, our management concluded that our internal control over financial reporting was effective as of June 30, 2022.

 

Changes in Internal Control over Financial Reporting

 

During the year ended June 30, 2022, there was no change in our internal control over financial reporting or in other factors that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 9B. OTHER INFORMATION

 

None.

 

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

 

Not applicable.

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

The following table sets forth information for our executive officers and directors, their ages and position(s) with the Company.

 

Name  Age  Position
Executive Officers      
Lyron Bentovim  53  President, Chief Executive Officer and Chairman of the Board
Maydan Rothblum  49  Chief Operating Officer, Chief Financial Officer, Secretary, Treasurer, and Director
D.J. Smith  46  Chief Creative Officer and Director
Jeff Meisner  61  Chief Revenue Officer and Director
Tyler Gates  36  Chief Futurist Officer and Board Observer
Non-Executive Directors      
Sharon Rowlands  63  Independent Director
Ian Charles  54  Independent Director and Chair of Audit Committee
Jeff Enslin  55  Independent Director and Chair of Governance Committee
Lemuel Amen  56  Independent Director and Chair of Strategy Committee
Alexander Ruckdaeschel  50  Independent Director and Chair of Compensation Committee

 

Directors are elected and hold office until the next annual meeting of the stockholders of the Company and until their successors are elected. Officers are elected and serve at the discretion of the Board of Directors.

 

40

 

 

Executive Officers

 

Lyron Bentovim has been President and Chief Executive Officer since he co-founded the Company in 2016. From July 2014 to August 2015, Mr. Bentovim was Chief Operating Officer and Chief Financial Officer of Top Image Systems, a Nasdaq-listed company. From March 2013 to July 2014, Mr. Bentovim served as Chief Operating Officer and Chief Financial Officer of NIT Health and Chief Operating Officer and Chief Financial Officer and Managing Director at Cabrillo Advisors. From August 2009 until July 2012, Mr. Bentovim served as the Chief Operating Officer and Chief Financial Officer of Sunrise Telecom, Inc. a Nasdaq-listed company. Prior to Sunrise Telecom, Inc., from January 2002 to July 2009, Mr. Bentovim was a Portfolio Manager for Skiritai Capital LLC, an investment advisor. Prior to Skiritai Capital LLC, Mr. Bentovim served as the President, Chief Operating Officer and co-founder of WebBrix, Inc. Mr. Bentovim serves on the board of directors of Manhattan Bridge Capital, a Nasdaq-listed company, and has served on the board of directors of the following publicly traded companies: Blue Sphere, RTW Inc., Ault, Inc., Top Image Systems Ltd., Three-Five Systems Inc., Sunrise Telecom Inc., and Argonaut Technologies Inc. Additionally, Mr. Bentovim was a Senior Engagement Manager with strategy consultancies USWeb/CKS, Mitchell Madison Group LLC and McKinsey & Company Inc. Mr. Bentovim has an MBA from Yale School of Management and a law degree from the Hebrew University, Israel.

 

Maydan Rothblum has been Chief Operating Officer and Chief Financial Officer since he co-founded the Company in 2016 and a member of our board of directors since July 2021. From 2004 to 2016, Mr. Rothblum served as the co-founder, Managing Director and Chief Operating Officer of Sigma Capital Partners, a middle-market private equity firm focused on making negotiated investments directly onto the balance sheets of, primarily, small-to-mid sized publicly traded technology companies. In addition to his role as principal investor, Mr. Rothblum oversaw the fund’s portfolio, managed the fund’s day-to-day operations and financial reporting. Prior to working at Sigma Capital Partners, Mr. Rothblum held positions at Apax Partners, a global private equity fund, and Booz, Allen & Hamilton, a global strategic consultancy. Additionally, Mr. Rothblum served as an Engineer for the Israel Defense Forces. Mr. Rothblum holds an MBA from Columbia Business School and a BS in Industrial Engineering and Management from the Technion - Israel Institute of Technology.

 

D.J. Smith has been the Chief Creative Officer since he co-founded the company in 2016. Since June 2016, Mr. Smith has served as the co-founder and Organizer of NYVR Meetup. Prior to co-founding the Company, Mr. Smith served as the Senior Project Manager at Avison Young, where he managed construction and real estate development projects. From April 2016 to August 2020, Mr. Smith was the Founder of VRTech Consulting LLC, which provided consulting for real estate development projects and virtual reality. Mr. Smith holds a B.S. in Civil Engineering from Pennsylvania State University.

 

Jeff Meisner has been Chief Revenue Officer and a member of our board of directors since February 2022. Mr. Meisner is the General Manager of Sector 5 Digital, LLC a wholly owned subsidiary of the Company. From 2014 to 2022, Mr. Meisner was the CEO of S5D, an immersive technology company focused on creating innovative Virtual Reality, Augmented Reality, and other digital experiences, which was acquired by the Company, as described above. From 2001 to 2019, Mr. Meisner was Chief Executive Officer and founder of Skyline Sector 5, an experiential marketing company focused on the trade show and event industry. Prior to 2001, Mr. Meisner held various business development, operations and executive roles for a number of technology companies. Additionally, Mr. Meisner currently serves on the Board of Directors of Cristo Rey Fort Worth, a non-profit college preparatory high school for economically disadvantaged youth. Mr. Meisner holds a BASc. in Electrical Engineering from The University of Waterloo in Ontario, Canada.

 

Tyler Gates, as of August 1, 2022, is the General Manager of Brightline Interactive, LLC (BLI), a wholly owned subsidiary of the Company and serves as the Company’s Chief Futurist Officer and as a non-voting Board Observer of the board of directors. Prior to the closing of the BLI acquisition, Mr. Gates was the Chief Executive Officer of BLI, and has been with BLI in several executive leadership roles since 2012. BLI focuses on interactive, spatial and immersive VR & AR technology solutions for training, simulation and brand experiences. Additionally, Mr. Gates has been the President of the VR/AR Association (VRARA) DC’s Chapter since its inception in 2017 and is the Host of VRARA’s Everything VR/AR Podcast. VRARA is a global industry association for VR/AR/MR with local chapters in major cities around the world. Mr. Gates holds a BA Degree in Corporate Communications and Interpersonal Psychology from Lenoir-Rhyne University.

 

41

 

 

Sharon Rowlands has served as a member of our board of directors since October 2017 and was the Chair of the Company’s Compensation Committee from 2018 to 2021. She has been the Chief Executive Officer and President of Newfold Digital (previously Web.com) since 2019. She has served on the board of directors of Everbridge, Inc., a Nasdaq-listed company, since 2019. Additionally, she has served on the board of directors of Pegasystems Inc., a Nasdaq-listed company, since April 2016. She served as President of USA Today Network Marketing Solutions at Gannett Co., a Nasdaq-listed company, from October 2017 to January 2019. Previously, Ms. Rowlands served as the Chief Executive Officer and member of the Board of Directors of ReachLocal, Inc., a Nasdaq-listed company, from April 2014 to January 2019. From November 2011 to December 2013, she was the Chief Executive Officer and member of the Board of Directors of Altegrity, Inc. From October 2008 to November 2011, Ms. Rowlands was the Chief Executive Officer of Penton Media, Inc. From 1997 to 2008, Ms. Rowlands held a variety of roles including Chief Executive Officer from 2005 to 2008, at Thomson Financial Inc. Ms. Rowlands received her post graduate certificate in education from the University of London and her Bachelor of Arts in History from the University of Newcastle.

 

Ian Charles has served as a member of our board of directors since January 2022 and as the Chair of the Company’s Audit Committee since January 2022. Mr. Charles has approximately 25 years of executive leadership experience in technology, public markets, mergers and acquisitions, and multinational operations. Since 2022, Mr. Charles has served as the Chief Financial Officer of Filevine, a provider of legal SaaS solutions. From 2019 to 2021, Mr. Charles served as the Chief Financial Officer of Scoop Technologies, Inc., a workplace management software provider. From 2014 to 2019, Mr. Charles served as the Chief Financial Officer of Planful (formerly Host Analytics), a financial planning and analysis platform that provides financial planning, consolidation, reporting and analytics.

 

Jeff Enslin has served as a member our board of directors since July 2018 and as the Chair of the Company’s Governance Committee since January 2022. Mr. Enslin was previously the Chair of the Company’s Audit Committee from 2018 to 2021. From 1995 to 2018, Mr. Enslin was a senior partner and senior portfolio manager at Caxton Associates LP, a macro-focused hedge fund. Mr. Enslin is the founder and managing member of Perimetre Capital LLC since 2018, where he actively manages a wide portfolio of early stage technology investments. Mr. Enslin has served on the Investment Committees at Lehigh University (2010 to 2019) and the Peddie School (2010 to present, Advisory Trustee). Mr. Enslin is an active mentor at both Creative Destruction Labs and Endless Frontier Labs. Mr. Enslin received his MBA in finance and international business from New York University’s Stern School of Business and his B.S. in Finance from Lehigh University.

 

Lemuel Amen has served as a member of our board of directors since May 2021 and as the Chair of the Company’s Strategy Committee since January 2022. Mr. Amen is the Founder and Chairman of Altius Manufacturing Group, LLC, an equity growth management firm, and has held senior executive positions and led global business units for Electronic Data Systems (EDS) and 3M. Mr. Amen has served on the board of directors for a privately held technology firm, AbeTech Inc., since 2009, and on the board of advisors of a privately held industrial firm, Diversified Chemical Technology, Inc., since 2018. Additionally, Mr. Amen is an experienced board governance professional serving high-growth technology, industrial services, and application software firms. Prior board governance service positions include: Chairman of the board of directors for Viking Engineering and Development Inc. (2011 to 2017); board director and operating committee member for Bauer Welding & Metal Fabricators, Inc. (2013 to 2016); and board President and lead director for HighJump Software, Inc. (2005 to 2008). Mr. Amen served as Chairman for the Federal Reserve Bank of Minneapolis, Ninth District Advisory Council from 2012 to 2015. Additional governance and board director service post includes: University of Michigan – Dearborn, College of Business, Board of Advisors (2019 to present); State of Minnesota Governor’s Workforce Development Council (2016 to 2019); Ordway Center for the Performing Arts (2015 to 2018); Junior Achievement Worldwide Inc., Global Board of Directors (2003 to 2008); and Northwestern University, McCormick School of Engineering & Computer Science, Industrial Advisory Board (2000 to 2006). Mr. Amen earned his M.S. in Civil and Environmental Engineering from Northwestern University, and his B.S. in Mechanical Engineering at California State University-Northridge.

 

Alexander Ruckdaeschel has served as a member of our board of directors since July 2021 and as the Chair of the Company’s Compensation Committee since January 2022. Mr. Ruckdaeschel has worked in the financial industry for over 20 years in the U.S. and Europe as a co-founder, partner and senior executive. Since 2012 and until recently, he served on the board of directors of Vuzix, a Nasdaq listed company and a leading supplier of smart glasses and AR technology products and services and was the Chairman of Vuzix’s compensation committee. Mr. Ruckdaeschel co-founded Herakles Capital Management and AMK Capital Advisors in 2008. He was also a partner with Alpha Plus Advisors and Nanostart AG, where he was the head of their U.S. group. Mr. Ruckdaeschel has significant experience in startup operations as the manager of DAC Nanotech-Fund and Biotech-Fund, and sits on several boards. Following service in the German military, Mr. Ruckdaeschel was a research assistant at Dunmore Management focusing on intrinsic value and identifying firms that were undervalued and had global scale potential.

 

42

 

 

Committees of Our Board of Directors

 

Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. The composition and responsibilities of each of the committees of our board of directors are described below. Members serve on these committees until their resignation or until otherwise determined by our board of directors. Our board of directors may establish other committees as it deems necessary or appropriate from time to time.

 

Audit Committee

 

Our Audit Committee consists of Ian Charles, Lemuel Amen and Jeff Enslin. The Chair of our Audit Committee is Ian Charles. Our board of directors has determined that Ian Charles is an “audit committee financial expert” within the meaning of SEC regulations. Each member of our audit committee can read and understand fundamental financial statements in accordance with applicable requirements. In arriving at these determinations, our board of directors has examined each audit committee member’s scope of experience and the nature of their employment. The Board has affirmatively determined that each member of the Audit Committee meets the additional independence criteria applicable to audit committee members under Nasdaq and SEC rules.

 

The primary purpose of our audit committee is to provide assistance to the board of directors in fulfilling its oversight responsibility to the shareholders and others relating to (1) the integrity of the Company’s financial statements, (2) the effectiveness of the Company’s internal control over financial reporting, (3) the Company’s compliance with legal and regulatory requirements, and (4) the independent auditor’s qualifications and independence. Specific responsibilities of our audit committee include:

 

  Reviewing and reassessing the charter at least annually and obtaining the approval of the board of directors;
     
  Reviewing and discussing quarterly and annual audited financial statements;
     
  Discussing the Company’s policies on risk assessment and risk management;
     
  Discussing with the independent auditor the overall scope and plans for their audit, including the adequacy of staffing and budget or compensation; and
     
  Reviewing and approving related party transactions;

 

Our Audit Committee previously operated under a written charter, adopted by our board of directors on November 21, 2018. On April 14, 2021, the Board approved the adoption of our Amended and Restated Audit Committee Charter. Our Audit Committee now operates under the Amended and Restated Audit Committee Charter. Our Audit Committee will review and reassess the adequacy of the written charter on an annual basis.

 

Compensation Committee

 

Our Compensation Committee consists of Alexander Ruckdaeschel, Sharon Rowlands and Jeff Enslin. The Chair of our Compensation Committee is Alexander Ruckdaeschel. The Board has affirmatively determined that each member of the Compensation Committee meets the additional independence criteria applicable to compensation committee members under Nasdaq and SEC rules.

 

The primary purpose of our compensation committee is to discharge the responsibilities of our board of directors with respect to all forms of compensation for the Company’s executive officers and to administer the Company’s equity incentive plan for employees. Specific responsibilities of our compensation committee include:

 

  Reviewing and overseeing the Company’s overall compensation philosophy, and overseeing the development and implementation of compensation programs aligned with the Company’s business strategy;
     
  Determining the form and amount of compensation to be paid or awarded to the Chief Executive Officer (“CEO”) and all other executive officers of the Company;

 

43

 

 

  Annually reviewing and approving all matters related to CEO compensation;
     
  Reviewing, adopting, amending, and terminating incentive compensation and equity plans, severance agreements, profit sharing plans, bonus plans, change-of-control protections, and any other compensatory arrangements for our executive officers and other senior management; and
     
  Reviewing and establishing general policies relating to compensation and benefits of our employees, including our overall compensation philosophy.

 

Our Compensation Committee previously operated under a written charter, adopted by our board of directors on November 21, 2018. On April 14, 2021, the Board approved the adoption of our Amended and Restated Compensation Committee Charter. Our Compensation Committee now operates under the Amended and Restated Compensation Committee Charter. Our Compensation Committee will review and reassess the adequacy of the written charter on an annual basis.

 

Nominating and Corporate Governance Committee

 

The members of our Nominating and Corporate Governance Committee are Jeff Enslin, Alexander Ruckdaeschel and Ian Charles. Jeff Enslin serves as the Chairperson of the committee. The Nominating and Corporate Governance Committee’s responsibilities include:

 

  identifying individuals qualified to become board members;
     
  recommending to our board of directors the persons to be nominated for election or appointed as directors and to each board committee;
     
  reviewing and recommending to our board of directors corporate governance principles, procedures and practices, and reviewing and recommending to our board of directors proposed changes to our corporate governance principles, procedures and practices from time to time; and
     
  reviewing and making recommendations to our board of directors with respect to the composition, size and needs of our board of directors.

 

Our Nominating and Corporate Governance Committee operates under a written charter, adopted by our board of directors on April 14, 2021. Our Nominating and Corporate Governance Committee will review and reassess the adequacy of the written charter on an annual basis.

 

Strategy Committee

 

The members of our Strategy Committee are Lem Amen, Alexander Ruckdaeschel, Jeff Enslin and Lyron Bentovim. Lem Amen serves as the Chairperson of the Strategy Committee. The Strategy Committee’s responsibilities include:

 

 

 

identifying strategic trends within the Company and industry

 

analyzing the potential strategic impact of various financial, operational, technological and M&A alternatives

     
  reviewing and making recommendations to our board of directors with respect to the Company’s strategic directions

 

Code of Ethics

 

On April 14, 2021, our board of directors adopted our Code of Ethics and Business Conduct. The code of ethics codifies the business and ethical principles that govern all aspects of our business.

 

44

 

 

Director or Officer Involvement in Certain Legal Proceedings

 

To our knowledge, (i) no director or executive officer has been a director or executive officer of any business which has filed a bankruptcy petition or had a bankruptcy petition filed against it during the past ten years; (ii) no director or executive officer has been convicted of a criminal offense or is the subject of a pending criminal proceeding during the past ten years; (iii) no director or executive officer has been the subject of any order, judgment or decree of any court permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities during the past ten years; and (iv) no director or officer has been found by a court to have violated a federal or state securities or commodities law during the past ten years.

 

Board Leadership Structure and Role in Risk Oversight

 

Although we have not adopted a formal policy on whether the Chairman and Chief Executive Officer positions should be separate or combined, in the past we determined that it was in the best interests of the Company and its shareholders to combine these roles.

 

Our Board of Directors receives and reviews periodic reports from management, auditors, legal counsel, and others, as considered appropriate regarding our Company’s assessment of risks. Our Board of Directors focuses on the most significant risks facing our Company and our Company’s general risk management strategy and ensures that risks undertaken by us are consistent with the Board’s appetite for risk. While the Board oversees our Company’s risk management, management is responsible for day-to-day risk management processes. We believe this division of responsibilities is the most effective approach for addressing the risks facing our Company and that our board leadership structure and role in risk oversight is effective.

 

Director Compensation

 

Because we are still in the development stage, our directors do not receive any cash compensation other than reimbursement for expenses incurred during the performance of their duties or their separate duties as officers of the Company.

 

The following table sets forth information concerning equity-based compensation for the fiscal year ending June 30, 2022 of our directors serving at such time who are not also named executive officers.

 

Name  Fiscal Year   Fees Earned ($)   Option Options (1)   Stock Awards ($)   All Other Compensation ($)   Total ($) 
Sharon Rowlands   2022          $      100,000                     $100,000 
                               
Jeffrey Enslin   2022        $100,000             $100,000 
                               
Lemuel Amen   2022        $100,000             $100,000 
                               
Alexander Ruckdaeschel   2022        $100,000             $100,000 
                               
Ian Charles   2022        $96,774             $96,774 

 

(1) The amounts disclosed represent the aggregate grant date fair value of stock options granted to our named directors during Fiscal Year 2022 under the 2016 The Glimpse Group Incentive Plan. The assumptions used to compute the fair value are disclosed in Note 8 to our audited financial statements for Fiscal Year 2022. Such grant date fair values do not take into account any estimated forfeitures related to service-vesting conditions. These amounts do not reflect the actual economic value that will be realized by the named director upon the vesting of the stock options, the exercise of the stock options, or the sale of common stock acquired under such stock options.

 

45

 

 

Risk Management

 

The Company does not believe risks arising from its compensation policies and practices for its employees are reasonably likely to have a material adverse effect on the Company.

 

Director Independence

 

The Board evaluates the independence of each nominee for election as a director of our Company in accordance with the Listing Rules (the “Nasdaq Listing Rules”) of the Nasdaq Stock Market LLC (“Nasdaq”). Pursuant to these rules, a majority of our Board must be “independent directors” within the meaning of the Nasdaq Listing Rules, and all directors who sit on our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee must also be independent directors.

 

The Nasdaq definition of “independence” includes a series of objective tests, such as the director or director nominee is not, and was not during the last three years, an employee of Glimpse or our Subsidiaries and has not received certain payments from, or engaged in various types of business dealings with us. In addition, as further required by the Nasdaq Listing Rules, the Board has made a subjective determination as to each independent director that no relationships exist, which, in the opinion of the Board, would interfere with such individual’s exercise of independent judgment in carrying out his or her responsibilities as a director. In making these determinations, the Board reviewed and discussed information provided by the directors with regard to each director’s business and personal activities as they may relate to the Company and its management.

 

As a result, the Board has affirmatively determined that each of Sharon Rowlands, Ian Charles, Lemuel Amen, Jeff Enslin and Alexander Ruckdaeschel, are independent in accordance with the Nasdaq listing rules. The Board has also affirmatively determined that all members of our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee are independent directors.

 

No family relationships exist between any of our officers or directors.

 

ITEM 11. EXECUTIVE COMPENSATION

 

The following table sets forth all compensation earned in respect of our Co-Chairman, Chief Executive Officers and our Chief Financial Officer for our last three completed fiscal years.

  

46

 

 

SUMMARY COMPENSATION TABLE

 

The following is a summary of the compensation we paid for each of the last three years ended June 30, 2022 and 2021, respectively, to our Executive Officers.

 

Name and

Principal

Position

 

Fiscal

Year

   Salary   Bonus  

Stock

Awards

($)

  

Option

Award

  

Non-Equity

Incentive Plan

Compensation

($)

  

Non-Qualified

Deferred

Compensation

Earnings ($)

  

All Other

Compensation

($)

   Total 
Lyron Bentovim   2022   $257,500   $100,000    -   $-    -    -    8,417   $357,500 
President & CEO   2021   $119,061   $225,000    -   $116,202    -    -    -   $460,263 
    2020   $113,000    -    -   $151,857    -    -    -   $264,857 
    2019   $120,000    -    -   $109,633    -    -    -   $229,633 
                                              
Maydan Rothblum   2022   $227,500   $75,000    -   $-    -    -    1,175   $302,500 
CFO & COO   2021   $116,500   $175,000    -   $90,355    -    -    -   $381,855 
    2020   $113,000    -    -   $118,773    -    -    -   $231,773 
    2019   $120,000    -    -   $84,340    -    -    -   $204,340 
                                              
David J Smith CCO   2022   $205,000   $40,000    -   $-    -    -    1,188   $245,000 
    2021   $94,000    -    -   $95,217    -    -    -   $189,217 
    2020   $92,000    -    -   $79,834    -    -    -   $171,834 
    2019   $96,000    -    -   $67,464    -    -    -   $163,464 
                                              
Jeff Meisner   2022   $91,667   $-    -   $-    -    -    -   $91,667 
CRO*                                             

 

* Partial from February 1, 2022

 

Employment Agreements

 

Lyron Bentovim

 

On May 13, 2021, we entered into an executive employment agreement with Mr. Lyron Bentovim. Mr. Bentovim is one of our co-founders and has been the Company’s President and Chief Executive Officer since its inception. Mr. Bentovim’s employment agreement shall continue until terminated by either the Company or Mr. Bentovim. Pursuant to Mr. Bentovim’s employment agreement, as of the Company’s IPO on July 1, 2021, he received an annual base cash salary of $250,000, amended to $265,000 as of January 1, 2022. In addition, Mr. Bentovim will be eligible to receive performance bonuses as determined by the Compensation Committee.

 

Maydan Rothblum

 

On May 13, 2021, we entered into an executive employment agreement with Mr. Maydan Rothblum. Mr. Rothblum is one of our co-founders and has been the Company’s Chief Financial Officer and Chief Operating Officer since its inception. Mr. Rothblum’s employment agreement shall continue until terminated by either the Company or Mr. Rothblum. Pursuant to Mr. Rothblum’s employment agreement, as of the Company’s IPO on July 1, 2021 he received an annual cash base salary of $220,000, amended to $235,000 as of January 1, 2022. In addition, Mr. Rothblum will be eligible to receive performance bonuses as determined by the Compensation Committee.

 

47

 

 

David J. Smith

 

On May 13, 2021, we entered into an executive employment agreement with Mr. David J. Smith. Mr. Smith is one of our co-founders and has been the Company’s Chief Creative Officer since its inception. Mr. Smith’s employment agreement shall continue until terminated by either the Company or Mr. Smith. Pursuant to Mr. Smith’s employment agreement, as of the Company’s IPO on July 1, 2021, he received an annual cash base salary of $200,000, amended to $210,000 as of January 1, 2022. In addition, Mr. Smith will be eligible to receive performance bonuses as determined by the Compensation Committee.

 

Jeff Meisner

 

On February 1, 2022, we entered into an executive employment agreement pursuant to which Mr. Meisner, our Chief Revenue Officer, will receive a base annual salary of $220,000. In addition, Mr. Meisner will be eligible for performance bonuses in accordance with the terms and conditions of the employment agreement.

 

Tyler Gates

 

On August 1, 2022, in connection with Mr. Gates’ appointment as Chief Futurist Officer, the Company and Mr. Gates entered into an executive employment agreement pursuant to which Mr. Gates will receive a base annual salary of $215,000. In addition, Mr. Gates will be eligible for performance bonuses in accordance with the terms and conditions of the employment agreement. Mr. Gates did not receive any compensation from the Company in fiscal year 2022.

 

Equity Incentive Plan

 

In October 2016, our majority shareholders approved our Equity Incentive Plan, as amended (the “Plan”), to be administered by our compensation committee. Pursuant to the Plan, we are authorized to grant options and other equity awards to employees of the Company or any subsidiary, non-employee directors or key consultants to the Company, or a subsidiary, and any person who has been offered employment by the Company or a subsidiary, provided that such prospective employee may not receive any payment or exercise any right relating to an Award until such person has commenced employment with the Company or a subsidiary (together, the “Eligible Persons”) The purchase price of each share of common stock purchasable under an award issued pursuant to the Plan, shall be determined by our compensation committee, in its sole discretion, at the time of grant, but shall not be less than 100% of the fair market of such share of common stock on the date the award is granted, subject to adjustment. Our compensation committee shall also have sole authority to set the terms of all awards at the time of grant.

 

Pursuant to the Plan, a maximum of 10,000,000 shares of our common stock shall be set aside and reserved for issuance. In addition, subject to adjustment as provided in the Plan, the share reserve will automatically increase on January 1 of each calendar year, for the period beginning on January 1, 2022 and ending on (and including) January 1, 2030 (each, an “Evergreen Date”) in an amount equal to five percent (5%) of the total number of shares of the Company’s common stock outstanding on December 31st immediately preceding the applicable Evergreen Date (the “Evergreen Increase”). Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide that there will be no Evergreen Increase for such year, or that the Evergreen Increase for such year will be a lesser number of shares of the Company’s common stock than would otherwise occur pursuant to the preceding sentence. Any shares of Stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares. Pursuant to these provisions, effective January 1, 2022 the number of shares of our common stock set aside for the Plan automatically increased to a total of 10,624,021.

 

Under the Plan, an Eligible Person may be granted options, stock appreciation rights, restricted stock, phantom stock, sale phantom stock, stock granted as a bonus, a performance award, other stock-based awards or an annual incentive award, together with any related right or interest.

 

The term of each award under the Plan shall be for such period as may be determined by the compensation committee, subject to the express limitations set forth in the Plan.

 

Unless earlier terminated by action of the Board of Directors, the Plan will remain in effect until such time as no shares of common stock remains available for delivery under the Plan and the Company has no further rights or obligations under the Plan with respect to outstanding awards under the Plan.

 

48

 

 

Outstanding Equity Awards at Fiscal Year-End

 

The following table discloses information regarding outstanding equity awards granted or accrued as of June 30, 2022, for our named executive officers.

 

Outstanding Equity Awards
   Option Awards   Stock Awards 
Name  Number of Securities Underlying Unexercised Options (#) Exercisable   Number of Securities Underlying Unexercised Options (#) Unexercisable   Option Exercise Price   Option Expiration Date  Number of Shares or Units of Stock that have not Vested (#)   Market Value of Shares or Units of Stock that have not Vested ($) 
Lyron Bentovim   32,508         -   $4.00   09/01/28      -      - 
    10,836    -   $4.00   09/01/29   -    - 
    28,896    -   $4.50   01/01/30   -    - 
    2,333    -   $4.50   05/01/30   -    - 
    1,167    -   $4.50   07/01/30   -    - 
    14,448    -   $4.50   01/01/31   -    - 
                             
Maydan Rothblum   250,000    -   $2.50   06/20/27   -    - 
    25,008    -   $4.00   09/01/28   -    - 
    8,336    -   $4.00   09/01/29   -    - 
    22,224    -   $4.50   01/01/30   -    - 
    2,333    -   $4.50   05/01/30   -    - 
    1,167    -   $4.50   07/01/30   -    - 
    11,112    -   $4.50   01/01/31   -    - 
                             
D.J. Smith   20,004    -   $4.00   09/01/28   -    - 
    6,668    -   $4.00   09/01/29   -    - 
    14,232    -   $4.50   01/01/30   -    - 
    1,333    -   $4.50   05/01/30   -    - 
    667    -   $4.50   07/01/30   -    - 
    889    -   $4.50   11/20/30   -    - 
    11,556    -   $4.50   01/01/31   -    - 

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

 

Except as otherwise indicated below, the following table sets forth certain information regarding beneficial ownership of our common stock as of September 20, 2022 by (1) each of our current directors; (2) each of the executive officers; (3) each person known to us to be the beneficial owner of more than 5% of the outstanding shares of our common stock based upon Schedules 13G or 13D filed with the SEC; and (4) all of our directors and executive officers as a group. As of September 20, 2022, there were 13,593,734 shares of our common stock issued and outstanding.

 

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Common stock subject to options or warrants that are currently exercisable or exercisable within 60 days of September 20, 2022 are deemed to be outstanding and to be beneficially owned by the person or group holding such options or warrants for the purpose of computing the percentage ownership of such person or group, but are not treated as outstanding for the purpose of computing the percentage ownership of any other person or group. Unless otherwise indicated by footnote, to our knowledge, the persons named in the table have sole voting and sole investment power with respect to all common stock shown as beneficially owned by them, subject to applicable community property laws.

 

49

 

 

Name of Beneficial Owner 

Common Stock

Beneficially

Owned

   Percentage of Common Stock Owned 
         
Directors and Officers:          
           
Lyron L. Bentovim          
President, Chief Executive Officer
and Chairman of the Board
   1,122,258(1)   8.20%
           
Maydan Rothblum          
Chief Operating Officer, Chief Financial          
Officer, Secretary and Treasurer   796,558(2)   5.72%
           
D.J. Smith          
Chief Creative Officer and Director   1,057,647(3)   7.75%
           
Jeff Meisner          
Chief Revenue Officer and Director   79,301(4)   0.58%
           
Tyler Gates          
Chief Futurist Officer   107,143(5)   0.79%
           
Sharon Rowlands          
Director   210,531(6)   1.53%
           
Jeff Enslin          
Director and Chair of Governance Committee   432,177(7)   3.10%
           
Lemuel Amen          
Director and Chair of Strategy Committee   84,323(8)   0.62%
           
Alexander Ruckdaeschel          
Director and Chair of Compensation Committee   20,796(9)   0.15%
           
Ian Charles          
Director and Chair of Audit Committee   8,800(10)   0.06%
           
All officers and directors (7 persons)   3,919,534    26.90%
           
Beneficial owners of more than 5%          
           
VRTech Consulting LLC(11)   1,002,298    7.37%
           
Darklight Partners LLC(12)   1,001,945    7.37%
           
Braden Ferrari(13)   691,331    5.09%
           
Kissa Capital LLC(14)   898,038    6.61%

 

50

 

 

Unless otherwise indicated, the business address of each of the individuals is c/o The Glimpse Group, Inc., 15 West 38 St., 9th Floor, New York, NY 10018.

 

  (1)Includes: 1,032,070 shares of common stock, of which 1,001,945 shares are owned by Darklight Partners LLC (an entity owned and managed by Mr. Bentovim) and fully vested options to purchase 90,188 shares of common stock.
    
  (2)Includes: 476,378 shares of common stock and fully vested options to purchase 320,180 shares of common stock, An additional 3,528 shares of common stock are held by Mr. Rothblum’s mother.
    
  (3)Includes: 1,002,298 shares of common stock owned by VRTech Consulting LLC (an entity owned and managed by Mr. Smith) and fully vested options to purchase 55,349 shares of common stock.
    
  (4)Represents 79,301 shares of common stock.
    
  (5)Represents 107,143 shares of common stock.
    
  (6)Includes: 83,163 shares of common stock, 125,386 fully vested options and 1,982 options that vest within 60 days.
    
  (7)Includes: 94,774 shares owned by Perimetre Capital, LLC (an entity owned and managed by Mr. Enslin), 335,421 fully vested option and 1,982 option that vest within 60 days.
    
  (8)Includes: 60,061 shares of common stock, 22,280 fully vested options and 1,982 options that vest within 60 days.
    
  (9)Includes: 5,000 shares of common stock, 13,814 fully vested options and 1,982 options that vest within 60 days.
    
  (10)Represents 7,040 fully vested options and 1,760 options that vest within 60 days.
    
  (11)VRTech Consulting LLC is an entity owned and managed by Mr. Smith, our Chief Creative Officer and Director.
    
  (12)Darklight Partners LLC is an entity owned and managed by Mr. Bentovim, our President, Chief Executive Officer and Chairman.
    
  (13)Includes: 686,039 shares of common stock owned by Gilded Conquest LLC (an entity owned and managed by Braden Ferrari and having an address of 199 Lincoln Ave, Portsmouth, NH 03801).
    
  (14)Kissa Capital LLC is an entity managed by Ariel Imas and having an address of 1775 York Avenue, New York, NY 10128.

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

 

Related Party Transactions

 

In March 2022, the Company lent to ARI, the entity from which the assets of AUGGD were bought from, $0.25 million pursuant to a secured promissory note due March 31, 2024. The two owners of ARI are currently an employee and a non-employee advisor to the Company.

 

The note bore interest at the rate of 1% per annum and was secured by the borrower’s common shares of the Company. Any sales of the secured shares by ARI were to be used first to prepay the note. The note was repaid subsequent to June 30, 2022 and the Company recognized no interest income on the note for the year ended June 30, 2022 or thereafter.

 

The convertible promissory notes issued in 2019 and converted to common stock at the IPO included participation by the Company’s executives and independent members of the Company’s Board in the amount of $0.2 million.

 

51

 

 

Director Independence

 

The Board evaluates the independence of each nominee for election as a director of our Company in accordance with the Listing Rules (the “Nasdaq Listing Rules”) of the Nasdaq Stock Market LLC (“Nasdaq”). Pursuant to these rules, a majority of our Board must be “independent directors” within the meaning of the Nasdaq Listing Rules, and all directors who sit on our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee must also be independent directors.

 

The Nasdaq definition of “independence” includes a series of objective tests, such as the director or director nominee is not, and was not during the last three years, an employee of Glimpse or our Subsidiaries and has not received certain payments from, or engaged in various types of business dealings with us. In addition, as further required by the Nasdaq Listing Rules, the Board has made a subjective determination as to each independent director that no relationships exist, which, in the opinion of the Board, would interfere with such individual’s exercise of independent judgment in carrying out his or her responsibilities as a director. In making these determinations, the Board reviewed and discussed information provided by the directors with regard to each director’s business and personal activities as they may relate to the Company and its management.

 

As a result, the Board has affirmatively determined that each of Ian Charles, Sharon Rowlands, Lemuel Amen, Alexander Ruckdaeschel and Jeff Enslin, are independent in accordance with the Nasdaq listing rules. The Board has also affirmatively determined that all members of our Audit Committee, Nominating and Corporate Governance Committee and Compensation Committee are independent directors.

 

No family relationships exist between any of our officers or directors.

 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

 

Audit Fees

 

The following is a summary of the fees billed or expected to be billed to us for professional services rendered with respect to the fiscal years ended June 30, 2022 and 2021:

 

   For the Year Ended 
   June 30, 
   2022   2021 
Audit fees  $119,000   $68,000 
Audit fees in connection with acquisitions   127,000    - 
Other fees   62,000      
Total Fees  $308,000   $68,000 

 

Audit fees represent fees for respective fiscal year audits, including the review of our quarterly financial statements. Audit fess in connection with acquisitions represent audits of the pre-acquisition financial statements of S5D and BLI. Other Fees are for the review of our S-1, Securities Registration Statement.

 

Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors

 

Our Board of Directors has adopted a policy governing the pre-approval by the Audit Committee of all services, audit and non-audit, to be provided to our Company by our independent auditors. Under the policy, the Audit Committee has pre-approved the provision by our independent auditors of specific audit, audit related, tax and other non-audit services as being consistent with auditor independence. Requests or applications to provide services that require the specific pre-approval of Audit Committee must be submitted to the Audit committee by the independent auditors, and the independent auditors must advise the board of directors as to whether, in the independent auditor’s view, the request or application is consistent with the SEC’s rules on auditor independence.

 

The Audit Committee has considered the nature and amount of the fees billed by Hoberman & Lesser CPA’s LLP and believes that the provision of the services for activities unrelated to the audit is compatible with maintaining the independence of Hoberman & Lesser CPA’s LLP.

 

52

 

 

PART IV

 

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 

Exhibit No.   Exhibit Description
3.1   Articles of Incorporation, incorporated by reference to Exhibit 3.1 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
3.2   Amended and Restated Bylaws, incorporated by reference to Exhibit 3.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.1+   Amended and Restated 2016 Incentive Plan, incorporated by reference to Exhibit 10.1 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.2   Limited Liability Company Agreement of Number 9, LLC entered into by the Company, effective as of February 13, 2018, incorporated by reference to Exhibit 10.2 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.3   Assignment of Technology, Patent, & Intellectual Property Agreement dated as of May 1, 2019, between the Company, Adept Reality, LLC and Aquinas Learning, Inc., incorporated by reference to Exhibit 10.3 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.4   Limited Liability Company Agreement of Adept Reality, LLC (f.k.a. Glimpse Group Consulting, LLC) entered into by the Company, effective as of May 3, 2017, incorporated by reference to Exhibit 10.4 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.5   Limited Liability Company Agreement of D6 VR, LLC (f.k.a. Dataview VR, LLC) (f.k.a. Marketview VR, LLC) entered into by the Company, effective as of August 8, 2017, incorporated by reference to Exhibit 10.5 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.6   Economics Interests Agreement dated as of March 30, 2017 by and between the Company, D6 VR, LLC (f.k.a Dataview VR, LLC) (f.k.a. Marketview VR, LLC), and Andy Maggio, incorporated by reference to Exhibit 10.6 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.7   Economics Interests Agreement dated as of March 30, 2017 by and between the Company, D6 VR, LLC (f.k.a Dataview VR, LLC) (f.k.a. Marketview VR, LLC), and Brennan McTernan, incorporated by reference to Exhibit 10.7 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.8   Master Acquisition Agreement, dated as of April 1, 2018, among the Company, Early Adopter LLC, Early Adopter and Jay Van Buren, Lynn Van Buren, Marjorie Van Buren, Valerie Eakes-Kann, Joe Unander, and Christopher Gaughan, incorporated by reference to Exhibit 10.8 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021
     
10.9   Bill of Sale entered into on April 1, 2018 by and between Early Adopter, and Jay Van Buren, Lynn Van Buren, Marjorie Van Buren, Valerie Eakes-Kann, Joe Unander, and Christopher Gaughan and Early Adopter, LLC, incorporated by reference to Exhibit 10.9 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.

 

53

 

 

10.10   Limited Liability Company Agreement of Early Adopter, LLC entered into by the Company, effective as of April 1, 2018, incorporated by reference to Exhibit 10.10 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.11   Master Acquisition Agreement dated as of October 31, 2016, by and between the Company, Crafty Games, LLC and Foretell Studios, LLC (f.k.a. Dire Studios, LLC) , incorporated by reference to Exhibit 10.11 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.12   Bill of Sale entered into on October 31, 2016 by and between Crafty Games, LLC and Foretell Studios, LLC (f.k.a. Dire Studios, LLC) , incorporated by reference to Exhibit 10.12 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.13   Right of First Refusal Agreement dated as of December 30, 2019 by and between The Company and Membit Inc., incorporated by reference to Exhibit 10.13 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.14   Limited Liability Company Agreement of Immersive Health Group, LLC entered into by the Company, effective as of October 13, 2017, incorporated by reference to Exhibit 10.14 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.15   Limited Liability Company Agreement of KabaQ 3D Technologies, LLC entered into by the Company, effective as of May 30, 2017, incorporated by reference to Exhibit 10.15 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.16   Master Acquisition Agreement dated as of November 8, 2016, among the Company, KabaQ 3D Food Technologies, LLC and Alper Guler, incorporated by reference to Exhibit 10.16 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.17   Bill of Sale entered into on November 8, 2016 by and between the Company, KabaQ Food Technologies, LLC and Alper Guler, incorporated by reference to Exhibit 10.17 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.18   Master Development Agreement dated as of July 14, 2017 by and between Pandora Reality LLC and KabaQ 3D Technologies, LLC, incorporated by reference to Exhibit 10.18 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.19   Agreement entered into as of June 12, 2017 by and among the Company, KabaQ 3D Food Technologies, LLC, Alper Guler and Caner Soyer, incorporated by reference to Exhibit 10.19 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.20   Master Acquisition Agreement dated as of October 28, 2016 among the Company, PresentAR and LocateAR and Liron Lerman, incorporated by reference to Exhibit 10.20 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.21   Limited Liability Company Agreement of Kreatar LLC entered into by the Company, effective as of May 30, 2017, incorporated by reference to Exhibit 10.21 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.22   Bill of Sale entered into on October 28, 2016 by and between the Company, PresentAR and LocateAR and Liron Lerman, incorporated by reference to Exhibit 10.22 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.

 

54

 

 

10.23   Amendment to Master Acquisition Agreement II dated as of November 12, 2018 by and between the Company and Liron Lerman, incorporated by reference to Exhibit 10.23 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.24   Technology & Intellectual Property Assignability Agreement dated as of March 29, 2018 among the Company, LocateAR, LLC and Kreatar, incorporated by reference to Exhibit 10.24 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.25+   Employment Agreement dated May 13, 2021 by and between the Company and Lyron Bentovim, incorporated by reference to Exhibit 10.25 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.26+   Employment Agreement dated May 13, 2021 by and between the Company and Maydan Rothblum, incorporated by reference to Exhibit 10.26 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.27+   Employment Agreement dated May 13, 2021 by and between the Company and David J. Smith, incorporated by reference to Exhibit 10.27 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.28   Form of Series A Round Subscription Agreement, incorporated by reference to Exhibit 10.28 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021. , incorporated by reference to Exhibit 10.28 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.29   Form of Seed Round Subscription Agreement, incorporated by reference to Exhibit 10.29 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.30   Form of Interim Round Subscription Agreement, incorporated by reference to Exhibit 10.30 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.31   Form of Convertible Note I Promissory Note, incorporated by reference to Exhibit 10.31 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.32   Form of Convertible Note II Securities Purchase Agreement, incorporated by reference to Exhibit 10.32 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.33   Form of Convertible Note II Promissory Note, incorporated by reference to Exhibit 10.33 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
10.34   Placement Agent Agreement dated October 28, 2021, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on November 3, 2021.
     
10.35   Form of Securities Purchase Agreement, incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed on November 3, 2021.
     
10.36   Form of Immediately Exercisable Warrants, incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed on November 3, 2021.
     
10.37   Form of Warrants Exercisable after Six Months, incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed on November 3, 2021.
     
10.38   Form of Registration Rights Agreement, incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K filed on November 3, 2021.

 

55

 

 

10.39+   Executive Employment Agreement dated February 1, 2022, by and between the Company and Jeff Meisner, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on February 1, 2022.
     
10.40   Membership Interest sale Agreement between the Company and Sector 5 Digital, LLC, dated December 2, 2021, incorporated by reference to Exhibit 10.6 to the Quarterly Report on Form 10-Q filed on February 14, 2022.
     
10.41*  

Agreement and Plan of Merger by and among the Company, Glimpse Merger Sub, LLC, and Erik Muendel, the Bradley S. Nierenberg Trust, Bruce Gates, Joyce Gates, Barton Gates and Tyler Gates (each a “Seller” and, collectively, the “Sellers”), Bruce Gates, solely in his capacity as representative of Sellers, and Brightline Interactive, LLC, a Virginia limited liability company (“BLI”) dated May 25, 2022.

     
10.42+  

Executive Employment Agreement dated August 1, 2022 by and between the Company and Tyler Gates, incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed on August 2, 2022.

 

14.1   Code of Ethics, incorporated by reference to Exhibit 14.1 of the Company’s Amendment No. 5 to the Registration Statement filed with the SEC on June 23, 2021.
     
21.1*   List of Subsidiaries

 

31.1*   Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2*   Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1**   Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
     
104   Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

 

+ Indicates management contract or compensatory plan or arrangement.

 

* Filed herewith.

 

** Furnished herewith.

 

ITEM 16. FORM 10-K SUMMARY

 

None.

 

56

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  THE GLIMPSE GROUP, INC.
September 28, 2022  
     
  By: /s/ Lyron Bentovim
    Lyron Bentovim
    Chief Executive Officer and Chairman
(Principal Executive Officer)
     
  By: /s/ Maydan Rothblum
    Maydan Rothblum
   

Chief Financial Officer and Director

(Principal Financial and Accounting Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Date   Name and Title   Signature
         
September 28, 2022   Lyron Bentovim   /s/ Lyron Bentovim
    President Chief Executive Officer & Chairman    
         
September 28, 2022   Maydan Rothblum   /s/ Maydan Rothblum
    Chief Financial Officer, Chief Operating Officer, Secretary, Treasurer & Director    
         
September 28, 2022   Jeff Meisner   /s/ Jeff Meisner
    Chief Revenue Officer & Director    
         
September 28, 2022   D.J. Smith   /s/ D.J. Smith
    Chief Creative Officer & Director    
         
September 28, 2022   Sharon Rowlands   /s/ Sharon Rowlands
    Director    
         
September 28, 2022   Jeff Enslin   /s/ Jeff Enslin
    Director    
         
September 28, 2022   Lemuel Amen   /s/ Lemuel Amen
    Director    
         
September 28, 2022   Alexander Ruckdaeschel   /s/ Alexander Ruckdaeschel
    Director    
         
September 28, 2022   Ian Charles   /s/ Ian Charles
    Director    

 

57

 

 

THE GLIMPSE GROUP, INC.

 

CONSOLIDATED FINANCIAL STATEMENTS

 

FOR THE YEARS ENDED JUNE 30, 2022 AND 2021

 

 

 

 

THE GLIMPSE GROUP, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

  Page
Index to Consolidated Financial Statements F-1
Independent Auditor’s Report (PCAOB ID: 694) F-2
Consolidated Balance Sheets F-3
Consolidated Statements of Operations F-4
Consolidated Statements of Stockholders’ Deficit F-5
Consolidated Statements of Cash Flows F-6
Notes to Consolidated Financial Statements F-7 - F-29

 

F-1

 

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Stockholders of

The Glimpse Group, Inc.

 

Opinion on the Consolidated Financial Statements

 

We have audited the accompanying consolidated balance sheets of The Glimpse Group, Inc. (the “Company”) as of June 30, 2022 and 2021, and the related consolidated statements of operations, stockholders’ equity (deficit) and cash flows for each of the years in the two-year period ended June 30, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2022 and 2021, and the results of its operations and its cash flows for each of the years in the two-year period ended June 30, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

 

We have served as the Company’s auditor since 2019.

Hoberman & Lesser CPA’s, LLP

New York NY

September 28, 2022

 

MGI Worldwide is a network of independent audit, tax, accounting and consulting firms. MGI Worldwide does not provide any services and its member firms are not an international partnership. Each member firm is a separate entity and neither MGI Worldwide nor any member firm accepts responsibility for the activities, work, opinions or services of any other member firm. For more information visit www.mgiworld.com/legal  

 

F-2

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED BALANCE SHEETS

 

           
   As of June 30, 
   2022   2021 
ASSETS          
Cash and cash equivalents  $16,249,666   $1,771,929 
Investments   239,314    - 
Accounts receivable   1,332,922    626,244 
Deferred costs/contract assets   39,484    29,512 
Prepaid expenses and other current assets   479,483    281,047 
Pre-offering costs   -    470,136 
Total current assets   18,340,869    3,178,868 
           
Equipment, net   245,970    42,172 
Note receivable   250,000    - 
Intangible assets, net   4,063,485    - 
Goodwill   13,464,760    - 
Other assets   32,000    - 
Restricted cash   2,000,000      
Total assets  $38,397,084   $3,221,040 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)          
Accounts payable  $340,139   $381,510 
Accrued liabilities   188,417    168,745 
Accrued bonuses   169,262    440,357 
Deferred revenue/contract liabilities   841,389    98,425 
Asset purchase payable   734,037    - 
Contingent consideration for acquisitions, current portion   1,966,171    1,250,000 
Total current liabilities   4,239,415    2,339,037 
           
Long term liabilities          
Contingent consideration for acquisition, net of current portion   5,340,800    - 
Paycheck Protection Program loan   -    623,828 
Convertible promissory notes, net   -    1,429,953 
Total liabilities   9,580,215    4,392,818 
Commitments and contingencies          
Stockholders’ Equity (Deficit)          
Preferred Stock, par value $0.001 per share, 20 million shares authorized; 0 shares issued and outstanding   -    - 
Common Stock, par value $0.001 per share, 300 million shares authorized; 12,747,624 and 7,579,285 issued and outstanding   12,749    7,580 
Additional paid-in capital   56,885,815    20,936,050 
Accumulated deficit   (28,081,695)   (22,115,408)
Total stockholders’ equity (deficit)   28,816,869    (1,171,778)
Total liabilities and stockholders’ equity (deficit)  $38,397,084   $3,221,040 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

 

           
   For the Years Ended 
   June 30, 
   2022   2021 
Revenue        
Software services  $6,720,416   $3,082,528 
Software license/software as a service   547,197    338,967 
Total Revenue   7,267,613    3,421,495 
Cost of goods sold   1,241,149    1,461,210 
Gross Profit   6,026,464    1,960,285 
Operating expenses:          
Research and development expenses   6,158,395    3,183,055 
General and administrative expenses   4,931,877    2,210,811 
Sales and marketing expenses   3,141,033    1,267,088 
Additional asset purchase consideration   568,571    1,250,000 
Change in fair value of acquisition contingent consideration   (2,430,800)   - 
Total operating expenses   12,369,076    7,910,954 
Loss from operations before other income (expense)   (6,342,612)   (5,950,669)
           
Other income (expense)          
Forgiveness of Paycheck Protection Program loan   623,828    548,885 
Interest income   32,227    6,202 
Interest expense   -    (180,641)
Loss on conversion of convertible notes   (279,730)   (515,464)
Total other income (expense), net   376,325    (141,018)
Net Loss  $(5,966,287)  $(6,091,687)
           
Basic and diluted net loss per share  $(0.51)   (0.84)
Weighted-average shares used to compute basic and diluted net loss per share   11,731,383    7,259,249 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

THE GLIMPSE GROUP, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR YEARS ENDED JUNE 30, 2022 and 2021

 

                          
   Common Stock  

Additional

Paid-In

   Accumulated     
   Shares   Amount   Capital   Deficit   Total 
Balance as of July 1, 2020   7,035,771   $7,036   $15,710,996   $(16,023,721)  $(305,689)
Sales of common stock to investors   76,891    77    345,933    -    346,010 
Common stock issued for convertible note conversion   332,063    332    1,486,727    -    1,487,059 
Common stock issued to satisfy contingent liability   13,435    13    67,162    -    67,175 
Common stock issued to employees for compensation   18,553    19    92,746    -    92,765 
Common stock issued to convertible promissory note holders for prepaid interest   29,500    30    147,471         147,501 
Common stock issued to convertible promissory note holders as additional consideration   44,250    44    192,347         192,391 
Common stock issued to vendors for compensation   28,822    29    134,387    -    134,416 
Stock option-based compensation expense   -    -    2,576,058    -    2,576,058 
Stock option-based board of directors expense   -    -    182,223    -    182,223 
Net loss   -    -    -    (6,091,687)   (6,091,687)
Balance as of June 30, 2021   7,579,285    7,580    20,936,050    (22,115,408)   (1,171,778)
Common stock issued in Initial Public Offering, net   1,912,500    1,913    11,819,451    -    11,821,364 
Common stock issued in Securities Purchase Agreement, net   1,500,000    1,500    13,576,900    -    13,578,400 
Common stock issued for convertible note conversion   324,150    324    1,605,852    -    1,606,176 
Common stock issued for acquisitions   388,342    388    3,346,915    -    3,347,303 
Common stock issued for legacy acquisition obligation   452,978    453    1,249,547    -    1,250,000 
Common stock issued to vendors for compensation   19,753    20    198,207    -    198,227 
Common stock issued for exercise of options   559,775    560    1,325,484    -    1,326,044 
Stock based compensation expense   10,841    11    2,348,460    -    2,348,471 
Stock option-based board of directors expense   -    -    478,949    -    478,949 
Net loss   -    -    -    (5,966,287)   (5,966,287)
Balance as of June 30, 2022   12,747,624   $12,749   $56,885,815   $(28,081,695)  $28,816,869 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

THE GLIMPSE GROUP, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS

 

           
   For the Years Ended June 30, 
   2022   2021 
Cash flows from operating activities:          
Net loss  $(5,966,287)  $(6,091,687)
Adjustments to reconcile net loss to net cash used in operating activities:          
Amortization and depreciation   540,196    27,054 
Common stock and stock option based compensation for employees and board of directors   2,893,297    2,945,487 
Accrued common stock issuance for additional asset acquisition consideration   568,571    1,250,000 
Issuance of common stock to vendors as compensation   188,336    134,416 
Loss on conversion of convertible notes   279,730    515,464 
Forgiveness of Paycheck Protection Program loan   (623,828)   (548,885)
Acquisition contingent consideration fair value adjustment   (2,430,800)   - 
Amortization of paid-in kind common stock interest on convertible notes   -    180,642 
Issuance of common stock to employees to satisfy contingent liability   -    92,765 
Issuance of common stock for additional cost to satisfy contingent liability   -    20,217 
           
Changes in operating assets and liabilities:          
Accounts receivable   (295,076)   (411,571)
Deferred costs/contract assets   (17,900)   136,925 
Prepaid expenses and other current assets   (330,496)   (25,933)
Pre-offering costs   470,136    - 
Other assets   (32,000)   - 
Accounts payable   (132,032)   260,002 
Accrued liabilities   (73,475)   97,068 
Accrued bonuses   (271,095)   440,357 
Deferred revenue/contract liabilities   291,858    (231,937)
Net cash used in operating activities   (4,940,865)   (1,209,616)
Cash flow from investing activities:          
Purchases of equipment   (201,998)   (28,003)
Acquisitions, net of cash acquired   (4,615,894)   - 
Purchase of investments   (239,314)   - 
Net cash used in investing activities   (5,057,206)   (28,003)
Cash flows from financing activities:          
Proceeds from initial public offering, net   11,821,364    - 
Proceeds from securities purchase agreement, net   13,578,400    - 
Proceeds from exercise of stock options   1,326,044    - 
Issuance of note receivable   (250,000)   - 
Proceeds from Paycheck Protection Program loan   -    623,828 
Proceeds from convertible promissory notes   -    1,475,000 
Proceeds from issuance of common equity to investors   -    346,010 
Pre-offering costs incurred   -    (470,136)
Net cash provided by financing activities   26,475,808    1,974,702 
           
Net change in cash, cash equivalents and restricted cash   16,477,737    737,083 
Cash, cash equivalents and restricted cash, beginning of year   1,771,929    1,034,846 
Cash, cash equivalents and restricted cash, end of year  $18,249,666   $1,771,929 
Non-cash Investing and Financing activities:          
Common stock issued for S5D acquisition  $2,297,303   $- 
Common stock issued for asset acquisitions  $1,050,000   $- 
Common stock to be issued for asset acquisitions  $734,037   $- 
Conversion of convertible promissory notes into common stock  $1,606,176   $1,487,059 
Contingent acquisition consideration liability  $6,738,400   $- 
Forgiveness of Paycheck Protection Program loan  $623,828   $548,885 
Issuance of warrants in connection with initial public offering  $522,360   $- 
Issuance of warrants in connection with securities purchase agreement  $8,797,546   $- 
Issuance of common stock for satisfaction of legacy acquisition liability  $1,250,000   $- 
Common stock issued to convertible note holders as additional compensation  $-   $192,347 
Common stock issued for interest paid-in kind on convertible notes  $-   $147,471 
Issuance of common stock for satisfaction of contingent liability  $-   $46,958 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

NOTE 1. DESCRIPTION OF BUSINESS

 

The Glimpse Group, Inc. (“Glimpse” and together with its wholly owned subsidiaries, collectively, the “Company”) is a Virtual (VR) and Augmented (AR) Reality company, comprised of a diversified portfolio of wholly owned VR and AR software and services companies. Glimpse’s subsidiary companies are located in the United States, Turkey and Australia. The Company was incorporated in the State of Nevada in June 2016.

 

Glimpse’s robust VR/AR ecosystem, collaborative environment and business model strive to simplify the many challenges faced by companies in an emerging industry. Glimpse cultivates, optimizes and manages business operations while providing a strong network of professional relationships, thereby allowing the subsidiary company to maximize their time and resources in pursuit of mission-critical endeavors, reducing time to market, optimizing costs, improving product quality and leveraging joint go-to-market strategies, while simultaneously providing investors an opportunity to invest directly into the VR/AR industry via a diversified platform.

 

The Company completed an initial public offering (“IPO”) of its common stock on the Nasdaq Capital Market Exchange (“Nasdaq”) on July 1, 2021, under the ticker VRAR. In addition, pursuant to a Securities Purchase Agreement (“SPA”) the Company sold additional common stock to certain institutional investors in November 2021. See Note 9.

 

NOTE 2. LIQUIDITY AND CAPITAL RESOURCES

 

The Company incurred losses of $5.97 million and $6.09 million during the years ended June 30, 2022 and 2021, respectively. These losses were incurred as the Company funded operational expenses, primarily research and development, general and administrative, and sales and marketing costs.

 

On July 1, 2021 the Company completed an IPO in which, as a result of the sale of its common shares at $7.00 per share, it raised approximately $11.8 million in net proceeds after fees and expenses. See Note 9. Furthermore, in November 2021 the Company completed a SPA whereby it sold additional common shares that resulted in approximately $13.6 million in net proceeds after fees and expenses. See Note 9.

 

The Company expects to continue to generate net losses for the foreseeable future as it makes investments to grow its business. Management believes that the Company’s existing balances of cash and cash equivalents, which are approximately $11.5 million, will be sufficient to meet its anticipated cash requirements for at least twelve months from the date that these financial statements are issued. However, should the Company’s current cash and cash equivalents not be sufficient to support the development of its business to the point at which it has positive cash flows from operations, the Company plans to meet its future needs for additional capital through equity and/or debt financings. Equity financings may include sales of common stock. Such financing may not be available on terms favorable to the Company, or at all. If the Company is unable to obtain adequate financing or financing on terms satisfactory to it when required, the Company’s ability to continue to support its business growth, scale its infrastructure, develop product enhancements and to respond to business challenges could be significantly impaired.

 

NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”).

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the balances of Glimpse and its wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

F-7

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Use of Accounting Estimates

 

The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the accompanying consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

The principal estimates relate to the valuation of allowance for doubtful accounts, common stock, stock options, warrants, revenue recognition, cost of goods sold and allocation of the purchase price of assets relating to business combinations.

 

Cash and Cash Equivalents, Restricted cash

 

Cash and cash equivalents consist of cash and deposits in bank checking accounts with immediate access and cash equivalents that represent highly liquid investments.

 

Restricted cash represents escrowed cash related to the Sector 5 Digital, LLC acquisition (see Note 4).

 

The components of cash, cash equivalents and restricted cash on the consolidated statement of cash flows as of June 30, 2022 and 2021 are as follows:

 

         
   As of June 30, 
   2022   2021 
Cash and cash equivalents  $16,249,666   $1,771,929 
Restricted cash   2,000,000    - 
Total  $18,249,666   $1,771,929 

 

Accounts Receivable

 

Accounts receivable consists primarily of amounts due from customers under normal trade terms. Allowances for uncollectible accounts are provided for based upon a variety of factors, including historical amounts written-off, an evaluation of current economic conditions, and assessment of customer collectability. As of June 30, 2022 and 2021 no allowance for doubtful accounts was recorded as all amounts were considered collectible.

 

Customer Concentration and Credit Risk

 

Two customers accounted for approximately 54% (40% and 14%, respectively) of the Company’s total gross revenues during the year ended June 30, 2022. One of the same customers and a different customer accounted for approximately 49% (26% and 23%, respectively) of the Company’s total gross revenues during the year ended June 30, 2021.

 

Two customers accounted for approximately 59% (37% and 22%, respectively) of the Company’s accounts receivable at June 30, 2022. One of the same customers and a different customer accounted for approximately 71% (57% and 14%, respectively) of the Company’s accounts receivable at June 30, 2021.

 

The Company maintains cash in accounts that, at times, may be in excess of the Federal Deposit Insurance Corporation limit. The Company has not experienced any losses on such accounts.

 

F-8

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Equipment, net

 

Equipment is stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. The costs of improvements and betterments are capitalized and expenditures for repairs and maintenance are expensed in the period incurred.

 

The Company assesses the recoverability of equipment whenever events or changes in circumstances indicate that their carrying value may not be recoverable. There was no impairment of equipment for the periods presented.

 

Business Combinations

 

The results of a business acquired in a business combination are included in the Company’s consolidated financial statements from the date of the acquisition. Purchase accounting results in assets and liabilities of an acquired business generally being recorded at their estimated fair values as of the acquisition date. Any excess consideration over the fair value of assets acquired and liabilities assumed is recognized as goodwill. Acquisition-related expenses are recognized separately from the business combination and are expensed as incurred.

 

The Company performs valuations of assets acquired and liabilities assumed and allocates the purchase price to its respective assets and liabilities. Determining the fair value of assets acquired and liabilities assumed may require management to use significant judgment and estimates, including the selection of valuation methodologies, estimates of future revenues, costs and cash flows. Estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, which is typically one year from the acquisition date, if new information is obtained about facts and circumstances that existed as of the acquisition date, changes in the estimated values of the net assets recorded may change the amount of the purchase price allocated to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statement of operations. At times, the Company engages the assistance of valuation specialists in concluding on fair value measurements in connection with determining fair values of assets acquired and liabilities assumed in a business combination.

 

Intangible assets (other than Goodwill)

 

Intangibles represent the allocation of a portion of the acquisitions purchase price (see Note 5). Intangibles are stated at allocated cost less accumulated amortization. Amortization is computed using the straight-line method over the estimated useful lives of the related assets. The Company reviews intangibles, being amortized, for impairment when current events indicate that the fair value may be less than the carrying value.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations accounted for under the acquisition method. Goodwill is not amortized but instead is tested at least annually for impairment, or more frequently when events or changes in circumstances indicate that goodwill might be impaired.

 

F-9

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Fair Value of Financial Instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy, which is based on three levels of inputs, the first two of which are considered observable and the last unobservable, that may be used to measure fair value, is as follows:

 

● Level 1 — quoted prices (unadjusted) in active markets for identical assets or liabilities;

 

● Level 2 — inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; or

 

● Level 3 — unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The Company classifies its cash equivalents and investments within Level 1 of the fair value hierarchy on the basis of valuations based on quoted prices for the specific securities in an active market.

 

The Company’s contingent consideration is categorized as Level 3 within the fair value hierarchy. Contingent consideration is recorded within contingent consideration, current and contingent consideration, non-current in the Company’s consolidated balance sheets as of June 30, 2022 and 2021. Contingent consideration has been recorded at its fair values using unobservable inputs and have included using the Monte Carlo simulation option pricing framework, incorporating contractual terms and assumptions regarding financial forecasts, discount rates, and volatility of forecasted revenue. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist.

 

The Company’s other financial instruments consist primarily of accounts receivable, note receivable, accounts payable, accrued liabilities and other liabilities approximate fair value due to the short-term nature of these instruments. The Company’s convertible debt approximated fair value due to its short-term nature and market rate of interest.

 

Revenue Recognition

 

Nature of Revenues

 

The Company reports its revenues in two categories:

 

  Software Services: Virtual and Augmented Reality projects, solutions and consulting services.
  Software License and Software-as-a-Service (“SaaS”): Virtual and Augmented Reality software that is sold either as a license or as a SaaS subscription.

 

The Company applies the following steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  identify the contract with a customer;
  identify the performance obligations in the contract;
  determine the transaction price;
  allocate the transaction price to performance obligations in the contract;
  recognize revenue as the performance obligation is satisfied;
  determine that collection is reasonably assured.

 

F-10

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Revenue is recognized when the Company satisfies its performance obligation under the contract by transferring the promised product to its customer or service is performed and collection is reasonably assured. A performance obligation is a promise in a contract to transfer a distinct product or service to a customer. A portion of the Company’s contracts have a single performance obligation, as the promise to transfer products or services is not separately identifiable from other promises in the contract and, therefore, not distinct. Other contracts can include various services and products which are at times capable of being distinct, and therefore may be accounted for as separate performance obligations.

 

Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services. As such, revenue is recorded net of returns, allowances, customer discounts, and incentives. Sales taxes and other taxes are excluded from revenues.

 

For distinct performance obligations recognized at a point in time, any unrecognized portion of revenue and any corresponding unrecognized expenses are presented as deferred revenue/contract liability and deferred costs/contract asset, respectively, in the accompanying consolidated balance sheets. Contract assets include cash and equity based payroll costs, and may include payments to consultants and vendors.

 

For distinct performance obligations recognized over time, the Company records a contract asset (costs in excess of billings) when revenue is recognized prior to invoicing, or a contract liability (billings in excess of costs) when revenue is recognized subsequent to invoicing.

 

Significant Judgments

 

The Company’s contracts with customers may include promises to transfer multiple products/services. Determining whether products/services are considered distinct performance obligations that should be accounted for separately versus together may require significant judgment. Further, judgment may be required to determine the standalone selling price for each distinct performance obligation.

 

Disaggregation of Revenue

 

The Company generated revenue for the years ended June 30, 2022 and 2021 by delivering: (i) Software Services, consisting primarily of VR/AR software projects, solutions and consulting services, and (ii) Software Licenses & SaaS, consisting primarily of VR and AR software licenses or SaaS. The Company currently generates its revenues primarily from customers in the United States.

 

Revenue for a significant portion of Software Services projects and solutions (projects whereby, the development of the project leads to an identifiable asset with an alternative use to the Company) is recognized at the point of time in which the customer obtains control of the project, customer accepts delivery and confirms completion of the project. Certain other Software Services revenues are custom project solutions (projects whereby, the development of the custom project leads to an identifiable asset with no alternative use to the Company, and, in which, the Company also has an enforceable right to payment under the contract) and are therefore recognized based on the percentage of completion using an input model with a master budget. The budget is reviewed periodically and percentage of completion adjusted accordingly.

 

Revenue for Software Services consulting services and website maintenance is recognized when the Company performs the services, typically on a monthly retainer basis.

 

Revenue for Software License is recognized at the point of time in which the Company delivers the software and customer accepts delivery. If there are significant contractually stated ongoing service obligations to be performed during the term of the Software License or SaaS contract, then revenues are recognized ratably over the term of the contract.

 

F-11

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Timing of Revenue

 

The timing of revenue recognition for the years ended June 30, 2022 and 2021 was as follows:

 

           
   For the Years Ended 
   June 30, 
   2022   2021 
Products and services transferred at a point in time  $5,181,482   $2,967,586 
Products and services transferred/recognized over time   2,086,131    453,909 
Total Revenue  $7,267,613   $3,421,495 

 

Remaining Performance Obligations

 

Timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally records a receivable/contract asset when revenue is recognized prior to invoicing, or deferred revenue/contract liability when revenue is recognized subsequent to invoicing.

 

For certain Software Services project contracts the Company invoices customers after the project has been delivered and accepted by the customer. Software Service project contracts typically consist of designing and programming software for the customer. In most cases, there is only one distinct performance obligation, and revenue is recognized upon completion, delivery and customer acceptance. Contracts may include multiple distinct projects that can each be implemented and operated independently of subsequent projects in the contract. In such cases, the Company accounts for these projects as separate distinct performance obligations and recognizes revenue upon the completion of each project or obligation, its delivery and customer acceptance.

 

For contracts recognized over time, contract liabilities include billings invoiced for software projects for which the contract’s performance obligations are not complete.

 

For certain other Software Services project contracts, the Company invoices customers for a substantial portion of the project upon entering into the contract due to their custom nature and revenue is recognized based upon percentage of completion. Revenue recognized subsequent to invoicing is recorded as a deferred revenue/contract liability (billings in excess of cost) and revenue recognized prior to invoicing is recorded as a deferred cost/contract asset (cost in excess of billings).

 

For Software Services consulting or retainer contracts, the Company generally invoices customers monthly at the beginning of each month in advance for services to be performed in the following month. The sole performance obligation is satisfied when the services are performed. Software Services consulting or retainer contracts typically consist of ongoing support for a customer’s software or specified business practices.

 

For Software License contracts, the Company generally invoices customers when the software has been delivered to and accepted by the customer, which is also when the performance obligation is satisfied. For SaaS contracts, the Company generally invoices customers in advance at the beginning of the service term.

 

For multi-period Software License contracts, the Company generally invoices customers annually at the beginning of each annual coverage period. Software License consist of providing clients with software designed by the Company. For Software License contracts, there are generally no ongoing support obligations unless specified in the contract (becoming a Software Service).

 

Unfulfilled performance obligations represent amounts expected to be earned by the Company on executed contracts. As of June 30, 2022, the Company had approximately $2.61 million in unfulfilled performance obligations.

 

F-12

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Employee Stock-Based Compensation

 

The Company recognizes stock-based compensation expense related to grants to employees or service providers based on grant date fair values of common stock or the stock options, which are amortized over the requisite period, as well as forfeitures as they occur.

 

The Company values the options using the Black-Scholes Merton (“Black Scholes”) method utilizing various inputs such as expected term, expected volatility and the risk-free rate. The expected term reflects the application of the simplified method, which is the weighted average of the contractual term of the grant and the vesting period for each tranche. Expected volatility is derived from a weighted average of volatility inputs for the Company since its IPO. Prior to its IPO, expected volatility is derived from a weighted average of volatility inputs for comparable software and technology service companies. The risk-free rate is based on the implied yield of U.S. Treasury notes as of the grant date with a remaining term approximately equal to the expected life of the award.

 

Research and Development Costs

 

Research and development expenses are expensed as incurred, and include payroll, employee benefits and stock-based compensation expense. Research and development expenses also include third-party development and programming costs. Given the emerging industry and uncertain market environment the Company operates in, research and development costs are not capitalized.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, or ASC 740, also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s consolidated financial statements. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial position.

 

The Company’s policy for recording interest and penalties associated with audits is to record such expense as a component of income tax expense. There were no amounts accrued for penalties or interest for the years ended June 30, 2022 and 2021. Management is currently unaware of any issues under review that could result in significant payments, accruals or material deviations from its position.

 

F-13

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Earnings Per Share

 

Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential shares of common stock outstanding during the period using the treasury stock method. Dilutive potential common shares include the issuance of potential shares of common stock for outstanding stock options, warrants and convertible debt.

 

Reclassifications

 

Certain accounts in the prior period financial statements have been reclassified for comparative purposes to conform with the presentation in the current period financial statements.

 

Recent Accounting Pronouncements

 

Leases

 

In February 2016, the FASB issued Accounting Standards Update No. 2016-02, Leases (Topic 842). The amendments under this pronouncement will change the way all leases with durations of one year or more are treated. Under this guidance, lessees will be required to capitalize virtually all leases on the balance sheet as a right-of-use asset and an associated financing lease liability or capital lease liability. The right-of-use asset represents the lessee’s right to use, or control the use of a specified asset for the specified lease term. The lease liability represents the lessee’s obligation to make lease payments arising from the lease, measured on a discounted basis. Based on certain characteristics, leases are classified as financing leases or operating leases. Financing lease liabilities, those that contain provisions similar to capitalized leases, are amortized in the same manner as capital leases are amortized under current accounting rules, as amortization expense and interest expense in the statement of operations. Operating lease liabilities are amortized on a straight-line basis over the life of the lease as lease expense in the statement of operations. The Company plans to adopt this standard on July 1, 2022. The Company does not anticipate this adoption will have a material effect on its consolidated financial statements.

 

Financial Instruments – Credit Losses

 

In June 2016, the FASB issued a new standard to replace the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to calculate credit loss estimates (ASC 326). The Company will be required to use a forward-looking expected credit loss model for accounts receivable, notes receivable, loans, and other financial instruments. Credit losses relating to available-for-sale debt securities, if any, will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

Income Taxes

 

In December 2019, the FASB issued ASU 2019-12 to simplify the accounting in ASC 740, Income Taxes. This standard removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. This guidance also clarifies and simplifies other areas of ASC 740. The Company does not expect to adopt this standard prior to July 1, 2023. The Company is currently evaluating the impact of this standard on its consolidated financial statements.

 

F-14

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

NOTE 4. ACQUISITIONS

 

Purchase of S5D

 

In December 2021, Glimpse entered into a Membership Interest Sale Agreement (the “Agreement”), with Sector 5 Digital, LLC (“S5D”) and each of the equity holders of S5D named therein (collectively, the “Members”). S5D is an enterprise focused, immersive technology company that combines innovative storytelling with emerging technologies for industry leading organizations. The acquisition significantly expands the Company’s operating and financial scale, introduces new tier 1 customers specifically in the defense contractor and industrial segments, and bolsters the executive management team.

 

In February 2022, S5D became a wholly-owned subsidiary of Glimpse.

 

The aggregate consideration consisted of: (a) $4.0 million cash paid at the February 1, 2022 closing (the “Closing”); (b) 277,201 shares of the Company’s common stock valued at the date of acquisition (escrowed and valued at $4.0 million at the time the Agreement was entered) and released from escrow to the Members at Closing; and (c) future purchase price considerations (“contingent consideration”) payable to the Members, up to $19.0 million ($2.0 million of which was escrowed at Closing and is recorded as Restricted cash on the June 30, 2022 balance sheet). The $19.0 million is based and payable on S5D’s and the Company’s achievement of certain revenue growth milestones during the three years post-Closing, as defined, the payment of which shall be made up to $2.0 million in cash and the remainder in common stock of the Company, priced at the dates of the future potential share issuance and subject to a common stock floor price of $7.00/share.

 

The fair value allocation for the purchase price consideration paid at close was recorded as follows:

 

Purchase price consideration:    
Cash paid to members at closing  $4,000,000 
Company common stock fair value when released from escrow at closing   2,297,303 
Fair value of contingent consideration to be achieved   9,169,200 
Total purchase price  $15,466,503 
      
Fair value allocation of purchase price:     
Cash and cash equivalents  $184,106 
Accounts receivable   411,602 
Other current assets   10,259 
Equipment, net   60,479 
Other assets   9,246 
Accounts payable and accrued expenses   (183,806)
Contract liability (billings in excess of cost)   (451,106)
Intangible assets - customer relationships   2,820,000 
Goodwill   12,605,723 
   $15,466,503 

 

The Company’s fair value estimate of the contingent consideration for the S5D acquisition was determined using a Monte Carlo simulation method which accounts for the probabilities of various outcomes. The Company’s fair value estimate related to the identified intangible asset of customer relationships was determined using the Multi-Period Excess Earnings Method. This valuation method requires management to project revenues, customer attrition and cash flows for the reporting unit over a multiyear period, as well as determine the weighted average cost of capital to be used as a discount rate.

 

The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and will be deductible for tax purposes.

 

F-15

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

In accordance with GAAP, the fair value of the contingent consideration was remeasured at June 30, 2022, based on market conditions as of that date. The remeasurement resulted in a fair value amount at June 30, 2022 of $6.74 million, a reduction of approximately $2.43 million since Closing. The reduction in fair value of the contingent consideration is driven by a reduction in the Company’s common stock price between the measurement dates. This reduction is recorded in operating expenses on the consolidated statement of operations.

 

Unaudited Pro Forma Results

 

The unaudited pro forma financial information in the table below summarizes the combined results of operations for Glimpse and S5D, as if the companies were combined for the years ended June 30, 2022 and 2021. The unaudited pro forma financial information includes the business combination accounting effects resulting from this acquisition, including adjustments to reflect recognition of intangible asset amortization. The unaudited pro forma financial information as presented below is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved if the acquisitions had taken place at July 1, 2020.

 

The approximate unaudited pro forma financial information if S5D was included since July 1, 2020 would be:

 

           
   For the Year Ended June 30, 
   2022   2021 
         
Revenue  $9,768,000   $5,973,000 
Net loss  $(5,841,000)  $(6,685,000)

 

The pro forma net loss was adjusted to exclude approximately $182,000 of acquisition-related costs incurred in 2022. The 2022 pro forma net loss includes a gain of approximately $2.43 million for contingent consideration fair value adjustments.

 

Costs related to the acquisition, which include legal, accounting and valuation fees, in the amount of approximately $182,000 have been charged directly to operations and are included in 2022 general and administrative expenses on the consolidated statements of operations.

 

The Company recognized approximately $1,395,000 in revenue and $1,784,000 (inclusive of contingent consideration fair value adjustment gain of $2,430,800) of net income related to S5D since the acquisition Closing date of February 1, 2022 through June 30, 2022 in the consolidated statement of operations.

 

AUGGD Asset Acquisition

 

In August 2021, the Company, through its wholly owned subsidiary company, MotionZone, LLC (dba AUGGD), completed an acquisition of certain assets, as defined, from Augmented Reality Investments Pty Ltd (“ARI”), an Australia based company providing augmented reality software and services. Over time, the acquisition may facilitate the Company’s endeavors in the Architecture, Engineering and Construction market segments.

 

Initial consideration for the purchase was $0.75 million payable in Company common stock. In August 2021, the Company issued 77,264 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through June 2024, which were not expected at time of purchase. Potential future common stock issuance shall be priced at the dates of the future potential share issuance and subject to a common stock floor price of $7.00/share. If this subsidiary is sold within three years from the acquisition date, certain performance related consideration will be accelerated and become due even if not earned.

 

F-16

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

No liabilities were assumed as part of the acquisition and the primary assets acquired included employees, customer relationships and technology. The Company recorded the purchase price allocation as follows:

 

      
Intangible assets:    
Customer relationships  $250,000 
Technology   250,000 
Goodwill   250,000 
Total  $750,000 

 

The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and will be deductible for tax purposes.

 

In June 2022, AUGGD achieved its initial revenue threshold as defined in the asset acquisition agreement, and was issued shares of Company stock in July 2022 reflecting the payment of additional asset acquisition consideration. This additional consideration of approximately $0.57 million is included in operating expense on the consolidated statement of operations (also see Note 12). As of June 30, 2022, it is not anticipated that AUGGD will meet any remaining further consideration thresholds as defined in the asset acquisition agreement.

 

The results of operations of AUGGD have been included in the Company’s consolidated financial statements from the date of acquisition and did not have a material impact on the Company’s consolidated financial statements.

 

XR Terra Asset Acquisition

 

In October 2021, the Company, through its wholly owned subsidiary company, XR Terra, LLC, completed an acquisition of certain assets, as defined, from XR Terra, Inc., a developer of teaching platforms utilized in coding software used in VR and AR programming, a potential strategic growth segment for the Company as the immersive technology industry expands.

 

Initial consideration for the purchase was $0.60 million payable 50% in Company common stock and 50% in cash. In October 2021, the Company paid $0.30 million cash and issued 33,877 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock if certain future revenue targets are achieved through September 2024, which were not expected at time of purchase. Potential future common stock issuance shall be priced at the dates of the future potential share issuance and subject to a common stock floor price of $7.00/share. If this subsidiary is sold within three years from the acquisition date, certain performance related consideration will be accelerated and become due even if not earned. As of June 30 2022, no additional acquisition consideration had been earned and it is not anticipated that future additional consideration thresholds will be met.

 

No liabilities were assumed as part of the acquisition and the primary assets acquired included employees and technology. The Company recorded the purchase price allocation as follows:

 

      
Intangible assets:    
Technology  $300,000 
Goodwill   300,000 
Total  $600,000 

 

The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and will be deductible for tax purposes.

 

The results of operations of XR Terra have been included in the Company’s consolidated financial statements from the date of acquisition and did not have a material impact on the Company’s consolidated financial statements.

 

F-17

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

PulpoAR Asset Acquisition

 

In May 2022, the Company, through its wholly owned subsidiary companies, Qreal, LLC and PulpoAR, LLC, completed an acquisition of certain assets, as defined, from PulpoAR Pulpoar Bilisim Anonim Sirketi, a Turkey based AR technology e-commerce company providing virtual try-on solutions primarily for the Beauty and Retail markets. Upon integration, PulpoAR’s technology is expected to propel the business development efforts of QReal.

 

Initial consideration for the purchase was $2.0 million payable 75% in Company common stock (subject to a common stock floor price as defined) and 25% in cash. In May and June 2022, the Company collectively paid $0.50 million cash and will issue in September 2022 214,286 shares of common stock to satisfy the purchase price. The acquisition agreement provides for additional contingent consideration in the form of Company common stock and cash if certain future revenue targets are achieved through December 2024, which were not anticipated at time of purchase. Potential future common stock issuance shall be priced at the dates of the future potential share issuance and subject to a common stock floor price of $7.00/share. If this subsidiary is sold before December 2024, certain performance related consideration will be accelerated and become due even if not earned. As of June 30, 2022, it is not anticipated that PulpoAR will meet any additional consideration thresholds as defined in the asset acquisition agreement.

 

No liabilities were assumed as part of the acquisition and the primary assets acquired included employees and technology. The Company recorded the purchase price allocation as follows:

 

      
Intangible assets:    
Technology  $925,000 
Goodwill   309,037 
Total  $1,234,037 

 

The goodwill recognized in connection with the acquisition is primarily attributable to new markets access and will be deductible for tax purposes.

 

The results of operations of PulpoAR have been included in the Company’s consolidated financial statements from the date of acquisition and did not have a material impact on the Company’s consolidated financial statements.

 

All acquisitions above were considered business combinations in accordance with GAAP.

 

F-18

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

NOTE 5. INTANGIBLE ASSETS

 

Intangible assets, their respective amortization period, and accumulated amortization at June 30, 2022 are as follows:

 

   As of June 30, 2022 
   Value ($)   Amortization Period (Years) 
   S5D   AUGGD   XR Terra   PulpoAR   Total     
Intangible Assets                              
Customer Relationships  $2,820,000   $250,000   $-    -   $3,070,000    5 (S5D) / 3 (AUGGD) 
Technology   -    250,000    300,000    925,000    1,475,000    3 
Less: Accumulated Amortization   (235,000)   (145,824)   (74,997)   (25,694)   (481,515)     
Intangible Assets, net  $2,585,000   $354,176   $225,003   $899,306   $4,063,485      

 

Intangible asset amortization expense for the year ended June 30, 2022 was approximately $482,000.

 

Estimated intangible asset amortization expense for the next five years is as follow:

 

      
Fiscal Year Ended June 30, 2023  $1,139,000 
Fiscal Year Ended June 30, 2024  $1,139,000 
Fiscal Year Ended June 30, 2025  $893,000 
Fiscal Year Ended June 30, 2026  $564,000 
Fiscal Year Ended June 30, 2027  $329,000 

 

NOTE 6. FINANCIAL INSTRUMENTS

 

Cash and Cash Equivalents and Investments

 

The Company’s money market funds and investments (short term, investment grade corporate bonds) are categorized as Level 1 within the fair value hierarchy. As of June 30, 2022, the Company’s cash and cash equivalents and investments were as follows:

 

 As of June 30, 2022
   Cost   Unrealized Gain (Loss)   Fair Value   Cash and Cash Equivalents   Investments 
Cash  $1,233,608   $-      $1,233,608    
Level 1:                         
Money market funds   15,016,058    -    15,016,058    15,016,058      
Total cash and cash equivalents  $16,249,666   $-   $15,016,058   $16,249,666      
                          
Level 1:                         
Investments  $245,187   $(5,873)  $239,314        $239,314 

 

As of June 30, 2021, cash and cash equivalents consisted only of cash.

 

Contingent Consideration

 

As of June 30, 2022, the Company’s contingent consideration liabilities related to the acquisitions are categorized as Level 3 within the fair value hierarchy. Contingent consideration was valued at the time of acquisitions and at June 30, 2022 using unobservable inputs and have included using the Monte Carlo simulation model. This model incorporates revenue volatility, internal rate of return, and risk-free rate. The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management with the assistance of a third-party valuation specialist.

 

F-19

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

A summary of the quantitative significant inputs used to value S5D’s contingent consideration as of June 30, 2022 was: revenue volatility of 60.1%, internal rate of return of 12.6% and risk-free rate of 3.0%. The market price of the Company’s common stock was also used.

 

As of June 30, 2022, the Company’s contingent consideration liability related to AUGGD is categorized as Level 3 within the fair value hierarchy as it is based on contractual amounts pursuant to the acquisition agreement.

 

As of June 30, 2022, the Company’s contingent consideration liabilities current and non-current balances were as follows:

 

   Cost   Changes in Fair Value   Fair Value   Contingent Consideration 
   As of June 30, 2022 
   Cost   Changes in Fair Value   Fair Value   Contingent Consideration 
Level 3:                    
Contingent consideration, current - S5D  $2,060,300   $(662,700)  $1,397,600   $1,397,600 
Contingent consideration, current - AUGGD   568,571    -    568,571    568,571 
Total contingent consideration, current  $2,628,871   $(662,700)  $1,966,171   $1,966,171 
                     
Level 3:                    
Contingent consideration, non-current - S5D  $7,108,900   $(1,768,100)  $5,340,800   $5,340,800 

 

As of June 30, 2021, the Company’s contingent consideration liabilities related to legacy acquisitions (see Note 13) are categorized as Level 3 within the fair value hierarchy as they are based on contractual amounts pursuant to the respective acquisition agreements.

 

As of June 30, 2021, the Company’s contingent consideration liabilities current balances were as follows:

 

   Cost   Changes in Fair Value   Fair Value   Contingent Consideration 
   As of June 30, 2021 
   Cost   Changes in Fair Value   Fair Value   Contingent Consideration 
Level 3:                    
Contingent consideration, current  $-   $1,250,000   $1,250,000   $1,250,000 

 

NOTE 7. DEFERRED COSTS/CONTRACT ASSETS and DEFERRED REVENUE/CONTRACT LIABILITIES

 

At June 30, 2022 and 2021, deferred costs/contract assets totaling $39,484 and $29,512, respectively, consists of costs deferred under contracts not completed and recognized at a point in time ($35,469 and $29,512, respectively), and costs in excess of billings under contracts not completed and recognized over time ($4,015 and $0, respectively). At June 30, 2022 and 2021, deferred revenue/contract liabilities, totaling $841,389 and $98,425, respectively, consists of revenue deferred under contracts not completed and recognized at a point in time ($533,214 and $98,425, respectively), and costs in excess of billings under contracts not completed and recognized over time ($308,175 and $0, respectively).

 

F-20

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

The following table shows the reconciliation of the costs in excess of billings and billings in excess of costs for contracts recognized over time:

 

   As of June 30, 2022 
     
Cost incurred on uncompleted contracts  $199,571 
Estimated earnings   437,944 
Earned revenue   637,515 
Less: billings to date   941,676 
Billings in excess of costs, net  $(304,161)
      
Balance Sheet Classification     
Contract assets includes, costs and estimated earnings in excess of billings on uncompleted contracts  $4,015 
Contract liabilities includes, billings in excess of costs and estimated earnings on uncompleted contracts   (308,175)
Billings in excess of costs, net  $(304,161)

 

NOTE 8. DEBT

 

Convertible Promissory Notes 1

 

In December 2019 the Company raised $1.33 million by the issuance of unsecured Convertible Promissory Notes with a three-year term (the “Note 1” or “Notes 1”), primarily from existing Company investors.

 

The Notes 1 bore an interest rate of 10% per annum.

 

Interest expense on the Notes 1 was approximately $103,000 for the year ended June 30, 2021, representing amortization of the original issue discount and prepaid interest for the period.

 

The Notes 1 were convertible by a Note 1 holder at any time during the term into common stock of the Company at a fixed price of $4.50/share, or approximately 295,000 shares of common stock upon full conversion.

 

In December 2020 and primarily in January 2021, Note 1 holders converted approximately $1.21 million of principal into approximately 0.33 million shares of common stock at a revised (to encourage early conversion) conversion price of $4.00/share. As a result, during the year ended June 30, 2021, the Company recorded a loss of approximately $0.52 million representing unamortized original issue discount and prepaid interest.

 

The holders of the remaining unconverted Notes 1, equating to approximately $117,000 (net of original discount of approximately $8,000) of outstanding principal at June 30, 2021, amended their Notes 1 to allow for auto conversion upon the Company’s potential IPO event at a conversion price of $4.25/share. As per the amendment, the residual Notes 1 converted upon the IPO and no further obligations existed. See Note 9.

 

The Company recorded a loss, during the year ended June 30, 2022, on conversion of the remaining Notes 1 of approximately $18,000 at time of the IPO, representing unamortized original issue discount and prepaid interest.

 

F-21

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Convertible Promissory Notes 2

 

In March 2021, the Company raised $1.48 million by the issuance of unsecured Convertible Promissory Notes with a two-year term (the “Notes 2”), to several investors.

 

The Notes 2 bore an interest rate of 10% per annum.

 

Interest expense on the Notes 2 was approximately $78,000 for the year ended June 30, 2021, representing amortization of the original issue discount and prepaid interest for the period.

 

The Notes 2 were convertible by a note holder at any time during the term into common stock of the Company at a fixed price of $5.00/share, or 295,000 shares of common stock upon full conversion. Notes 2 had a maturity date of March 5, 2023. All outstanding amounts at the time of the Company’s IPO automatically converted at $5.00/share in the aggregate. Convertible Notes 2 totaled approximately $1.313 million (net of original issue discount of approximately $0.16 million) at June 30, 2021. The Notes 2 converted upon the IPO and no further obligations existed. See Note 9.

 

The Company recorded a loss, during the year ended June 30, 2022, on conversion of the Notes 2 of approximately $0.26 million at time of the IPO, representing unamortized original issue discount and prepaid interest.

 

Paycheck Protection Program Loan

 

In March 2022 and February 2021, the Small Business Administration forgave principal and interest on $0.62 million and $0.55 million, respectively, Paycheck Protection Program loans to the Company. The forgiveness is recorded in other income (expenses) on the consolidated statements of operations.

 

NOTE 9. EQUITY

 

Initial Public Offering (“IPO”)

 

On July 1, 2021, the Company completed an IPO of common stock on the Nasdaq under the symbol “VRAR”, at a price of $7.00 per share.

 

The Company sold approximately 1.91 million shares of common stock and realized net proceeds (after underwriting, professional fees and listing expenses) of $11.82 million.

 

In connection with the IPO, and for services rendered, the underwriter was issued a warrant to purchase 87,500 shares of common stock at $7.00 per share. The warrant could not be exercised prior to December 30, 2021 and expires in June 2026. The warrant was valued at approximately $0.52 million based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 129% expected volatility, 0.87% risk-free rate and 0% expected dividend yield.

 

As stated in Note 8, in conjunction with the IPO, the outstanding convertible promissory Notes 1 and 2 were satisfied in full through the issuance of 324,150 shares of common stock. A loss of approximately $0.28 million was recorded on this conversion at the time of the IPO.

 

Securities Purchase Agreement (“SPA”)

 

In November 2021, the Company sold $15.0 million worth of its common stock and warrants to certain institutional investors in a private placement pursuant to a SPA. The Company realized net proceeds (after underwriting, professional fees and listing expenses) of $13.58 million.

 

Under the terms of the SPA, the Company sold 1.50 million shares of its common stock and warrants to purchase 0.75 million shares of common stock. The purchase price for one share of common stock and half a corresponding warrant was $10.00. The warrants have an exercise price of $14.63 per share. Warrants to purchase 0.56 million shares could be exercised immediately and expire five years from the date of the SPA. Warrants to purchase 0.19 million shares were not exercisable prior to May 2, 2022 and expire five years after. The warrants are valued at approximately $8.80 million based on the Black-Scholes options pricing model method with the following assumptions: 5 year expected term, 146% expected volatility, 1.22% risk-free rate and 0% expected dividend yield.

 

F-22

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Common Stock Issued

 

Common stock sold to Investors

 

During the year ended June 30, 2022, the Company sold approximately 1.91 million shares of common stock to investors at the IPO at a price of $7.00 per share, for total net proceeds of approximately $11.82 million. In addition, the Company sold 1.50 million shares of common stock and 0.75 million warrants to investors pursuant to a SPA for total net proceeds of approximately $13.58 million.

 

During the year ended June 30, 2021, the Company sold approximately 77,000 shares of common stock to investors at a price of $4.50 per share, for total net proceeds of approximately $0.35 million.

 

Common stock issued to Investors

 

During the year ended June 30, 2022, in connection with the conversion of convertible promissory notes and in conjunction with the IPO, the Company issued approximately 324,000 shares of common stock (see Note 8). During the year ended June 30, 2021, in connection with the conversion of Notes 1, the Company issued approximately 332,000 shares of common stock; and in connection with the issuance of Notes 2, the Company issued approximately 74,000 shares of common stock (see Note 8).

 

Common stock issued for Acquisitions

 

During the year ended June 30, 2022, the Company issued approximately 111,000 shares of common stock, valued at $1.05 million, as consideration for the acquisition of AUGGD and XR Terra (see Note 4). In addition, the Company issued approximately 277,000 shares of common stock, fair valued at $2.30 million, as consideration for the acquisition of S5D (see Note 4).

 

Common stock issued for satisfaction of contingent consideration

 

During the year ended June 30, 2022 the Company issued approximately 453,000 shares of common stock to satisfy legacy acquisition obligations of $1.25 million (see Note 13). During the year ended June 30, 2021, the Company issued approximately 32,000 shares of common stock in final payment of all contingent liabilities related to the 2018 acquisition of subsidiary Early Adopter LLC.

 

Common stock issued to Vendors

 

During the years ended June 30, 2022 and 2021, the Company issued approximately 20,000 and 29,000 shares of common stock, respectively, to various vendors for services performed and recorded share-based compensation of approximately $198,000 and $134,000, respectively.

 

Common stock issued for Exercise of Stock Options

 

During the year ended June 30, 2022, the Company issued approximately 560,000 shares of common stock upon exercise of the respective option grants and realized cash proceeds of approximately $1.33 million.

 

Common stock-based Compensation expense

 

During the year ended June 30, 2022, the Company issued approximately 11,000 shares of common stock, to an employee and recorded share-based compensation of approximately $96,000.

 

F-23

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Employee Stock-Based Compensation

 

The Company’s 2016 Equity Incentive Plan (the “Plan”), as amended, has approximately 10.62 million common shares reserved for issuance. As of June 30, 2022, there were approximately 5.17 million shares available for issuance under the Plan.

 

The Company recognizes compensation expense relating to awards ratably over the requisite period, which is generally the vesting period.

 

Stock options have been recorded at their fair value. The Black-Scholes option-pricing model assumptions used to value the issuance of stock options under the Plan, are noted in the following table:

 

   2022   2021 
   For the Years Ended June 30, 
   2022   2021 
Weighted average expected terms (in years)   5.7    5.3 
Weighted average expected volatility   236.7%   126.6%
Weighted average risk-free interest rate   1.7%   0.5%
Expected dividend yield   0.0%   0.0%

 

The grant date fair value, for options granted during the years ended June 30, 2022 and 2021 was approximately $8.83 million and $2.94 million, respectively.

 

The following is a summary of the Company’s stock option activity for the years ended June 30, 2022 and 2021:

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2020   4,092,593   $3.19    8.4   $5,553,916 
Options Granted   766,419    4.66    9.7    383,210 
Options Exercised   -    -    -    - 
Options Forfeited / Cancelled   (118,102)   4.28    8.9    (89,956)
Outstanding at June 30, 2021   4,740,910   $3.40    8.5   $7,893,467 
Exercisable at June 30, 2021   4,346,734   $3.29    8.4   $7,659,692 

 

       Weighted Average     
           Remaining     
       Exercise   Contractual   Intrinsic 
   Options   Price   Term (Yrs)   Value 
Outstanding at July 1, 2021   4,740,910   $3.40    8.5   $7,893,467 
Options Granted   1,037,252    9.15    9.6    2,578,954 
Options Exercised   (969,775)   2.90    5.4    (8,419,947)
Options Forfeited / Cancelled   (323,771)   5.65    7.9    (1,908,018)
Outstanding at June 30, 2022   4,484,616   $4.68    7.0   $2,404,249 
Exercisable at June 30, 2022   3,546,297   $3.54    6.3   $2,404,249 

 

F-24

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

The Company’s stock option-based expense for the years ended June 30, 2022 and 2021 consisted of the following:

SCHEDULE OF STOCK OPTION-BASED EXPENSE  

           
   Year Ended
June 30, 2022
   Year Ended
June 30, 2021
 
Stock option-based expense:          
Research and development expenses  $1,470,039   $1,381,168 
General and administrative expenses   210,876    373,506 
Sales and marketing expenses   585,380    477,561 
Cost of goods sold   49,617    526,156 
Board option expense   481,386    187,096 
Total  $2,797,298   $2,945,487 

 

At June 30, 2022 total unrecognized compensation expense to employees, board members and vendors related to stock options was approximately $6.71 million, and is expected to be recognized over a weighted average period of 2.42 years.

 

The intrinsic value of stock options at June 30, 2022 and 2021 was computed using a fair market value of the common stock of $3.98/share and $5.00/share, respectively.

 

NOTE 10. EARNINGS PER SHARE

 

The following table presents the computation of basic and diluted net loss per common share:

 

 

         
   For the Years Ended 
   June 31 
Numerator:  2022   2021 
Net loss  $(5,966,287)  $(6,091,687)
Denominator:          
Weighted-average common shares outstanding for basic and diluted net loss per share   11,731,383    7,259,249 
Basic and diluted net loss per share  $(0.51)  $(0.84)

 

Potentially dilutive securities that were not included in the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive are as follows (in common equivalent shares):

 

SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES 

  

At June 30,

2022

  

At June 30,

2021

 
Stock Options   4,484,616    4,740,910 
Warrants   837,500    - 
Convertible Notes   -    324,150 
Total   5,322,116    5,065,060 

 

F-25

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

NOTE 11. PROVISION FOR INCOME TAXES

 

There was no current or deferred income tax provision for the years ended June 30, 2022 and 2021.

 

The Company’s deferred tax assets as of June 30, 2022 and 2021 consist of the following:

 

   2022   2021 
   As of June 30,   As of June 30, 
   2022   2021 
Deferred tax assets:          
Net-operating loss carryforward  $7,795,509   $3,923,012 
Stock-based compensation   392,174    536,265 
Intangible asset amortization and other   180,297    - 
Total Deferred Tax Assets   8,367,980    4,459,277 
Valuation allowance   (8,367,980)   (4,459,277)
Deferred Tax Asset, Net  $-   $- 

 

The Company maintains a valuation allowance on deferred tax assets due to the uncertainty regarding the ability to utilize these deferred tax assets in the future. At June 30, 2022, the Company had potential utilizable aggregate net operating loss carryforwards (“NOLs”) of approximately $22.56 million. NOLs for the periods ending June 30, 2018 and prior ($2.88 million) begin to expire in 2037. NOLs for the years ending June 30, 2019 through 2022 ($19.68 million), in accordance with changes to the U.S. Internal Revenue Code, have no expiration.

 

Section 382 of the U.S. Internal Revenue Code generally imposes an annual limitation on the amount of net operating loss carryforwards that might be used to offset taxable income when a corporation has undergone significant changes in stock ownership. The Company has not completed a Section 382 analysis of the NOL carryforwards. Consequently, the Company’s NOL carryforwards may be subject to annual limitations under Section 382.

 

In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxing strategies in making this assessment. As a result of the uncertainty in the realization of the Company’s deferred tax assets, the Company has provided a valuation allowance for the full amount of the deferred tax assets at June 30, 2022 and June 30, 2021.

 

The Company’s valuation allowance during the years ended June 30, 2022 and 2021 increased by approximately $3.91 million and $1.30 million, respectively.

 

The expected tax expense (benefit) based on the U.S. federal statutory rate is reconciled with actual tax expense (benefit) as follows:

SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION STATUTORY RATE  

   For the year ended
June 30, 2022
   For the year ended
June 30, 2021
 
         
Statutory Federal Income Tax Rate   (21.00)%   (21.00)%
State and Local Taxes, Net of Federal Tax Benefit   (13.56)%   (13.56)%
Stock Based Compensation Expense (ISO)   12.78%   13.20%
Change in Valuation Allowance   21.78%   21.36%
Income Taxes Provision (Benefit)   0.00    0.00 

 

Upon completion of its 2022 U.S. income tax return, the Company may identify additional remeasurement adjustments. The Company will continue to assess its provision for income taxes as future guidance is issued, but does not currently anticipate significant revisions will be necessary.

 

F-26

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

NOTE 12. RELATED PARTY TRANSACTIONS

 

ARI

 

In March 2022, the Company lent to ARI, the entity from which the assets of AUGGD were bought (see Note 4), $0.25 million pursuant to a secured promissory note due March 31, 2024. The two owners of ARI are currently an employee and a non-employee advisor to the Company.

 

The note bears interest at the rate of 1% per annum and is secured by the borrower’s common shares of the Company. Any sales of said shares shall be used to prepay the note, unless otherwise agreed to by the Company.

 

The Company recognized no interest income on the note for the year ended June 30, 2022.

 

The note was extinguished subsequent to June 30, 2022. See note 14.

 

Debt

 

The convertible promissory Notes 1 included participation by the Company’s executives and independent members of the Company’s Board in the amount of $0.2 million (see Note 8).

 

NOTE 13. COMMITMENTS AND CONTINGENCIES

 

Operating Leases

 

New York

 

The Company has an office space lease expiring on December 31, 2024.

 

Texas

 

The Company has an office space lease expiring, as amended, on February 28, 2025. The lease requires the Company to pay a pro-rata share of common area maintenance, insurance and real estate taxes.

 

Turkey

 

The Company has four office space leases expiring in November 2022 through January 2023.

 

The approximate future aggregate minimum rental commitments under all non-cancelable operating leases (including common area maintenance) are as follows:

 SCHEDULE OF OPERATING LEASES MINIMUM RENTAL COMMITMENT 

      
Fiscal Year Ended June 30, 2023  $390,000 
Fiscal Year Ended June 30, 2024  $309,000 
Fiscal Year Ended June 30, 2025  $178,000 

 

Rent expense for the years ended June 30, 2022 and 2021 was approximately $408,000 and $296,000, respectively.

 

F-27

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

Contingent Consideration for Acquisitions

 

Contingent consideration for acquisitions, consists of the following as of June 30, 2022 and 2021, respectively:

 

   2022   2021 
   As of June 30, 
   2022   2021 
S5D, current portion (see Note 4)  $1,397,600   $- 
AUGGD (see Note 4)   568,571    - 
Kabaq 3D Technologies, LLC   -    750,000 
KreatAR, LLC   -    500,000 
Subtotal  $1,966,171   $1,250,000 
S5D, net of current portion (see Note 4)   5,340,800    - 
Total contingent consideration for acquisitions   $7,306,971   $1,250,000 

 

Kabaq 3D Technologies, LLC

 

The Company’s November 2016 acquisition of assets relating to the acquisition of Kabaq 3D Technologies, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met and the Company incurred $0.75 million of additional acquisition cost. In accordance with GAAP, the cost has been accrued as a legacy acquisition liability on the Company’s balance sheet at June 30, 2021. This obligation was satisfied in August 2021 through the issuance of common stock in settlement of 375,000 stock options at $2.00 per share.

 

KreatAR, LLC

 

The Company’s October 2016 acquisition of assets relating to the acquisitions of KreatAR, LLC contained a provision for additional acquisition consideration triggered by a potential listing of the Company’s common stock on a national securities exchange and certain stock trading volume thresholds. In August 2021, the milestones triggering the additional consideration were met. In connection therewith, the Company incurred $0.5 million of additional acquisition cost. In accordance with GAAP, the cost has been accrued as a legacy acquisition liability on the Company’s balance sheet at June 30, 2021. This obligation was satisfied in December 2021 and January 2022 through the issuance of common stock in settlement of 35,000 stock options at $2.00 per share and through the issuance of 42,978 shares of common stock valued at $0.43 million.

 

Potential Future Distributions Upon Divestiture or Sale

 

Upon a divestiture or sale of a subsidiary company, the Company is contractually obligated to distribute up to 10% of the net proceeds from such divestiture or sale to the senior management team of the divested subsidiary company. Currently, there were no active discussions pertaining to a potential divestiture or sale of any of the Company’s subsidiaries.

 

COVID-19

 

The COVID-19 pandemic caused significant business and financial markets disruption worldwide and there was significant uncertainty around the duration of this disruption and its ongoing effects on our business. This has primarily manifested itself in prolonged sales cycles.

 

We continue to monitor the situation and the effects on our business and operations. While some level of potential uncertainty remains, given the current state of the pandemic, our expected revenue growth and current cash balance, we do not expect the impact of COVID-19 to be material to our business and operations.

 

F-28

 

 

THE GLIMPSE GROUP, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2022 AND 2021

 

NOTE 14. SUBSEQUENT EVENTS

 

Purchase of Brightline Interactive, LLC

 

In May 2022, the Company entered into an Agreement and Plan of Merger (the “BLI Agreement”) to purchase all of the membership interests of Brightline Interactive, LLC (“BLI”), an immersive technology company that provides VR and AR based training scenarios and simulations for commercial and government customers. The transaction’s total potential purchase price is $32.5 million, with an initial payment of $8.0 million upon closing, consisting of $3.0 million in cash and $5.0 million of Company common stock (approximately 0.71 million shares based on a common stock floor price as defined in the BLI Agreement). Future potential purchase price considerations, up to $24.5 million, are based on BLI’s achievement of revenue growth milestones in the three years post-closing, the payment of which shall be made up to $12 million in cash and the remainder in common shares of the Company, priced at the date of the future potential share issuance with a floor price of $7.00/share.

 

In August 2022, the BLI transaction closed and BLI became a wholly-owned subsidiary of the Company. $3 million in cash was paid and approximately 0.71 million shares of Company common stock were issued to the sellers.

 

BLI had revenue for the year ended December 31, 2021 of approximately $5 million.

 

The Company is currently in the process of determining its potential contingent liability for the purchase, as well as allocation of the purchase price amongst the assets purchased, intangible assets, goodwill and liabilities assumed. Accordingly, these amounts are not included here.

 

Extinguishment of ARI Note Receivable

 

In July 2022, the Company and ARI agreed to extinguish the note, including all accrued interest. The note amount reduced the amount the Company owed ARI for AUGGD achieving its initial revenue threshold as defined in the asset purchase agreement.

 

F-29

 

 

Exhibit 10.41

 

 

 

AGREEMENT AND PLAN OF MERGER

among


THE GLIMPSE GROUP, INC.,


GLIMPSE MERGER SUB, LLC,

 

THE SELLERS,

 

THE SELLERS’ REPRESENTATIVE,

and


BRIGHTLINE INTERACTIVE, LLC

 

Dated as of May 25, 2022

 

 

 

This document is intended solely to facilitate discussions among the parties identified herein. It is not intended to create, and shall not be deemed to create, a legally binding or enforceable offer or agreement of any type or nature prior to the duly authorized and approved execution of this document by all such parties and the delivery of an executed copy hereof by all such parties to all other parties.

 

 
 

 

TABLE OF CONTENTS

 

  Page
   
ARTICLE I DEFINITIONS 1
Section 1.1 Definitions 1
ARTICLE II The Merger 13
Section 2.1 The Merger 13
Section 2.2 Closing 13
Section 2.3 Closing Deliverables. 13
Section 2.4 Effective Time 14
Section 2.5 Effects of the Merger 14
Section 2.6 Certificate of Formation; Operating Agreement 15
ARTICLE III Effect of the Merger; PURCHASE PRICE 15
Section 3.1 Effect of the Merger on Membership Interests 15
Section 3.2 Purchase Price 15
Section 3.3 Purchase Price Adjustment. 20
Section 3.4 U.S. Tax Matters 22
ARTICLE IV Representations and Warranties of Company 23
Section 4.1 Organization; Standing and Power; Charter Documents; Subsidiaries 23
Section 4.2 Capital Structure 23
Section 4.3 Authority; Non-Contravention; Governmental Consents; Board Approval 23
Section 4.4 Financial Statements; Undisclosed Liabilities 25
Section 4.5 Absence of Certain Changes or Events 25
Section 4.6 Taxes 25
Section 4.7 Intellectual Property 26
Section 4.8 Compliance; Permits 28
Section 4.9 Litigation 29
Section 4.10 Brokers’ and Finders’ Fees 29
Section 4.11 Related Person Transactions 29
Section 4.12 Employee Benefit Issues 29
Section 4.13 Real Property and Personal Property Matters 31
Section 4.14 Environmental Matters 32
Section 4.15 Material Contracts 32
Section 4.16 Insurance 33
Section 4.17 Intended Tax Treatment 34
Section 4.18 Accounts Receivable 34
Section 4.19 Customers and Suppliers 34
Section 4.20 No Other Representations 34
ARTICLE V REPRESENTATIONS AND WARRANTIES OF SELLERS 34
Section 5.1 Good and Valid Title 34
Section 5.2 Authority of the Sellers. 35
Section 5.3 Own Account 35
Section 5.4 Seller Status 35
Section 5.5 Experience of Seller 35
Section 5.6 Restrictions. 35
Section 5.7 Certain Transactions 36
ARTICLE VI Representations and Warranties of Buyer and Merger Sub 36
Section 6.1 Organization; Standing and Power; Charter Documents 36
Section 6.2 Capitalization. 37
Section 6.3 Authority; Non-Contravention; Governmental Consents; Board Approval 38
Section 6.4 Reservation of Common Stock 39

 

i
 

 

TABLE OF CONTENTS
(continued)

 

    Page
     
Section 6.5 Brokers 39
Section 6.6 Intended Tax Treatment 39
Section 6.7 Merger Sub 40
Section 6.8 Litigation 40
Section 6.9 SEC Filings; Financial Statements; Undisclosed Liabilities. 40
Section 6.10 No Other Representations 41
ARTICLE VII TAX MATTERS 41
Section 7.1 Tax Matters 41
Section 7.2 Straddle Period 42
Section 7.3 Contests 42
Section 7.4 Amendment of Tax Returns, etc. 42
Section 7.5 Tax Refunds and Credits 42
Section 7.6 Cooperation and Exchange of Information 42
Section 7.7 Survival 43
Section 7.8 Overlap 43
ARTICLE VIII Covenants 43
Section 8.1 Conduct of the Business 43
Section 8.2 Access to Information 44
Section 8.3 Non-Circumvention 44
Section 8.4 Notices of Certain Events 45
Section 8.5 Directors’ and Officers’ Indemnification and Insurance 45
Section 8.6 Reasonable Best Efforts 46
Section 8.7 Public Announcements 46
Section 8.8 Anti-Takeover Statutes 47
Section 8.9 Reorganization Efforts 47
Section 8.10 Transfer Taxes 47
Section 8.11 Continuing Employees 47
Section 8.12 Non-Competition. Non-Solicitation. 48
Section 8.13 Further Assurances 49
ARTICLE IX Conditions TO CLOSING 49
Section 9.1 Conditions to Obligation of Buyer to Effect the Closing 49
Section 9.2 Conditions to Obligations of Company to Effect the Closing 49
ARTICLE X INDEMNIFICATION 50
Section 10.1 Survival 50
Section 10.2 Indemnification by Sellers 51
Section 10.3 Indemnification by Buyer 51
Section 10.4 Certain Limitations 51
Section 10.5 Indemnification Procedures 52
Section 10.6 Payments 54
Section 10.7 Tax Treatment 54
Section 10.8 Effect of Investigation 55
ARTICLE XI Termination, Amendment, and Waiver 55
Section 11.1 Termination by Mutual Consent 55
Section 11.2 Termination by Either Buyer or Company 55
Section 11.3 Termination by Buyer 55
Section 11.4 Termination by Company 55
Section 11.5 Notice of Termination; Effect of Termination 56
Section 11.6 Expenses 56

 

 

ii
 

 

TABLE OF CONTENTS

(continued)

 

    Page
     
Section 11.7 Amendment 56
Section 11.8 Extension; Waiver 56
ARTICLE XII Miscellaneous 56
Section 12.1 Interpretation; Construction 56
Section 12.2 Governing Law 57
Section 12.3 Submission to Jurisdiction 57
Section 12.4 Waiver of Jury Trial 57
Section 12.5 Notices 58
Section 12.6 Entire Agreement 58
Section 12.7 No Third-Party Beneficiaries 58
Section 12.8 Severability 59
Section 12.9 Assignment 59
Section 12.10 Remedies Cumulative 59
Section 12.11 Disclosure Letters 59
Section 12.12 Specific Performance 59
Section 12.13 Counterparts; Effectiveness 60
Section 12.14 No Recourse Against Third Parties 60
Section 12.15 Provision Respecting Legal Representation 60
Section 12.16 Sellers’ Representative 61

 

Exhibits

 

Exhibit A Form of Certificate of Formation
 
Exhibit B Form of Sellers’ Lock-up Agreement
 
Exhibit C Form of T. Gates Employment Agreement
 
Exhibit D Form of E. Muendel Employment Agreement

 

iii
 

 

AGREEMENT AND PLAN OF MERGER

 

This AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 25, 2022, by and among The Glimpse Group, Inc., a Nevada corporation (“Buyer”), Glimpse Merger Sub, LLC, a Nevada limited liability company and wholly-owned Subsidiary of Buyer (“Merger Sub”), and Erik Muendel, the Bradley S. Nierenberg Trust, Bruce Gates, Joyce Gates, Barton Gates and Tyler Gates (each a “Seller” and, collectively, the “Sellers”), Bruce Gates, solely in his capacity as representative of Sellers (the “Sellers’ Representative”) and Brightline Interactive, LLC, a Virginia limited liability company (“Company” and, together with Sellers, Sellers’ Representative, Buyer and Merger Sub, the “Parties”).

 

WHEREAS, Buyer and Sellers wish to effect a strategic business combination by means of a merger of Company with and into Merger Sub, with Merger Sub being the surviving entity in the Merger, as a result of which the Company will become a wholly-owned Subsidiary of Buyer (“Merger”) on the terms and subject to the conditions set forth herein;

 

WHEREAS, Sellers collectively own 100% of the issued and outstanding membership interests in the Company and, in accordance with the Company’s amended and restated operating agreement dated as of December 22, 2015, as amended (“Operating Agreement”) and the Virginia Limited Liability Company Act (“VLLCA”), have unanimously approved this Agreement and the consummation of the transactions contemplated hereby, including the Merger;

 

WHEREAS, the Managers (as defined in the Operating Agreement) have unanimously approved this Agreement and the consummation of the transactions contemplated hereby, including the Merger;

 

WHEREAS, the respective Boards of Directors of Buyer (the “Buyer Board”) and Merger Sub (the “Merger Sub Board”) have each unanimously: (a) determined that it is in the best interests of Buyer or Merger Sub, as applicable, and its respective stockholders or its member, as applicable, and declared it advisable, to enter into this Agreement; and (b) approved the execution, delivery, and performance of this Agreement and the consummation of the transactions contemplated hereby, including the Merger; in each case, in accordance with the Nevada Revised Statutes, as amended (the “NRS”);

 

WHEREAS, for U.S. federal income Tax purposes, the parties intend that the Merger qualify as a “reorganization” within the meaning of Section 368(a) of the Internal Revenue Code of 1986, as amended (the “Code”), and that this Agreement be, and is hereby, adopted as a “plan of reorganization” within the meaning of Section 368(a) of the Code and the Treasury Regulations promulgated thereunder; and

 

NOW, THEREFORE, in consideration of the foregoing and of the representations, warranties, covenants, and agreements contained in this Agreement, the Parties, intending to be legally bound, agree as follows:

 

ARTICLE I
DEFINITIONS

 

Section 1.1 Definitions. For purposes of this Agreement, the following terms will have the following meanings when used herein with initial capital letters:

 

Acquisition Proposal” has the meaning set forth in Section 8.3.

 

Affiliate” means, with respect to any Person, any other Person that directly or indirectly controls, is controlled by, or is under common control with, such first Person. For the purposes of this definition, “control” (including, the terms “controlling,” “controlled by,” and “under common control with”), as applied to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of that Person, whether through the ownership of voting securities, by Contract, or otherwise.

 

1
 

 

Affordable Care Act” means the Patient Protection and Affordable Care Act (PPACA), as amended by the Health Care and Education Reconciliation Act (HCERA).

 

Agreement” has the meaning set forth in the Preamble.

 

Ancillary Documents” means the T. Gates Employment Agreement, E. Muendel Employment Agreement and Sellers Lock-Up Agreements.

 

Articles of Merger” has the meaning set forth in Section 2.4.

 

Auditor” means Hoberman & Lesser, LLP.

 

Balance Sheet Date” has the meaning set forth in Section 4.4(a).

 

Basket” has the meaning set forth in Section 10.4(a).

 

Brightline Budget” has the meaning set forth in Section 3.2(c)(viii)(B).

 

Business Day” means any day, other than Saturday, Sunday, or any day on which banking institutions located in New York, New York are authorized or required by Law or other governmental action to close.

 

Buyer” has the meaning set forth in the Preamble.

 

Buyer Board” has the meaning set forth in the Recitals.

 

Buyer Disclosure Letter” means the disclosure letter, dated as of the date of this Agreement and delivered by Buyer and Merger Sub to Company concurrently with the execution of this Agreement.

 

Buyer Indemnitees” has the meaning set forth in Section 10.3.

 

Buyer Material Adverse Effect” means any Effect that is, or would reasonably be expected to become, individually or in the aggregate, materially adverse to: (a) the business, results of operations, condition (financial or otherwise), or assets of Buyer and its Subsidiaries, taken as a whole; or (b) the ability of Buyer to timely perform its obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis; provided, however, that a Buyer Material Adverse Effect shall not be deemed to include any Effect (alone or in combination) arising out of, relating to, or resulting from: (i) changes generally affecting the economy, financial or securities markets, or political conditions; (ii) the execution and delivery, announcement, or pendency of the transactions contemplated by this Agreement, including the impact thereof on relationships, contractual or otherwise, of Buyer and its Subsidiaries with employees, suppliers, customers, Governmental Entities, or other third Persons (it being understood and agreed that this clause shall not apply with respect to any representation or warranty that is intended to address the consequences of the execution and delivery of this Agreement or the announcement or the pendency of this Agreement); (iii) any changes in applicable Law or GAAP or other applicable accounting standards, including interpretations thereof, (iv) any outbreak or escalation of war or any act of terrorism, (v) the existence or worsening of any natural disasters, epidemics, pandemics, disease outbreaks (including in the case of the COVID-19 virus, only the worsening of the pandemic) or public health emergencies, or other force majeure events; (vi) general conditions in the industry in which Buyer and its Subsidiaries operate; (vii) any failure, in and of itself, by Buyer to meet any internal or published projections, forecasts, estimates, or predictions in respect of revenues, earnings, or other financial or operating metrics for any period (it being understood that any Effect underlying such failure may be deemed to constitute, or be taken into account in determining whether there has been or would reasonably be expected to become, a Buyer Material Adverse Effect, to the extent permitted by this definition and not otherwise excepted by another clause of this proviso); (viii) any change, in and of itself, in the market price or trading volume of Buyer’s securities or in its credit ratings (it being understood that any Effect underlying such change may be deemed to constitute, or be taken into account in determining whether there has been or would reasonably be expected to become, a Buyer Material Adverse Effect, to the extent permitted by this definition and not otherwise excepted by another clause of this proviso); or (ix) actions taken as required or specifically permitted by the Agreement or actions or omissions taken with Company’s or Sellers’ Representative’s consent; provided further, however, that any Effect referred to in clauses (i), (iii), (iv), (v), or (vi) immediately above shall be taken into account in determining whether a Buyer Material Adverse Effect has occurred or would reasonably be expected to occur if it has a disproportionate effect on Buyer and its Subsidiaries, taken as a whole, compared to other participants in the industries in which Buyer and its Subsidiaries conduct their businesses.

 

2
 

 

Buyer SEC Documents” means registration statements, prospectuses, reports, schedules, forms, statements, and other documents (including exhibits and all other information incorporated by reference) filed or furnished by the Buyer with the SEC.

 

Buyer Securities” has the meaning set forth in Section 6.2(b)(ii).

 

Buyer Stock” means shares of Buyer’s common stock, par value $0.001 per share.

 

Buyer Stock Consideration” has the meaning set forth in Section 5.3.

 

Buyer Stock Issuance” means any issuance (or issuances) of shares of Buyer Stock in connection with the Merger (including as Earnout Consideration, if applicable) on the terms and subject to the conditions set forth in this Agreement.

 

Buyer Stock Option” means any option to purchase Buyer Stock granted under any Buyer Stock Plan.

 

Buyer Stock Plan” means The Glimpse Group, Inc. 2016 Equity Incentive Plan.

 

Buyer Subsidiary Securities” has the meaning set forth in Section 6.2(d).

 

Buyer Voting Debt” has the meaning set forth in Section 6.2(c).

 

Cap” has the meaning set forth in Section 10.4(a).

 

Cash Revenue Target” has the meaning set forth in Section 3.2(c)(i).

 

Change in Control” means, with respect to any Person, a single transaction or group of related transactions (whether by way of purchase agreement, tender offer, merger, consolidation, business combination or other similar transaction) involving such Person, pursuant to which (i) the holders of more than fifty percent (50%) of the combined voting power of such Person immediately prior to such transaction (or their Affiliates) would cease to hold more than fifty percent (50%) of the combined voting power of such Person (or its successor entity) following such transaction or (ii) all or substantially all of the assets of such Person (including its Subsidiaries) are sold, leased, transferred, exclusively licensed or otherwise disposed, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of such Person.

 

Charter Documents” means: (a) with respect to a corporation, the charter, articles or certificate of incorporation, as applicable, and bylaws thereof; (b) with respect to a limited liability company, the certificate of formation or organization, as applicable, and the operating or limited liability company agreement, as applicable, thereof; (c) with respect to a partnership, the certificate of formation and the partnership agreement; and (d) with respect to any other Person the organizational, constituent and/or governing documents and/or instruments of such Person.

 

3
 

 

Closing” and “Closing Date” have the meaning set forth in Section 2.2.

 

Closing Adjustment” has the meaning set forth in Section 3.3(a)(ii).

 

Closing Certificate” has the meaning set forth in Section 2.3(a)(i).

 

Closing Working Capital” means (a) the Current Assets of the Company, less (b) the Current Liabilities of the Company, determined as of 11:59 p.m. Eastern time on the Closing Date.

 

Closing Working Capital Statement” has the meaning set forth in Section 3.3(b)(i).

 

COBRA” means the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, and as codified in Section 4980B of the Code and Section 601 et. seq. of ERISA.

 

Code” has the meaning set forth in the Recitals.

 

Company” has the meaning set forth in the Preamble.

 

Company Action” has the meaning set forth in Section 4.3(d).

 

Company Cash” shall mean all cash and cash equivalents (expressed in Dollars) of any kind of the Company (including, without limitation, all cash in bank accounts and cash on hand, restricted cash, cash on deposit, cash deposited with third parties and cash posted for bonds or with respect to escrows), as of the Effective Time; provided, that such amount shall not exceed $500,000.

 

Company Disclosure Letter” means the disclosure letter, dated as of the date of this Agreement and delivered by Company and Sellers to Buyer concurrently with the execution of this Agreement.

 

Company Employee” and “Company Employee Plans” have the meanings set forth in Section 4.12(a).

 

Company ERISA Affiliate” means all employers, trades, or businesses (whether or not incorporated) that would be treated together with Company or any of its Affiliates as a “single employer” within the meaning of Section 414 of the Code.

 

Company IP” has the meaning set forth in Section 4.7(b).

 

Company IP Agreements” means all licenses, sublicenses, consent to use agreements, settlements, coexistence agreements, covenants not to sue, waivers, releases, permissions, and other Contracts, whether written or oral, relating to Intellectual Property and to which Company or any of its Subsidiaries is a party, beneficiary, or otherwise bound.

 

Company IT Systems” means all software, computer hardware, servers, networks, platforms, peripherals, and similar or related items of automated, computerized, or other information technology networks and systems (including telecommunications networks and systems for voice, data, and video) owned, leased, licensed, or used (including through cloud-based or other third-party service providers) by Company or any of its Subsidiaries.

 

4
 

 

Company Material Adverse Effect” means any event, circumstance, development, occurrence, fact, condition, effect, or change (each, an “Effect”) that is, or would reasonably be expected to become, individually or in the aggregate, materially adverse to: (a) the business, results of operations, condition (financial or otherwise), or assets of Company and its Subsidiaries, taken as a whole; or (b) the ability of Company to timely perform its obligations under this Agreement or consummate the transactions contemplated hereby on a timely basis; provided, however, that a Company Material Adverse Effect shall not be deemed to include any Effect (alone or in combination) arising out of, relating to, or resulting from: (i) changes generally affecting the economy, financial or securities markets, or political conditions; (ii) the execution and delivery, announcement, or pendency of the transactions contemplated by this Agreement, including the impact thereof on relationships, contractual or otherwise, of Company and its Subsidiaries with employees, suppliers, customers, Governmental Entities, or other third Persons (it being understood and agreed that this clause shall not apply with respect to any representation or warranty that is intended to address the consequences of the execution and delivery of this Agreement or the announcement or the pendency of this Agreement); (iii) any changes in applicable Law or GAAP or other applicable accounting standards, including interpretations thereof, (iv) any outbreak or escalation of war or any act of terrorism, (v) the existence or worsening of any natural disasters, epidemics, pandemics, disease outbreaks (including in the case of the COVID-19 virus, only the worsening the pandemic) or public health emergencies, or other force majeure events; (vi) general conditions in the industry in which Company and its Subsidiaries operate; (vii) any failure, in and of itself, by Company to meet any internal or published projections, forecasts, estimates, or predictions in respect of revenues, earnings, or other financial or operating metrics for any period (it being understood that any Effect underlying such failure may be deemed to constitute, or be taken into account in determining whether there has been or would reasonably be expected to become, a Company Material Adverse Effect, to the extent permitted by this definition and not otherwise excepted by another clause of this proviso); or (viii) actions taken as required or specifically permitted by the Agreement or actions or omissions taken with Buyer’s consent; provided further, however, that any Effect referred to in clauses (i), (iii), (iv), (v), or (vi) immediately above shall be taken into account in determining whether a Company Material Adverse Effect has occurred or would reasonably be expected to occur if it has a disproportionate effect on Company and its Subsidiaries, taken as a whole, compared to other participants in the industries in which Company and its Subsidiaries conduct their businesses.

 

Company Material Contract” has the meaning set forth in Section 4.15(a).

 

Company Membership Units” has the meaning set forth in Section 4.2(a).

 

Company Owned IP” means all Intellectual Property owned by Company or any of its Subsidiaries.

 

Company Registered IP” has the meaning set forth in Section 4.7(a).

 

Consent” has the meaning set forth in Section 4.3(c).

 

Continuing Employees” shall mean all employees of the Company who continue their employment with the Surviving Entity.

 

Contracts” means any contracts, agreements, licenses, notes, bonds, mortgages, indentures, leases, or other binding instruments or binding commitments, whether written or oral.

 

Current Assets” means accounts receivable, inventory and prepaid expenses, but excluding (a) the portion of any prepaid expense of which Buyer will not receive the benefit following the Closing; (b) deferred Tax assets; (c) receivables from any of the Company’s Affiliates, Managers, employees, officers or members and any of their respective Affiliates and (d) Company Cash, determined in accordance with the same accounting methods, practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies (including with respect to reserves) that were used in the preparation of the Interim Financial Statements.

 

5
 

 

Current Liabilities” means accounts payable, accrued Taxes and accrued expenses, but excluding (a) payables to any of the Company’s Affiliates, Managers, employees, officers or members and any of their respective Affiliates; (b) deferred Tax liabilities; and (c) Indebtedness and Expenses, determined in accordance with the same accounting methods, practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies (including with respect to reserves) that were used in the preparation of the Interim Financial Statements.

 

D&O Indemnified Party” has the meaning set forth in Section 8.5(a).

 

Direct Claim” has the meaning set forth in Section 10.5(c).

 

Disclosed Litigation” has the meaning set forth in Section 4.9.

 

Disputed Amounts” has the meaning set forth in Section 3.3(c)(iii).

 

E. Muendel Employment Agreement” means that certain employment agreement between Buyer and Erik Muendel, substantially in the form of the agreement attached as Exhibit D.

 

Earnout Calculations” has the meaning set forth in Section 3.2(c)(iii).

 

Earnout Cash Payments” has the meaning set forth in Section 3.2(c)(i).

 

Earnout Consideration” has the meaning set forth in Section 3.2(c).

 

Earnout Notice” has the meaning set forth in Section 3.2(c)(iii).

 

Earnout Objection Period” and “Earnout Objection Notice” have the meanings set forth in Section 3.2(c)(iv).

 

Earnout Period” means, collectively, First Earnout Period, Second Earnout Period, and Third Earnout Period.

 

Earnout Revenue Targets” means, collectively, the Cash Revenue Targets and the Stock Revenue Targets.

 

Earnout Stock” means, (i) with respect to the First Stock Revenue Target or Second Stock Revenue Target, a number of validly issued, fully paid and non-assessable shares of Buyer Stock, equal to the quotient of $5,000,000 divided by the 360-Day VWAP (as measured as of the final day of the applicable Earnout Period) and (ii) with respect to the Third Stock Revenue Target, a number of validly issued, fully paid and non-assessable shares of Buyer Stock, equal to the quotient of $2,500,000 divided by the 360-Day VWAP (as measured as of the final day of the applicable Earnout Period).

 

Effect” has the meaning set forth in the definition of “Company Material Adverse Effect.”

 

Effective Time” has the meaning set forth in Section 2.4.

 

End Date” means September 30, 2022.

 

6
 

 

Environmental Laws” means any applicable Law, and any Order or binding agreement with any Governmental Entity: (a) relating to pollution (or the cleanup thereof) or the protection of natural resources, endangered or threatened species, human health or safety, or the environment (including ambient air, soil, surface water or groundwater, or subsurface strata); or (b) concerning the presence of, exposure to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge, transportation, processing, production, disposal or remediation of any Hazardous Materials. The term “Environmental Law” includes, without limitation, the following (including their implementing regulations and any state analogs): the Comprehensive Environmental Response, Compensation, and Liability Act of 1980, as amended by the Superfund Amendments and Reauthorization Act of 1986, 42 U.S.C. §§ 9601 et seq.; the Solid Waste Disposal Act, as amended by the Resource Conservation and Recovery Act of 1976, as amended by the Hazardous and Solid Waste Amendments of 1984, 42 U.S.C. §§ 6901 et seq.; the Federal Water Pollution Control Act of 1972, as amended by the Clean Water Act of 1977, 33 U.S.C. §§ 1251 et seq.; the Toxic Substances Control Act of 1976, as amended, 15 U.S.C. §§ 2601 et seq.; the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. §§ 11001 et seq.; the Clean Air Act of 1966, as amended by the Clean Air Act Amendments of 1990, 42 U.S.C. §§ 7401 et seq.; and the Occupational Safety and Health Act of 1970, as amended, 29 U.S.C. §§ 651 et seq.

 

ERISA” means the Employee Retirement Income Security Act of 1974, as amended.

 

Estimated Closing Working Capital” and “Estimated Closing Working Capital Statement” have the meanings set forth in Section 3.3(a)(i).

 

Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

Expenses” means, with respect to any Person, all reasonable and documented out-of-pocket fees and expenses (including all fees and expenses of counsel, accountants, financial advisors, and investment bankers of such Person and its Affiliates), incurred by such Person or on its behalf in connection with or related to the authorization, preparation, negotiation, execution, and performance of this Agreement and any transactions related thereto, any litigation with respect thereto, the filing of any required notices under antitrust Laws, or in connection with other regulatory approvals, and all other matters related to the Merger, the Buyer Stock Issuance, and the other transactions contemplated by this Agreement.

 

Financial Statements” has the meaning section forth in Section 4.4(a).

 

First Cash Revenue Target” has the meaning set forth in Section 3.2(c)(i).

 

First Earnout Cash Payment” has the meaning set forth in Section 3.2(c)(i).

 

First Earnout Period” means a one-year period, beginning on the first day of the month that begins on or most immediately after the Closing Date.

 

First Stock Revenue Target” means Recognized Revenue totaling at least $6,000,000 in the aggregate at any time during the First Earnout Period.

 

Fully Diluted Amount” means the sum of the number of issued and outstanding Company Membership Units, as of immediately prior to the Effective Time.

 

GAAP” means United States generally accepted accounting principles in effect from time to time.

 

Governmental Entity” has the meaning set forth in Section 4.3(c).

 

Hazardous Substance” means: (a) any material, substance, chemical, waste, product, derivative, compound, mixture, solid, liquid, mineral, or gas, in each case, whether naturally occurring or man-made, that is hazardous, acutely hazardous, toxic, or words of similar import or regulatory effect under Environmental Laws; and (b) any petroleum or petroleum-derived products, radon, radioactive materials or wastes, asbestos in any form, lead or lead-containing materials, urea formaldehyde foam insulation, and polychlorinated biphenyls.

 

7
 

 

HIPAA” means the Health Insurance Portability and Accountability Act of 1996, as amended.

 

Indebtedness” means, without duplication, (a) all Liabilities for borrowed money, (b) all Liabilities evidenced by notes, bonds, debentures, mortgage or other instruments, (c) all Liabilities under any debt security, interest rate, currency or other hedging or swap, derivative obligation or other similar arrangement and (d) all Liabilities for the reimbursement of draws under outstanding letters of credit, performance bonds or similar instruments (but only to the extent drawn), in each case including any amounts payable to terminate such arrangements.

 

Indebtedness Payoff Amount” has the meaning set forth in Section 2.3(b)(i).

 

Independent Accountant” means an independent accounting or financial consulting firm of recognized national standing mutually selected by Buyer and the Sellers’ Representative, which shall not have any material relationship with Buyer, the Company or any of their respective Affiliates.

 

Initial Cash Consideration” has the meaning set forth in Section 3.2(a).

 

Initial Per Unit Cash Consideration” means the Initial Cash Consideration divided by the Fully Diluted Amount.

 

Initial Stock Consideration” means a number of validly issued, fully paid and non-assessable shares of Buyer Stock, equal to the quotient of $5,000,000 divided by the 30-Day VWAP (as measured as of the Closing Date).

 

Intellectual Property” means any and all of the following arising pursuant to the Laws of any jurisdiction throughout the world: (a) trademarks, service marks, trade names, and similar indicia of source or origin, all registrations and applications for registration thereof, and the goodwill connected with the use of and symbolized by the foregoing; (b) copyrights and all registrations and applications for registration thereof; (c) trade secrets and know-how; (d) patents and patent applications; (e) internet domain name registrations; and (f) other intellectual property and related proprietary rights.

 

IPO” means the consummation of (i) the first underwritten public offering of equity securities of the IPO Corporation pursuant to an effective registration statement under the Securities Act, excluding registration statements on Form S-4, Form S-8 or similar limited purpose forms, or under the corresponding provisions of the securities laws of any non-U.S. jurisdiction, (ii) a direct listing of equity securities of the IPO Corporation on a national securities exchange under the Exchange Act or (iii) a merger involving a special purpose acquisition company (“SPAC”), pursuant to which equity securities of the IPO Corporation are exchanged for securities of the SPAC or its parent company that are registered under the Exchange Act and are listed for trading on a national securities exchange.

 

IPO Corporation” means the entity which undertakes the IPO, which may be, without limitation, the Surviving Entity or any successor to the Surviving Entity, a parent holding company of the Surviving Entity or any Subsidiary of the Surviving Entity.

 

IRS” means the United States Internal Revenue Service.

 

Knowledge” means: (a) with respect to Company and its Subsidiaries, the actual knowledge of Tyler Gates and Erik Muendel after due inquiry; and (b) with respect to Buyer and its Subsidiaries, the actual knowledge of Lyron Bentovim, Maydan Rothblum and Jeff Meisner after due inquiry.

 

8
 

 

Laws” means any federal, state, local, municipal, foreign, multi-national or other laws, common law, statutes, constitutions, ordinances, rules, regulations, codes, Orders, or legally enforceable requirements enacted, issued, adopted, promulgated, enforced, ordered, or applied by any Governmental Entity.

 

Lease” means all leases, subleases, licenses, concessions, and other agreements (written or oral) under which Company or any of its Subsidiaries holds any Leased Real Estate, including the right to all security deposits and other amounts and instruments deposited by or on behalf of Company or any of its Subsidiaries thereunder.

 

Leased Real Estate” means all leasehold or subleasehold estates and other rights to use or occupy any land, buildings, structures, improvements, fixtures, or other interest in real property held by Company or any of its Subsidiaries.

 

Legal Action” means any claim, action, cause of action, demand, lawsuit, arbitration, inquiry, audit, notice of violation, proceeding, litigation, citation, summons, subpoena or investigation of any nature, civil, criminal, administrative, regulatory or otherwise, whether at law or in equity.

 

Liability” means any liability, indebtedness, commitment or obligation of any kind (whether asserted, unasserted, known, unknown, accrued, unaccrued, absolute, contingent, matured, unmatured, determined, determinable, or otherwise, and whether or not required to be recorded or reflected on a balance sheet under GAAP).

 

Liens” means, with respect to any property or asset, all pledges, liens, mortgages, charges, encumbrances, hypothecations, options, rights of first refusal, rights of first offer, and security interests of any kind or nature whatsoever.

 

Losses” means losses, damages, liabilities, deficiencies, Legal Actions, judgments, interest, awards, penalties, fines, costs or expenses of whatever kind, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers; provided, however, that “Losses” shall not include punitive, consequential, speculative or indirect damages, except to the extent actually awarded to a Governmental Entity or other third party.

 

Material Customer” has the meaning set forth in Section 4.19(a).

 

Material Supplier” has the meaning set forth in Section 4.19(b).

 

Merger” has the meaning set forth in the Recitals.

 

Merger Consideration” means, collectively, the Initial Cash Consideration, Initial Stock Consideration, and Earnout Consideration.

 

Merger Sub” has the meaning set forth in the Preamble.

 

Merger Sub Board” has the meaning set forth in the Recitals.

 

Minimum Capital Amounts” has the meaning set forth in Section 3.2(c)(viii)(B).

 

NASDAQ” has the meaning set forth in the definition of “30-Day VWAP.”

 

NRS” has the meaning set forth in the Recitals.

 

Order” means any order, decision, ruling, judgment, writ, injunction, stipulation, award or decree issued by any Governmental Entity.

 

9
 

 

Other Governmental Approvals” has the meaning set forth in Section 4.3(c).

 

Owned Real Estate” means all land, together with all buildings, structures, fixtures, and improvements located thereon and all easements, rights of way, and appurtenances relating thereto, owned by Company.

 

Parties” has the meaning set forth in the Preamble.

 

Permits” has the meaning set forth in Section 4.8(b).

 

Permitted Liens” means: (a) statutory Liens for current Taxes or other governmental charges not yet due and payable or the amount or validity of which is being contested in good faith (provided appropriate reserves required pursuant to GAAP have been made in respect thereof); (b) mechanics’, carriers’, workers’, repairers’, and similar statutory Liens arising or incurred in the ordinary course of business for amounts which are not delinquent or which are being contested by appropriate proceedings (provided appropriate reserves required pursuant to GAAP have been made in respect thereof); (c) zoning, entitlement, building, and other land use regulations imposed by Governmental Entities having jurisdiction over such Person’s owned or leased real property, which are not violated by the current use and operation of such real property; (d) covenants, conditions, restrictions, easements, and other similar non-monetary matters of record affecting title to such Person’s owned or leased real property, which do not materially impair the occupancy or use of such real property for the purposes for which it is currently used in connection with such Person’s businesses; (e) any right of way or easement related to public roads and highways, which do not materially impair the occupancy or use of such real property for the purposes for which it is currently used in connection with such Person’s businesses; and (f) Liens arising under workers’ compensation, unemployment insurance, social security, retirement, and similar legislation.

 

Person” means any individual, corporation, limited or general partnership, limited liability company, limited liability partnership, trust, association, joint venture, Governmental Entity, or other entity.

 

Post-Closing Adjustment” has the meaning set forth in Section 3.3(b)(ii).

 

Pre-Closing Tax Period” means any taxable period ending on or before the Closing Date and, with respect to any taxable period beginning before and ending after the Closing Date, the portion of such taxable period ending on and including the Closing Date.

 

Pro Rata Portion” means, as to any Seller, a percentage equal to the number of Company Membership Units held by such Seller immediately prior to the Effective Time divided by Fully Diluted Amount.

 

Purchase Price” has the meaning set forth in Section 3.2.

 

Real Estate” means the Owned Real Estate and the Leased Real Estate.

 

Recognized Revenue” means, with respect to an applicable Earnout Period, determined in accordance with GAAP, the sum of: (i) gross revenue of the Surviving Entity for such Earnout Period; and (ii) gross revenue of Buyer or any of its Subsidiaries for such Earnout Period that is determined by Buyer in its reasonable and good faith discretion to be attributable to (x) the product lines or technologies of the Surviving Entity or (y) introductions to customers made by the Surviving Entity, subject to Buyer’s prior written consent to such introductions (provided, that Buyer may only withhold such consent if Buyer can reasonably establish that, as of the date that the Surviving Entity proposes such introduction, any such customer is (or was) already a customer of, or is being actively pursued as a customer by, Buyer or any of its Subsidiaries) (including, for the avoidance of doubt, any revenue generated from Buyer selling services or products provided by the Surviving Entity and any revenue generated from the Surviving Entity selling services or products provided by Buyer or its Subsidiaries other than the Surviving Entity).

 

10
 

 

Representatives” has the meaning set forth in Section 8.3.

 

Requisite Company Vote” has the meaning set forth in Section 4.3(a).

 

Resolution Period” has the meaning set forth in Section 3.3(c)(ii).

 

Restricted Business” has the meaning set forth in Section 8.12.

 

Restricted Period” has the meaning set forth in Section 8.12.

 

Revenue Amounts” has the meaning set forth in Section 3.2(c)(viii)(B).

 

Revenue Shortfall Amount” has the meaning set forth in Section 3.2(c)(viii)(B).

 

Review Period” has the meaning set forth in Section 3.3(c)(i).

 

SEC” means the Securities and Exchange Commission.

 

Second Cash Revenue Target” has the meaning set forth in Section 3.2(c)(i).

 

Second Earnout Cash Payment” has the meaning set forth in Section 3.2(c)(i).

 

Second Earnout Period” means a two-year period, beginning on the first day of the month that begins on or most immediately after the Closing Date.

 

Second Stock Revenue Target” means Recognized Revenue totaling at least $15,000,000 in the aggregate at any time during the Second Earnout Period.

 

Securities Act” means the Securities Act of 1933, as amended.

 

Seller Indemnitees” has the meaning set forth in Section 10.3.

 

Sellers Lock-Up Agreement” has the meaning set forth in Section 3.2(b), substantially in the form of the agreement attached as Exhibit B.

 

Statement of Objections” has the meaning set forth in Section 3.3(c)(ii).

 

Stock Revenue Targets” means, collectively, the First Stock Revenue Target, the Second Stock Revenue Target and the Third Stock Revenue Target.

 

Subsidiary” of a Person means a corporation, partnership, limited liability company, or other business entity of which a majority of the shares of voting securities is at the time beneficially owned, or the management of which is otherwise controlled, directly or indirectly, through one or more intermediaries, or both, by such Person.

 

Surviving Entity” has the meaning set forth in Section 2.1.

 

T. Gates Employment Agreement” means that certain employment agreement between Buyer and Tyler Gates, substantially in the form of the agreement attached as Exhibit C.

 

Target Working Capital” means $0.

 

11
 

 

Tax” or “Taxes” means all federal, state, local, foreign and other income, gross receipts, sales, use, production, ad valorem, transfer, franchise, registration, profits, license, lease, service, service use, withholding, payroll, employment, unemployment, estimated, excise, severance, environmental, stamp, occupation, premium, property (real or personal), real property gains, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with any interest, additions or penalties with respect thereto and any interest in respect of such additions or penalties.

 

Tax Returns” means any return, declaration, report, claim for refund, information return or statement, or other document relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof.

 

Territory” has the meaning set forth in Section 8.12.

 

Third Cash Revenue Target” has the meaning set forth in Section 3.2(c)(i).

 

Third Earnout Cash Payment” has the meaning set forth in Section 3.2(c)(i).

 

Third Earnout Period” means a three-year period, beginning on the first day of the month that begins on or most immediately after the Closing Date.

 

Third Party Claim” has the meaning set forth in Section 10.5.

 

Third Stock Revenue Target” means Recognized Revenue totaling at least $28,500,000 in the aggregate at any time during the Third Earnout Period.

 

Trading Day” means any day on which shares of Buyer Stock are traded on the NASDAQ.

 

Treasury Regulations” means the Treasury regulations promulgated under the Code.

 

Undisputed Amounts” has the meaning set forth in Section 3.3(c)(iii).

 

VLLCA” has the meaning set forth in the Recitals.

 

Voting Debt” has the meaning set forth Section 4.2(b).

 

Year-End Financial Statements” has the meaning set forth in Section 4.4(a).

 

30-Day VWAP” means, as of an applicable measurement date, the volume weighted average price per share of Buyer Stock on the Nasdaq Capital Market (“NASDAQ”) (as reported by Bloomberg L.P. or, if not reported therein, in another authoritative source mutually selected by the parties) measured on a cumulative basis over the thirty (30) consecutive Trading Days ending on and including the Trading Day immediately preceding such measurement date; provided that the 30-Day VWAP shall not be less than $7.00 per share (adjusted for stock splits and similar events).

 

360-Day VWAP” means, as of an applicable measurement date, the volume weighted average price per share of Buyer Stock on NASDAQ (as reported by Bloomberg L.P. or, if not reported therein, in another authoritative source mutually selected by the parties) measured on a cumulative basis over the three hundred sixty (360) consecutive Trading Days ending on and including the Trading Day immediately preceding such measurement date; provided that the 360-Day VWAP shall not be less than $7.00 per share (adjusted for stock splits and similar events).

 

12
 

 

ARTICLE II
The Merger

 

Section 2.1 The Merger. On the terms and subject to the conditions set forth in this Agreement, and in accordance with the NRS and VLLCA, at the Effective Time: (a) Company will merge with and into Merger Sub; (b) the separate existence of Company will cease; and (c) Merger Sub will continue its existence under the NRS as the surviving entity in the Merger and a Subsidiary of Buyer (sometimes referred to herein as the “Surviving Entity”).

 

Section 2.2 Closing. Upon the terms and subject to the conditions set forth herein, the closing of the Merger (the “Closing”) will take place at 5:00 p.m., Eastern Daylight Time, on August 1, 2022 or as soon as practicable thereafter (and, in any event, within three (3) Business Days) after the satisfaction or, to the extent permitted hereunder, waiver of all conditions to the Merger set forth in ARTICLE IX (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or, to the extent permitted hereunder, waiver of all such conditions), unless this Agreement has been terminated pursuant to its terms or unless another time or date is agreed to in writing by the Buyer and the Sellers’ Representative (such date, the “Closing Date”). The Closing shall take place remotely by exchange of documents and signatures (or their electronic counterparts), unless another place is agreed to in writing by the parties hereto.

 

Section 2.3 Closing Deliverables.

 

(a) At the Closing, the Company shall deliver to Buyer the following:

 

(i) a certificate, dated the Closing Date and signed by a duly authorized officer of the Company, setting forth (x) the amounts of all Indebtedness outstanding immediately prior to the Closing Date and identifying the holders of such Indebtedness and (y) the amounts of all Expenses of the Company outstanding (subject to Section 11.6) immediately prior to the Closing Date and identifying the payee of such Expenses (the “Closing Certificate”);

 

(ii) a certificate, dated the Closing Date and signed by a duly authorized officer of the Company, that each of the conditions set forth in Section 9.1(a) and Section 9.1(b) have been satisfied;

 

(iii) a certificate of the Secretary of the Company certifying that (A) attached thereto are true and complete copies of (1) all resolutions adopted by Company Action authorizing the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby and (2) resolutions adopted by Company Action approving the Merger and adopting this Agreement, and (B) all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby;

 

(iv) a certificate of the Secretary of the Company certifying the names and signatures of the officers of the Company authorized to sign this Agreement and the other documents to be delivered by the Company hereunder;

 

(v) a good standing certificate (or its equivalent) from the State Corporation Commission for the Commonwealth of Virginia; and

 

(vi) the Ancillary Documents and such other documents or instruments as the Buyer reasonably requests and are reasonably necessary to consummate the transactions contemplated by this Agreement.

 

13
 

 

(b) At the Closing, Buyer shall deliver to Sellers or Company, as specified herein, the following:

 

(i) the Initial Cash Consideration;

 

(ii) evidence (reasonably satisfactory to the Sellers’ Representative) that the Initial Stock Consideration has been issued and delivered pursuant to Section 3.2(b);

 

a certificate, dated the Closing Date and signed by a duly authorized officer of Buyer, that each of the conditions set forth in Section 9.2(a) and Section 9.2(b) have been satisfied;

 

(iii) a certificate of the Secretary of Buyer and Merger Sub certifying that attached thereto are true and complete copies of all resolutions adopted by the board of directors of Buyer and Merger Sub authorizing the execution, delivery and performance of this Agreement and the Ancillary Documents and the consummation of the transactions contemplated hereby and thereby, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated hereby and thereby;

 

(iv) a certificate of the Secretary of Buyer and Merger Sub certifying the names and signatures of the officers of Buyer and Merger Sub authorized to sign this Agreement, the Ancillary Documents and the other documents to be delivered hereunder and thereunder; and

 

(v) the Ancillary Documents and such other documents or instruments as the Company reasonably requests and are reasonably necessary to consummate the transactions contemplated by this Agreement.

 

(c) At the Closing, Buyer shall deliver by wire transfer of immediately available funds to each holder of the Indebtedness set forth on the Closing Certificate the portion of the Indebtedness Payoff Amount required to pay off in full such holder’s Indebtedness.

 

(d) At the Closing, Buyer shall deliver by wire transfer of immediately available funds to each payee of the Expenses of the Company, the applicable amount set forth in the Closing Certificate.

 

Section 2.4 Effective Time. Subject to the provisions of this Agreement, at the Closing, Company, Buyer, and Merger Sub will cause articles of merger (the “Articles of Merger”) to be executed, acknowledged, and filed with the Secretary of State of Nevada and the State Corporation Commission for the Commonwealth of Virginia in accordance with the relevant provisions of the NRS and VLLCA, respectively, and shall make all other filings or recordings required under the NRS and VLLCA, in each case in such form as is reasonably satisfactory to each party. The Merger will become effective at such time as the Articles of Merger has been duly filed with and accepted by the Secretary of State of the State of Nevada and the State Corporation Commission for the Commonwealth of Virginia or at such later date or time as may be agreed by Company and Buyer in writing and specified in the Articles of Merger in accordance with the NRS and the VLLCA (the effective time of the Merger being hereinafter referred to as the “Effective Time”).

 

Section 2.5 Effects of the Merger. The Merger shall have the effects set in this Agreement and in the applicable provisions of the NRS and VLLCA. Without limiting the generality of the foregoing, and subject thereto, from and after the Effective Time, all property, rights, privileges, immunities, powers, franchises, licenses, and authority of Company shall vest in the Surviving Entity, and all debts, liabilities, obligations, restrictions, and duties of each of Company shall become the debts, liabilities, obligations, restrictions, and duties of the Surviving Entity.

 

14
 

 

Section 2.6 Certificate of Formation; Operating Agreement. At the Effective Time: (a) the certificate of formation of the Surviving Entity shall be amended and restated so as to read in its entirety as set forth in Exhibit A, and, as so amended and restated, shall be the certificate of formation of the Surviving Entity until thereafter amended in accordance with the terms thereof and applicable Law; and (b) the operating agreement of Merger Sub as in effect immediately prior to the Effective Time shall be the operating agreement of the Surviving Entity, except that references to Merger Sub’s name shall be replaced with references to “Brightline Interactive, LLC” until thereafter amended in accordance with the terms thereof, the certificate of formation of the Surviving Entity, and applicable Law.

 

ARTICLE III
Effect of the Merger; PURCHASE PRICE

 

Section 3.1 Effect of the Merger on Membership Interests. At the Effective Time, as a result of the Merger and without any action on the part of Buyer, Merger Sub, or Company or the holder of any capital stock or equity interests of Buyer, Merger Sub, or Company, each Company Membership Unit that is issued and outstanding immediately prior to the Effective Time shall be converted into the right to receive, without interest for each Company Membership Unit:

 

(a) (x) a number of validly issued, fully paid and non-assessable shares of Buyer Stock, equal to the Initial Stock Consideration divided by the Fully Diluted Amount and (y) the Initial Per Unit Cash Consideration; and

 

(b) the right to receive Earnout Consideration, in accordance with Section 3.2(c).

 

Section 3.2 Purchase Price. The aggregate purchase price for the Company Membership Units shall be up to $32,500,000, subject to adjustment pursuant to Section 3.2(a) and Section 3.3, comprised of Initial Cash Consideration, Initial Stock Consideration, and Earnout Consideration as set forth in this Section 3.2 (“Purchase Price”). Subject to the effectiveness of the Merger, the Buyer shall deliver the following consideration:

 

(a) Initial Cash Consideration. At Closing, Buyer shall pay a total of $3,000,000, plus the Closing Adjustment, plus the aggregate amount of Company Cash, less the total amount of Indebtedness set forth in the Closing Certificate (the “Indebtedness Payoff Amount”), less the total amount of Expenses set forth in the Closing Certificate (“Initial Cash Consideration”), to the Sellers, in accordance with their Pro Rata Portion, by wire transfer of immediately available funds in the amounts and in accordance with the wire transfer instructions on Schedule 3.2(a) attached hereto (or such other instructions provided by a Seller to Buyer within three (3) Business Days of the Closing Date); and

 

(b) Initial Stock Consideration. At the Closing, Buyer shall deliver the Initial Stock Consideration to each of the Sellers in the amounts and in accordance with the account instructions set forth in Schedule 3.2(b) (or such other instructions provided by a Seller to Buyer within three (3) Business Days of the Closing Date), and shall cause its transfer agent to record a book entry evidencing the issuance of the Initial Stock Consideration in the name of such Sellers. At or prior to Closing, each of the Sellers agrees to execute a lock-up agreement, substantially in the form attached hereto as Exhibit B (“Sellers Lock-Up Agreement”).

 

(c) Earnout Consideration. During the three years after the Closing Date, as consideration for the Company Membership Units, Buyer shall pay to the Sellers, in accordance with their Pro Rata Portion, certain cash and stock earnout payments as provided for in this Section 3.2(c) (collectively, the “Earnout Consideration”).

 

15
 

 

(i) Earnout Cash. At any time during the Third Earnout Period, calculated quarterly, on a cumulative basis, when Recognized Revenue totals (x) at least $7,000,000 (in the aggregate), $10,000,000 (in the aggregate), or $12,500,000 (in the aggregate) (each a “First Cash Revenue Target”), Sellers shall receive, in accordance with their Pro Rata Portion, $1,500,000 for meeting each such First Cash Revenue Target (each a “First Earnout Cash Payment”), (y) at least $28,500,000 (in the aggregate) (the “Second Cash Revenue Target”), Sellers shall receive, in accordance with their Pro Rata Portion, $2,500,000 for meeting such Second Cash Revenue Target (the “Second Earnout Cash Payment”) and (z) at least $35,000,000 (in the aggregate) (the “Third Cash Revenue Target” and, together with the First Cash Revenue Target and Second Cash Revenue Target, the “Cash Revenue Targets”), Sellers shall receive, in accordance with their Pro Rata Portion, $5,000,000 for meeting such Third Cash Revenue Target (the “Third Earnout Cash Payment” and, together with the First Earnout Cash Payment and Second Earnout Cash Payment, the “Earnout Cash Payments”), in each case, promptly after exceeding the applicable Cash Revenue Target, by wire transfer of immediately available funds in the amounts and in accordance with the wire transfer instructions on Schedule 3.2(a) attached hereto (or such other instructions provided by a Seller to Buyer within three (3) Business Days of the applicable distribution) (provided, that, for the avoidance of doubt, Sellers shall receive in aggregate $12,000,000 in cash pursuant to this Section 3.2(c)(i) in the event that Recognized Revenue equals at least $35,000,000 at any time during the Third Earnout Period). Within thirty (30) days after the end of such quarterly periods, Sellers’ Representative may submit written notice to Buyer requesting Buyer’s calculation of the Recognized Revenue as of such period, which Buyer shall promptly provide after receipt of such request (the “Quarterly Notice”).

 

(ii) Earnout Stock. Sellers shall receive, in accordance with their Pro Rata Portion to each of Sellers’ brokerage accounts in accordance with the account instructions in Schedule 3.2(b) attached hereto (or such other instructions provided by a Seller to Buyer within three (3) Business Days of the applicable issuance date), an amount of Earnout Stock in the event (and in each instance) that any of the following Stock Revenue Targets are achieved: the First Stock Revenue Target at any time during the First Earnout Period, the Second Stock Revenue Target at any time during the Second Earnout Period and the Third Stock Revenue Target at any time during the Third Earnout Period (provided, that, for the avoidance of doubt, Sellers shall receive in aggregate three separate amounts of Earnout Stock in the event that each of the Stock Revenue Targets is achieved).

 

A. In the event that (i) the First Stock Revenue Target is not achieved during the First Earnout Period, but a subsequent Stock Revenue Target is achieved during its applicable Earnout Period or (ii) the Second Revenue Target is not achieved during the Second Earnout Period, but a subsequent Stock Revenue Target is achieved during its applicable Earnout Period, then, promptly upon the end of the subsequent applicable Earnout Period, Sellers shall receive, in accordance with their Pro Rata Portion to each of Sellers’ brokerage accounts in accordance with the account instructions in Schedule 3.2(b) attached hereto (or such other instructions provided by a Seller to Buyer within three (3) Business Days of the applicable issuance date), an amount of Earnout Stock for the First Earnout Period and/or the Second Earnout Period, as applicable (with the 30-Day VWAP as measured as of the final day of such subsequent Earnout Period).

 

B. Buyer shall continue to reserve and keep available at all times, free of Liens and preemptive rights, a sufficient number of shares of Buyer Stock for the purpose of enabling Buyer to issue the Buyer Stock Consideration pursuant to this Agreement.

 

16
 

 

(iii) Earnout Notice. Within thirty (30) days after the expiration of each Earnout Period, Buyer will provide the Sellers’ Representative with written notice (each, an “Earnout Notice”) setting forth: (i) Buyer’s calculation of the Recognized Revenue for the applicable Earnout Period; and (ii) whether any applicable Earnout Consideration was earned during the applicable Earnout Period (collectively, the “Earnout Calculations”). If an Earnout Notice is not so timely delivered, then the Sellers’ Representative shall be permitted, within fifteen (15) calendar days after such 30th day, to prepare and deliver a written notice setting forth the Earnout Calculations (each, a “Seller Earnout Notice”). In the event that the Sellers’ Representative delivers to Buyer a Seller Earnout Notice within such fifteen (15) calendar day period, Buyer will have fifteen (15) calendar days to review such Seller Earnout Notice. If Buyer provides written notice to the Sellers’ Representative setting forth its objections to the calculations included in the Seller Earnout Notice, together with supporting documentation relating thereto, within such fifteen (15) calendar day period, then such disputed itemized amounts shall be resolved in accordance with the procedures set forth in Section 3.2(c)(v), mutatis mutandis. Unless Buyer delivers written notice to the Sellers’ Representative on or prior to the fifteenth (15th) calendar day after Buyer’s receipt of the Seller Earnout Notice, Buyer will be deemed to have accepted and agreed to the Seller Earnout Notice and the calculations contained therein will be deemed final, conclusive and binding on the parties hereto.

 

(iv) Sellers’ Review; Earnout Objection Notice. Upon the receipt by Sellers’ Representative of an Earnout Notice, Sellers’ Representative shall have thirty (30) days to review the Earnout Notice and may have the same verified by its accountants; provided, that such thirty (30) day period shall be tolled by one (1) day for each day (or part thereof) that Buyer fails to provide the access required by this Section 3.2(c)(iv). Sellers’ Representative will be entitled to perform reasonable procedures (including review of the accounting records of the Surviving Entity and Buyer or any of its Subsidiaries, as applicable, supporting such calculations and other materials as he may reasonably request) and to take other reasonable steps to confirm that the amount of the Earnout Calculations for the applicable Earnout Period set forth in the Earnout Notice has been prepared in accordance with the terms of this Agreement.

 

A. If Sellers’ Representative has an objection to the calculation of the Earnout Calculations set forth in an Earnout Notice, then within thirty (30) days of receipt of such Earnout Notice (the “Earnout Objection Period”), Sellers’ Representative shall deliver to Buyer a written statement (the “Earnout Objection Notice”) setting forth the component or components of the Earnout Notice that are in dispute, the basis of such dispute and, if known, the amount proposed as an adjustment. Sellers’ Representative and Buyer shall in good faith attempt to resolve any such dispute and, if the parties so resolve all such disputes, then the calculation of the Earnout Calculations set forth in the Earnout Notice for the applicable Earnout Period as resolved by the parties, shall be conclusive and binding on the parties upon written acknowledgement of such resolution.

 

B. The failure of Sellers’ Representative to deliver an Earnout Objection Notice within the Earnout Objection Period shall constitute the acceptance by Sellers of the calculations and determinations made by Buyer as set forth in the Earnout Notice, whereupon such amounts shall be final, binding and conclusive for all purposes hereunder.

 

(v) Earnout Referee. If Sellers’ Representative and Buyer fail to resolve all of the items in dispute within thirty (30) days after Sellers’ Representative’s delivery of the Earnout Objection Notice to Buyer (or such longer period as they may mutually agree in writing), then Buyer or Sellers’ Representative may elect to submit any remaining disputed items to an Independent Accountant (the “Earnout Referee”) and who shall be retained to review promptly the Earnout Calculations set forth in the Earnout Notice and the disputed items or amounts; provided, however, that if Buyer and Sellers’ Representative are unable to mutually agree on an Earnout Referee within five (5) Business Days after Buyer or Sellers’ Representative elects to initiate the dispute resolution procedures hereunder, then each of Buyer and Sellers’ Representative shall designate an independent third-party accounting firm and such designees shall promptly (and in any event within ten (10) days) select an individual to act as the Earnout Referee.

 

17
 

 

A. If any disputed items are referred to the Earnout Referee, the parties shall cooperate in good faith with the determination process and the Earnout Referee’s requests for information, including providing the Earnout Referee with information as promptly as practicable after its request therefor. Each party shall be entitled to receive copies of all materials provided by the other to the Earnout Referee in connection with the determination process. In making its determination on the disputed items, the Earnout Referee shall make such determinations (i) only in accordance with the standards set forth in this Agreement, (ii) only with respect to the disputed items submitted to the Earnout Referee and no other items and (iii) where the result of the Earnout Referee’s determination for such disputed item is neither greater then nor less than the amounts presented by the parties to the Earnout Referee with respect to the item in dispute. The fees, costs and expenses of the Earnout Referee shall be allocated to and borne by Buyer, on the one hand, and the Sellers’ Representative on behalf of Sellers, on the other hand, based on the inverse of the percentage that the Earnout Referee’s determination (before such allocation) bears to the total amount of all disputed items as originally submitted to the Earnout Referee. For example, should the disputed items total in amount to one thousand dollars ($1,000) and the Earnout Referee awards six hundred dollars ($600) in favor of the Sellers’ Representative’s position, sixty percent (60%) of the costs of its review would be borne by Buyer and forty percent (40%) of the costs would be borne by the Sellers’ Representative, on behalf of Sellers. The determination of the Earnout Referee shall be final, conclusive and binding on the parties, absent manifest error. The parties shall instruct the Earnout Referee to provide its determination in writing to the parties within thirty (30) days of the date it is engaged on such project. Neither party shall have any ex parte conversations or meetings with the Earnout Referee without the prior written consent of the other party.

 

(vi) The Earnout Calculations for the applicable Earnout Period, and the earning of the applicable Earnout Consideration therefrom, either as accepted or deemed to have been accepted by Sellers or as adjusted and resolved in the manner provided in Section 3.2(c), shall fix the Earnout Calculations for the applicable Earnout Period and the earning of the Earnout Consideration determined therefrom. Each party shall bear its own expenses, including its accountants, in connection with the preparation, review, dispute (if any) and final determination of the Earnout Calculations for the applicable Earnout Period, and the earning of any Earnout Consideration calculated therefrom.

 

(vii) Payment Distribution. Within ten (10) Business Days after the date that is the later of (i) the acceptance of the Earnout Notice or Seller Earnout Notice or (ii) a determination is made in accordance with Section 3.2(c), Buyer shall distribute the requisite Earnout Consideration provided for in Section 3.2(c)(i) (Earnout Cash) and Section 3.2(c)(ii) (Earnout Stock); provided, that, in the event that Buyer delivers a Quarterly Notice which provides that a Cash Revenue Target has been met, Buyer shall distribute the requisite Earnout Cash Payment within ten (10) Business Days after the date of such Quarterly Notice.

 

(viii) Post-Closing Operation. The Parties agree that Buyer’s executive officers and board of directors have a fiduciary duty to all of its shareholders and, as such, will at all times retain the right to manage and make decisions in a manner that is in the best interests of Buyer’s shareholders. Within that constraint, during the Earnout Period, Buyer shall not, and shall cause each of its controlled Affiliates not to:

 

A. actively divert any revenue generating opportunity away from the Surviving Entity to Buyer or any of its other Affiliates or Subsidiaries, unless all such revenue is included as Recognized Revenue;

 

18
 

 

B. take any actions reasonably likely to prevent the Surviving Entity from meeting any Earnout Revenue Target (including depriving the Surviving Entity of sufficient personnel, technical or financial resources reasonably required for the Surviving Entity to meet all Earnout Revenue Targets; provided that, for the avoidance of doubt, through December 31, 2023, Buyer shall provide at least an amount of capital (the “Minimum Capital Amounts”) to the Surviving Entity consistent with the budget of the Surviving Entity set forth on Schedule 3.2 (“Brightline Budget”); provided, further, that, in the event that the Surviving Entity does not achieve the applicable revenue amounts set forth in the Brightline Budget (the “Revenue Amounts”) for two consecutive fiscal quarters (any such shortfall amount, a “Revenue Shortfall Amount”), Buyer may review and reasonably reduce the Minimum Capital Amounts, so long as such reduction is proportionately consistent with the extent to which the applicable Revenue Shortfall Amounts are less than the applicable Revenue Amounts);

 

C. take any actions reasonably likely to inhibit Buyer’s ability to deliver the Earnout Consideration; and

 

D. terminate Tyler Gates from the role of General Manager (or equivalent position) of the Surviving Entity in order to inhibit the Surviving Entity from meeting any Earnout Revenue Target.

 

In the event that Buyer materially breaches any of the foregoing provisions (A)-(D), which is not cured within thirty (30) days after written notice of such breach delivered to Buyer, then (1) all Earnout Cash Payments shall be paid to Sellers, in accordance with their Pro Rata Portion, regardless of the performance of the underlying Earnout Revenue Targets and (2) all unissued Earnout Stock shall be issued in accordance with their Pro Rata Portion to Sellers, regardless of the performance of the underlying Earnout Revenue Targets, promptly after the expiration of such cure period.

 

(ix) Sale of Buyer; Sale of Surviving Entity or Spinout. At any time prior to the payment of all Earnout Consideration to Sellers under this Section 3.2(c) (or a final determination that no further Earnout Consideration may be payable to Sellers), in the event of:

 

A. a Change in Control of Buyer, (1) all Earnout Cash Payments (other than the Earnout Cash Payments with respect to the Second Cash Revenue Target and the Third Cash Revenue Target) shall be paid to Sellers, in accordance with their Pro Rata Portion, regardless of the performance of the underlying Earnout Revenue Targets, upon consummation of such transaction, (2) all earned but unissued Earnout Stock shall be issued in accordance with their Pro Rata Portion to Sellers, prior to the consummation of such transaction, and (3) unmet Stock Revenue Targets and the Second Cash Revenue Target and the Third Cash Revenue Target shall survive and Buyer shall make provision for its acquiror or successor to assume and succeed to such obligations of Buyer in respect of such Earnout Revenue Targets, on the same terms and conditions set forth herein; and

 

B. a Change in Control of the Surviving Entity or an IPO, (1) all Earnout Cash Payments shall be paid to Sellers, in accordance with their Pro Rata Portion, regardless of the performance of the underlying Earnout Revenue Targets and (2) all unissued Earnout Stock shall be issued in accordance with their Pro Rata Portion to Sellers, regardless of the performance of the underlying Earnout Revenue Targets, in each case upon consummation of such transaction or IPO.

 

(d) Withholding Rights. Each of Buyer, Merger Sub, and the Surviving Entity shall be entitled to deduct and withhold from the consideration otherwise payable to any Person pursuant to this ARTICLE III such amounts as may be required to be deducted and withheld with respect to the making of such payment under any Tax Laws and to pay such deducted or withheld amounts to the appropriate Governmental Entity or other taxing authority. Prior to withholding or deducting any amounts, the Buyer, Merger Sub, or the Surviving Entity shall provide notice of such intention to withhold and shall permit the recipient to take reasonable steps to eliminate or mitigate any such withholding or deduction. To the extent that amounts are so deducted and withheld by the Buyer, Merger Sub, or the Surviving Entity, as the case may be, such amounts shall be treated for all purposes of this Agreement as having been paid to the Person in respect of which Buyer, Merger Sub, or the Surviving Entity, as the case may be, made such deduction and withholding.

 

19
 

 

Section 3.3 Purchase Price Adjustment.

 

(a) Closing Adjustment.

 

(i) At least five (5) Business Days before the Closing, Company shall prepare and deliver to Buyer a statement setting forth its good faith estimate of Closing Working Capital (the “Estimated Closing Working Capital”), which statement shall contain an estimated balance sheet of the Company as of the Closing Date (without giving effect to the transactions contemplated herein), a calculation of Estimated Closing Working Capital (the “Estimated Closing Working Capital Statement”), and a certificate executed by an officer of Company stating that the Estimated Closing Working Capital Statement was prepared in accordance with the same accounting methods, practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies (including with respect to reserves) that were used in the preparation of the Interim Financial Statements; provided, that, notwithstanding the foregoing, and solely for the purposes of calculating the amount of Estimated Closing Working Capital, the Estimated Closing Working Capital Statement (but not, for the avoidance of doubt, the Closing Working Capital Statement) shall include an additional $40,000 as a Current Liability of the Company (the “Additional Liability”).

 

(ii) The “Closing Adjustment” shall be an amount equal to the Estimated Closing Working Capital minus the Target Working Capital. For the avoidance of doubt, (i) if the Closing Adjustment is a positive number, the Initial Cash Consideration shall be increased by the amount of the Closing Adjustment and (ii) if the Closing Adjustment is a negative number, the Initial Cash Consideration shall be reduced by the absolute value of the amount of the Closing Adjustment, in each case pursuant to Section 3.2(a).

 

(b) Post-Closing Adjustment.

 

(i) Within 180 days after the Closing Date, Buyer shall prepare and deliver to Seller a statement setting forth its good faith calculation of Closing Working Capital (which shall not include, for the avoidance of doubt, the Additional Liability), which statement shall contain an audited balance sheet of the Company as of the Closing Date (without giving effect to the transactions contemplated herein), a calculation of Closing Working Capital (the “Closing Working Capital Statement”) and a certificate executed by the Chief Financial Officer of Buyer stating that the Closing Working Capital Statement was prepared in accordance with GAAP applied using the same accounting methods, practices, principles, policies and procedures, with consistent classifications, judgments and valuation and estimation methodologies (including with respect to reserves) that were used in the preparation of the Interim Financial Statements. If the Closing Working Capital Statement is not so timely delivered, then the Sellers’ Representative shall be permitted, within fifteen (15) calendar days after such 180th day, to prepare and deliver a written notice to Buyer setting forth the itemized amounts, if any, included in the Estimated Closing Working Capital calculation that, after giving effect to the Closing, the Sellers’ Representative disputes (such itemized amounts, the “Sellers’ Representative Disputed Amounts” and such notice, together with the calculations contained therein, the “Sellers’ Representative Closing Notice”). If the Sellers’ Representative does not deliver such Sellers’ Representative Closing Notice on or prior to such fifteenth (15th) calendar day, then the Estimated Closing Working Capital will be deemed final for all purposes of this Agreement. In the event that the Sellers’ Representative delivers to Buyer such Sellers’ Representative Closing Notice within such fifteen (15) calendar day period, Buyer will have fifteen (15) calendar days to review the Sellers’ Representative Closing Notice. If Buyer provides written notice to the Sellers’ Representative setting forth the itemized amounts, if any, included in the Sellers’ Representative Disputed Amounts to which Buyer objects, together with supporting documentation relating thereto, within such fifteen (15) calendar day period, then such disputed itemized amounts (but not any other amounts) shall be resolved in accordance with the procedures set forth in Section 3.3(c) mutatis mutandis. Unless Buyer delivers written notice to the Sellers’ Representative on or prior to the fifteenth (15th) calendar day after Buyer’s receipt of the Sellers’ Representative Closing Notice, Buyer will be deemed to have accepted and agreed to the Sellers’ Representative Closing Notice and such statement (and the calculations contained therein) will be final for all purposes of this Agreement.

 

20
 

 

(ii) The post-closing adjustment shall be an amount equal to the Closing Working Capital minus the Estimated Closing Working Capital (the “Post-Closing Adjustment”). If the Post-Closing Adjustment is a positive number, Buyer shall pay to Sellers’ Representative (on behalf of Sellers) an amount equal to the Post-Closing Adjustment. If the Post-Closing Adjustment is a negative number, Sellers, severally and not jointly and in accordance with their Pro Rata Portion, shall pay to Buyer the absolute value of the amount equal to the Post-Closing Adjustment.

 

(c) Examination and Review

 

(i) Examination. After receipt of the Closing Working Capital Statement, Sellers’ Representative shall have thirty (30) days (the “Review Period”) to review the Closing Working Capital Statement. During the Review Period, Sellers’ Representative and its accountants shall have full access to the relevant books and records of Company and Buyer, the personnel of, and work paper prepared by Buyer and/or Buyer’s accountants to the extent that they relate to the Closing Working Capital Statement and to such historical financial information (to the extent in Buyer’s possession) relating to the Closing Working Capital Statement as Sellers’ Representative may reasonably request for the purpose of reviewing the Closing Working Capital Statement and to prepare a Statement of Objections (defined below), provided that such access shall be in a manner that does not interfere with the normal business operations of Buyer.

 

(ii) Objection. On or prior to the last day of the Review Period, Sellers’ Representative may object to the Closing Working Capital Statement by delivering to Buyer a written statement setting forth Sellers’ Representative’s objections in reasonable detail, indicating each disputed item or amount and the basis for Sellers’ Representative’s disagreement therewith (the “Statement of Objections”). If Sellers’ Representative fails to deliver the Statement of Objections before the expiration of the Review Period, the Closing Working Capital Statement and the Post-Closing Adjustment, as the case may be, reflected in the original Closing Working Capital Statement delivered by Buyer shall be deemed to have been accepted by Sellers. If Sellers’ Representative delivers the Statement of Objections before the expiration of the Review Period, within thirty (30) days after the delivery of the Statement of Objections (the “Resolution Period”), Buyer’s accountant and the Sellers’ Representative’s accountant shall cooperate in good faith (under supervision of Buyer and Sellers’ Representative) to review and resolve any disputes or objections and if the Statement of Objection is so resolved within the Resolution Period, the Post-Closing Adjustment and the Closing Working Capital Statement shall be modified to comply with such resolved and agreed changes as are agreed in writing by Buyer and Sellers’ Representative whereupon such adjusted Post-Closing Adjustment being final, binding and conclusive on all parties.

 

(iii) Resolution of Disputes. If Sellers’ Representative and Buyer fail to reach an agreement with respect to all of the matters set forth in the Statement of Objections before the expiration of the Resolution Period, then any amounts remaining in dispute (“Disputed Amounts” and any amounts not so disputed, the “Undisputed Amounts”) shall be submitted for resolution to the Independent Accountant who, acting as experts and not arbitrators, shall resolve the Disputed Amounts only and make any adjustments to the Post-Closing Adjustment, as the case may be, and the Closing Working Capital Statement. The parties hereto agree that all adjustments shall be made without regard to materiality. The Independent Accountant shall only decide the specific items under dispute by the parties and their decision for each Disputed Amount must be within the range of values assigned to each such item in the Closing Working Capital Statement and the Statement of Objections, respectively.

 

21
 

 

(iv) Fees of the Independent Accountant. The fees, costs and expenses of the Independent Accountant shall be allocated to and borne by Buyer, on the one hand, and the Sellers’ Representative on behalf of Sellers, on the other hand, based on the inverse of the percentage that the Independent Accountant’s determination (before such allocation) bears to the total amount of all disputed items as originally submitted to the Independent Accountant. For example, should the disputed items total in amount to one thousand dollars ($1,000) and the Independent Accountant awards six hundred dollars ($600) in favor of the Sellers’ Representative’s position, sixty percent (60%) of the costs of its review would be borne by Buyer and forty percent (40%) of the costs would be borne by the Sellers’ Representative, on behalf of Sellers.

 

(v) Determination by Independent Accountant. The Independent Accountant shall make a determination (by delivery of a written report to Buyer and Sellers’ Representative) as soon as practicable within thirty (30) days (or such other time as the parties hereto shall agree in writing) after their engagement, and their resolution of the Dispute Amounts and their adjustments to the Closing Working Capital Statement and/or the Post-Closing Adjustment shall be conclusive and binding upon the parties hereto (absent manifest error).

 

(d) Payments of Post-Closing Adjustment. Except as otherwise provided herein, any payment of the Post-Closing Adjustment shall (a) be due (x) within ten (10) Business Days of acceptance of the applicable Closing Working Capital Statement or (y) if there are Disputed Amounts, then within ten (10) Business Days of the resolution described in clause (v) above; and (b) be paid by wire transfer of immediately available funds to such account as is directed by Buyer or Sellers’ Representative, as the case may be.

 

(e) Treatments for Tax Purposes. Any payments made pursuant to Section 3.3 shall be treated as an adjustment to the Purchase Price by the Parties for Tax purposes, unless otherwise required by Law.

 

Section 3.4 U.S. Tax Matters. For U.S. federal income Tax purposes, it is intended that the Merger qualify as a “reorganization” within the meaning of Section 368(a) of the Code, and the regulations promulgated thereunder, that this Agreement will constitute a “plan of reorganization” for purposes of Sections 354, 361 and 368 of the Code and the Treasury Regulations promulgated thereunder. Each Party agrees to treat the Merger as a reorganization within the meaning of Section 368(a) of the Code for all U.S. federal income Tax purposes, to treat this Agreement as a “plan of reorganization” within the meaning of Sections 354, 361 and 368 of the Code and the Treasury Regulations promulgated thereunder, and to not take any position on any Tax Return or otherwise take any Tax reporting position inconsistent with such treatment. Within 45 days after the Effective Date, Buyer shall complete and post on its website an IRS Form 8937 reporting the Merger as a Tax-deferred reorganization under Section 368(a) of the Code. Each Party agrees to act in good faith, consistent with the intent of the Parties and the intended treatment of the Merger as set forth herein and to use commercially reasonable efforts to not take any action, or knowingly fail to take any action, if such action or failure to act would reasonably be expected to prevent the Merger from qualifying as a reorganization within the meaning of Section 368(a) of the Code. Neither Party makes any representation, warranty, or covenant to the other Party, or to any holder of Company Membership Units or holder of shares of Buyer Stock or any other Person regarding the United States federal income Tax treatment of the Merger including, but not limited to, whether the Merger will qualify as a reorganization within the meaning of Section 368(a) of the Code or as a Tax-deferred transaction for purposes of any United States state or local income Tax Law.

 

22
 

 

ARTICLE IV
Representations and Warranties of Company

 

Except as set forth in the Company Disclosure Letter, dated as of the date of this Agreement and delivered by Company to Buyer concurrently with the execution of this Agreement, Company hereby represents and warrants to Buyer and Merger Sub as follows:

 

Section 4.1 Organization; Standing and Power; Charter Documents; Subsidiaries.

 

(a) Organization; Standing and Power. Company is a limited liability company duly organized, validly existing, and in good standing under the Laws of the Commonwealth of Virginia, and has the requisite limited liability company power and authority to own, lease, and operate its assets and to carry on its business as now conducted. The Company is duly qualified or licensed to do business as a foreign corporation, limited liability company, or other legal entity and is in good standing (to the extent that the concept of “good standing” is applicable in the case of any jurisdiction outside the United States) in each jurisdiction where the character of the assets and properties owned, leased, or operated by it or the nature of its business makes such qualification or license necessary, except where the failure to be so qualified or licensed or to be in good standing, would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(b) Charter Documents. The copies of the Charter Documents of Company as made available to Buyer are true, correct, and complete copies of such documents as in effect as of the date of this Agreement. The Company is not in violation of any of the provisions of its Charter Documents.

 

(c) Subsidiaries. There are no Subsidiaries of the Company as of the date hereof.

 

Section 4.2 Capital Structure.

 

(a) Company Membership Units. The Company has authorized the issuance of 200 membership units, representing 100% of the membership interests in the Company (the “Company Membership Units”), all of which are issued and outstanding and held by the Sellers collectively. As of the date hereof, (i) the Company Membership Interests are held by the Sellers as set forth on Section 4.2(a)(i) of Company Disclosure Letter and (ii) all of the Company Membership Units are issued, outstanding and held by the Sellers. All of the issued and outstanding Company Membership Units are duly authorized and validly issued and are fully paid, nonassessable and not subject to or in violation of any preemptive or similar rights of any Person.

 

(b) Voting Debt. No bonds, debentures, notes, or other indebtedness issued by Company: (i) having the right to vote on any matters on which members may vote (or which is convertible into, or exchangeable for, membership units having such right); or (ii) the value of which is directly based upon or derived from membership units or other ownership interests of Company, are issued or outstanding (collectively, “Voting Debt”).

 

Section 4.3 Authority; Non-Contravention; Governmental Consents; Board Approval.

 

(a) Authority. Company has all requisite power and authority to enter into and to perform its obligations under this Agreement and, subject to, in the case of the consummation of the Merger, adoption of this Agreement by the affirmative vote or consent of the holders of a majority of the outstanding Company Membership Units (the “Requisite Company Vote”), to consummate the transactions contemplated by this Agreement. The execution and delivery of this Agreement by Company and the consummation by Company of the transactions contemplated hereby have been duly authorized by all necessary action on the part of Company and no other company proceedings on the part of Company are necessary to authorize the execution and delivery of this Agreement or to consummate the Merger and the other transactions contemplated hereby, subject only, in the case of consummation of the Merger, to the receipt of the Requisite Company Vote. The Requisite Company Vote is the only vote or consent of the holders of any class or series of Company’s equity interests necessary to approve and adopt this Agreement, approve the Merger, and consummate the Merger and the other transactions contemplated hereby. This Agreement has been duly executed and delivered by Company and, assuming due execution and delivery by Buyer and Merger Sub, constitutes the legal, valid, and binding obligation of Company, enforceable against Company in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, moratorium, and other similar Laws affecting creditors’ rights generally and by general principles of equity.

 

23
 

 

(b) Non-Contravention. The execution, delivery, and performance of this Agreement by Company, and the consummation by Company of the transactions contemplated by this Agreement, including the Merger, do not and will not: (i) subject to obtaining the Requisite Company Vote, contravene or conflict with, or result in any violation or breach of, the Charter Documents of Company; (ii) assuming that all Consents contemplated by clauses (i) through (v) of Section 4.3(c) have been obtained or made and, in the case of the consummation of the Merger, obtaining the Requisite Company Vote, conflict with or violate any Law applicable to Company or any of its respective properties or assets; (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in Company’s loss of any benefit or the imposition of any additional payment or other liability under, or alter the rights or obligations of any third party under, or give to any third party any rights of termination, amendment, acceleration, or cancellation, or require any Consent under, any Contract to which Company is a party or otherwise bound as of the date hereof; or (iv) result in the creation of a Lien (other than Permitted Liens) on any of the properties or assets of Company, except, in the case of each of clauses (ii), (iii), and (iv), for any conflicts, violations, breaches, defaults, loss of benefits, additional payments or other liabilities, alterations, terminations, amendments, accelerations, cancellations, or Liens that, or where the failure to obtain any Consents, in each case, would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(c) Governmental Consents. No consent, approval, order, or authorization of, or registration, declaration, or filing with, or notice to (any of the foregoing being a “Consent”), any supranational, national, state, municipal, local, or foreign government, any instrumentality, subdivision, court, administrative agency or commission, or other governmental authority, or any quasi-governmental or private body exercising any regulatory or other governmental or quasi-governmental authority (a “Governmental Entity”) is required to be obtained or made by Company in connection with the execution, delivery, and performance by Company of this Agreement or the consummation by Company of the Merger and other transactions contemplated hereby, except for: (i) the filing of the Articles of Merger with the State Corporation Commission for the Commonwealth of Virginia; (ii) the other Consents of Governmental Entities listed in Section 4.3(c) of Company Disclosure Letter (the “Other Governmental Approvals”); and (iii) such other Consents which if not obtained or made would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(d) Member Approval. The Company, by resolutions duly adopted by a unanimous vote of its members, has approved this Agreement, including the execution, delivery, and performance thereof, and the consummation of the transactions contemplated by this Agreement, including the Merger, upon the terms and subject to the conditions set forth herein (the “Company Action”).

 

24
 

 

Section 4.4 Financial Statements; Undisclosed Liabilities.

 

(a) Financial Statements. Complete copies of Company’s unaudited consolidated financial statements consisting of the balance sheet of Company as at fiscal year ended December 31, 2021 (“Balance Sheet Date”) and at fiscal year ended December 31, 2020 and the related statements of income and retained earnings, members’ equity and cash flow for the years then ended (the “Year-End Financial Statements”), and unaudited financial statements consisting of the balance sheet of Company as at March 31, 2022 and the related statements of income and retained earnings, members’ equity and cash flow for the three-month period then ended (the “Interim Financial Statements” and, together with the Year-End Financial Statements, the “Financial Statements”) are included in Section 4.4(a) of the Company Disclosure Letter. The Financial Statements have been prepared in accordance with sound accounting practices and are based on the books and records of Company, which books and records are complete and correct in all material respects and have been regularly kept and maintained. Company has established and maintains a system of internal controls over financial reporting sufficient to provide reasonable assurance (i) regarding the reliability of Company’s financial reporting and the preparation of the Financial Statements for external purposes, (ii) that receipts and expenditures of Company are being made only in accordance with the authorization of Company’s management, and (iii) regarding prevention and timely detection of the unauthorized acquisition, use or disposition of Company’s assets that could have a material effect on the Financial Statements. The Financial Statements fairly present the financial condition of Company as of the respective dates they were prepared and the results of the operations of Company for the periods indicated.

 

(b) Undisclosed Liabilities. Company has no material Liabilities except (i) those which are adequately reflected or reserved against in the Financial Statements, and (ii) those which have been incurred in the ordinary course of business consistent with past practice since the date of the Interim Financial Statements.

 

Section 4.5 Absence of Certain Changes or Events. Since the date of the Interim Financial Statements, except in connection with the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby, there has not been or occurred any Company Material Adverse Effect or any event, condition, change, or effect that could reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

Section 4.6 Taxes.

 

(a) Tax Returns and Payment of Taxes. Company and each of its Subsidiaries have duly and timely filed or caused to be filed (taking into account any valid extensions) all material Tax Returns required to be filed by them. Such Tax Returns are true, complete, and correct in all material respects. Neither Company nor any of its Subsidiaries is currently the beneficiary of any extension of time within which to file any Tax Return other than extensions of time to file Tax Returns obtained in the ordinary course of business consistent with past practice. All material Taxes due and owing by Company or any of its Subsidiaries (whether or not shown on any Tax Return) have been timely paid or, where payment is not yet due, Company has made an adequate provision for such Taxes in the Financial Statements.

 

(b) Availability of Tax Returns. Company has made available to Buyer complete and accurate copies of all federal, state, local, and foreign income, franchise, and other material Tax Returns filed by or on behalf of Company or its Subsidiaries for any Tax period ending after December 31, 2019.

 

(c) Withholding. Company and each of its Subsidiaries have withheld and timely paid each material Tax required to have been withheld and paid in connection with amounts paid or owing to any Company Employee, creditor, customer, stockholder, or other party (including, without limitation, withholding of Taxes pursuant to Sections 1441 and 1442 of the Code or similar provisions under any state, local, and foreign Laws), and materially complied with all information reporting and backup withholding provisions of applicable Law.

 

(d) Liens. There are no Liens for material Taxes upon the assets of Company or any of its Subsidiaries other than for current Taxes not yet due and payable or for Taxes that are being contested in good faith by appropriate proceedings and for which adequate reserves has been made in Company’s most recent financial statements.

 

25
 

 

(e) Tax Deficiencies and Audits. No deficiency for any material amount of Taxes which has been proposed, asserted, or assessed in writing by any taxing authority against Company or any of its Subsidiaries remains unpaid. There are no waivers or extensions of any statute of limitations currently in effect with respect to Taxes of Company or any of its Subsidiaries. There are no audits, suits, proceedings, investigations, claims, examinations, or other administrative or judicial proceedings ongoing or pending with respect to any material Taxes of Company or any of its Subsidiaries.

 

(f) Tax Jurisdictions. No claim has ever been made in writing by any taxing authority in a jurisdiction where Company and its Subsidiaries do not file Tax Returns that Company or any of its Subsidiaries is or may be subject to Tax in that jurisdiction.

 

(g) Tax Rulings. Neither Company nor any of its Subsidiaries has requested or is the subject of or bound by any private letter ruling, technical advice memorandum, or similar ruling or memorandum with any taxing authority with respect to any material Taxes, nor is any such request outstanding.

 

(h) Change in Accounting Method. Neither Company nor any of its Subsidiaries has agreed to make, nor is it required to make, any material adjustment under Section 481(a) of the Code or any comparable provision of state, local, or foreign Tax Laws by reason of a change in accounting method or otherwise.

 

(i) Post-Closing Tax Items. Company and its Subsidiaries will not be required to include any material item of income in, or exclude any material item of deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: (i) “closing agreement” as described in Section 7121 of the Code (or any corresponding or similar provision of state, local or foreign income Tax Law) executed on or prior to the Closing Date; (ii) installment sale or open transaction disposition made on or prior to the Closing Date; (iii) prepaid amount received on or prior to the Closing Date; (iv) any income under Section 965(a) of the Code, including as a result of any election under Section 965(h) of the Code with respect thereto; or (v) election under Section 108(i) of the Code.

 

(j) Section 355. Neither Company nor any of its Subsidiaries has been a “distributing corporation” or a “controlled corporation” in connection with a distribution described in Section 355 of the Code.

 

(k) Reportable Transactions. Neither Company nor any of its Subsidiaries has been a party to, or a material advisor with respect to, a “reportable transaction” within the meaning of Section 6707A(c)(1) of the Code and Treasury Regulations Section 1.6011-4(b).

 

(l) The Company is not a party, or bound by, any Tax indemnity, Tax sharing or Tax allocation agreement.

 

Section 4.7 Intellectual Property.

 

(a) Scheduled Company Owned IP. Section 4.7(a) of Company Disclosure Letter contains a true and complete list, as of the date hereof, of all: (i) Company Owned IP that is the subject of any issuance, registration, certificate, application, or other filing by, to or with any Governmental Entity or authorized private registrar, including patents, patent applications, trademark registrations and pending applications for registration, copyright registrations and pending applications for registration, and internet domain name registrations (collectively, the “Company Registered IP”), specifying as to each, as applicable: the title, mark, or design; the record owner and inventor(s), if any; the jurisdiction by or in which it has been issued, registered, or filed; the patent, registration, or application serial number; the issue, registration, or filing date; and the current status; (ii) material unregistered trademarks; and (iii) all proprietary Software of Company.

 

26
 

 

(b) Right to Use; Title. Company or one of its Subsidiaries is the sole and exclusive owner of all right, title, and interest in and to Company Registered IP, and has the valid and enforceable right to use all other Intellectual Property used in or necessary for the conduct of the business of Company and its Subsidiaries as currently conducted (“Company IP”), in each case, free and clear of all Liens other than Permitted Liens, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Company has entered into binding, valid and enforceable, written Contracts with each current and former employee and independent contractor whereby such employee or independent contractor (i) acknowledges Company’s exclusive ownership of all Intellectual Property invented, created, or developed by such employee or independent contractor within the scope of his or her employment or engagement with Company; (ii) grants to Company a present, irrevocable assignment of any ownership interest such employee or independent contractor may have in or to such Intellectual Property; and (iii) irrevocably waives any right or interest, including any moral rights, regarding any such Intellectual Property, to the extent permitted by applicable Law. Company has provided Buyer true and complete copies of all such Contracts. All assignments and other instruments necessary to establish, record, and perfect Company’s ownership interest in the Company IP Registrations have been validly executed, delivered, and filed with the relevant Governmental Entity and authorized registrars.

 

(c) Validity and Enforceability. Company and its Subsidiaries’ rights in Company Owned IP are valid, subsisting, and enforceable, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Company and each of its Subsidiaries have taken reasonable steps to maintain Company IP and to protect and preserve the confidentiality of all trade secrets included in Company IP, except where the failure to take such actions would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(d) Non-Infringement. Except as would not be reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect: (i) to the Knowledge of the Company, the conduct of the businesses of Company and any of its Subsidiaries has not infringed, misappropriated, or otherwise violated, and is not infringing, misappropriating, or otherwise violating, any Intellectual Property of any other Person; and (ii) to the Knowledge of Company, no third party is infringing upon, violating, or misappropriating any Company IP.

 

(e) IP Legal Actions and Orders. There are no Legal Actions pending or, to the Knowledge of Company, threatened: (i) alleging any infringement, misappropriation, or violation by Company or any of its Subsidiaries of the Intellectual Property of any Person; or (ii) challenging the validity, enforceability, or ownership of any Company Owned IP or Company rights with respect to any Company IP, in each case except for such Legal Actions that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Company and its Subsidiaries are not subject to any outstanding Order that restricts or impairs the use of any Company Owned IP, except where compliance with such Order would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(f) Company IP Agreements. Section 4.7(f) of the Company Disclosure Letter contains a correct, current and complete list of all Company IP Agreements (A) by Company to another Person or (B) by another Person to Company, in either case except any (1) Contract under which any Intellectual Property Right or Technology is licensed on a non-exclusive basis to a contractor or vendor of Company for the benefit of and to provide services to Company, (2) non-exclusive license granted by Company to its customers in the ordinary course, (3) off-the-shelf software licensed pursuant to a click-wrap or shrink wrap Contract or other unmodified standard contract form, or (4) Contract containing a non-exclusive license that is merely incidental to the transaction contemplated in such Contract, the commercial purpose of which is primarily for something other than such license, such as an equipment lease or distribution or marketing Contract that includes an incidental license to use the trademarks of either party thereto for the purposes of advertising or marketing.

 

27
 

 

(g) Company IT Systems. In the past twelve (12) months, there has been no malfunction, failure, continued substandard performance, denial-of-service, or other cyber incident, including any cyberattack, or other impairment of Company IT Systems, in each case except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Company and its Subsidiaries have taken all reasonable best effort steps to safeguard the confidentiality, availability, security, and integrity of Company IT Systems, including implementing and maintaining appropriate backup, disaster recovery, and software and hardware support arrangements, in each case except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(h) Privacy and Data Security. Company and each of its Subsidiaries have complied with all applicable Laws and all internal or publicly posted policies, notices, and statements concerning the collection, use, processing, storage, transfer, and security of personal information in the conduct of Company’s and its Subsidiaries’ businesses, in each case except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. In the past twelve months, Company and its Subsidiaries have not: (i) experienced any actual, alleged, or suspected data breach or other security incident involving personal information in their possession or control; or (ii) been subject to or received any notice of any audit, investigation, complaint, or other Legal Action by any Governmental Entity or other Person concerning Company’s or any of its Subsidiaries’ collection, use, processing, storage, transfer, or protection of personal information or actual, alleged, or suspected violation of any applicable Law concerning privacy, data security, or data breach notification, and to Company’s Knowledge, there are no facts or circumstances that could reasonably be expected to give rise to any such Legal Action, in each case except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

Section 4.8 Compliance; Permits.

 

(a) Compliance. Company and each of its Subsidiaries are in material compliance with, all Laws or Orders applicable to Company or any of its Subsidiaries or by which Company or any of its Subsidiaries or any of their respective businesses or properties is bound. In the past twelve (12) months, no Governmental Entity has issued any notice or notification stating that Company or any of its Subsidiaries is not in compliance with any Law in any material respect.

 

(b) Permits. Company and its Subsidiaries hold, to the extent necessary to operate their respective businesses as such businesses are being operated as of the date hereof, all permits, licenses, registrations, variances, clearances, consents, commissions, franchises, exemptions, Orders, authorizations, and approvals from Governmental Entities (collectively, “Permits”), except for any Permits for which the failure to obtain or hold would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. No suspension, cancellation, non-renewal, or adverse modifications of any Permits of Company or any of its Subsidiaries is pending or, to the Knowledge of Company, threatened, except for any such suspension or cancellation which would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Company and each of its Subsidiaries is in compliance with the terms of all Permits, except where the failure to be in such compliance would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(c) Industry Certifications. Section 4.8(c) of the Company Disclosure Letter contains a true, current and complete list of all industry certifications that Company has obtained, including, without limitation, all such certifications listed on its website (collectively, the “Certificates”). Company is in compliance in all material respects with the requirements of all Certifications.

 

28
 

 

Section 4.9 Litigation. Except as set forth in Section 4.9 of the Company Disclosure Letter (the “Disclosed Litigation”), there is no Legal Action pending, or to the Knowledge of Company, threatened against Company or any of its Subsidiaries or any of their respective properties or assets or, to the Knowledge of Company, any officer or Manager of Company or any of its Subsidiaries in their capacities.

 

Section 4.10 Brokers’ and Finders’ Fees. Except for fees payable to Primary Capital LLC (which shall be paid by Buyer), neither Company nor any of its Subsidiaries has incurred, nor will it incur, directly or indirectly, any liability for investment banker, brokerage, or finders’ fees or agents’ commissions, or any similar charges in connection with this Agreement or any transaction contemplated by this Agreement.

 

Section 4.11 Related Person Transactions. Other than (i) Charter Documents, (ii) standard employee benefits generally made available to all employees and standard employee offer letters and (iii) transactions related to the purchase or issuance of Company Membership Units, there are no Contracts, transactions, arrangements, or understandings between Company, on the one hand, and any Affiliate (including any Manager, officer, or employee or any of their respective family members) thereof or any holder of 5% or more of Company Membership Units (or any of their respective family members).

 

Section 4.12 Employee Benefit Issues.

 

(a) Schedule. Section 4.12(a) of Company Disclosure Letter contains a true and complete list, as of the date hereof, of each plan, program, policy, agreement, collective bargaining agreement, or other arrangement providing for compensation, severance, deferred compensation, performance awards, stock or stock-based awards, health, dental, retirement, life insurance, death, accidental death & dismemberment, disability, material fringe, or wellness benefits, or other material employee benefits or compensatory remuneration of any kind, including each employment, termination, severance, retention, change in control, or consulting or independent contractor plan, program, arrangement, or agreement, in each case whether written or unwritten or otherwise, funded or unfunded, insured or self-insured, including each “employee benefit plan,” within the meaning of Section 3(3) of ERISA, whether or not subject to ERISA, which is sponsored, maintained, contributed to, or required to be contributed to, by Company for the benefit of any current or former employee of Company (each, a “Company Employee”), or any current or former independent contractor, consultant, or Manager of Company, or with respect to which Company or any Company ERISA Affiliate has or may have any Liability (collectively, the “Company Employee Plans”), provided that any at-will employment offer letters or agreements or independent contractor agreements made in the ordinary course of business in each case cancellable without material penalty to Company (other than any statutory severance obligations) shall not be required to be specifically listed.

 

(b) Documents. Company has made available to Buyer correct and complete copies (or, if a plan or arrangement is not written, a written description) of all Company Employee Plans and amendments thereto, and, to the extent applicable: (i) all related trust agreements, funding arrangements, insurance contracts, and service provider agreements now in effect; (ii) the most recent determination, advisory or opinion letter received regarding the tax-qualified status of each Company Employee Plan (to the extent applicable); (iii) the most recent financial statements for each Company Employee Plan (to the extent applicable); (iv) the Form 5500 Annual Returns/Reports and Schedules for the most recent plan year for each Company Employee Plan; (v) the current summary plan description and any related summary of material modifications and, if applicable, summary of benefits and coverage, for each Company Employee Plan; and (vi) all actuarial valuation reports related to any Company Employee Plans (to the extent applicable).

 

29
 

 

(c) Employee Plan Compliance. (i) Each Company Employee Plan has within the last six years been established, administered, and maintained in all material respects in accordance with its terms and in material compliance with applicable Laws, including but not limited to ERISA and the Code; (ii) all Company Employee Plans that are intended to be qualified under Section 401(a) of the Code are so qualified and have received timely determination letters from the IRS and no such determination letter has been revoked nor, to the Knowledge of Company, has any such revocation been threatened, or with respect to a prototype or volume submitter plan, can rely on an opinion or advisory letter from the IRS to the prototype or volume submitter plan sponsor, to the effect that such qualified retirement plan and the related trust are exempt from federal income taxes under Sections 401(a) and 501(a), respectively, of the Code, and to the Knowledge of Company no circumstance exists that is likely to result in the loss of such qualified status under Section 401(a) of the Code; (iii) Company, where applicable, has timely made all material contributions, benefits, premiums, and other material payments required by and due under the terms of each Company Employee Plan and applicable Law and accounting principles, and all benefits accrued under any unfunded Company Employee Plan have been paid, accrued, or otherwise adequately reserved to the extent required by GAAP, and in accordance with Company’s historic accounting practices; (iv) except to the extent limited by applicable Law, each Company Employee Plan can be amended, terminated, or otherwise discontinued after the Effective Time in accordance with its terms, without material liability to Buyer or Company (other than ordinary administration expenses and in respect of accrued benefits thereunder); (v) there are no investigations, audits, inquiries, enforcement actions, or Legal Actions pending or, to the Knowledge of Company, threatened by the IRS, U.S. Department of Labor, Health and Human Services, Equal Employment Opportunity Commission, or any similar Governmental Entity with respect to any Company Employee Plan; (vi) there are no material Legal Actions pending, or, to the Knowledge of Company, threatened with respect to any Company Employee Plan (in each case, other than routine claims for benefits); and (vii) to the Knowledge of Company, neither Company nor any of its Company ERISA Affiliates has engaged in a transaction that would reasonably be expected to subject Company or any Company ERISA Affiliate to a tax or penalty imposed by either Section 4975 of the Code or Section 502(i) of ERISA.

 

(d) Potential Governmental or Lawsuit Liability. Other than routine claims for benefits: (i) there are no pending or, to the Knowledge of Company, threatened claims by or on behalf of any participant in any Company Employee Plan, or otherwise involving any Company Employee Plan or the assets of any Company Employee Plan; and (ii) no Company Employee Plan is presently or has within the three years prior to the date hereof, been the subject of an examination or audit by a Governmental Entity or is the subject of an application or filing under, or is a participant in, an amnesty, voluntary compliance, self-correction, or similar program sponsored by any Governmental Entity.

 

(e) Section 409A Compliance. Each Company Employee Plan that is subject to Section 409A of the Code has been operated in compliance in all material respects with the applicable provisions of such section and all applicable regulatory guidance (including, without limitation, proposed regulations, notices, rulings, and final regulations).

 

(f) Health Plan Compliance. Company currently complies in all material respects with the applicable requirements under ERISA and the Code, including COBRA, HIPAA, and the Affordable Care Act, and other federal requirements for employer-sponsored health plans, as applicable, and any corresponding requirements under similar applicable state statutes, with respect to each Company Employee Plan that is a group health plan within the meaning of Section 733(a) of ERISA, Section 5000(b)(1) of the Code, or such state statute.

 

(g) Employment Law Matters. Company is in compliance with all applicable Laws and agreements regarding hiring, employment, termination of employment, plant closing and mass layoff, employment discrimination, harassment, retaliation, and reasonable accommodation, leaves of absence, terms and conditions of employment, wages and hours of work, employee classification, employee health and safety, use of genetic information, leasing and supply of temporary and contingent staff, engagement of independent contractors, including proper classification of same, payroll taxes, and immigration with respect to Company Employees and contingent workers, except where the failure to be in compliance with the foregoing would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

30
 

 

(h) Labor Unions. Company is not party to, or subject to, any collective bargaining agreement or other agreement with any labor organization, work council, or trade union with respect to any of its or their operations. No material work stoppage, slowdown, or labor strike against Company with respect to Company Employees who are employed within the United States is pending, threatened, or has occurred in the last two years. To the Knowledge of Company, none of Company Employees is represented by a labor organization, work council, or trade union and there is no organizing activity, Legal Action, election petition, union card signing or other union activity, or union corporate campaigns of or by any labor organization, trade union, or work council directed at Company, or any Company Employees.

 

Section 4.13 Real Property and Personal Property Matters.

 

(a) Owned Real Estate. Company does not own any Owned Real Estate. Company is not a party to any agreement or option to purchase any real property or interest therein.

 

(b) Leased Real Estate. Section 4.13(b) of Company Disclosure Letter contains a true and complete list of all Leases (including all amendments, extensions, renewals, guaranties, and other agreements with respect thereto) as of the date hereof for each such Leased Real Estate (including the date and name of the parties to such Lease document). Company has delivered to Buyer a true and complete copy of each such Lease. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or as set forth on Section 4.13(b) of Company Disclosure Letter, with respect to each of the Leases: (i) such Lease is legal, valid, binding, enforceable, and in full force and effect; (ii) neither Company nor, to the Knowledge of Company, any other party to the Lease, is in breach or default under such Lease, and no event has occurred or circumstance exists which, with or without notice, lapse of time, or both, would constitute a breach or default under such Lease; (iii) Company’s possession and quiet enjoyment of the Leased Real Estate under such Lease has not been disturbed, and to the Knowledge of Company, there are no disputes with respect to such Lease; and (iv) there are no Liens on the estate created by such Lease other than Permitted Liens. Company has not assigned, pledged, mortgaged, hypothecated, or otherwise transferred any Lease or any interest therein nor has Company subleased, licensed, or otherwise granted any Person (other than another wholly-owned Subsidiary of Company) a right to use or occupy such Leased Real Estate or any portion thereof.

 

(c) Real Estate Used in the Business. The Leased Real Estate identified in Section 4.13(b) of Company Disclosure Letter comprise all of the real property used or intended to be used in, or otherwise related to, the business of Company.

 

(d) Personal Property. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) Company is in possession of and have good and marketable title to, or valid leasehold interests in or valid rights under contract to use, the machinery, equipment, furniture, fixtures, and other tangible personal property and assets owned, leased, or used by Company, free and clear of all Liens other than Permitted Liens, (ii) the buildings, plants, structures, furniture, fixtures, machinery, equipment, vehicles and other items of tangible personal property of Company are structurally sound, are in good operating condition and repair, and are adequate for the uses to which they are being put, and none of such buildings, plants, structures, furniture, fixtures, machinery, equipment, vehicles and other items of tangible personal property is in need of maintenance or repairs except for ordinary, routine maintenance and repairs that are not material in nature or cost, and (iii) the buildings, plants, structures, furniture, fixtures, machinery, equipment, vehicles and other items of tangible personal property currently owned or leased by Company, together with all other properties and assets of Company, are sufficient for the continued conduct of Company’s business after the Closing in substantially the same manner as conducted prior to the Closing and constitute all of the rights, property and assets necessary to conduct the business of Company as currently conducted.

 

31
 

 

Section 4.14 Environmental Matters. Except for such matters as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect:

 

(a) Compliance with Environmental Laws. Company is, and has been, in compliance with all Environmental Laws, which compliance includes the possession, maintenance of, compliance with, or application for, all Permits required under applicable Environmental Laws for the operation of the business of Company as currently conducted.

 

(b) No Disposal, Release, or Discharge of Hazardous Substances. Company has not disposed of, released, or discharged any Hazardous Substances on, at, under, in, or from any real property currently or, to the Knowledge of Company, formerly owned, leased, or operated by it or at any other location that is: (i) currently subject to any investigation, remediation, or monitoring; or (ii) reasonably likely to result in liability to Company, in either case of (i) or (ii) under any applicable Environmental Laws.

 

(c) No Production or Exposure of Hazardous Substances. Company has not: (i) produced, processed, manufactured, generated, transported, treated, handled, used, or stored any Hazardous Substances, except in compliance with Environmental Laws, at any Real Estate; or (ii) exposed any employee or any third party to any Hazardous Substances under circumstances reasonably expected to give rise to any material Liability or obligation under any Environmental Law.

 

(d) No Legal Actions or Orders. Company has not received written notice of and there is no Legal Action pending, or to the Knowledge of Company, threatened against Company, alleging any Liability or responsibility under or non-compliance with any Environmental Law or seeking to impose any financial responsibility for any investigation, cleanup, removal, containment, or any other remediation or compliance under any Environmental Law. Company is not subject to any Order, settlement agreement, or other written agreement by or with any Governmental Entity or third party imposing any material Liability or obligation with respect to any of the foregoing.

 

(e) No Assumption of Environmental Law Liabilities. Company has not expressly assumed or retained any Liabilities under any applicable Environmental Laws of any other Person, including in any acquisition or divestiture of any property or business.

 

Section 4.15 Material Contracts.

 

(a) Material Contracts. For purposes of this Agreement, “Company Material Contract” shall mean the following to which Company is a party or any of its respective assets are bound (excluding any Leases):

 

(i) any employment or consulting Contract (in each case with respect to which Company has continuing obligations as of the date hereof) (other than any Company Employee Plan set forth on Section 4.12(a) of the Company Disclosure Letter);

 

(ii) any Contract providing for indemnification or any guaranty by Company, in each case that is material to Company, taken as a whole, other than (A) any guaranty by Company that was entered into in the ordinary course of business pursuant to or in connection with a customer Contract, or (B) any Contract providing for indemnification of customers or other Persons pursuant to Contracts entered into in the ordinary course of business;

 

32
 

 

(iii) any Contract that purports to limit in any material respect the right of Company (or, at any time after the consummation of the Merger, Buyer or any of its Subsidiaries) (A) to engage in any line of business, (B) compete with any Person or solicit any client or customer, or (C) operate in any geographical location;

 

(iv) any Contract relating to the disposition or acquisition, directly or indirectly (by merger, sale of stock, sale of assets, or otherwise), by Company or any of its Subsidiaries after the date of this Agreement of material assets or capital stock or other equity interests of any Person;

 

(v) any Contract that grants any right of first refusal, right of first offer, or similar right with respect to any material assets, rights, or properties of Company;

 

(vi) any Contract that obligates Company to conduct business on an exclusive or preferential basis or that contains a “most favored nation” or similar covenant with any third party or upon consummation of the Merger will obligate Buyer, the Surviving Entity, or any of their respective Subsidiaries to conduct business on an exclusive or preferential basis or that contains a “most favored nation” or similar covenant with any third party;

 

(vii) any partnership, joint venture, limited liability company agreement, or similar Contract relating to the formation, creation, operation, management, or control of any material joint venture, partnership, or limited liability company, other than any Charter Document of Company;

 

(viii) any mortgages, indentures, guarantees, loans, or credit agreements, security agreements, or other Contracts, in each case relating to indebtedness for borrowed money, whether as borrower or lender, in each case in excess of $20,000, other than (A) accounts receivables and payables, (B) loans to direct or indirect wholly-owned Subsidiaries of Company and (C) loans to current and former Company Employees under any tax-qualified Company Employee Plan;

 

(ix) any employee collective bargaining agreement or other Contract with any labor union; or

 

(x) any Company IP Agreement, other than licenses for shrinkwrap, clickwrap, or other similar commercially available off-the-shelf software that has not been modified or customized by a third party for Company or any of its Subsidiaries.

 

(b) Schedule of Material Contracts; Documents. Section 4.15(b) of Company Disclosure Letter sets forth a true and complete list as of the date hereof of all Company Material Contracts. Company has made available to Buyer correct and complete copies of all Company Material Contracts, including any amendments thereto.

 

(c) No Breach. (i) All Company Material Contracts are legal, valid, and binding on Company, enforceable against it in accordance with its terms, and is in full force and effect, in all material respects; (ii) neither Company nor, to the Knowledge of Company, any third party has materially violated any provision of, or failed to perform any material obligation required under the provisions of, any Company Material Contract as of the date hereof; (iii) neither Company nor, to the Knowledge of Company, any third party is in material breach, or has received written notice of material breach, of any Company Material Contract as of the date hereof; and (iv) entering into this Agreement and performing under this Agreement shall not result in any material breach of, material default under, or material violation of any Company Material Contract.

 

Section 4.16 Insurance. Except as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect, all insurance policies maintained by Company are in full force and effect and provide insurance in such amounts and against such risks as Company reasonably has determined to be prudent, taking into account the industries in which Company operates, and as is sufficient to comply with applicable Law.

 

33
 

 

Section 4.17 Intended Tax Treatment. Company has not taken or agreed to take any action, and to the Knowledge of Company there exists no fact or circumstance, that is reasonably likely to prevent or impede the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code.

 

Section 4.18 Accounts Receivable. The accounts receivable reflected on the Interim Balance Sheet and the accounts receivable arising after the date thereof: (a) have arisen from bona fide transactions entered into by Company involving the sale of goods or the rendering of services in the ordinary course of business consistent with past practice and (b) constitute only valid, undisputed claims of Company not subject to claims of set-off or other defenses or counterclaims other than normal cash discounts accrued in the ordinary course of business consistent with past practice. The reserve for bad debts shown on the Interim Balance Sheet or, with respect to accounts receivable arising after the Interim Balance Sheet Date, on the accounting records of Company have been determined in accordance with sound accounting practices.

 

Section 4.19 Customers and Suppliers.

 

(a) Section 4.19(a) of the Company Disclosure Letter sets forth (i) each customer who has paid aggregate consideration to Company for goods or services rendered in an amount greater than or equal to $100,000 for each of the two (2) most recent fiscal years (collectively, the “Material Customers”); and (ii) the amount of consideration paid by each Material Customer during such periods. Company has not received any notice, and has no Knowledge, that any of its Material Customers has ceased, or intends to cease after the Closing, to use its goods or services or to otherwise terminate or materially reduce its relationship with Company.

 

(b) Section 4.19(b) of the Company Disclosure Letter sets forth (i) each supplier to whom Company has paid consideration for goods or services rendered in an amount greater than or equal to $20,000 for each of the two (2) most recent fiscal years (collectively, the “Material Suppliers”); and (ii) the amount of purchases from each Material Supplier during such periods. Except as set forth in Section 4.19(b) of the Company Disclosure Letter, Company has not received any notice, and has no Knowledge, that any of its Material Suppliers has ceased, or intends to cease, to supply goods or services to Company or to otherwise terminate or materially reduce its relationship with Company.

 

Section 4.20 No Other Representations. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS SECTION 4 (as modified by the COMPANY Disclosure LETTER), THE COMPANY MAKES NO EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, AND THE COMPANY HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY, WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE OTHER ANCILLARY DOCUMENTS AND THE CONSUMMATION OF THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THEREUNDER.

 

ARTICLE V
REPRESENTATIONS AND WARRANTIES OF SELLERS

 

Except as set forth in the Company Disclosure Letter, each of the Sellers hereby, severally and not jointly, represent and warrant to Buyer as follows:

 

Section 5.1 Good and Valid Title. Such Seller is the record owner of and has good and valid title to the Company Membership Units to be sold by such Seller hereunder, free and clear of all Liens, and, upon consummation of the transfer of such Company Membership Units as contemplated hereby, Buyer shall have good and valid title to such Company Membership Units free and clear of any Liens.

 

34
 

 

Section 5.2 Authority of the Sellers.

 

(a) Capacity. Each Seller has the requisite legal capacity, power and authority to: (i) execute and deliver this Agreement and any Ancillary Document to which such Seller is a party; (ii) perform his, her or its obligations hereunder and thereunder; and (iii) consummate the transactions contemplated hereby and thereby.

 

(b) This Agreement (assuming due authorization, execution and delivery by each other party thereto) constitutes a legal, valid and binding obligation of such Seller enforceable against such Seller in accordance with its terms (subject to any applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to creditors’ rights generally or to general principles of equity). When each other Ancillary Document to which such Seller is or will be a party has been duly executed and delivered by such Seller (assuming due authorization, execution and delivery by each other party thereto), such Ancillary Document will constitute a legal and binding obligation of such Seller, enforceable against it in accordance with its terms (subject to any applicable bankruptcy, insolvency, reorganization, moratorium or similar Laws now or hereafter in effect relating to creditors’ rights generally or to general principles of equity).

 

Section 5.3 Own Account. Such Seller understands that the shares of Buyer Stock issuable to such Seller under this Agreement (the “Buyer Stock Consideration”) are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring the Buyer Stock Consideration as principal for its own account and not with a view to or for distributing or reselling such Buyer Stock Consideration or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any of such shares in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Buyer Stock Consideration in violation of the Securities Act or any applicable state securities law.

 

Section 5.4 Seller Status. Except for those Sellers identified as non-accredited on Section 5.4 of the Seller Disclosure Letter, at the time such Seller was offered the Buyer Stock Consideration, he, she or it was, and as of the date hereof it is, an “accredited investor” as defined in Rule 501(a) under the Securities Act. Such Seller represents that he, she or it has had the opportunity to receive all information he, she or it considers necessary or appropriate for deciding whether to receive Buyer Stock as consideration hereunder. Such Seller further represents that he, she or it has had an opportunity to ask questions and receive answers from Buyer regarding the rights of holders of Buyer Stock and the business, properties, prospects and financial condition of Buyer and to obtain additional information (to the extent Buyer possessed such information or could acquire it without unreasonable effort or expense) necessary to verify the accuracy of any information furnished to such Seller.

 

Section 5.5 Experience of Seller. Each Seller has such knowledge, sophistication and experience in business and financial matters, so as to be capable of evaluating the merits and risks of the prospective investment in the Buyer Stock Consideration, and has so evaluated the merits and risks of such investment. Such Seller is able to bear the economic risk of an investment in the Buyer Stock Consideration and, at the present time, is able to bear such economic risk indefinitely.

 

Section 5.6 Restrictions.

 

(a) The Buyer Stock Consideration may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Buyer Stock Consideration other than pursuant to an effective registration statement or Rule 144 under the Securities Act, Buyer may require the transferor thereof to provide to Buyer information necessary for Buyer to obtain an opinion of counsel to the effect that such transfer does not require registration of such transferred Buyer Stock Consideration under the Securities Act or any other state, federal or foreign securities law. As a condition of transfer, any such transferee shall agree in writing to be bound by the restrictions with respect to the Buyer Stock Consideration set forth in this Agreement if applicable.

 

35
 

 

(b) Such Seller agrees, so long as is required by applicable Law or the Sellers Lock-Up Agreement of such Seller, that the Buyer Stock Consideration shall bear the following legend:

 

THIS SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE GLIMPSE GROUP, INC. THIS SECURITY IS ALSO SUBJECT TO THE TERMS OF A LOCK-UP AGREEMENT. THIS SECURITY MAY NOT BE SOLD, TRANSFERRED, PLEDGED, GIFTED OR OTHERWISE DISPOSED OF OTHER THAN IN ACCORDANCE WITH THE TERMS OF SUCH AGREEMENT, AND ANY ATTEMPT TO DO SO SHALL BE VOID.

 

Section 5.7 Certain Transactions. Other than consummating the transactions contemplated hereunder, each Seller has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Seller, executed any purchases or sales of the securities of Buyer during the period commencing as of the time that such Seller first received a term sheet (written or oral) from the Buyer or any other Person representing the Buyer setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof.

 

ARTICLE VI
Representations and Warranties of Buyer and Merger Sub

 

Except (a) as disclosed in the Buyer SEC Documents at least five Business Days prior to the date hereof and that is reasonably apparent on the face of such disclosure to be applicable to the representation and warranty set forth herein (other than any disclosures contained or referenced therein under the captions “Risk Factors,” “Forward-Looking Statements,” “Quantitative and Qualitative Disclosures About Market Risk,” and any other disclosures contained or referenced therein of information, factors, or risks that are predictive, cautionary, or forward-looking in nature), or (b) as set forth in the Buyer Disclosure Letter, Buyer and Merger Sub hereby jointly and severally represent and warrant to Company and Sellers as follows:

 

Section 6.1 Organization; Standing and Power; Charter Documents.

 

(a) Organization; Standing and Power. Each of Buyer and its Subsidiaries (including Merger Sub) is a corporation, limited liability company, or other legal entity duly organized, validly existing, and in good standing (to the extent that the concept of “good standing” is applicable in the case of any jurisdiction outside the United States) under the Laws of its jurisdiction of organization, and has the requisite corporate, limited liability company, or other organizational, as applicable, power and authority to own, lease, and operate its assets and to carry on its business as now conducted. Each of Buyer and its Subsidiaries is duly qualified or licensed to do business as a foreign corporation, limited liability company, or other legal entity and is in good standing (to the extent that the concept of “good standing” is applicable in the case of any jurisdiction outside the United States) in each jurisdiction where the character of the assets and properties owned, leased, or operated by it or the nature of its business makes such qualification or license necessary, except where the failure to be so qualified or licensed or to be in good standing, would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect.

 

36
 

 

(b) Charter Documents. The copies of the Certificate of Incorporation and By-Laws of Buyer as most recently filed with the Buyer SEC Documents are true, correct, and complete copies of such documents as in effect as of the date of this Agreement. Buyer has delivered or made available to Company a true and correct copy of the Charter Documents of Merger Sub. Neither Buyer nor Merger Sub is in violation of any of the provisions of its Charter Documents.

 

Section 6.2 Capitalization.

 

(a) Capital Stock. The authorized capital stock of Buyer consists of 300,000,000 shares of Buyer Stock, par value $0.001 per share. As of the close of business on May 19, 2022: (A) 12,746,295 shares of Buyer Stock were issued and outstanding (not including shares held in treasury); and (B) no shares of Buyer Stock were issued and held by Buyer in its treasury; and since May 19, 2022 and through the date hereof, no additional shares of Buyer Stock have been issued other than the issuance of shares of Buyer Stock upon the exercise or settlement of stock options granted under Buyer’s equity incentive plan. All of the outstanding shares of capital stock of Buyer are, and all shares of capital stock of Buyer which may be issued as contemplated or permitted by this Agreement, including the shares of Buyer Stock constituting the Merger Consideration, will be, when issued, duly authorized, validly issued, fully paid, and non-assessable, and not subject to any pre-emptive rights. No Subsidiary of Buyer owns any shares of Buyer Stock.

 

(b) Stock Awards.

 

(i) As of the close of business on May 19, 2022, an aggregate of approximately 4,700,000 shares of Buyer Stock were reserved for issuance pursuant to Buyer Stock Options not yet granted under the Buyer Stock Plan. All shares of Buyer Stock subject to issuance under the Buyer Stock Plan upon issuance in accordance with the terms and conditions specified in the instruments pursuant to which they are issuable, will be duly authorized, validly issued, fully paid, and non-assessable.

 

(ii) Other than the Buyer Stock Options, as of the date hereof, there are no outstanding (A) securities of Buyer or any of its Subsidiaries convertible into or exchangeable for Buyer Voting Debt or shares of capital stock of Buyer, (B) options, warrants, or other agreements or commitments to acquire from Buyer or any of its Subsidiaries, or obligations of Buyer or any of its Subsidiaries to issue, any Buyer Voting Debt or shares of capital stock of (or securities convertible into or exchangeable for shares of capital stock of) Buyer, or (C) restricted shares, restricted stock units, stock appreciation rights, performance shares, profit participation rights, contingent value rights, “phantom” stock, or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital stock of Buyer, in each case that have been issued by Buyer or its Subsidiaries (the items in clauses (A), (B), and (C), together with the capital stock of Buyer, being referred to collectively as “Buyer Securities”). All outstanding shares of Buyer Stock, all outstanding Buyer Stock Options, and all outstanding shares of capital stock, voting securities, or other ownership interests in any Subsidiary of Buyer, have been issued or granted, as applicable, in compliance in all material respects with all applicable securities Laws.

 

(iii) As of the date hereof, there are no outstanding Contracts requiring Buyer or any of its Subsidiaries to repurchase, redeem, or otherwise acquire any Buyer Securities or Buyer Subsidiary Securities. Neither Buyer nor any of its Subsidiaries is a party to any voting agreement with respect to any Buyer Securities or Buyer Subsidiary Securities.

 

37
 

 

(c) Voting Debt. No bonds, debentures, notes, or other indebtedness issued by Buyer or any of its Subsidiaries: (i) having the right to vote on any matters on which stockholders or equity holders of Buyer or any of its Subsidiaries may vote (or which is convertible into, or exchangeable for, securities having such right); or (ii) the value of which is directly based upon or derived from the capital stock, voting securities, or other ownership interests of Buyer or any of its Subsidiaries, are issued or outstanding (collectively, “Buyer Voting Debt”).

 

(d) Buyer Subsidiary Securities. As of the date hereof, there are no outstanding: (i) securities of Buyer or any of its Subsidiaries convertible into or exchangeable for Buyer Voting Debt, capital stock, voting securities, or other ownership interests in any Subsidiary of Buyer; (ii) options, warrants, or other agreements or commitments to acquire from Buyer or any of its Subsidiaries, or obligations of Buyer or any of its Subsidiaries to issue, any Buyer Voting Debt, capital stock, voting securities, or other ownership interests in (or securities convertible into or exchangeable for capital stock, voting securities, or other ownership interests in) any Subsidiary of Buyer; or (iii) restricted shares, restricted stock units, stock appreciation rights, performance shares, profit participation rights, contingent value rights, “phantom” stock, or similar securities or rights that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any capital stock or voting securities of, or other ownership interests in, any Subsidiary of Buyer, in each case that have been issued by a Subsidiary of Buyer (the items in clauses (i), (ii), and (iii), together with the capital stock, voting securities, or other ownership interests of such Subsidiaries, being referred to collectively as “Buyer Subsidiary Securities”).

 

Section 6.3 Authority; Non-Contravention; Governmental Consents; Board Approval.

 

(a) Authority. Each of Buyer and Merger Sub has all requisite corporate or limited liability company power and authority to enter into and to perform its obligations under this Agreement and to consummate the transactions contemplated by this Agreement. The execution and delivery of this Agreement by Buyer and Merger Sub and the consummation by Buyer and Merger Sub of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate action on the part of Buyer and Merger Sub and no other corporate proceedings on the part of Buyer or Merger Sub are necessary to authorize the execution and delivery of this Agreement or to consummate the Merger, the Buyer Stock Issuance, and the other transactions contemplated by this Agreement. This Agreement has been duly executed and delivered by Buyer and Merger Sub and, assuming due execution and delivery by Company, constitutes the legal, valid, and binding obligation of Buyer and Merger Sub, enforceable against Buyer and Merger Sub in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, moratorium, and other similar Laws affecting creditors’ rights generally and by general principles of equity.

 

(b) Non-Contravention. The execution, delivery, and performance of this Agreement by Buyer and Merger Sub and the consummation by Buyer and Merger Sub of the transactions contemplated by this Agreement, do not and will not: (i) contravene or conflict with, or result in any violation or breach of, the Charter Documents of Buyer or Merger Sub; (ii) assuming that all of the Consents contemplated by clauses (i) through (v) of Section 6.3(c) have been obtained or made, conflict with or violate any Law applicable to Buyer or Merger Sub or any of their respective properties or assets; (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in Buyer’s or any of its Subsidiaries’ loss of any benefit or the imposition of any additional payment or other liability under, or alter the rights or obligations of any third party under, or give to any third party any rights of termination, amendment, acceleration, or cancellation, or require any Consent under, any Contract to which Buyer or any of its Subsidiaries is a party or otherwise bound as of the date hereof; or (iv) result in the creation of a Lien (other than Permitted Liens) on any of the properties or assets of Buyer or any of its Subsidiaries, except, in the case of each of clauses (ii), (iii), and (iv), for any conflicts, violations, breaches, defaults, loss of benefits, additional payments or other liabilities, alterations, terminations, amendments, accelerations, cancellations, or Liens that, or where the failure to obtain any Consents, in each case, would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect. The Buyer Stock Issuance does not require the approval of Buyer’s stockholders pursuant to applicable Law or the rules and regulations of NASDAQ.

 

38
 

 

(c) Governmental Consents. No Consent of any Governmental Entity is required to be obtained or made by Buyer or Merger Sub in connection with the execution, delivery, and performance by Buyer and Merger Sub of this Agreement or the consummation by Buyer and Merger Sub of the Merger, the Buyer Stock Issuance, and the other transactions contemplated hereby, except for: (i) the filing of the Articles of Merger with the Secretary of State of the State of Nevada; (ii) the filing with the SEC of such reports under the Exchange Act as may be required in connection with this Agreement, the Merger, the Buyer Stock Issuance, and the other transactions contemplated by this Agreement; (iii) such Consents as may be required under applicable state securities or “blue sky” Laws and the securities Laws of any foreign country or the rules and regulations of NASDAQ; (iv) the Other Governmental Approvals; and (v) such other Consents which if not obtained or made would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect.

 

(d) Board Approval.

 

(i) The Buyer Board by resolutions duly adopted by a unanimous vote at a meeting of all directors of Buyer duly called and held and, not subsequently rescinded or modified in any way, has (A) determined that this Agreement and the transactions contemplated hereby, including the Merger, and the Buyer Stock Issuance, upon the terms and subject to the conditions set forth herein, are fair to, and in the best interests of, Buyer and the Buyer’s stockholders and (B) approved and declared advisable this Agreement, including the execution, delivery, and performance thereof, and the consummation of the transactions contemplated by this Agreement, including the Merger and the Buyer Stock Issuance, upon the terms and subject to the conditions set forth herein.

 

(ii) The Merger Sub Board by resolutions duly adopted by a unanimous vote at a meeting of all directors of Merger Sub duly called and held and, not subsequently rescinded or modified in any way, has (A) determined that this Agreement and the transactions contemplated hereby, including the Merger, upon the terms and subject to the conditions set forth herein, are fair to, and in the best interests of, Merger Sub and Buyer, as the sole member of Merger Sub and (B) approved and declared advisable this Agreement, including the execution, delivery, and performance thereof, and the consummation of the transactions contemplated by this Agreement, including the Merger, upon the terms and subject to the conditions set forth herein. Buyer, as the sole member of Merger Sub, has approved Merger Sub’s adoption of this Agreement in accordance with the NRS.

 

Section 6.4 Reservation of Common Stock. Each Buyer Stock Issuance hereunder has been duly authorized and, upon issuance and delivery thereof pursuant to the terms hereof, shall be fully paid and non-assessable. As of the date hereof, Buyer has reserved and shall continue to reserve and keep available at all times, free of Liens and preemptive rights, a sufficient number of shares of Buyer Stock for the purpose of enabling Buyer to issue the Buyer Stock Consideration pursuant to this Agreement.

 

Section 6.5 Brokers. Except for fees payable to Primary Capital LLC, the fees and expenses of which will be paid by Buyer, neither Buyer, Merger Sub, nor any of their respective Affiliates has incurred, nor will it incur, directly or indirectly, any liability for investment banker, brokerage, or finders’ fees or agents’ commissions or any similar charges in connection with this Agreement or any transaction contemplated hereby for which Company would be liable in connection the Merger.

 

Section 6.6 Intended Tax Treatment. Neither Buyer nor any of its Subsidiaries has taken or agreed to take any action, and to the Knowledge of Buyer there exists no fact or circumstance, that is reasonably likely to prevent or impede the Merger from qualifying as a “reorganization” within the meaning of Section 368(a) of the Code.

 

39
 

 

Section 6.7 Merger Sub. Merger Sub: (a) has engaged in no business activities other than those related to the transactions contemplated by this Agreement; and (b) is a direct, wholly-owned Subsidiary of Buyer.

 

Section 6.8 Litigation. Except as set forth in Section 6.8 of the Buyer Disclosure Letter, there is no Legal Action pending, or to the Knowledge of Buyer, threatened against Buyer or any of its Subsidiaries or any of their respective properties or assets or, to the Knowledge of Buyer, any officer or director of Buyer or any of its Subsidiaries in their capacities, that, in each case, individually or in the aggregate, challenges, or could have the effect of preventing, delaying, hindering, impeding, making illegal, imposing limitations or conditions on, or otherwise interfering with, any of the transactions contemplated by this Agreement or the other Ancillary Documents.

 

Section 6.9 SEC Filings; Financial Statements; Undisclosed Liabilities.

 

(a) SEC Filings. Buyer has timely filed with or furnished to, as applicable, the SEC all Buyer SEC Documents required to be filed or furnished by it with the SEC since June 30, 2021. True, correct, and complete copies of all the Buyer SEC Documents are publicly available on EDGAR. As of their respective filing dates or, if amended or superseded by a subsequent filing prior to the date hereof, as of the date of the last such amendment or superseding filing (and, in the case of registration statements and proxy statements, on the dates of effectiveness and the dates of the relevant meetings, respectively), each of the Buyer SEC Documents complied as to form in all material respects with the applicable requirements of the Securities Act, the Exchange Act, and the Sarbanes-Oxley Act, and the rules and regulations of the SEC thereunder applicable to such Buyer SEC Documents. None of the Buyer SEC Documents, including any financial statements, schedules, or exhibits included or incorporated by reference therein at the time they were filed (or, if amended or superseded by a subsequent filing prior to the date hereof, as of the date of the last such amendment or superseding filing), contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. To the Knowledge of Buyer, none of the Buyer SEC Documents is the subject of ongoing SEC review or outstanding SEC investigation and there are no outstanding or unresolved comments received from the SEC with respect to any of the Buyer SEC Documents. None of Buyer’s Subsidiaries is required to file or furnish any forms, reports, or other documents with the SEC and neither Buyer nor any of its Subsidiaries is required to file or furnish any forms, reports, or other documents with any securities regulation (or similar) regime of a non-United States Governmental Entity.

 

(b) Financial Statements. Each of the consolidated financial statements (including, in each case, any notes and schedules thereto) contained in or incorporated by reference into the Buyer SEC Documents: (i) complied as to form in all material respects with the published rules and regulations of the SEC with respect thereto as of their respective dates; (ii) was prepared in accordance with GAAP applied on a consistent basis throughout the periods involved (except as may be indicated in the notes thereto and, in the case of unaudited interim financial statements, as may be permitted by the SEC for Quarterly Reports on Form 10-Q or other rules and regulations of the SEC); and (iii) fairly presented in all material respects the consolidated financial position and the results of operations and cash flows of Buyer and its consolidated Subsidiaries as of the respective dates of and for the periods referred to in such financial statements, subject, in the case of unaudited interim financial statements, to normal and year-end audit adjustments as permitted by the applicable rules and regulations of the SEC (but only if the effect of such adjustments would not, individually or in the aggregate, be material).

 

40
 

 

(c) Undisclosed Liabilities. The audited balance sheet of Buyer dated as of June 30, 2021 contained in the Buyer SEC Documents filed prior to the date hereof is hereinafter referred to as the “Buyer Balance Sheet.” Neither Buyer nor any of its Subsidiaries has any Liabilities other than Liabilities that: (i) are reflected or reserved against in the Buyer Balance Sheet (including in the notes thereto); (ii) were incurred since the date of the Buyer Balance Sheet in the ordinary course of business consistent with past practice; (iii) are incurred in connection with the transactions contemplated by this Agreement; or (iv) would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect.

 

(d) NASDAQ Compliance. Buyer is in compliance in all material respects with all of the applicable listing and corporate governance rules of NASDAQ.

 

Section 6.10 No Other Representations. EXCEPT FOR THE REPRESENTATIONS AND WARRANTIES CONTAINED IN THIS SECTION 6 (as modified by the BUYER Disclosure LETTER), BUYER MAKES NO EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY, AND BUYER HEREBY DISCLAIMS ANY SUCH REPRESENTATION OR WARRANTY, WITH RESPECT TO THE EXECUTION AND DELIVERY OF THIS AGREEMENT AND THE OTHER ANCILLARY DOCUMENTS AND THE CONSUMMATION OF THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THEREUNDER.

 

ARTICLE VII
TAX MATTERS

 

Section 7.1 Tax Matters.

 

(a) The Sellers shall prepare and timely file, or cause to be prepared and timely filed, all Tax Returns required to be filed by Company that (i) are due on or before the Closing Date (taking into account any extensions) or (ii) are income Tax Returns for any Pre-Closing Tax Period, and shall timely pay all Taxes that are due and payable on or before the Closing Date (taking into account any extensions). Any such Tax Return shall be prepared in a manner consistent with past practice (unless otherwise required by Law).

 

(b) Buyer shall prepare and timely file, or cause to be prepared and timely filed, all Tax Returns required to be filed by the Company after the Closing Date other than those described in Section 7.1(a). Any such Tax Return shall be prepared in a manner consistent with past practice (unless otherwise required by Law) and, if it is an income or other material Tax Return, shall be submitted by Buyer to Sellers’ Representative (together with schedules, statements and, to the extent requested by Sellers’ Representative, supporting documentation) at least twenty (20) days prior to the due date (including extensions) of such Tax Return. If Sellers’ Representative objects to any item on any such Tax Return that relates to a Pre-Closing Tax Period, it shall, within ten (10) days after delivery of such Tax Return, notify Buyer in writing that it so objects, specifying with particularity any such item and stating the specific factual or legal basis for any such objection. If a notice of objection shall be duly delivered, Buyer and Sellers’ Representative shall negotiate in good faith and use their reasonable best efforts to resolve such items. If Buyer and Sellers’ Representative are unable to reach such agreement within ten (10) days after receipt by Buyer of such notice, the disputed items shall be resolved by the Independent Accountant and any determination by the Independent Accountant shall be final. The Independent Accountant shall resolve any disputed items within twenty (20) days of having the item referred to it pursuant to such procedures as it may require. If the Independent Accountant is unable to resolve any disputed items before the due date for such Tax Return, the Tax Return shall be filed as prepared by Buyer and then amended to reflect the Independent Accountant’s resolution. The costs, fees and expenses of the Independent Accountant shall be borne equally by Buyer and Sellers’ Representative. The preparation and filing of any Tax Return of the Company that does not relate to a Pre-Closing Tax Period or Straddle Period shall be exclusively within the control of Buyer.

 

41
 

 

Section 7.2 Straddle Period. In the case of Taxes that are payable with respect to a taxable period that begins before and ends after the Closing Date (each such period, a “Straddle Period”), the portion of any such Taxes that are treated as Pre-Closing Taxes for purposes of this Agreement shall be: (a) in the case of Taxes (i) based upon, or related to, income, receipts, profits, wages, capital or net worth, (ii) imposed in connection with the sale, transfer or assignment of property, or (iii) required to be withheld, deemed equal to the amount which would be payable if the taxable year ended with the Closing Date; and (b) in the case of other Taxes, deemed to be the amount of such Taxes for the entire period multiplied by a fraction the numerator of which is the number of days in the period ending on the Closing Date and the denominator of which is the number of days in the entire period.

 

Section 7.3 Contests. Buyer agrees to give written notice to Sellers’ Representative of the receipt of any written notice by the Company, Buyer or any of Buyer’s Affiliates which involves the assertion of any claim, or the commencement of any Action, in respect of which an indemnity may be sought by Buyer pursuant to this Agreement (a “Tax Claim”); provided, that failure to comply with this provision shall not affect Buyer’s right to indemnification hereunder. Sellers’ Representative shall control the contest or resolution of any Tax Claim; provided, however, that Sellers’ Representative shall obtain the prior written consent of Buyer (which consent shall not be unreasonably withheld, conditioned or delayed) before entering into any resolution or settlement of any Tax Claim. Buyer shall be entitled to participate in the defense of such claim and to employ counsel of its choice for such purpose, the fees and expenses of which separate counsel shall be borne solely by Buyer.

 

Section 7.4 Amendment of Tax Returns, etc. Without the prior written consent of the Sellers’ Representative (which consent shall not be unreasonably withheld, conditioned, or delayed), the Buyer will not and will not cause or permit the Company to (A) grant an extension of any applicable statute of limitations with respect to any Pre-Closing Tax Period, (B) take any action from and after the Closing Date including but not limited to the distribution of any dividend or the effectuation of any redemption, that could give rise to any Tax liability or reduce any Tax asset of the Sellers in respect of any Pre-Closing Tax Period, (C) make any election or deemed election under Section 338 of the Code in connection with this transaction, or (D) make or change any Tax election, initiate a voluntary disclosure with respect to any Tax, amend any Tax Return or take any Tax position on any Tax Return, take any action, omit to take any action or enter into any transaction, merger or restructuring that results, in each case, in any increased Tax liability in respect of any Pre-Closing Tax Period.

 

Section 7.5 Tax Refunds and Credits. Any refund (or credit received in lieu of a refund) of Taxes of the Company for any Pre-Closing Tax Period, that is actually received by the Buyer or the Company shall be for the account of the Sellers. Promptly upon receipt, the Buyer or the Company shall pay the amount of any such refund (or the amount of the credit received in lieu of such refund) to the Sellers, in accordance with their Pro Rata Portion, by wire transfer of immediately available funds to one or more account(s) designated in writing by the Sellers’ Representative, net of any expenses or costs incurred by the Buyer the Company in connection with the receipt of the refund (or credit) and any Taxes of such relevant party attributable to such refund (or credit). The Buyer shall, at the written request of Sellers, use commercially reasonable efforts to make any necessary filings to claim available income Tax refunds.

 

Section 7.6 Cooperation and Exchange of Information. The Sellers’ Representative, the Company and Buyer shall provide each other with such cooperation and information as either of them reasonably may request of the others in filing any Tax Return pursuant to this ARTICLE VII or in connection with any audit or other proceeding in respect of Taxes of the Company. Such cooperation and information shall include providing copies of relevant Tax Returns or portions thereof, together with accompanying schedules, related work papers and documents relating to rulings or other determinations by tax authorities. Each of Sellers’ Representative, the Company and Buyer shall retain all Tax Returns, schedules and work papers, records and other documents in its possession relating to Tax matters of the Company for any taxable period beginning before the Closing Date until the expiration of the statute of limitations of the taxable periods to which such Tax Returns and other documents relate, without regard to extensions except to the extent notified by any of the other parties in writing of such extensions for the respective Tax periods. Prior to transferring, destroying or discarding any Tax Returns, schedules and work papers, records and other documents in its possession relating to Tax matters of the Company for any taxable period beginning before the Closing Date, Sellers’ Representative, the Company or Buyer (as the case may be) shall provide the other parties with reasonable written notice and offer the other parties the opportunity to take custody of such materials.

 

42
 

 

Section 7.7 Survival. Notwithstanding anything in this Agreement to the contrary, the provisions of Section 4.6 and this ARTICLE VII shall survive for the full period of all applicable statutes of limitations (giving effect to any waiver, mitigation or extension thereof) plus 60 days.

 

Section 7.8 Overlap. To the extent that any obligation or responsibility pursuant to ARTICLE X may overlap with an obligation or responsibility pursuant to this ARTICLE VII, the provisions of this ARTICLE VII shall govern.

 

ARTICLE VIII
Covenants

 

Section 8.1 Conduct of the Business. During the period from the date of this Agreement until the Effective Time, Company shall, except as expressly permitted or required by this Agreement or as required by applicable Law, or with the prior written consent of Buyer (which consent shall not be unreasonably withheld, conditioned, or delayed), conduct its business in the ordinary course consistent with past practice in all material respects and shall minimize the hiring of any new employees, other than any new employee hired to (i) fulfill a position described on Section 8.1(i) of Company Disclosure Letter or (ii) replace any current employee that departs from the Company after the date hereof (the “Permitted Hires”). Without limiting the generality of the foregoing, between the date of this Agreement and the Effective Time, except as otherwise expressly required by this Agreement or as required by applicable Law, Company shall not, without the prior written consent of Buyer, which consent shall not be unreasonably withheld, conditioned, or delayed:

 

(a) enter into any Contracts that provide for payments by the Company in excess of $100,000 in any calendar year (other than in connection with any Permitted Hire);

 

(b) authorize or make payments of corporate expenses in excess of $20,000 on a monthly basis (other than in connection with any Permitted Hire);

 

(c) amend its Charter Documents;

 

(d) (i) split, combine, or reclassify any securities in a manner that would adversely affect the other party or the holders of the other party’s securities relative to the other holders of the first party’s securities, (ii) repurchase, redeem, or otherwise acquire, or offer to repurchase, redeem, or otherwise acquire, any of its securities, or (iii) declare, set aside, or pay any distribution (in property other than cash) in respect of, or enter into any Contract with respect to the voting of, any Company Membership Units;

 

(e) issue, sell, pledge, dispose of, or encumber any securities;

 

(f) acquire, by merger, consolidation, acquisition of stock or assets, or otherwise, any business or Person or division thereof or make any loans, advances, or capital contributions to or investments in any Person, in each case that would reasonably be expected to prevent, impede, or materially delay the consummation of the Merger or other transactions contemplated by this Agreement;

 

43
 

 

(g) adopt or effect a plan of complete or partial liquidation, dissolution, restructuring, recapitalization, or other reorganization; or

 

(h) agree or commit to do any of the foregoing.

 

Section 8.2 Access to Information. From the date of this Agreement until the earlier to occur of the Effective Time or the termination of this Agreement in accordance with the terms set forth in ARTICLE XI, Company shall afford to Buyer and Buyer’s Representatives reasonable access, at reasonable times and in a manner as shall not unreasonably interfere with the business or operations of Company, to the officers, employees, accountants, agents, properties, offices, and other facilities and to all books, records, contracts, and other assets of Company and its Subsidiaries, and Company shall furnish promptly to Buyer such other information concerning the business and properties of Company as Buyer may reasonably request from time to time. Company shall not be required to provide access to or disclose information where such access or disclosure would jeopardize the protection of attorney-client privilege or contravene any Law (it being agreed that the parties shall use their reasonable best efforts to cause such information to be provided in a manner that would not result in such jeopardy or contravention). No investigation shall affect Company’s representations, warranties, covenants, or agreements contained herein, or limit or otherwise affect the remedies available to Buyer or Merger Sub pursuant to this Agreement. Buyer shall, and shall cause its Representatives and Affiliates to, hold information received from Company pursuant to this Section 8.2 in confidence in accordance with the terms of the Mutual Confidentiality and Non-Circumvention Agreement, dated as of September 9, 2021, between Buyer and Company.

 

Section 8.3 Non-Circumvention.

 

(a) From the date of this Agreement until the earlier to occur of the Effective Time or the termination of this Agreement in accordance with the terms set forth in ARTICLE XI, each Seller and the Company shall not authorize or permit any of directors, officers, employees, investment bankers, attorneys, accountants, consultants, or other agents or advisors (with respect to any Person, the foregoing Persons are referred to herein as such Person’s “Representatives”) to, directly or indirectly, (i) encourage, solicit, initiate, facilitate or continue inquiries regarding an Acquisition Proposal; (ii) enter into discussions or negotiations with, or provide any information to, any Person concerning a possible Acquisition Proposal; or (iii) enter into any agreements or other instruments (whether or not binding) regarding an Acquisition Proposal. Each Seller shall immediately cease and cause to be terminated, and shall cause its Affiliates (including the Company) and all of its and their Representatives to immediately cease and cause to be terminated, all existing discussions or negotiations with any Persons conducted heretofore with respect to, or that could lead to, an Acquisition Proposal. For purposes hereof, “Acquisition Proposal” shall mean any inquiry, proposal or offer from any Person (other than Buyer or any of its Affiliates) concerning (i) a merger, consolidation, liquidation, recapitalization, exchange or other business combination transaction involving the Company; (ii) the issuance or acquisition of Company Membership Units by a third-party; or (iii) the sale, lease, exchange or other disposition of any significant portion of the Company’s properties or assets. Immediately following the execution and delivery of this Agreement, Buyer, as sole member of Merger Sub, shall adopt this Agreement and approve the Merger, in accordance with the NRS. Buyer shall cause Merger Sub to perform its obligations under this Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement.

 

44
 

 

Section 8.4 Notices of Certain Events. Subject to applicable Law, Company shall notify Buyer and Merger Sub, and Buyer and Merger Sub shall notify Company, promptly of: (a) any notice or other communication from any Person alleging that the consent of such Person is or may be required in connection with the transactions contemplated by this Agreement; (b) any notice or other communication from any Governmental Entity in connection with the transactions contemplated by this Agreement; and (c) any event, change, or effect between the date of this Agreement and the Effective Time which individually or in the aggregate causes or is reasonably likely to cause or constitute the failure of any of the conditions set forth in Article IX of this Agreement to be satisfied; provided that, the delivery of any notice pursuant to this Section 8.4 shall not cure any breach of, or noncompliance with, any other provision of this Agreement or limit the remedies available to the party receiving such notice.

 

Section 8.5 Directors’ and Officers’ Indemnification and Insurance.

 

(a) Indemnification. Buyer and Merger Sub agree that all rights to indemnification, advancement of expenses, and exculpation by Company now existing in favor of each Person who is now, or has been at any time prior to the date hereof or who becomes prior to the Effective Time an officer or Manager of Company (each an “D&O Indemnified Party”) as provided in the Charter Documents of Company, in each case as in effect on the date of this Agreement, or pursuant to any other Contracts in effect on the date hereof and disclosed in Section 4.15 of Company Disclosure Letter, shall be assumed by the Surviving Entity in the Merger, without further action, at the Effective Time and shall survive the Merger and shall remain in full force and effect in accordance with their terms. For a period of six years from the Effective Time, the Surviving Entity shall, and Buyer shall cause the Surviving Entity to, maintain in effect the exculpation, indemnification, and advancement of expenses equivalent to the provisions of the Charter Documents of Company as in effect immediately prior to the Effective Time with respect to acts or omissions by any D&O Indemnified Party occurring prior to the Effective Time, and shall not amend, repeal, or otherwise modify any such provisions in any manner that would adversely affect the rights thereunder of any D&O Indemnified Party; provided that all rights to indemnification in respect of any claim made for indemnification within such period shall continue until the disposition of such action or resolution of such claim.

 

(b) Survival. The obligations of Buyer, Merger Sub, and the Surviving Entity under this Section 8.5 shall survive the consummation of the Merger and shall not be terminated or modified in such a manner as to adversely affect any D&O Indemnified Party to whom this Section 8.5 applies without the consent of such affected D&O Indemnified Party (it being expressly agreed that the D&O Indemnified Parties to whom this Section 8.5 applies shall be third party beneficiaries of this Section 8.5, each of whom may enforce the provisions of this Section 8.5).

 

(c) Assumptions by Successors and Assigns; No Release or Waiver. In the event Buyer, the Surviving Entity, or any of their respective successors or assigns: (i) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity in such consolidation or merger; or (ii) transfers all or substantially all of its properties and assets to any Person, then, and in either such case, proper provision shall be made so that the successors and assigns of Buyer or the Surviving Entity, as the case may be, shall assume all of the obligations set forth in this Section 8.5. The agreements and covenants contained herein shall not be deemed to be exclusive of any other rights to which any D&O Indemnified Party is entitled, whether pursuant to Law, Contract, or otherwise. Nothing in this Agreement is intended to, shall be construed to, or shall release, waive, or impair any rights to directors’ and officers’ insurance claims under any policy that is or has been in existence with respect to Company or its officers, directors, and employees, it being understood and agreed that the indemnification provided for in this Section 8.5 is not prior to, or in substitution for, any such claims under any such policies.

 

45
 

 

Section 8.6 Reasonable Best Efforts.

 

(a) Governmental and Other Third-Party Approval; Cooperation and Notification. Upon the terms and subject to the conditions set forth in this Agreement (including those contained in this Section 8.6), each of the parties hereto shall, and shall cause its Subsidiaries to, use its reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper, or advisable to consummate and make effective, and to satisfy all conditions to, in the most expeditious manner practicable/as promptly as reasonably practicable (and in any event no later than the End Date), the Merger and the other transactions contemplated by this Agreement, including: (i) the obtaining of all necessary Permits, waivers, and actions or nonactions from Governmental Entities and the making of all necessary registrations, filings, and notifications (including filings with Governmental Entities) and the taking of all steps as may be necessary to obtain an approval or waiver from, or to avoid an action or proceeding by, any Governmental Entities; (ii) the obtaining of all necessary consents or waivers from third parties; and (iii) the execution and delivery of any additional instruments necessary to consummate the Merger and to fully carry out the purposes of this Agreement. Company and Buyer shall, subject to applicable Law, promptly: (A) cooperate and coordinate with the other in the taking of the actions contemplated by clauses (i), (ii), and (iii) immediately above; and (B) supply the other with any information that may be reasonably required in order to effectuate the taking of such actions. Each party hereto shall promptly inform the other party or parties hereto, as the case may be, of any communication from any Governmental Entity regarding any of the transactions contemplated by this Agreement. If Company, on the one hand, or Buyer or Merger Sub, on the other hand, receives a request for additional information or documentary material from any Governmental Entity with respect to the transactions contemplated by this Agreement, then it shall use reasonable best efforts to make, or cause to be made, as soon as reasonably practicable and after consultation with the other party, an appropriate response in compliance with such request, and, if permitted by applicable Law and by any applicable Governmental Entity, provide the other party’s counsel with advance notice and the opportunity to attend and participate in any meeting with any Governmental Entity in respect of any filing made thereto in connection with the transactions contemplated by this Agreement.

 

(b) Actions or Proceedings. In the event that any administrative or judicial action or proceeding is instituted (or threatened to be instituted) by a Governmental Entity or private party challenging the Merger or any other transaction contemplated by this Agreement, or any other agreement contemplated hereby, each party shall cooperate in all respects with the other parties and shall use its reasonable best efforts to contest and resist any such action or proceeding and to have vacated, lifted, reversed, or overturned any Order, whether temporary, preliminary, or permanent, that is in effect and that prohibits, prevents, or restricts consummation of the transactions contemplated by this Agreement.

 

(c) No Divestitures; Other Limitations. Notwithstanding anything to the contrary set forth in this Agreement, none of the parties, or any of their respective Subsidiaries shall be required to, and may not, without the prior written consent of the other parties, become subject to, consent to, or offer or agree to, or otherwise take any action with respect to, any requirement, condition, limitation, understanding, agreement, or Order to: (i) sell, license, assign, transfer, divest, hold separate, or otherwise dispose of any assets, business, or portion of business of Company, the Surviving Entity, Buyer, Merger Sub, or any of their respective Subsidiaries; (ii) conduct, restrict, operate, invest, or otherwise change the assets, business, or portion of business of Company, the Surviving Entity, Buyer, Merger Sub, or any of their respective Subsidiaries in any manner; or (iii) impose any restriction, requirement, or limitation on the operation of the business or portion of the business of Company, the Surviving Entity, Buyer, Merger Sub, or any of their respective Subsidiaries.

 

Section 8.7 Public Announcements. Buyer, in its sole discretion, may issue or cause the publication of any press release or public announcement with respect to this Agreement or the transactions contemplated hereby without the consent of Sellers or the Company; provided, that, to the extent permitted by Law, the Sellers’ Representative shall be given at least 24 hours’ prior written notice of any such publication and shall have the right to review and provide comments for Buyer’s good faith consideration.

 

46
 

 

Section 8.8 Anti-Takeover Statutes. If any “control share acquisition,” “fair price,” “moratorium,” or other anti-takeover Law becomes or is deemed to be applicable to Buyer, Merger Sub, Company, the Merger, or any other transaction contemplated by this Agreement, then each of Company and Sellers on the one hand, and Buyer and the Buyer Board on the other hand, shall grant such approvals and take such actions as are necessary so that the transactions contemplated hereby may be consummated as promptly as practicable on the terms contemplated hereby and otherwise act to render such anti-takeover Law inapplicable.

 

Section 8.9 Reorganization Efforts. Each of Company and Buyer shall (and Company and Buyer shall cause their respective Subsidiaries to) use its reasonable best efforts to cause the Merger to qualify, and not take or fail to take any action which action (or failure to act) would reasonably be expected to prevent or impede the Merger from qualifying, as a “reorganization” within the meaning of Section 368(a) of the Code.

 

Section 8.10 Transfer Taxes. Any and all transfer, documentary, sales, use, stamp, registration, value added and other such Taxes and fees (including any penalties and interest) incurred in connection with the transactions contemplated by this Agreement and the Ancillary Documents (including any real property transfer Tax and any other similar Tax) shall be paid equally by Buyer, on the one hand, and Company, on the other. Buyer and Company shall cooperate, at their joint and equal expense, in timely filing any Tax Return or other document with respect to such Taxes or fees.

 

Section 8.11 Continuing Employees. The Surviving Entity shall offer employment to any Continuing Employee, effective from and after the Closing Date, on such terms as it may determine (except that offers of employment to Tyler Gates and Erik Muendel shall be on the terms set forth in their respective agreements included in the Ancillary Documents). Notwithstanding the foregoing, Buyer shall provide to each Continuing Employee for a period of one (1) year following the Closing (or through their termination date if earlier) with (a) annual base salaries and base wages that are no less than those provided immediately prior to the Closing, (b) cash incentive compensation opportunities that are no less favorable than those provided immediately prior to the Closing, and (c) benefit plans that are substantially similar in the aggregate to those provided immediately prior to the Closing, but excluding any equity based compensation or change of control or retention incentives. To the extent Buyer does not continue a Company Employee Plan, Buyer will make its employee benefit plans and arrangements available to Continuing Employees as follows: Buyer shall credit Continuing Employees with their period of employment with Company or its applicable Affiliate for purposes of eligibility, vesting, participation and benefit accrual (but not benefit accrual under any defined benefit pension plan) in any “employee benefit plan” (as such term is defined by Section 3(3) of ERISA) maintained by Buyer or one of its Affiliates and any vacation, sick, paid-time off, severance pay plan, program or arrangement offered by Buyer or one of its Affiliates, as applicable (collectively, the “Buyer Benefit Plans”), for which such Continuing Employees are eligible, effective as of the date of eligibility. In addition, from and after the Closing Date, Buyer shall use commercially reasonable efforts to (x) cause any pre-existing conditions or limitations and eligibility waiting periods under any Buyer Benefit Plan that is a group health plan to be waived with respect to the Continuing Employees and their eligible dependents to the extent such conditions, limitations, and waiting periods were waived or satisfied under the corresponding Company Employee Plans and (y) give each of the Continuing Employees credit for the plan year in which the Closing occurs toward applicable deductibles and annual out of pocket limits for expenses incurred prior to the Closing for which payment has been made. In addition, Buyer shall take any and all actions as may be required to permit each Continuing Employee to make rollover contributions of “eligible rollover distributions” (within the meaning of Section 401(a)(31) of the Code, including plan loans) to a Buyer Benefit Plan that includes a cash or deferred arrangement under Section 401(k) of the Code for which such Continuing Employees are eligible, effective as of the date of eligibility, in an amount equal to any eligible rollover distribution made to such Continuing Employee from the Company’s 401(k) plan or other applicable tax-qualified retirement plan (including any plan loans). Notwithstanding the foregoing, nothing in this Section 8.11 shall operate to result in a duplication of benefits. Nothing in this Section 8.11, whether express or implied, shall (x) create any rights to continued employment with the Company, the Buyer or any of their Affiliates or in any way prohibit the Buyer, the Company or any of their Affiliates from terminating the employment of any Continuing Employee at any time and for any reason, (y) be construed as an amendment of any Company Plan or Buyer Benefit Plan or (z) grant any third party beneficiary rights under this Agreement to any Person. Notwithstanding anything to the contrary set forth in this Agreement, no provision of this Agreement shall be deemed to (i) guarantee employment for any period of time for, or preclude the ability of Buyer or the Surviving Entity to terminate, any Continuing Employee for any reason, (ii) require Buyer or the Surviving Entity to continue any Company Employee Plan or prevent the amendment, modification or termination thereof after the Effective Time, (iii) be construed as an amendment of any Company Employee Plan or Buyer Benefit Plan, (iv) grant any third party beneficiary rights under this Agreement to any Person or (v) restrict Buyer or the Surviving Entity from reducing the annual base salary, base wage or cash incentive compensation opportunities of any Continuing Employee, so long as such reduction is consistent (in amount and duration) with a company-wide reduction in the annual base salaries, base wages or cash incentive compensation opportunities of the employees of the Buyer and its Subsidiaries generally.

 

47
 

 

Section 8.12 Non-Competition. Non-Solicitation.

 

(a) For a period of three years commencing on the Closing Date (the “Restricted Period”), each of Erik Muendel and Tyler Gates shall not, and shall not permit any of its controlled Affiliates to, directly or indirectly, (i) engage in or assist others in engaging in any business that competes with the business engaged in by Company as of the Closing Date (the “Restricted Business”) anywhere in the world (the “Territory”); (ii) have an interest in any Person that engages directly or indirectly in the Restricted Business in the Territory in any capacity, including as a partner, shareholder, member, employee, principal, agent, trustee or consultant; or (iii) cause, induce or encourage any material actual or prospective client or customer of Company during the one-year period preceding the prohibited conduct with whom the applicable Seller has had substantial dealings or supervisory authority (each, a “Covered Customer”) to terminate or modify any such actual or prospective relationship. Notwithstanding the foregoing, such Seller may (1) engage in the activities set forth on Section 8.12 of the Company Disclosure Letter or (2) own, directly or indirectly, solely as an investment, securities of any Person traded on any national securities exchange or national market system if such Seller is not a controlling Person of, or a member of a group which controls, such Person and does not, directly or indirectly, own 2% or more of any class of securities of such Person.

 

(b) During the Restricted Period, each Seller shall not, and shall not permit any of its controlled Affiliates to, directly or indirectly, hire or solicit any Person who is offered employment by Buyer pursuant hereto or is or was employed by the Buyer during the Restricted Period, or encourage any such employee to leave such employment or hire any such employee who has left such employment, except pursuant to a general solicitation which is not directed specifically to any such employees; provided, that nothing in this Section 8.12(b) shall prevent such Seller or any of its Affiliates from hiring (i) any employee whose employment has been terminated by Buyer or (ii) after 180 days from the date of termination of employment, any employee whose employment has been terminated by the employee.

 

(c) Each Seller acknowledges that a breach or threatened breach of this Section 8.12 may give rise to irreparable harm to Buyer, for which monetary damages would not be an adequate remedy, and hereby agrees that in the event of a breach or a threatened breach by such Seller of any such obligations, Buyer shall, in addition to any and all other rights and remedies that may be available to it in respect of such breach, be entitled to equitable relief, including a temporary restraining order, an injunction, specific performance and any other relief that may be available from a court of competent jurisdiction (without any requirement to post bond).

 

48
 

 

Section 8.13 Further Assurances. At and after the Effective Time, the officers and directors of the Surviving Entity shall be authorized to execute and deliver, in the name and on behalf of Surviving Entity, any deeds, bills of sale, assignments, or assurances and to take and do, in the name and on behalf of Company or Merger Sub, any other reasonable actions and things to vest, perfect, or confirm of record or otherwise in the Surviving Entity any and all right, title, and interest in, to and under any of the rights, properties, or assets of Company acquired or to be acquired by the Surviving Entity as a result of, or in connection with, the Merger, pursuant to the terms of this Agreement. Buyer shall cause Merger Sub to perform its obligations under this Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement.

 

ARTICLE IX
Conditions TO CLOSING

 

Section 9.1 Conditions to Obligation of Buyer to Effect the Closing. The obligation of Buyer and Merger Sub to effect the Closing is subject to the satisfaction or waiver by Buyer, at or prior to the Closing Date, of each of the following conditions:

 

(a) Representations and Warranties. The representations and warranties of Company set forth in ARTICLE IV and of Sellers in ARTICLE V of this Agreement shall be true and correct in all respects (without giving effect to any limitation indicated by the words “Company Material Adverse Effect,” “in all material respects,” “in any material respect,” “material,” or “materially”) as of the date of this Agreement and as of the Closing Date, as if made on and as of such date (except those representations and warranties that address matters only as of a particular date, which shall be true and correct in all respects as of that date), except where the failure of such representations and warranties to be so true and correct would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.

 

(b) Performance of Covenants. Company shall have performed in all material respects all obligations, and complied in all material respects with the agreements and covenants, in this Agreement required to be performed by or complied with by it at or prior to the Closing.

 

(c) Auditor Consent. Buyer shall have received from the Auditors written notice that, in their sole discretion, the preparation of the Company’s audited financial statements has made sufficient progress as of the date of such notice (provided, that, notwithstanding anything in this Agreement to the contrary, the condition set forth in this Section 9.1(c) shall automatically be deemed satisfied beginning on August 1, 2022).

 

(d) Company Material Adverse Effect. Since the date of this Agreement, there shall not have been any Company Material Adverse Effect or any event, change, or effect that would, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect.

 

(e) Officers Certificate. Buyer will have received a certificate, signed by the chief executive officer or chief financial officer of Company, certifying as to the matters set forth in Section 9.1(a) and Section 9.1(b) hereof.

 

Section 9.2 Conditions to Obligations of Company to Effect the Closing. The obligation of Company to effect the Closing is subject to the satisfaction or waiver by Company, at or prior to the Closing Date, of each of the following conditions:

 

(a) Representations and Warranties. (i) The representations and warranties of Buyer and Merger Sub (other than Section 6.2) set forth in ARTICLE VI of this Agreement shall be true and correct in all respects (without giving effect to any limitation indicated by the words “Buyer Material Adverse Effect,” “in all material respects,” “in any material respect,” “material,” or “materially”) as of the date of this Agreement and as of the Closing Date, as if made on and as of such date (except those representations and warranties that address matters only as of a particular date, which shall be true and correct in all respects as of that date), except where the failure of such representations and warranties to be so true and correct would not reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect; and (ii) the representations and warranties of Buyer and Merger Sub contained in Section 6.2 will be true and correct (other than de minimis inaccuracies) as of the date of this Agreement and as of the Closing Date, as if made on and as of such date (except those representations and warranties that address matters only as of a particular date, which shall be true and correct in all material respects as of that date).

 

49
 

 

(b) Performance of Covenants. Buyer and Merger Sub shall have performed in all material respects all obligations, and complied in all material respects with the agreements and covenants, of this Agreement required to be performed by or complied with by them at or prior to the Closing.

 

(c) Buyer Material Adverse Effect. Since the date of this Agreement, there shall not have been any Buyer Material Adverse Effect or any event, change, or effect that would, individually or in the aggregate, reasonably be expected to have a Buyer Material Adverse Effect.

 

(d) Officers Certificate. Company will have received a certificate, signed by an officer of Buyer, certifying as to the matters set forth in Section 9.2(a), Section 9.2(b), and Section 9.2(c).

 

(e) Listing. The shares of Buyer Stock constituting the Buyer Stock Consideration shall have been approved for listing on NASDAQ, subject to official notice of issuance.

 

ARTICLE X
INDEMNIFICATION

 

Section 10.1 Survival. Subject to the limitations and other provisions of this Agreement, the representations and warranties contained herein shall survive the Closing and shall remain in full force and effect until the date that is the eighteen (18) month anniversary of the Closing Date; provided, that (i) the representations and warranties in Section 4.1 (Organization; Standing and Power), Section 4.2 (Capital Structure), Section 4.3(a) (Authority), Section 4.6 (Taxes) and Section 4.10 (Brokers) (the “Company Fundamental Reps”) shall survive until the applicable statute of limitations, (ii) the representations and warranties in Section 4.7 (Intellectual Property) (the “Intellectual Property Reps”) shall survive until the date that is the twenty-four (24) month anniversary of the Closing Date, and (iii) the representations and warranties in Section 6.1 (Organization; Standing and Power; Charter Documents), Section 6.2 (Capitalization), Section 6.3(a) (Authority), and Section 6.5 (Brokers) (the “Buyer Fundamental Reps”) shall survive until the applicable statute of limitations. All covenants and agreements of the parties contained herein that require performance after the Closing shall survive the Closing until fully performed or observed in accordance with their terms. Notwithstanding the foregoing, any claims asserted in good faith with reasonable specificity (to the extent known at such time) and in writing by notice from the Indemnified Party to the Indemnifying Party prior to the expiration date of the applicable survival period shall not thereafter be barred by the expiration of the relevant representation or warranty and such claims shall survive until finally resolved.

 

50
 

 

Section 10.2 Indemnification by Sellers. Subject to the other terms and conditions of this ARTICLE X, Sellers, severally and not jointly (in accordance with their Pro Rata Portion), shall indemnify and defend each of Buyer and its Affiliates (including the Surviving Entity after the Closing) and their respective Representatives (collectively, the “Buyer Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Buyer Indemnitees based upon, arising out of, with respect to or by reason of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of the Company or the Sellers contained in this Agreement or in any certificate delivered by or on behalf of the Company pursuant to Sections 2.3(a)(i)-(iv) of this Agreement, as of the date such representation or warranty was made or as if such representation or warranty was made on and as of the Closing Date (except for representations and warranties that expressly relate to a specified date, the inaccuracy in or breach of which will be determined with reference to such specified date);

 

(b) any breach or non-fulfillment of any covenant, agreement or obligation to be performed by the Company or the Sellers pursuant to this Agreement;

 

(c) any claim made by any Seller relating to such Person’s rights with respect to the Merger Consideration; and

 

(d) any Disclosed Litigation.

 

Section 10.3 Indemnification by Buyer. Subject to the other terms and conditions of this ARTICLE X, Buyer shall indemnify and defend each of the Sellers and their Affiliates and their respective Representatives (collectively, the “Seller Indemnitees”) against, and shall hold each of them harmless from and against, and shall pay and reimburse each of them for, any and all Losses incurred or sustained by, or imposed upon, the Seller Indemnitees based upon, arising out of, with respect to or by reason of:

 

(a) any inaccuracy in or breach of any of the representations or warranties of Buyer and Merger Sub contained in this Agreement or in any certificate delivered by or on behalf of Buyer or Merger Sub pursuant to Sections 2.3(b)(iii)-(v) of this Agreement, as of the date such representation or warranty was made or as if such representation or warranty was made on and as of the Closing Date (except for representations and warranties that expressly relate to a specified date, the inaccuracy in or breach of which will be determined with reference to such specified date); or

 

(b) any breach or non-fulfillment of any covenant, agreement or obligation to be performed by Buyer or Merger Sub pursuant to this Agreement.

 

Section 10.4 Certain Limitations. The indemnification provided for in Section 10.2 and Section 10.3 shall be subject to the following limitations:

 

(a) Sellers shall not be liable to the Buyer Indemnitees for indemnification under Section 10.2(a) until the aggregate amount of all Losses in respect of indemnification under Section 10.2(a) exceeds $100,000 (the “Basket”), in which event Sellers shall only be required to pay or be liable for Losses in excess of the Basket. The aggregate amount of all Losses for which Sellers may be liable pursuant to Section 10.2(a) shall not exceed fifteen percent (15%) of the Purchase Price actually received by the Sellers (the “Cap”); provided that such limitation shall not apply to any such Losses (i) with respect to breaches of Company Fundamental Reps, for which the maximum amount recoverable by the Buyer Indemnitees shall be limited to the Purchase Price actually received by the Sellers and (ii) with respect to breaches of the Intellectual Property Reps, for which the maximum amount recoverable by the Buyer Indemnitees shall be limited to thirty percent (30%) of the Purchase Price actually received by the Sellers. The aggregate Liability of a particular Seller in respect of any Loss for which such Seller indemnifies the Buyer Indemnitees pursuant to Section 10.2 shall not exceed an amount equal to the Purchase Price actually received by such Seller pursuant to this Agreement.

 

51
 

 

(b) Buyer shall not be liable to the Seller Indemnitees for indemnification under Section 10.3(a) until the aggregate amount of all Losses in respect of indemnification under Section 10.3(a) exceeds the Basket, in which event Buyer shall only be required to pay or be liable for Losses in excess of the Basket. The aggregate amount of all Losses for which Buyer shall be liable pursuant to Section 10.3(a) shall not exceed the Cap; provided that such limitation shall not apply to any such Losses with respect to breaches of Buyer Fundamental Reps, for which the maximum amount recoverable by any Seller Indemnitee shall be limited to the Purchase Price actually received by such Seller.

 

(c) For purposes of calculating the monetary amount of Losses for which any Legal Action may be made against any Indemnifying Party, (i) the amount of any Losses corresponding to any inaccuracy in or breach of any representation or warranty shall be determined without regard to any materiality, Material Adverse Effect or other similar qualification contained in or otherwise applicable to such representation or warranty, (ii) there shall be no duplication of recovery by reason of the state of facts giving rise to such Losses constituting a breach of more than one representation, warranty, covenant or agreement (and no Indemnified Party will be entitled to indemnification or reimbursement under any provision of this Agreement for any amount to the extent such Indemnified Party or its Affiliate has received indemnification payments for or been reimbursed for such amount under any other provision of this Agreement or any other document executed in connection with this Agreement (i.e., no double recovery)) and (iii) such monetary amount shall be decreased to the extent of any amounts actually recovered by an Indemnified Party under applicable insurance policies. Each Indemnified Party agrees that it shall, and cause its Affiliates to, use commercially reasonable efforts to (x) make or cause to be made all reasonable claims for insurance under insurance policies that may be applicable to the matter giving rise to the indemnification claim hereunder, and (y) mitigate any Losses after becoming aware of such Losses or any event or condition that could reasonably be expected to give rise to any such Losses.

 

(d) Except with respect to an action for which specific performance is sought (and solely to the extent such action seeks such relief), each Party acknowledges and agrees that its sole and exclusive remedy with respect to all claims relating to any breach, inaccuracy, or nonfulfillment of any representation, warranty, covenant or agreement in this Agreement or otherwise relating to the transactions contemplated hereby shall be in accordance with, and limited by, the indemnification provisions set forth in this ARTICLE X. In furtherance of the foregoing, except with respect to Section 12.11, each Party hereby waives, to the fullest extent permitted under Law, any and all rights, claims and causes of action for any breach of any representation, warranty, covenant, agreement or obligation set forth herein or otherwise relating to the subject matter of this Agreement it may have against the other parties hereto and their Affiliates and each of their respective Representatives arising under or based upon any Law, except pursuant to the indemnification provisions set forth in this ARTICLE X.

 

Section 10.5 Indemnification Procedures. The party making a claim under this ARTICLE X is referred to as the “Indemnified Party”, and the party against whom such claims are asserted under this ARTICLE X is referred to as the “Indemnifying Party”. For purposes of this ARTICLE X, (i) if Buyer (or any other Buyer Indemnitee) comprises the Indemnified Party, any references to Indemnifying Party (except provisions relating to an obligation to make payments) shall be deemed to refer to Sellers, and (ii) if Buyer comprises the Indemnifying Party, any references to the Indemnified Party shall be deemed to refer to Sellers. Any payment received by any Seller as the Indemnified Party shall be distributed to the other Sellers in accordance with this Agreement.

 

52
 

 

(a) Third Party Claims. If any Indemnified Party receives notice of the assertion or commencement of any Legal Action made or brought by any Person who is not a party to this Agreement or an Affiliate of a party to this Agreement or a Representative of the foregoing (a “Third Party Claim”) against such Indemnified Party with respect to which the Indemnifying Party is obligated to provide indemnification under this Agreement, the Indemnified Party shall give the Indemnifying Party reasonably prompt written notice thereof, but in any event not later than 30 calendar days after receipt of such notice of such Third Party Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the Third Party Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have the right to participate in, or by giving written notice to the Indemnified Party, to assume the defense of any Third Party Claim at the Indemnifying Party’s expense and by the Indemnifying Party’s own counsel, and the Indemnified Party shall cooperate in good faith in such defense; provided, that if the Indemnifying Party is a Seller, such Indemnifying Party shall not have the right to defend or direct the defense of any such Third Party Claim that (x) is asserted directly by or on behalf of a Person that is a then-current material supplier or customer of the Surviving Entity, or (y) seeks an injunction or other equitable relief against the Indemnified Parties. In the event that the Indemnifying Party assumes the defense of any Third Party Claim, subject to Section 10.5(b), it shall have the right to take such action as it deems necessary to avoid, dispute, defend, appeal or make counterclaims pertaining to any such Third Party Claim in the name and on behalf of the Indemnified Party. The Indemnified Party shall have the right to participate in the defense of any Third Party Claim with counsel selected by it subject to the Indemnifying Party’s right to control the defense thereof. The fees and disbursements of such counsel shall be at the expense of the Indemnified Party, provided, that if in the reasonable opinion of counsel to the Indemnified Party, (A) there are legal defenses available to an Indemnified Party that are different from or additional to those available to the Indemnifying Party; or (B) there exists a conflict of interest between the Indemnifying Party and the Indemnified Party that cannot be waived, the Indemnifying Party shall be liable for the reasonable fees and expenses of counsel to the Indemnified Party in each jurisdiction for which the Indemnified Party determines counsel is required. If the Indemnifying Party elects not to compromise or defend such Third Party Claim, fails to promptly notify the Indemnified Party in writing of its election to defend as provided in this Agreement, or fails to diligently prosecute the defense of such Third Party Claim, the Indemnified Party may, subject to Section 10.5(b), pay, compromise, defend such Third Party Claim and seek indemnification for any and all Losses based upon, arising from or relating to such Third Party Claim. Sellers and Buyer shall cooperate with each other in all reasonable respects in connection with the defense of any Third Party Claim, including making available records relating to such Third Party Claim and furnishing, without expense (other than reimbursement of actual out-of-pocket expenses) to the defending party, management employees of the non-defending party as may be reasonably necessary for the preparation of the defense of such Third Party Claim.

 

(b) Settlement of Third Party Claims. Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not enter into settlement of any Third Party Claim without the prior written consent of the Indemnified Party, except as provided in this Section 10.5(b). If a firm offer is made to settle a Third Party Claim without leading to liability or the creation of a financial or other obligation on the part of the Indemnified Party and provides, in customary form, for the unconditional release of each Indemnified Party from all liabilities and obligations in connection with such Third Party Claim and the Indemnifying Party desires to accept and agree to such offer, the Indemnifying Party shall give written notice to that effect to the Indemnified Party. If the Indemnified Party fails to consent to such firm offer within five (5) days after its receipt of such notice, the Indemnified Party may continue to contest or defend such Third Party Claim and in such event, the maximum liability of the Indemnifying Party as to such Third Party Claim shall not exceed the amount of such settlement offer. If the Indemnified Party fails to consent to such firm offer and also fails to assume defense of such Third Party Claim, the Indemnifying Party may settle the Third Party Claim upon the terms set forth in such firm offer to settle such Third Party Claim. If the Indemnified Party has assumed the defense pursuant to Section 10.5(a), it shall not agree to any settlement without the written consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed).

 

53
 

 

(c) Direct Claims. Any Action by an Indemnified Party on account of a Loss which does not result from a Third Party Claim (a “Direct Claim”) shall be asserted by the Indemnified Party giving the Indemnifying Party reasonably prompt written notice thereof, but in any event not later than thirty (30) days after the Indemnified Party becomes aware of such Direct Claim. The failure to give such prompt written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, except and only to the extent that the Indemnifying Party forfeits rights or defenses by reason of such failure. Such notice by the Indemnified Party shall describe the Direct Claim in reasonable detail, shall include copies of all material written evidence thereof and shall indicate the estimated amount, if reasonably practicable, of the Loss that has been or may be sustained by the Indemnified Party. The Indemnifying Party shall have thirty (30) days after its receipt of such notice to respond in writing to such Direct Claim. The Indemnified Party shall allow the Indemnifying Party and its professional advisors to investigate the matter or circumstance alleged to give rise to the Direct Claim, and whether and to what extent any amount is payable in respect of the Direct Claim and the Indemnified Party shall assist the Indemnifying Party’s investigation by giving such information and assistance (including access to the Company’s premises and personnel and the right to examine and copy any accounts, documents or records) as the Indemnifying Party or any of its professional advisors may reasonably request. If the Indemnifying Party does not so respond within such thirty (30) day period, the Indemnifying Party shall be deemed to have rejected such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions of this Agreement.

 

Section 10.6 Payments

 

(a) Once a Loss is agreed to by the Indemnifying Party or finally adjudicated to be payable pursuant to this ARTICLE X, the Indemnifying Party shall satisfy its obligations within fifteen (15) Business Days of such final, non-appealable adjudication, in accordance with Section 10.6(c). The parties hereto agree that should an Indemnifying Party not make full payment of any such obligations within such fifteen (15) Business Day period, any amount payable shall accrue interest from and including the date of agreement of the Indemnifying Party or final, non-appealable adjudication to, but excluding, the date such payment has been made at a rate per annum equal to 5%. Such interest shall be calculated daily on the basis of a 365 day year and the actual number of days elapsed.

 

(b) Except as expressly set forth herein, any Losses payable to a Buyer Indemnitee pursuant to ARTICLE X shall be satisfied from the Sellers pro rata, severally and not jointly, in accordance with each Seller’s Pro Rata Portion.

 

(c) Any indemnification payment owed by a Seller pursuant to this ARTICLE X shall be effected by a combination of (i) a cash payment (either by wire transfer of immediately available funds to an account designated by the Indemnified Party or, at the Buyer’s option, by right of set-off (“Right of Set-Off’) against cash payments otherwise payable by Buyer to Sellers hereunder) and (ii) forfeiture and cancellation of Buyer Stock held by such Seller and acquired pursuant to this Agreement (calculated by dividing the applicable portion of the indemnification payment by the 30-Day VWAP (as measured as of the date of such forfeiture)), in each case, in proportions equal to the respective proportions of cash and Buyer Stock that comprise the Merger Consideration that such Seller has received to date; provided, that in the event that relevant indemnification payment is less than $200,000, such Seller may elect to effect such payment solely through the forfeiture and cancellation of Buyer Stock pursuant to clause (ii) above. To the extent that Buyer plans to exercise its Right of Set-Off, Buyer shall first provide at least ten (10) Business Days’ prior written notice to each of the Sellers detailing Buyer’s intent to exercise its Right of Set-Off.

 

Section 10.7 Tax Treatment. All indemnification payments made under this Agreement shall be treated by the parties as an adjustment to the Purchase Price for Tax purposes, unless otherwise required by Law.

 

54
 

 

Section 10.8 Effect of Investigation. The representations, warranties and covenants of the Indemnifying Party, and the Indemnified Party’s right to indemnification with respect thereto, shall not be affected or deemed waived by reason of any investigation made by or on behalf of the Indemnified Party (including by any of its Representatives) or by reason of the fact that the Indemnified Party or any of its Representatives knew or should have known that any such representation or warranty is, was or might be inaccurate or by reason of the Indemnified Party’s waiver of any condition set forth in Section 9.1 or Section 9.2, as the case may be.

 

ARTICLE XI
Termination, Amendment, and Waiver

 

Section 11.1 Termination by Mutual Consent. This Agreement may be terminated at any time prior to the Closing by the mutual written consent of Buyer and Company.

 

Section 11.2 Termination by Either Buyer or Company. This Agreement may be terminated by either Buyer or Company at any time prior to the Closing if any Governmental Entity of competent jurisdiction shall have enacted, issued, promulgated, enforced, or entered any Law or Order making illegal, permanently enjoining, or otherwise permanently prohibiting the consummation of the Merger, the Buyer Stock Issuance, or the other transactions contemplated by this Agreement, and such Law or Order shall have become final and nonappealable; provided, however, that the right to terminate this Agreement pursuant to this Section 11.2 shall not be available to any party whose breach of any representation, warranty, covenant, or agreement set forth in this Agreement has been the principal cause of, or was a contributing factor that resulted in, the issuance, promulgation, enforcement, or entry of any such Law or Order:

 

Section 11.3 Termination by Buyer. This Agreement may be terminated by Buyer at any time prior to the Closing:

 

(a) if Company shall have approved or adopted, or recommended the approval or adoption of, any Acquisition Proposal; or

 

(b) if there shall have been a breach of any representation, warranty, covenant, or agreement on the part of Company or Sellers set forth in this Agreement such that the conditions to the Closing of the Merger set forth in Section 9.1(a) or Section 9.1(b), as applicable, would not be satisfied and, in either such case, such breach is incapable of being cured by the End Date; provided, that Buyer shall have given Company at least 30 days written notice prior to such termination stating Buyer’s intention to terminate this Agreement pursuant to this Section 11.3(b); provided further, that Buyer shall not have the right to terminate this Agreement pursuant to this Section 11.3(b) if Buyer or Merger Sub is then in breach of any representation, warranty, covenant, or obligation hereunder that would cause any condition set forth in Section 9.2(a) or Section 9.2(b) not to be satisfied.

 

Section 11.4 Termination by Company. This Agreement may be terminated by Company at any time prior to the Closing if there shall have been a breach of any representation, warranty, covenant, or agreement on the part of Buyer or Merger Sub set forth in this Agreement such that the conditions to the Closing of the Merger set forth in Section 9.2(a) or Section 9.2(b), as applicable, would not be satisfied and, in either such case, such breach is incapable of being cured by the End Date; provided, that Company shall have given Buyer at least 30 days written notice prior to such termination stating Company’s intention to terminate this Agreement pursuant to this Section 11.4; provided further, that Company shall not have the right to terminate this Agreement pursuant to this Section 11.4 if Company is then in material breach of any representation, warranty, covenant, or obligation hereunder that would cause any condition set forth in Section 9.2(a) or Section 9.2(b) not to be satisfied:

 

55
 

 

Section 11.5 Notice of Termination; Effect of Termination. The party desiring to terminate this Agreement pursuant to this ARTICLE XI (other than pursuant to Section 11.1) shall deliver written notice of such termination to each other party hereto specifying with particularity the reason for such termination, and any such termination in accordance with this Section 11.5 shall be effective immediately upon delivery of such written notice to the other party. If this Agreement is terminated pursuant to ARTICLE XI, it will become void and of no further force and effect, with no liability on the part of any party to this Agreement (or any stockholder, member, director, officer, employee, agent, or Representative of such party) to any other party hereto, except: (a) this Section 11.5, Section 11.6, and ARTICLE XII (and any related definitions contained in any such Sections or Article), which shall remain in full force and effect; and (b) with respect to any liabilities or damages incurred or suffered by a party, to the extent such liabilities or damages were the result of fraud or the willful breach by another party of any of its representations, warranties, covenants, or other agreements set forth in this Agreement.

 

Section 11.6 Expenses. All Expenses incurred in connection with this Agreement and the transactions contemplated hereby will be paid by the party incurring such Expenses, except Buyer shall bear all expenses incurred in connection with: the preparation of the Company’s audited financial statements; and the preparation, filing and delivery of any current report filed on Form 8-K relating to the Merger and this Agreement.

 

Section 11.7 Amendment. At any time prior to the Effective Time, this Agreement may be amended or supplemented in any and all respects, by written agreement signed by each of the parties hereto.

 

Section 11.8 Extension; Waiver. At any time prior to the Effective Time, Buyer or Merger Sub, on the one hand, or Company, on the other hand, may: (a) extend the time for the performance of any of the obligations of the other party(ies); (b) waive any inaccuracies in the representations and warranties of the other party(ies) contained in this Agreement or in any document delivered under this Agreement; or (c) unless prohibited by applicable Law, waive compliance with any of the covenants, agreements, or conditions contained in this Agreement. Any agreement on the part of a party to any extension or waiver will be valid only if set forth in an instrument in writing signed by such party. The failure of any party to assert any of its rights under this Agreement or otherwise will not constitute a waiver of such rights.

 

ARTICLE XII
Miscellaneous

 

Section 12.1 Interpretation; Construction.

 

(a) The table of contents and headings herein are for convenience of reference only, do not constitute part of this Agreement and shall not be deemed to limit or otherwise affect any of the provisions hereof. Where a reference in this Agreement is made to a Section, Exhibit, Article, or Schedule, such reference shall be to a Section of, Exhibit to, Article of, or Schedule of this Agreement unless otherwise indicated. Unless the context otherwise requires, references herein: (i) to an agreement, instrument, or other document means such agreement, instrument, or other document as amended, supplemented, and modified from time to time to the extent permitted by the provisions thereof; and (ii) to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. Whenever the words “include,” “includes,” or “including” are used in this Agreement, they shall be deemed to be followed by the words “without limitation,” and the word “or” is not exclusive. The word “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and does not simply mean “if.” A reference in this Agreement to $ or dollars is to U.S. dollars. The definitions of terms herein shall apply equally to the singular and plural forms of the terms defined. The words “hereof,” “herein,” “hereby,” “hereto,” and “hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. References to “this Agreement” shall include Company Disclosure Letter and Buyer Disclosure Letter.

 

56
 

 

(b) The parties have participated jointly in negotiating and drafting this Agreement. In the event that an ambiguity or a question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provision of this Agreement.

 

Section 12.2 Governing Law. This Agreement and all Legal Actions (whether based on contract, tort, or statute) arising out of, relating to, or in connection with this Agreement or the actions of any of the parties hereto in the negotiation, administration, performance, or enforcement hereof, shall be governed by and construed in accordance with the internal laws of the State of New York without giving effect to any choice or conflict of law provision or rule (whether of the State of Nevada or any other jurisdiction) that would cause the application of Laws of any jurisdiction other than those of the State of New York.

 

Section 12.3 Submission to Jurisdiction. Each of the parties hereto irrevocably agrees that any Legal Action with respect to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and the rights and obligations arising hereunder brought by any other party hereto or its successors or assigns shall be brought and determined exclusively in the federal and state courts sitting in New York County of the State of New York. Each of the parties hereto agrees that mailing of process or other papers in connection with any such Legal Action in the manner provided in Section 12.5 or in such other manner as may be permitted by applicable Laws, will be valid and sufficient service thereof. Each of the parties hereto hereby irrevocably submits with regard to any such Legal Action for itself and in respect of its property, generally and unconditionally, to the personal jurisdiction of the aforesaid courts and agrees that it will not bring any Legal Action relating to this Agreement or any of the transactions contemplated by this Agreement in any court or tribunal other than the aforesaid courts. Each of the parties hereto hereby irrevocably waives, and agrees not to assert, by way of motion, as a defense, counterclaim, or otherwise, in any Legal Action with respect to this Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of any judgment in respect of this Agreement and the rights and obligations arising hereunder: (a) any claim that it is not personally subject to the jurisdiction of the above named courts for any reason other than the failure to serve process in accordance with this Section 12.3; (b) any claim that it or its property is exempt or immune from jurisdiction of any such court or from any legal process commenced in such courts (whether through service of notice, attachment prior to judgment, attachment in aid of execution of judgment, execution of judgment or otherwise); and (c) to the fullest extent permitted by the applicable Law, any claim that (i) the suit, action, or proceeding in such court is brought in an inconvenient forum, (ii) the venue of such suit, action, or proceeding is improper, or (iii) this Agreement, or the subject matter hereof, may not be enforced in or by such courts.

 

Section 12.4 Waiver of Jury Trial. EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES AND, THEREFORE, EACH SUCH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LEGAL ACTION ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY TO THIS AGREEMENT CERTIFIES AND ACKNOWLEDGES THAT: (A) NO REPRESENTATIVE OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT SEEK TO ENFORCE THE FOREGOING WAIVER IN THE EVENT OF A LEGAL ACTION; (B) SUCH PARTY HAS CONSIDERED THE IMPLICATIONS OF THIS WAIVER; (C) SUCH PARTY MAKES THIS WAIVER VOLUNTARILY; AND (D) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION 12.4.

 

57
 

 

Section 12.5 Notices. All notices, requests, consents, claims, demands, waivers, and other communications hereunder shall be in writing and shall be deemed to have been given upon the earlier of actual receipt or (a) when delivered by hand providing proof of delivery; (b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); or (c) on the date sent by email if sent during normal business hours of the recipient, and on the next Business Day if sent after normal business hours of the recipient. Such communications must be sent to the respective parties at the following addresses (or to such other Persons or at such other address for a party as shall be specified in a notice given in accordance with this Section 12.5):

 

If to Buyer, Merger Sub or Company (after the Closing), to:

 

  With a copy (which shall not constitute notice) to:
   
The Glimpse Group, Inc. Sichenzia Ross Ference LLP
15 West 38th Street, 9th Floor 1185 Avenue of the Americas, 31st Floor
New York, New York 10018 New York, New York 10036
Attention: Lyron Bentovim, President and Attention: Darrin Ocasio
Chief Executive Officer  
   
E-mail: Lyron@theglimpsegroup.com E-mail: dmocasio@srf.law

 

If to Company (before the Closing), to:

 

  With a copy (which shall not constitute notice) to:
   
Brightline Interactive, LLC Pillsbury Winthrop Shaw Pittman LLP
21745 Red Rum Drive, Suite 242 1200 Seventeenth Street NW
Ashburn, VA 20147 Washington, D.C. 20036-3006
Attention : Tyler Gates, CEO Attention: Steven Kaplan
E-mail: tyler@brightlineinteractive.com E-mail: steven.kaplan@pillsburylaw.com
   
If to Sellers’ Representative, to: With a copy (which shall not constitute notice):
   
Bruce Gates Pillsbury Winthrop Shaw Pittman LLP
221 South Yellowstone Street 1200 Seventeenth Street NW
Livingston, MT 59047 Washington, D.C. 20036-3006
E-mail : bruceagates@gmail.com Attention: Steven Kaplan
  E-mail: steven.kaplan@pillsburylaw.com

 

Section 12.6 Entire Agreement. This Agreement (including all exhibits, annexes, and schedules referred to herein), Company Disclosure Letter, the Buyer Disclosure Letter and the Ancillary Documents constitute the entire agreement among the parties with respect to the subject matter of this Agreement and supersede all other prior agreements and understandings, both written and oral, among the parties to this Agreement with respect to the subject matter of this Agreement. In the event of any inconsistency between the statements in the body of this Agreement, the Buyer Disclosure Letter, Company Disclosure Letter (other than an exception expressly set forth as such in the Buyer Disclosure Letter or Company Disclosure Letter) or an Ancillary Document, the statements in the body of this Agreement will control.

 

Section 12.7 No Third-Party Beneficiaries. Except as expressly provided herein, this Agreement is for the sole benefit of the parties hereto and their permitted assigns and respective successors and nothing herein is intended to or shall confer upon any other Person or entity any legal or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

 

58
 

 

Section 12.8 Severability. If any term or provision of this Agreement is invalid, illegal, or unenforceable in any jurisdiction, such invalidity, illegality, or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon such determination that any term or other provision is invalid, illegal, or unenforceable, the parties hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.

 

Section 12.9 Assignment. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and permitted assigns. Neither Buyer or Merger Sub, on the one hand, nor Company or Sellers on the other hand, may assign its or their rights or obligations hereunder without the prior written consent of the other parties, which consent shall not be unreasonably withheld, conditioned, or delayed. No assignment shall relieve the assigning party of any of its obligations hereunder.

 

Section 12.10 Remedies Cumulative. Except as otherwise provided in this Agreement, any and all remedies expressly conferred upon a party to this Agreement will be cumulative with, and not exclusive of, any other remedy contained in this Agreement, at Law, or in equity. The exercise by a party to this Agreement of any one remedy will not preclude the exercise by it of any other remedy.

 

Section 12.11 Disclosure Letters. Each of the Company Disclosure Letter and Buyer Disclosure Letter has been arranged, for purposes of convenience only, in separate sections and subsections corresponding to the Sections and subsections of ARTICLE IV, ARTICLE V and ARTICLE VI, as applicable. Any information set forth in any subsection of the Company Disclosure Letter or Buyer Disclosure Letter shall be deemed to be disclosed and incorporated by reference in each of the other subsections of such Disclosure Letter as though fully set forth in such other subsections (whether or not specific cross-references are made) to the extent it is reasonably apparent that such disclosure also qualifies or applies to such other subsections. No reference to or disclosure of any item or other matter in the Company Disclosure Letter or Buyer Disclosure Letter shall be construed, in and of itself, as an admission or indication that such item or other matter is material or that such item or other matter is required to be referred to or disclosed in such Disclosure Letter. The information set forth in the Company Disclosure Letter or Buyer Disclosure Letter is disclosed solely for purposes of this Agreement, and no information set forth therein shall be deemed, in and of itself, to be an admission by any party hereto to any third party of any matter whatsoever, including any violation of Law or breach of any Contract.

 

Section 12.12 Specific Performance.

 

(a) The parties hereto agree that irreparable damage would occur if any provision of this Agreement were not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement or to enforce specifically the performance of the terms and provisions hereof in any federal or state court sitting in New York County of the State of New York , in addition to any other remedy to which they are entitled at Law or in equity.

 

(b) Each party further agrees that: (i) no such party will oppose the granting of an injunction or specific performance as provided herein on the basis that the other party has an adequate remedy at law or that an award of specific performance is not an appropriate remedy for any reason at law or equity; (ii) no such party will oppose the specific performance of the terms and provisions of this Agreement; and (iii) no other party or any other Person shall be required to obtain, furnish, or post any bond or similar instrument in connection with or as a condition to obtaining any remedy referred to in this Section 12.12, and each party irrevocably waives any right it may have to require the obtaining, furnishing, or posting of any such bond or similar instrument.

 

59
 

 

Section 12.13 Counterparts; Effectiveness. This Agreement may be executed in any number of counterparts, all of which will be one and the same agreement. This Agreement will become effective when each party to this Agreement will have received counterparts signed by all of the other parties.

 

Section 12.14 No Recourse Against Third Parties. Notwithstanding any other provision of this Agreement, except to the extent otherwise agreed in writing, no claim (whether at law or in equity, whether in contract, tort, statute or otherwise) may be asserted by Company, the Sellers, Buyer, Merger Sub, any Affiliate of any of the foregoing (including, with respect to Buyer, from and after the Closing, Company) or any Person claiming by, through or for the benefit of any of them, against any Person who is not party to this Agreement, including any equity holders, partners, members, controlling persons, directors, officers, employees, incorporators, managers, agents, Representatives, or Affiliates of Buyer or the Company, Seller or the heirs, executors, administrators, successors or assigns of any of the foregoing (or any Affiliate of any of the foregoing) that is not a party to this Agreement (each a “Non-Party Affiliate”) with respect to matters arising in whole or in part out of, related to, based upon, or in connection with the business of the Company, the Company, this Agreement, the Ancillary Documents or their subject matter or the transactions contemplated hereby or thereby or with respect to any actual or alleged inaccuracies, misstatements or omissions with respect to information furnished by or on behalf of the Company or any Non-Party Affiliate in any way concerning the business of the Company, the Company, this Agreement or its subject matter or the transactions contemplated hereby.

 

Section 12.15 Provision Respecting Legal Representation. Each of the parties to this Agreement hereby agrees, on its own behalf and on behalf of its directors, managers, members, partners, officers, employees and Affiliates, that Pillsbury Winthrop Shaw Pittman LLP is serving as counsel to the Company and the Sellers’ Representative in connection with the negotiation, preparation, execution and delivery of this Agreement prior to Closing and the consummation of the transactions contemplated hereby, and that, following Closing and consummation of the transactions contemplated hereby, Pillsbury Winthrop Shaw Pittman LLP (or any successor) may serve as counsel to the Sellers and the Sellers’ Representative (individually and collectively, the “Seller Group” (which will no longer include the Company)) or any director, manager, member, partner, officer, employee, Affiliate or Representative of the Seller Group (which will no longer include the Company), in connection with any litigation, claim or obligation arising out of or relating to this Agreement or the transactions contemplated by this Agreement notwithstanding such representation, and each of the parties hereto hereby consents thereto and waives any conflict of interest arising therefrom, and each of such parties shall cause any Affiliate thereof to consent to waive any conflict of interest arising from such representation. In addition, all communications involving attorney-client confidences between any Sellers, the Sellers’ Representative and their respective Affiliates which pertain to the negotiation, documentation and consummation of the transactions contemplated hereby shall be deemed to be attorney-client confidences that belong solely to such Sellers, the Sellers’ Representative and their respective Affiliates (and not the Company). Accordingly, the Company shall not have access to any such communications, or to the files of Pillsbury Winthrop Shaw Pittman LLP relating to such engagement. Without limiting the generality of the foregoing, upon and after the Closing, (a) the Sellers, the Sellers’ Representative and their respective Affiliates (and not the Company) shall be the sole holders of the attorney-client privilege with respect to such engagement, and the Company shall not be the holders thereof, (b) to the extent that files of Pillsbury Winthrop Shaw Pittman LLP in respect of such engagement constitute property of the client, only the Sellers, the Sellers’ Representative and their respective Affiliates (and not the Company) shall hold such property rights, and (c) Pillsbury Winthrop Shaw Pittman LLP shall have no duty whatsoever to reveal or disclose any such attorney-client communications or files to the Company by reason of any attorney-client relationship between Pillsbury Winthrop Shaw Pittman LLP and the Company.

 

60
 

 

Section 12.16 Sellers’ Representative.

 

(a) Appointment. By executing this Agreement, each Seller shall be deemed to have constituted and appointed, effective from and after the Effective Time, Bruce Gates as agent and attorney-in-fact for and on behalf of each Seller to act as the Sellers’ Representative under this Agreement, including in respect of the following matters:

 

(i) giving and receiving any notice or instruction permitted or required to be given to or received by any Seller under this Agreement;

 

(ii) coordinating the common defense of all indemnity claims against the Sellers by any Indemnified Party pursuant to this Agreement (a “Indemnity Claim”),

 

(iii) consenting to, compromising or settling all Indemnity Claims,

 

(iv) conducting negotiations with Buyer and its Representatives regarding such Indemnity Claims,

 

(v) dealing with Buyer under this Agreement with respect to all matters arising under this Agreement, and

 

(vi) engaging counsel, accountants or other advisors in connection with the foregoing matters.

 

(b) Authorization. Each Seller shall authorize the Sellers’ Representative, on such Seller’s behalf, to:

 

(i) receive all notices or documents given or to be given to any of the Sellers by Buyer or the Surviving Entity pursuant hereto or in connection herewith and to receive and accept service of legal process in connection with any suit or proceeding arising under this Agreement;

 

(ii) engage counsel, and such accountants and other advisors for any of the Sellers and incur such other expenses on behalf of any of the Sellers in connection with this Agreement and the transactions contemplated hereby or thereby as the Sellers’ Representative may in its sole discretion deem appropriate;

 

(iii) take such action on behalf of any of the Sellers as the Sellers’ Representative may in its sole discretion deem appropriate in respect of: (A) taking such other action as the Sellers’ Representative is authorized to take under this Agreement; (B) receiving all documents or certificates and making all determinations, on behalf of any of the Sellers, required under this Agreement; and (C) all such action as may be necessary after the Closing Date to carry out any of the transactions contemplated by this Agreement, including, the defense and/or settlement of any claims for which indemnification is sought pursuant to ARTICLE X and any waiver of any obligation of Buyer or the Surviving Entity.

 

61
 

 

(c) Decisions. All actions, decisions and instructions of the Sellers’ Representative shall be conclusive and binding upon all of the Sellers and such Seller’s successors as if expressly confirmed and ratified in writing by such Seller and no Seller shall have any claim or cause of action against the Sellers’ Representative, and the Sellers’ Representative shall have no liability to any Seller, for any action taken, decision made or instruction given by the Sellers’ Representative in connection with this Agreement, except in the case of its own gross negligence or willful misconduct. The Sellers shall severally and not jointly (in accordance with their Pro Rata Portion), indemnify and hold harmless Sellers’ Representative from and against, compensate it for, reimburse it for and pay any and all losses, liabilities, claims, actions, damages, fees and expenses, including reasonable attorneys’ fees and disbursements, arising out of and in connection with its activities as Sellers’ Representative under this Agreement (the “Representative Losses”), in each case as such Representative Loss is suffered or incurred; provided, that in the event it is finally adjudicated that a Representative Loss or any portion thereof was primarily caused by the gross negligence or willful misconduct of the Sellers’ Representative, then Sellers’ Representative shall reimburse the Sellers the amount of such indemnified Representative Loss attributable to such gross negligence or intentional misconduct. The Sellers’ Representative may engage attorneys, accountants, investment bankers, advisors, consultants and clerical personnel and obtain such other professional and expert assistance, and maintain such records, as the Sellers’ Representative may deem necessary or desirable and incur other out-of-pocket expenses related to performing its services hereunder (which shall, for the avoidance of doubt, constitute Representative Losses).

 

(d) Confidentiality. The Sellers’ Representative (i) shall not disclose to any other Person any information provided to it by Buyer or any of its Representatives in connection with this Agreement and the transactions contemplated except (a) to the Sellers’ Representative’s advisors, officers, directors and employees, so long as such parties are informed of the confidential nature of such information, (b) as required by applicable Law, (c) in connection with the enforcement of any rights of Sellers’ Representative hereunder or otherwise related to the transactions contemplated herein and (d) to the extent that such information can be shown to have been in the public domain through no fault of the Sellers’ Representative and (ii) shall not use such information other than solely in its capacity as Sellers’ Representative hereunder.

 

(e) Successor Sellers’ Representative. If the Sellers’ Representative shall die, become disabled, resign or otherwise be unable to fulfill its responsibilities hereunder, the Sellers who in the aggregate held at least a majority of the Company Membership Units immediately prior to the Effective Time shall appoint a new Sellers’ Representative as soon as reasonably practicable by written consent by sending notice and a copy of the duly executed written consent appointing such new Sellers’ Representative to Buyer and the Surviving Entity. Such appointment will be effective upon the later of the date indicated in the consent or the date such consent is received by Buyer and the Surviving Entity. Sellers who in the aggregate held at least a majority of the Company Membership Units immediately prior to the Effective Time shall have the right at any time to remove the then-acting Sellers’ Representative and to appoint a successor Sellers’ Representative; provided, however, that neither such removal of the then acting Sellers’ Representative nor such appointment of a successor Sellers’ Representative shall be effective until the delivery to Buyer and the Surviving Entity of executed counterparts of a writing signed by each such Seller with respect to such removal and appointment, together with an acknowledgment signed by the successor Sellers’ Representative appointed in such writing that it, he or she accepts the responsibility of successor Sellers’ Representative and agrees to perform and be bound by all of the provisions of this Agreement applicable to the Sellers’ Representative. Each successor Sellers’ Representative shall have all of the power, authority, rights, privileges and obligations conferred by this Agreement upon the original Sellers’ Representative, and the term “Sellers’ Representative” as used herein shall be deemed to include any interim or successor Sellers’ Representative.

 

[Signature Page Follows]

 

62
 

 

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed as of the date first written above by their respective officers thereunto duly authorized.

 

  THE GLIMPSE GROUP, INC.
   
  By: /s/ Lyron L. Bentovim
    Lyron L. Bentovim
    Chief Executive Officer
     
  GLIMPSE MERGER SUB, LLC
   
  By: /s/ Lyron L. Bentovim
    Lyron L. Bentovim
    President

 

[Signature Page to Agreement and Plan of Merger]

 

 
 

 

  BRIGHTLINE INTERACTIVE, LLC
   
  By: /s/ Tyler Gates
    Tyler Gates
    Chief Executive Officer
     
  SELLERS:
   
  By: /s/ Erik Muendel
    Erik Muendel
     
  By: /s/ Bradley Nierenberg
    Bradley Nierenberg, as Trustee of the Bradley S. Nierenberg Trust
     
  By: /s/ Bruce Gates
    Bruce Gates
     
  By: /s/ Joyce Gates
    Joyce Gates
     
  By: /s/ Barton Gates
    Barton Gates
     
  By: /s/ Tyler Gates
    Tyler Gates
     
  SELLERS’ REPRESENTATIVE:
   
  By: /s/ Bruce Gates
    Bruce Gates

 

[Signature Page to Agreement and Plan of Merger]

 

 

 

 

Exhibit 21.1

 

Subsidiaries of the Registrant

 

Name of Subsidiary   Incorporation State
Adept Reality, LLC (dba Adept Reality Learning)   Nevada
Qreal, LLC (dba QReal)   Nevada
KreatAR, LLC (dba PostReality)   Nevada
Foretell Studios, LLC (dba Foretell Reality)   Nevada
In-It, VR LLC (dba Mezmos, in-active)   Nevada
D6 VR, LLC   Nevada
Immersive Health Group, LLC   Nevada
Number 9, LLC (dba Pagoni VR)   Nevada
Early Adopter, LLC   Nevada
MotionZone, LLC (in-active)   Nevada
Glimpse Group Yazilim ve ARGE Ticaret Anonim Sirketi (Glimpse Turkey)   Turkey
Brightline Interactive, LLC   Nevada
XR Terra, LLC   Nevada
Sector 5 Digital, LLC   Nevada
PuploAR, LLC (Subsidiary of Qreal, LLC)   Nevada

 

 

 

 

Exhibit 31.1

 

Certification of

Principal Executive Officer

of The Glimpse Group, Inc.

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Lyron Bentovim, certify that:

 

1. I have reviewed this annual report on Form 10-K of The Glimpse Group, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:
   
  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is likely to materially affect, the registrant’s internal control over financial reporting; and
     
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):
   
  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: September 28, 2022 By: /s/ Lyron Bentovim
    Lyron Bentovim
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

Exhibit 31.2

 

Certification of

Principal Financial Officer

of The Glimpse Group, Inc.

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Maydan Rothblum, certify that:

 

1. I have reviewed this annual report on Form 10-K of The Glimpse Group, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f) for the registrant and we have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that has materially affected, or is likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: September 28, 2022 By: /s/ Maydan Rothblum
    Maydan Rothblum
    Chief Financial Officer
    (Principal Financial Officer)

 

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of The Glimpse Group, Inc. (the “Company”) on Form 10-K for the fiscal year ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to such officer’s knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

 

Dated: September 28, 2022 By: /s/ Lyron Bentovim
    Lyron Bentovim
    Chief Executive Officer
    (Principal Executive Officer)

 

Dated: September 28, 2022 By: /s/ Maydan Rothblum
    Maydan Rothblum
    Chief Financial Officer
    (Principal Financial Officer)